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Abstract 
 
Hereditary spastic paraplegia (HSP) was first described in the late 1800s and has since 
become a term used to describe this relatively large, clinically and genetically diverse 
group of inherited neurodegenerative or neurodevelopmental disorders. HSPs are 
characterised by progressive lower limb spasticity and pyramidal weakness, caused 
by genetic mutations. This defining clinical feature is thought to be due to the 
progressive, length-dependent neuronal degeneration or axonopathy, which 
predominantly involves the lateral corticospinal tracts. Although unified by their 
defining clinical feature, HSPs are some of the most genetically diverse diseases. To 
date, 78 spastic gait disease-loci (SPG1-78) and 61 corresponding spastic paraplegia 
genes have been identified, and these are likely to increase further still.  
 
A critical step towards unravelling the complex molecular relationships in living 
systems is the mapping of protein-protein interactions. Proteins with similar 
functions and cellular localisations tend to cluster together within these networks, 
with the majority sharing at least one function. Proteins that interact with known 
disease-causing HSP proteins may in some cases also acquire mutations that 
contribute to specific HSP-related phenotypes. Therefore, identification of proteins 
that interact with known HSP proteins, or exist in common molecular complexes, 
may provide new insight into the molecular mechanisms fundamental to the 
pathogenesis of this group of disorders.  
 
The sequence-verified HSP ORFs generated were used to construct a collection of 
Y2H HSP bait and prey clones. The ‘traditional’ yeast two-hybrid system was then 
used to test a number of predicted binary interactions, using high-throughput 
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targeted assays, whilst novel HSP interaction partners were identified using high-
throughput library screens. 
 
Membrane-associated proteins are one of the most biologically important protein 
classes, with key roles in various cellular processes including cell signalling, molecular 
transport, metabolism and cell structure maintenance. However, detection of 
protein-protein interactions (PPIs) of membrane proteins is challenging, due to their 
hydrophobic nature and non-nuclear localisation, making them difficult to analyse 
using conventional interaction detection methods. As there is a significant number 
of membrane-associated HSP proteins, sequence-verified HSP ORFs were used to 
generate a collection of membrane yeast two-hybrid (MYTH) HSP bait clones. The 
MYTH system was used to investigate potentially novel interaction profiles for each 
of the membrane-associated HSP bait constructs, using the optimised high-
throughput MYTH library screen approach. 
 
In total, 365 novel binary HSP interactions were identified in this study, increasing 
the complexity of the HSP interactome. This high-density, comprehensive HSP 
interactome can be used to inform future hypothesis-driven research, looking at the 
physiological mechanisms and functional relevance of these interactions, providing 
a greater understanding of the pathogenic mechanisms of HSP, as well as for the 
development of new strategies for therapeutic intervention.  
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Chapter 1: Introduction 
 
1.1    Introduction 
 
In humans, voluntary movements rely on the multi-synaptic pathways of the central 
nervous system (CNS) that extend from the cerebral motor cortex to the 
neuromuscular junctions thereby innervating the skeletal muscle. This is known as 
the pyramidal motor system (Blackstone, 2012), and it has two parts. In the first, 
axons of the upper motor neurons (neurons of the cerebral motor cortex) pass 
through the medullary pyramids, where most decussate in the caudal medulla to 
form the lateral corticospinal tract of the spinal cord (Soderblom and Blackstone, 
2006). These corticospinal axons are able to form synapses either directly or 
indirectly (via spinal interneurons) with the lower motor neurons in the anterior horn 
of the spinal cord (Blackstone, O’Kane and Reid, 2011; Blackstone, 2012). In the 
second, axons originating from the lower motor neurons of the spinal cord terminate 
in specialised synapses at neuromuscular junctions throughout the body, to mediate 
skeletal muscle contraction (Blackstone, 2012). 
 
The distances covered by the upper and lower motor neurons are extremely long, 
some of the longest in the CNS, with axons reaching up to 1 m in length (Soderblom 
and Blackstone, 2006; Blackstone, O’Kane and Reid, 2011). This length permits the 
rapid relay of action potentials which mediate voluntary movement, with the 
additional complex intracellular machineries which are required for the proper 
sorting and distribution of proteins, lipids, organelles and other molecules 
(Blackstone, O’Kane and Reid, 2011). These machineries exploit the intricate 
cytoskeletal scaffold, which serves as a molecular ‘rail system’ along which motor 
proteins can mediate the selective transport of components throughout the cell. This 
active transport of proteins and other molecules is essential for neuronal function 
and survival, as most of the proteins required in the nerve terminals and axons need 
to be transported from the cell body (Erlich et al., 2011). Axonal transport 
machineries are highly dependent upon microtubules, which can function as 
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polarised tracks with their plus ends orientated towards the axon terminal 
(Blackstone, 2012). 
 
Not surprisingly, these long axons are particularly vulnerable to length-dependent 
defects in cellular processes such as trafficking, transport and cytoskeletal 
organisation. All of which have been shown to affect axonal development and 
maintenance (Soderblom and Blackstone, 2006; Blackstone, 2012), giving rise to a 
host of neurological disorders, including the inherited Mendelian disorder, 
hereditary spastic paraplegias (HSPs). 
 
1.2    Hereditary Spastic Paraplegias (HSPs) 
 
Hereditary spastic paraplegia (HSP) was first described in the late 1800s and has since 
become a term used to describe this relatively large, clinically and genetically diverse 
group of inherited neurodegenerative or neurodevelopmental disorders. Hereditary 
spastic paraplegias (HSPs) are characterised by progressive lower limb spasticity and 
pyramidal weakness, caused by genetic mutations (Harding, 1983). This defining 
clinical feature is thought to be due to the progressive, length-dependent neuronal 
degeneration or axonopathy, which predominantly involves the lateral corticospinal 
tracts, and is often more severe at the distal ends (DeLuca, Ebers and Esiri, 2004). 
 
Although unified by their defining clinical feature, HSPs are some of the most 
genetically diverse diseases. To date, 78 spastic gait disease-loci (SPG1-78) and 61 
corresponding spastic paraplegia genes have been identified (Klebe, Stevanin and 
Depienne, 2015; de Souza et al., 2016). As shown in Table 1.1, this number does not 
include those genes involved in complex forms not referred to as HSP, such as 
mitochondrial genes MT-ATP6 (Verny et al., 2011) and MT-TI (Corona et al., 2002), 
or other causative genes that are not yet part of the spastic paraplegia gene (SPG) 
classification system, such as LYST (Shimazaki et al., 2014) and CCT5 (Bouhouche et 
al., 2005). 
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Inheritance and clinical features of each HSP form are described in Table 1.2, with 
the age of symptom onset varying greatly, from early childhood to late adulthood 
(Salinas et al., 2008; Schüle et al., 2016). It depends on the underlying genetic defect, 
but can also vary significantly even between family members with the same mutation 
(Soderblom and Blackstone, 2006; Klebe, Stevanin and Depienne, 2015). 
 
Table 1.1 
SPG Gene Gene ID Locusa Referencesb 
SPG1 L1CAM 3897 Xq28 Jouet et al., 1994 
SPG2 PLP1 5354 Xq22.2 Saugier-Veber et al., 1994 
SPG3 ATL1 51062 14q22.1 Zhao et al., 2001 
SPG4 SPAST 6683 2p22.3 Hazan et al., 1999 
SPG5A CYP7B1 9420 8q12.3 Tsaousidou et al., 2008 
SPG6 NIPA1 123606 15q11.2 Rainier et al., 2003 
SPG7 SPG7 6687 16q24.3 Casari et al., 1998 
SPG8 WASHC5 9897 8q24.13 Valdmanis et al., 2007 
SPG9 SPG9 9193 10q24.1 Seri et al., 1999, Panza et al., 2016 
SPG10 KIF5A 3798 12q13.3 Reid et al., 2002 
SPG11 SPG11 80208 15q21.1 Stevanin et al., 2007 
SPG12 RTN2 6253 19q13.32 Montenegro et al., 2012 
SPG13 HSPD1 3329 2q33.1 Hansen et al., 2002 
SPG14 SPG14 57309 3q27-q28 Vazza et al., 2000 
SPG15 ZFYVE26 23503 14q24.1 Hanein et al., 2008 
SPG16 SPG16 57760 Xq11.2 Steinmuller et al., 1997 
SPG17 BSCL2 26580 11q12.3 Windpassinger et al., 2004 
SPG18 ERLIN2 11160 8p11.23 Alazami et al., 2011 
SPG19 SPG19 140907 9q33-q34 Valente et al., 2002 
SPG20 SPART 23111 13q12.3 Patel et al., 2002 
SPG21 SPG21 51324 15q22.31 Simpson et al., 2003 
SPG22 SLC16A2 6567 Xq13.2 Schwartz et al., 2006 
SPG23 SPG23 353293 1q24-q32 Blumen et al., 2003 
SPG24 SPG24 338090 13q14 Hodgkinson et al., 2002 
SPG25 SPG25 387583 6q23-24.1 Zortea et al., 2002 
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SPG26 B4GALNT1 2583 12q13.3 Boukhris et al., 2013 
SPG27 SPG27 414886 10q22.1-q24.1 Meijer et al., 2004, Ribaï et al., 2006 
SPG28 DDHD1 80821 14q22.1 Tesson et al., 2012 
SPG29 SPG29 619379 1p31.1-21.1 Orlacchio et al., 2005 
SPG30 KIF1A 547 2q37.3 Erlich et al., 2011, Klebe et al., 2012 
SPG31 REEP1 65055 2p11.2 Zuchner et al., 2006 
SPG32 SPG32 724107 14q12-q21 Stevanin et al., 2007 
SPG33 ZFYVE27 118813 10q24.2 Mannan et al., 2006 
SPG34 SPG34 724110 Xq24-q25 Macedo-Souza et al., 2008 
SPG35 FA2H 79152 16q23.1 Dick et al., 2010 
SPG36 SPG36 791228 12q23-24 Schüle et al., 2009 
SPG37 SPG37 100049159 8p21.1-q13.3 Hanein et al., 2007 
SPG38 SPG38 100049707 4p16-p15 Orlacchio et al., 2008 
SPG39 PNPLA6 10908 19p13.2 Rainier et al., 2008 
SPG40 - - - Subramony et al., 2009 
SPG41 SPG41 100359402 11p14.1-11p.2 Zhao et al., 2008 
SPG42 SLC33A1 9197 3q25.31 Lin et al., 2008 
SPG43 C19orf12 83636 19p13.11-q12 Landoure et al., 2013 
SPG44 GJC2 57165 1q42.13 Orthmann-Murphy et al., 2009 
SPG45 SPG45 100322879 10q24.3-q25.1 
Dorsun et al., 2009,  
 
SPG46 GBA2 57704 9p13.3 Martin et al., 2013 
SPG47 AP4B1 10717 1p13.2 Abou Jamra et al., 2011 
SPG48 AP5Z1 9907 7p22.1 Slabicki et al., 2010 
SPG49 TECPR2 9895 4q25 Oz-Levi et al., 2012 
SPG50 AP4M1 9179 7q22.1 Verkerk et al 2009 
SPG51 AP4E1 23431 15q21.2 Abou Jamra et al., 2011,  Moreno-De-Luca et al., 2011 
SPG52 AP4S1 11154 14q12 Abou Jamra et al., 2011 
SPG53 VPS37A 137492 8p22 Zivony-Elboum et al., 2012 
SPG54 DDHD2 23259 8p11.23 Schuurs-Hoeijmakers et al., 2012 
SPG55 C12orf65 91574 12q24.31 Shimazaki et al., 2012 
SPG56 CYP2U1 113612 14q32.31 Oz-Levi et al., 2012 
SPG57 TFG 10342 3q12.2 Ishiur et al., 2012, Beetz et al., 2013 
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SPG58 KIF1C 10749 17p13.2 Novarino et al., 2014,  Dor et al., 2014 
SPG59 USP8 9101 15q21.2 Novarino et al., 2014 
SPG60 WDR48 57599 3p22.2 Novarino et al., 2014 
SPG61 ARL6IP1 23204 16p12.3 Novarino et al., 2014 
SPG62 ERLIN1 10613 10q24.31 Novarino et al., 2014 
SPG63 AMPD2 271 1p13.3 Novarino et al., 2014 
SPG64 ENTPD1 953 10q24.1 Novarino et al., 2014 
SPG65 NT5C2 22978 10q24.32-q24.33 Novarino et al., 2014 
SPG66 ARSI 340075 5q32 Novarino et al., 2014 
SPG67 PGAP1 80055 2q33.1 Novarino et al., 2014 
SPG68 FLRT1 23769 11q13.1 Novarino et al., 2014 
SPG69 RAB3GAP2 25782 1q31 Novarino et al., 2014 
SPG70 MARS 4141 12q13.3 Novarino et al., 2014 
SPG71 ZFR 51663 5p13.3 Novarino et al., 2014 
SPG72 REEP2 51308 5q31.2 Esteves et al., 2014 
SPG73 CPT1C 126129 19q13.33 Carrasco et al., 2013, Rinaldi et al., 2015 
SPG74 IBA57 200205 1q42.13 Lossos et al., 2015 
SPG75 MAG 4099 19q13.1 Novarino et al., 2014,  Lossos et al., 2015 
SPG76 CAPN1 823 11q13.1 Gan-Or et al., 2016 
SPG77 FARS2 10667 6p25.1 Yang et al., 2016 
SPG78 ATP13A2 23400 1p36.13 Estrada-Cuzcano et al., 2017 
- AFG3L2 10939 18p11.21 Koppen et al., 2007,  Di Bella et al., 2010 
- ALS2 57679 2q33.1 Eymard-Pierre et al., 2002,  Rowland 2005, Daud et al., 2016 
- BICD2 23299 9q22.32 Oates et al., 2013,  Novarino et al., 2014 
- CCT5 22948 5p15.2 Bouhouche et al., 2006 
- ELOVL4 6785 6q14.1 Aldahmesh et al., 2011 Fink, 2013 
- EXOSC3 51010 9p13.2 Zanni et al., 2013, Halevy et al., 2014 
- RETREG1 54463 5p15.1 Aydinlar et al., 2014 
- GAD1 2571 2q31.1 McHale et al., 1999,  Lynex et al., 2004 
- GJA1 2697 6q22.31 Paznekas et al., 2003 
- HACE1 57531 6q16.3 Hollstein et al., 2015 
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- IFIH1 64135 2q24.2 Crow et al., 2014 
- KANK1 23189 9p24.3 Novarino et al., 2014 
- KCNA2 3737 1p13.3 Helbig et al., 2016 
- KIDINS220 57498 2p25.1 Josifova et al., 2016 
- LYST 1130 1q42.3 Shimazaki et al., 2014 
- ATP6 4508 - Verny et al., 2011 
- ND4 4538 - Clarençon et al., 2006,  Sgobbi de Souza et al., 2016 
- TRNI 4565 - Corona et al., 2002 
- COX3 4514 - Tiranti et al., 2000,  Sgobbi de Souza et al., 2016 
- TPP1 1200 11p15.4 Kara et al., 2016 
- VCP 7415 9p13.3 De Bot et al., 2012 
 
Table 1.1. List of human HSP loci and genes. HSP genes are listed by spastic gait 
disease-loci (SPG), numbered sequentially based on the order of locus discovery 
(Fink, 2013). HSP genes not part of the SPG classification system are listed 
alphabetically. Entrez Gene IDs were obtained from the NCBI database (Maglott et 
al., 2007) and are the most updated identifiers for the corresponding genes at the 
time of submission.  
a Loci from OMIM (http://www.ncbi.nlm.nih.gov/omim/) 
b Locus/gene discovery association with HSP 
 
1.2.1 Clinical Classification 
 
The clinical classification of HSPs as “pure” or “complicated” was based on the 
description by Anita Harding in 1983. According to this, HSPs are classified based on 
the absence (pure) or presence (complicated) of any neurological and/or non-
neurological features, which arise in addition to the spastic paraplegia phenotype, in 
the absence of any co-existing diseases (Harding, 1983; Fink, 2013; Noreau, Dion and 
Rouleau, 2014). These additional features are also shown in Table 1.2, and include 
neurological manifestations such as, cerebellar dysfunction (ataxia, nystagmus, 
tremor); axonal or demyelinating peripheral neuropathy (dysautonomia and sensory 
disturbances); cognitive impairment (dementia and mental retardation/intellectual 
disability); epilepsy; extrapyramidal features (Parkinsonism, chorea, dystonia); brain 
and spine MRI abnormalities (including mild white matter changes, thin corpus 
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callosum, spinal cord atrophy, brain iron accumulation, hydrocephalus, and 
cerebellar atrophy) (Fink, 2013; Novarino et al., 2014; Klebe, Stevanin and Depienne, 
2015; de Souza et al., 2016). The extensive heterogeneous non-neurological 
manifestations include, ophthalmological abnormalities (cataracts, optic 
neuropathy, optic atrophy, macular degeneration); dysmorphic features 
(microcephaly, macrocephaly, facial dysmorphism, short stature); and orthopaedic 
abnormalities (scoliosis, hip dislocation, foot deformities) (Lo Giudice et al., 2014; 
Klebe, Stevanin and Depienne, 2015; de Souza et al., 2016). 
 
1.2.2 Genetic Classification 
 
All modes of Mendelian inheritance (autosomal dominant, autosomal recessive and 
X-linked), and the rarer non-Mendelian mitochondrial maternal inheritance have also 
been described for HSPs, as shown in Table 1.2 (Finsterer et al., 2012; Lo Giudice et 
al., 2014; Klebe, Stevanin and Depienne, 2015). Autosomal recessive HSP (AR-HSP) is 
the most common mode of inheritance in HSP, and is even more common in 
consanguineous families and non-European populations (de Souza et al., 2016), with 
mutations in the SPG11 (15q21.1) and SPG15 (14q24.1) genes being the most 
common causes of AR-HSP (Goizet et al., 2009; Siri et al., 2010; Pensato et al., 2014). 
Moreover, ‘complicated’ forms of HSP tend to be autosomal recessive (Salinas et al., 
2008; Fink, 2013), while ‘pure’ forms of HSP tend to be autosomal dominant (AD), 
with mutations in genes encoding spastin, atlastin and REEP1 accounting for an 
estimated 50 % of all AD-HSP cases (Finsterer et al., 2012). 
 
Autosomal Dominant (AD) HSPs 
Thus far, 26 genetic SPG loci have been identified for AD-HSP, with only 19 known 
corresponding genes. There are 7 AD-HSP loci, namely SPG19 (Valente et al., 2002), 
SPG29 (Orlacchio et al., 2005), SPG36 (Schule et al., 2009), SPG37 (Hanein et al., 
2007), SPG38 (Orlacchio et al., 2008), SPG40 (Subramony et al., 2009) and SPG41 
(Zhao et al., 2008), with unidentified genes associated with both pure and 
complicated forms of HSP (Table 1.1 and 1.2).
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Table 1.2 
SPG 
Gene 
Inheritance 
Age of onset 
Phenotype 
Additional features 
SPG1 
L1CAM
 
X-linked 
EO 
C 
M
ental retardation, aphasia, shuffling gait, adducted thum
bs, hydrocephalus, ACC 
SPG2 
PLP1 
X-linked 
VO 
P or C 
Seizures, m
ental retardation, nystagm
us, ataxia, W
M
Ls, PNP 
SPG3A 
ATL1 
AD 
EO 
P or C 
Low
er lim
b m
uscle atrophy, seizures, ataxia, optic atrophy, spasticity in the upper 
lim
bs, sensorim
otor axonal neuropathy, cognitive and cranial nerve im
pairm
ent, 
intellectual disability, pes cavus, TCC 
SPG4 
SPAST 
AD 
VO 
P or C 
Cognitive decline, epilepsy, ataxia, psychosis, upper lim
b spasticity, pes cavus, 
posterior fossa abnorm
alities, PNP, hand trem
or, W
M
Ls, am
yotrophy of sm
all 
hand m
uscles 
SPG5A 
CYP7B1 
AR 
VO 
P or C 
Optic atrophy, W
M
Ls, cerebellar ataxia 
SPG6 
NIPA1 
AD 
TO 
P or C 
Idiopathic generalized epilepsy (IGE), dysarthria, PNP, facial dystonia, atrophy of 
the sm
all hand m
uscles and upper lim
bs spasticity, pes cavus 
SPG7 
SPG7 
AR 
VO 
P or C 
Cerebellar signs, cerebellar atrophy, PNP, optic atrophy, supranuclear palsy, 
cognitive im
pairm
ent of attention and executive functions, TCC, scoliosis, pes 
cavus 
SPG8 
W
ASHC5 
AD 
AO 
P 
- 
SPG9 
SPG9 
AD 
TO 
C 
Cataracts, m
otor neuropathy, skeletal abnorm
alities, gastroesophageal reflux 
SPG10 
KIF5A 
AD 
EO 
P or C 
Distal am
yotrophy in the upper extrem
ities, cognitive decline, PNP, 
dysautonom
ia, parkinsonism
, deafness, retinitis pigm
entosa 
SPG11 
SPG11 
AR 
VO 
C 
Cerebellar signs, PNP, W
M
Ls, cerebellar atrophy, TCC, seizures, cognitive decline, 
abnorm
al eye signs, am
yotrophy, parkinsonism
, m
aculopathy, action trem
or, 
m
ental retardation, upper lim
bs w
eakness 
SPG12 
RTN2 
AD 
EO 
P 
- 
SPG13 
HSPD1 
AD 
VO 
P or C 
Dystonia 
SPG14 
SPG14 
AR 
AO 
C 
M
otor PNP, m
ental retardation 
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SPG15 
ZFYVE26 
AR 
EO 
C 
Pigm
entary retinopathy, cerebellar signs, PNP, am
yotrophy, seizures, m
ental 
retardation, TCC 
SPG16 
SPG16 
X-linked 
EO 
P or C 
Aphasia, nystagm
us, m
ental retardation 
SPG17 
BSCL2 
AD 
TO 
C 
Am
yotrophy of sm
all hand and feet m
uscles, low
er m
otor neuron disease 
SPG18 
ERLIN2 
AR 
EO 
C 
Epilepsy, m
ental retardation, congenital hip dislocation, m
ultiple joint 
contractures 
SPG19 
SPG19 
AD 
AO 
P 
- 
SPG20 
SPART 
AR 
EO 
C 
M
ental retardation, dysarthria, upper lim
bs spasticity, cerebellar signs, euphoria, 
crying, W
M
Ls 
SPG21 
SPG21 
AR 
EO 
C 
Dem
entia, TCC, W
M
Ls, cerebellar signs, extrapyram
idal features, callosal 
disconnection syndrom
e 
SPG22 
SLC16A2 
X-linked 
EO 
C 
M
ental retardation, m
uscle atrophy, distal w
asting, dyskinesia, nystagm
us, ataxia 
SPG23 
SPG23 
AR 
EO 
C 
Cognitive im
pairm
ent, pigm
entary abnorm
alities, facial and skeletal 
dysm
orphism
, trem
or 
SPG24 
SPG24 
AR 
EO 
C 
Pseudobulbar signs 
SPG25 
SPG25 
AR 
AO 
C 
Cataracts, neuropathy, disc herniation 
SPG26 
B4GALNT1 
AR 
EO 
C 
Intellectual disability, cortical atrophy, peripheral neuropathy, distal atrophy, 
cerebellar ataxia, W
M
Ls 
SPG27 
SPG27 
AR 
VO 
C 
Dysarthria, m
ental retardation, polyneuropathy 
SPG28 
DDHD1 
AR 
EO 
P or C 
Saccadic eye pursuit, axonal neuropathy 
SPG29 
SPG29 
AD 
TO 
C 
Pes cavus, hearing loss, hiatal hernia, hyperbilirubinaem
ia 
SPG30 
KIF1A 
AR 
TO 
P or C 
Sensory PNP, cerebellar signs, hypoacusis, distal m
uscle w
asting 
SPG31 
REEP1 
AD 
EO 
P or C 
PNP, cerebellar ataxia, trem
or, dem
entia, am
yotrophy of sm
all hand m
uscles, pes 
cavus 
SPG32 
SPG32 
AR 
EO 
C 
M
ental retardation, pontine dysraphism
, TCC 
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SPG33 
ZFYVE27 
AD 
AO 
C 
Pes equines 
SPG34 
SPG34 
X-linked 
VO 
P 
- 
SPG35 
FA2H 
AR 
EO 
P or C 
Cognitive decline, epilepsy 
SPG36 
SPG36 
AD 
VO 
C 
Sensory polyneuropathy 
SPG37 
SPG37 
AD 
VO 
P 
- 
SPG38 
SPG38 
AD 
VO 
C 
Am
yotrophy of sm
all hand m
uscles, PNP 
SPG39 
PNPLA6 
AR 
EO 
C 
Distal w
asting in all four lim
bs, axonal neuropathy 
SPG40 
- 
AD 
AO 
P or C 
Hyperreflexia of upper lim
bs, cognitive im
pairm
ent 
SPG41 
SPG41 
AD 
TO 
P 
- 
SPG42 
SLC33A1 
AD 
VO 
P 
- 
SPG43 
C19orf12 
AR 
VO 
C 
Am
yotrophy of sm
all hand m
uscles, bilateral optic atrophy, axonal sensory and 
m
otor neuropathy 
SPG44 
GJC2 
AR 
AO 
C 
M
ild cognitive im
pairm
ent, m
oderate cerebellar dysfunction, dysarthria, W
M
Ls. 
pes cavus, TCC, scoliosis, upper lim
b involvem
ent 
SPG45 
SPG45 
AR 
EO 
C 
M
ental retardation, pendular nystagm
us, optic atrophy 
SPG46 
GBA2 
AR 
EO 
C 
M
ental im
pairm
ent, cataract, cerebellar atrophy, TCC, hypogonadism
 in m
ales 
SPG47 
AP4B1 
AR 
EO 
C 
Periventricular W
M
Ls, TCC, m
icrocephaly, epilepsy, w
addling gait, joint 
hyperlaxity 
SPG48 
AP5Z1 
AR 
AO 
P or C 
Spinal cord hyperintensities 
SPG49 
TECPR2 
AR 
EO 
P or C 
TCC, cognitive decline, upper lim
bs involvem
ent, basal-ganglia calcification. 
dystonic postures, W
M
Ls Optic atrophy, PNP 
SPG50 
AP4M
1 
AR 
EO 
C 
Tetraplegic cerebral palsy, m
ental retardation, reduction of cerebral w
hite 
m
atter, atrophy of the cerebellum
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SPG51 
AP4E1 
AR 
EO 
C 
M
icrocephaly, grow
th and intellectual retardation 
SPG52 
AP4S1 
AR 
EO 
C 
Delayed speech, stereotypic laughter, grow
th retardation 
SPG53 
VPS37A 
AR 
EO 
C 
Spasticity in upper extrem
ities, delays in cognition and speech, kyphosis, pectus 
carinatum
 (pigeon chest), hypertrichosis 
SPG54 
DDHD2 
AR 
EO 
C 
M
ental retardation, strabism
us, dysarthria, dysphagia, optic-nerve hypoplasia, 
short stature, TCC, laterally deviated feet, W
M
Ls 
SPG55 
C12orf65 
AR 
EO 
C 
Optic atrophy, neuropathy, club foot 
SPG56 
CYP2U1 
AR 
EO 
C 
Delayed psychom
otor developm
ent, m
ental retardation, TCC, cerebral and 
cerebellar dysfunction, dysm
orphic features 
SPG57 
TFG 
AR 
EO 
C 
Optic atrophy, PNP 
SPG58 
KIF1C 
AR 
EO 
P or C 
Chorea, m
yoclonus, ataxia, hypodontia, deafness, short stature, pes planus, 
ptosis, developm
ental delay, m
ental retardation, W
M
Ls 
SPG59 
USP8 
AR 
EO 
C 
Nystagm
us, borderline intelligence 
SPG60 
W
DR48 
AR 
EO 
C 
Neuropathy in low
er lim
bs, nystagm
us 
SPG61 
ARL6IP1 
AR 
EO 
C 
Loss of term
inal digits, acrom
utilation, PNP 
SPG62 
ERLIN1 
AR 
EO 
P 
- 
SPG63 
AM
PD2 
AR 
EO 
C 
TCC, W
M
Ls, underw
eight, short stature 
SPG64 
ENTPD1 
AR 
EO 
C 
Club foot, aggressiveness, delayed puberty, m
icrocephaly, borderline intelligence 
SPG65 
NT5C2 
AR 
EO 
P or C 
TCC, defective m
yelination, sm
all bilateral cystic occipital leukom
alacia, learning 
disability, club foot 
SPG66 
ARSI 
AR 
EO 
C 
Corpus callosum
 and cerebellar hypoplasia, colpocephaly, borderline intelligence, 
PNP, club foot 
SPG67 
PGAP1 
AR 
EO 
C 
Distended abdom
en, borderline intelligence, ACC, verm
is hypoplasia, defective 
m
yelination 
SPG68 
FLRT1 
AR 
EO 
C 
Nystagm
us, optic atrophy, PNP, am
yotrophy, foot drop 
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SPG69 
RAB3GAP2 
AR 
EO 
C 
Intellectual disability, deafness, cataract 
SPG70 
M
ARS 
AR 
EO 
C 
Scoliosis, bilateral Achilles contracture, borderline intelligence, nephrotic 
syndrom
e 
SPG71 
ZFR 
AR 
EO 
C 
TCC 
SPG72 
REEP2 
AR 
EO 
P 
- 
SPG73 
CPT1C 
AD 
EO 
P 
- 
SPG74 
IBA57 
AR 
EO 
C 
Optic atrophy and reduced visual acuity 
SPG75 
M
AG 
AR 
EO 
C 
M
ental retardation, cerebellar ataxia, am
yotrophy 
SPG76 
CAPN1 
AR 
VO 
C 
Upper lim
b involvem
ent, foot deform
ities and dysarthria 
SPG77 
FARS2 
AR 
EO 
P 
- 
SPG78 
ATP13A2 
AR 
AO 
C 
M
ild cognitive im
pairm
ent, dysarthria, oculom
otor disturbances, cerebellar 
atrophy 
- 
AFG3L2 
AR 
EO 
C 
Significantly im
paired am
bulation, cerebellar ataxia, oculom
otor apraxia, 
dystonia, and m
yoclonic epilepsy 
- 
ALS2 
AR 
EO 
C 
Late dysphagia, pes cavus, and slow
 saccadic eye m
ovem
ent. 
- 
BICD2 
AD 
EO 
P 
- 
- 
CCT5 
AR 
VO 
C 
Severe axonal sensory neuropathy w
ith m
arked distal pan-m
odal sensory loss, 
m
utilating acropathy, and vagal hyperactivity 
- 
ELOVL4 
AR 
EO 
C 
M
ental retardation, ichthyosis 
- 
EXOSC3 
AR 
EO 
C 
M
ild cognitive im
pairm
ent, m
ild cerebellar ataxia, strabism
us, short stature, distal 
am
yotrophy, tongue atrophy, adducted thum
bs, and talipes valgus. 
- 
RETREG1 
AR 
EO 
C 
Painless axonal neuropathy, progressive m
utilating ulcerations in hands and feet, 
hyperhidrosis, urinary incontinence 
- 
GAD1 
AR 
EO 
C 
M
ental retardation, occasional seizures, m
icrocephaly, m
ultiple contractures, and 
scoliosis 
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- 
GJA1 
AD 
VO 
C 
Craniofacial and lim
b dysm
orphism
, deafness and cardiac abnorm
alities 
- 
HACE1 
AR 
EO 
C 
Seizures, speech delay, ocular abnorm
alities, foot deform
ities 
- 
IFIH1 
AD 
EO 
P 
- 
- 
KANK1 
- 
EO 
C 
M
ental retardation 
- 
KCNA2 
AD 
EO 
C 
M
ild cognitive defects 
- 
KIDINS220 
AD 
TO 
C 
Intellectual disability, nystagm
us and obesity 
- 
LYST 
AR 
AO 
C 
PNP, cerebellar ataxia 
- 
ATP6 
M
itochondrial 
AO 
C 
Diabetes m
ellitus, hypertrophic cardiom
yopathy, supraventricular arrhythm
ia, 
cerebellar syndrom
e 
- 
ND4 
M
itochondrial 
AO 
C 
Visual loss (optic atrophy or other retinal changes) 
- 
TRNI 
M
itochondrial 
EO 
C 
Cerebellar ataxia, m
ental retardation, chronic progressive external 
ophthalm
oplegia, cardiom
yopathy, hearing loss, diabetes 
- 
COX3 
M
itochondrial 
EO 
C 
M
ental retardation, ophthalm
oplegia, severe lactic acidosis, Leigh-like features, 
COX deficiency 
- 
TPP1 
AR 
EO 
C 
Bulbar palsy, dystonic neck posturing and also severe cognitive problem
s 
- 
VCP 
AD 
AO 
C 
Frontotem
poral dem
entia 
 Table 1.2. List of hum
an HSP inheritance and clinical features. HSP genes are listed by spastic gait disease-loci (SPG), genes not part of the SPG 
classification system
 are listed alphabetically. Inheritance and clinical features (including age of onset, clinical phenotype) w
ere obtained from
 
literature and online resources, such as OM
IM
 (http://w
w
w
.ncbi.nlm
.nih.gov/om
im
/). 
Abbreviations: ACC = agenesis corpus callosum
; AD = autosom
al dom
inant; AO = adult onset; AR = autosom
al recessive; C = com
plicated; EO
 = 
early onset (infancy); IGE = idiopathic generalised epilepsy; P = pure; PNP = polyneuropathy; TCC = thin corpus callosum
; TO = teenage onset;  
VO = variable onset; W
M
Ls = w
hite m
atter lesions. Adapted from
 Lo Giudice et al., 2014; de Souza et al., 2016. 
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Autosomal Recessive (AR) HSPs 
So far, 63 genetic SPG loci and 56 genes have been identified for AR-HSP, with 7 AR-
HSP loci, namely SPG14 (Vazza et al., 2000), SPG23 (Blumen et al., 2003), SPG24 
(Hodgkinson et al., 2002), SPG25 (Zortea et al., 2002), SPG27 (Meijer et al., 2004; 
Ribai et al., 2006), SPG32 (Stevanin et al., 2007) and SPG45 (Dursun et al., 2009), with 
gene identity still unknown (Table 1.1 and 1.2). 
 
X-linked (XL) HSPs 
Only 5 X-linked SPG loci (SPG1, SPG2, SPG16, SPG22 and SPG34), and 3 corresponding 
genes (L1CAM, PLP1 and SLC16A2) have been identified to date. For SPG16 
(Steinmüller et al., 1997) and SPG34 (Macedo-Souza et al., 2008), gene identity is still 
unknown (Table 1.1 and 1.2). 
 
1.3    Epidemiology 
 
There are several earlier epidemiological studies, with the reported prevalence of 
HSP varying considerably between studies (Polo et al., 1991; McMonagle, Webb and 
Hutchinson, 2002). This discrepancy in part reflects the diverse genetic make-up of 
the populations, in combination with the diagnostic criteria and epidemiological 
methodologies employed. Also, for many areas of the world, prevalence rates are as 
yet unknown (McDermott et al., 2000; Ruano et al., 2014). However, after employing 
similar criteria and methodologies, the prevalence of HSP was estimated at 3-10 
cases per 100,000 population in Europe (Filla et al., 1992; Leone et al., 1995; 
McDermott et al., 2000). More recently, to gain a better understanding of the global 
distribution and prevalence of HSP, a systematic review was carried out by Ruano et 
al. (2014) of all the epidemiological studies published after 1983, following the wide 
use of Harding’s diagnostic and classification criteria for HSP (Harding, 1983). Using 
predefined methodological parameters, the prevalence estimated was 1.8/100,000 
for both autosomal dominant and autosomal recessive HSP (Ruano et al., 2014). 
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1.4    Diagnosis 
 
The diagnosis of HSP is based on several factors, which include: (i) a clinical history 
identifying characteristic progressive spastic paraparesis in a pure or complicated 
form (associated with additional neurological or non-neurological manifestations); 
(ii) neurological examination demonstrating corticospinal tract deficits; (iii) family 
history to determine type of transmission (autosomal dominant, recessive or X-linked 
recessive, or maternal inheritance); (iv) identification of genetic mutation in a locus 
associated with a previously described HSP phenotype; and (v) exclusion of any other 
differential diagnoses (de Souza et al., 2016).  
 
The diagnosis of ‘complicated’ forms of HSP is often more difficult due to the 
additional neurological and non-neurological features typically associated with such 
forms, which may precede the onset of spastic paraparesis (Lo Giudice et al., 2014; 
Klebe, Stevanin and Depienne, 2015). 
 
1.5    Functional Modules 
 
The identification of disease-loci/genes implicated in HSPs has been critical to our 
understanding of the clinical and pathological features of this group of disorders, and 
has also improved our understanding of the cellular processes required for axonal 
maintenance or degeneration (Blackstone, O’Kane and Reid, 2011). HSP forms and 
putative protein function for each HSP gene product are summarised in Table 1.3. 
Although large numbers of HSP-associated genes have been identified, and continue 
to be identified, the genetic heterogeneity of HSPs has in fact been advantageous in 
identifying common disease-related functional modules and cellular pathways (see 
Figure 1.1), through the recognition that encoded proteins function in similar 
biological pathways, or perform similar functions (Soderblom and Blackstone, 2006; 
Blackstone, 2012; Klebe, Stevanin and Depienne, 2015). The same protein is often 
implicated in several of the functional modules highlighted (Lo Giudice et al., 2014). 
Identification of these functional modules likely indicates their importance in 
corticospinal tract axon development and maintenance (Blackstone, 2012).
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Table 1.3 
Disease/Gene 
Protein nam
e (UniProt) 
Cellular function 
Reference 
SPG1/L1CAM
 
Neural cell adhesion m
olecule L1 
Neuronal cell adhesion and signalling, Neurite outgrow
th 
Jouet et al., 1994;  
Finsterer et al., 2012 
SPG2/PLP1 
M
yelin proteolipid protein 
M
yelination and axonal survival  
Saugier-Veber et al., 1994 
SPG3A/ATL1 
Atlastin-1 
M
em
brane trafficking, ER and Golgi m
orphogenesis and 
BM
P signalling 
Park et al., 2010;  
Guelly et al., 2011 
SPG4/SPAST 
Spastin (M
1 and M
87 isoform
s) 
M
icrotubule dynam
ics, ER m
orphogenesis, endosom
al 
trafficking, BM
P signalling 
Hazan et al., 1999;  
Solow
ska et al., 2010 
SPG5A/CYP7B1 
25-hydroxycholesterol 7-alpha-
hydroxylase 
Cholesterol m
etabolism
 in brain 
Tsaousidou et al., 2008; 
Finsterer et al., 2012 
SPG6/N
IPA1 
M
agnesium
 transporter NIPA1 
Endosom
al/ER m
orphogenesis, protein folding, M
g
2+ 
transport and BM
P signalling 
Rainier et al., 2003;  
Tsang et al., 2009 
SPG7/PGN 
Paraplegin 
M
itochondrial protease, ribosom
e m
aturation 
Casari et al., 1998;  
Tzoulis et al., 2008 
SPG8/W
ASHC5 
W
ASH com
plex subunit strum
pellin 
Endosom
al trafficking, cytoskeletal (actin) regulation, 
protein aggregation 
Valdm
anis et al., 2007;  
Derivery et al., 2009 
SPG9/ALDH18A1 
Delta-1-pyrroline-5-carboxylate synthase 
Ornithine m
etabolism
  
Coutelier et al., 2015;  
Sgobbi de Souza et al., 2017 
SPG10/KIF5A 
Kinesin heavy chain isoform
 5A 
M
icrotubule-based m
otor protein 
Ebbing et al., 2008;  
Crim
ella et al., 2011 
SPG11 
Spatacsin 
Autophagy, Endosom
al trafficking 
Stevanin et al., 2007;  
M
urm
u et al., 2011; 
Ebrahim
i-Fakhari et al., 2016 
SPG12/RTN
2 
Reticulon-2 
ER m
orphogenesis 
M
ontenegro et al., 2012 
SPG13/HSPD1 
60 kDa heat shock protein, m
itochondrial 
M
itochondrial chaperone – protein folding and assem
bly 
Hansen et al., 2002; 
Anderson et al., 2011 
SPG14 
- 
- 
- 
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SPG15/ZFYVE26 
Zinc finger FYVE dom
ain-containing 
protein 26  
Endosom
al trafficking, cytokinesis, autophagy 
Hanein et al., 2008;  
Sagona et al., 2010;  
M
urm
u et al., 2011  
SPG16 
- 
- 
- 
SPG17/BSCL2 
Seipin 
Lipid droplet biogenesis, ER stress response 
W
indpassinger et al., 2004; 
Lundin et al., 2006 
SPG18/ERLIN
2 
Erlin-2 
ERAD regulation 
Pearce et al., 2007; 
Huber et al., 2013 
SPG19 
- 
- 
- 
SPG20 
Spartin 
Endosom
al trafficking, Lipid droplet turnover, 
M
itochondrial regulation, BM
P signalling, cytokinesis 
Patel et al., 2002; 
Edw
ards et al., 2009; 
Finsterer et al., 2012 
SPG21 
M
aspardin 
Endosom
al trafficking and sorting 
Sim
pson et al., 2003 
SPG22/SLC16A2 
M
onocarboxylate transporter 8 
Thyroid horm
one transporter (axon developm
ent) 
Friesem
a et al., 2003;  
Vaurs-Barriere et al., 2009; 
Boccone et al., 2010 
SPG23 
- 
- 
- 
SPG24 
- 
- 
- 
SPG25 
- 
- 
- 
SPG26/B4GALN
T1 
Beta-1,4 N-
acetylgalactosam
inyltransferase 1 
Ganglioside m
etabolism
 
Boukhris et al., 2013 
SPG27 
- 
- 
- 
SPG28/DDHD1 
Phospholipase DDHD1 
Fatty acid and/or phospholipid m
etabolism
 
Tesson et al., 2012 
SPG29 
- 
- 
- 
SPG30/KIF1A 
Kinesin-like protein KIF1A 
M
icrotubule-based m
otor protein  
(anterograde transport) 
Erlich et al., 2011; 
Finsterer et al., 2012 
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SPG31/REEP1 
Receptor expression-enhancing protein 1 
ER m
orphogenesis and ER-m
icrotubule interaction 
Züchner et al., 2006; 
Park et al., 2010 
SPG32 
- 
- 
- 
SPG33/ZFYVE27 
Protrudin 
ER m
orphogenesis 
Chang et al., 2013 
SPG34 
- 
- 
- 
SPG35/FA2H 
Fatty acid 2-hydroxylase 
Sphingolipid synthesis 
Alderson et al., 2004; 
Zöller et al., 2008  
Cao et al., 2013 
SPG36 
- 
- 
- 
SPG37 
- 
- 
- 
SPG38 
- 
- 
- 
SPG39/PN
PLA6 
Neuropathy target esterase 
Axonal m
aintenance, phospholipid hom
eostasis 
Rainier et al., 2008;  
Hein et al., 2010 
SPG40 
- 
- 
- 
SPG41 
- 
- 
- 
SPG42/SLC33A1 
Acetyl-coenzym
e A transporter 1 
Acetyl-CoA transporter 
Hirabayashi et al., 2004 
SPG43/C19orf12 
Protein C19orf12 
Function unknow
n - m
itochondrial and ER m
em
brane 
localisation 
Fink et al., 2013 
SPG44/GJC2 
Gap junction gam
m
a-2 protein 
Intracellular gap junction channel 
Orthm
ann-M
urphy et al., 2007; 
Orthm
ann-M
urphy et al., 2009 
SPG45 
- 
- 
- 
SPG46/GBA2 
Non-lysosom
al glucosylceram
idase 
Ganglioside m
etabolism
 
Ham
m
er et al., 2013 
SPG47/AP4B1 
AP-4 com
plex subunit beta-1 
Endosom
al trafficking  
Abou Jam
ra et al., 2011 
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SPG48/AP5Z1 
AP-5 com
plex subunit zeta-1 
Helicase that repairs DNA double-strand break, 
endosom
al trafficking 
Slabicki et al., 2010; 
Hirst et al., 2011 
SPG49/TECPR2 
Tectonin beta-propeller repeat- 
containing protein 2 
Autophagy 
Oz-Levi et al., 2012 
SPG50/AP4M
1 
AP-4 com
plex subunit m
u-1 
Endosom
al trafficking 
Abou Jam
ra et al., 2011 
SPG51/AP4E1 
AP-4 com
plex subunit epsilon-1 
Endosom
al trafficking 
Abou Jam
ra et al., 2011 
SPG52/AP4S1 
AP-4 com
plex subunit sigm
a-1 
Endosom
al trafficking 
Abou Jam
ra et al., 2011 
SPG53/VPS37A 
Vacuolar protein sorting-associated 
protein 37A 
Endosom
al trafficking 
Zivony-Elboum
 et al., 2012 
SPG54/DDHD2 
Phospholipase DDHD2 
Phospholipid m
etabolism
 (phospholipase) 
Sato et al., 2010; 
Schuurs-Hoeijm
akers et al., 
2012 
SPG55/C12orf65 
Probable peptide chain release factor 
C12orf65, m
itochondrial 
Peptide chain term
ination in m
itochondrial translation 
m
achinery 
Antonicka et al., 2010; 
Shim
azaki et al., 2012 
SPG56/CYP2U
1 
Cytochrom
e P450 2U1 
Lipid m
etabolism
 (fatty acid hydroxylation) 
Chuang et al., 2004 
SPG57/TFG 
Protein TFG 
Endosom
al trafficking, ER shaping 
W
itte et al., 2011; 
Beetz et al., 2013 
SPG58/KIF1C 
Kinesin-like protein KIF1C 
M
icrotubule-based m
otor protein  
(retrograde Golgi to ER transport) 
Dorner et al., 1998 
SPG59/U
SP8 
Ubiquitin carboxyl-term
inal hydrolase 8 
Deubiquitinating enzym
e, endosom
al trafficking.  
Row
 et al., 2006;  
Coyne and W
ing, 2016 
SPG60/W
DR48 
W
D repeat-containing protein 48 
Regulator of deubiquitination 
Cohn et al., 2007;  
Novarino et al., 2014 
SPG61/ARL6IP1 
ADP-ribosylation factor-like protein 6-
interacting protein 1 
ER m
orphogenesis, protein transport 
Yam
am
oto et al., 2014; 
Novarino et al., 2014 
SPG62/ERLIN
1 
Erlin-1  
ERAD 
Pearce et al., 2009; 
Novarino et al., 2014 
SPG63/AM
PD2 
AM
P deam
inase 2 
Purine nucleotide m
etabolism
 
Akizu et al., 2013 
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SPG64/EN
TPD1 
Ectonucleoside triphosphate 
diphosphohydrolase 1 
Nucleotide m
etabolism
 to regulate purinergic 
transm
ission 
M
unkonda et al., 2007 
SPG65/N
T5C2 
Cytosolic purine 5'-nucleotidase 
Purine/pyrim
idine nucleotide m
etabolism
 
Oka et al., 1994; 
Dursun et al., 2009 
SPG66/ARSI 
Arylsulfatase I 
Horm
one biosynthesis 
Sardiello et al., 2005 
SPG67/PGAP1 
GPI inositol-deacylase 
GPI biosynthesis 
Tanaka et al., 2004 
SPG68/FLRT1 
Leucine-rich repeat transm
em
brane 
protein FLRT1 
Neurite outgrow
th, Cell-cell adhesion, Receptor 
signalling 
Lacy et al., 1999; 
Novarino et al., 2014 
SPG69/RAB3GAP2 
Rab3 GTPase-activating protein non-
catalytic subunit 
Exocytosis of neurotransm
itters and horm
ones 
Nagano et al., 1998; 
Aligianis et al., 2006 
SPG70/M
ARS 
M
ethionine--tRNA ligase, cytoplasm
ic 
Nucleotide m
etabolism
 
Deniziaki and Barciszew
ski, 
2001 
SPG71/ZFR 
Zinc finger RNA-binding protein 
Neuron developm
ent/synapse related 
Elvira et al., 2006 
SPG72/REEP2 
Receptor expression-enhancing protein 2 
ER m
orphogenesis 
Esteves et al., 2014 
SPG73/CPT1C 
Carnitine O-palm
itoyltransferase 1, brain 
isoform
 
Lipid (ceram
ide) m
etabolism
 
Carrasco et al., 2013 
SPG74/IBA57 
Putative transferase CAF17, 
m
itochondrial 
M
aturation of m
itochondrial proteins involved in the 
iron-sulphur cluster assem
bly pathw
ay 
Sheftel et al., 2012 
SPG75/M
AG 
M
yelin-associated glycoprotein 
Cell adhesion m
olecule involved in m
yelin m
aintenance 
Lossos et al., 2015 
SPG76/CAPN
1 
Calpain-1 catalytic subunit 
Calcium
-regulated non-lysosom
al protease involved in 
cytoskeletal rem
odelling 
Ohno et al., 1990 
SPG77/FARS2 
Phenylalanine--tRNA ligase, 
m
itochondrial 
M
itochondrial phenylalanyl transfer RNA (tRNA) 
synthetase 
Bullard et al., 1999 
SPG78/ATP13A2 
Probable cation-transporting ATPase 
13A2 
Cation hom
eostasis and m
aintenance of neuronal 
integrity, lysosom
al and m
itochondrial m
aintenance 
Ram
onet et al., 2012; 
Estrada-Cuzcano et al., 2017 
AFG3L2 
AFG3-like protein 2 
Protease essential for axonal and neuronal developm
ent 
Koppen et al., 2007 
ALS2 
Alsin 
Endosom
al trafficking 
Eym
ard-Pierre et al., 2002; 
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Hadano et al., 2006; 
BICD2 
Protein bicaudal D hom
olog 2 
M
otor adaptor protein 
Oates et al., 2013 
Neveling et al., 2013 
CCT5 
T-com
plex protein 1 subunit epsilon 
M
olecular chaperone - protein folding and assem
bly 
Liou and W
illison, 1997 
ELOVL4 
Elongation of very long chain fatty acids 
protein 4 
Lipid m
etabolism
 
Agbaga et al., 2008 
EXOSC3 
Exosom
e com
plex com
ponent RRP40 
Non-catalytic com
ponent of RNA exosom
e com
plex 
Brouw
er et al., 2001 
FAM
134B 
Reticulophagy receptor FAM
134B 
Autophagy (ER-phagy), ER m
orphogenesis 
Kham
inets et al., 2015 
GAD1 
Glutam
ate decarboxylase 1 
Catalyses production of GABA 
Fenalti et al., 2007 
GJA1 
Gap junction alpha-1 protein 
Intracellular gap junction channel protein 
De Block et al., 2013 
HACE1 
E3 ubiquitin-protein ligase HACE1 
Regulates GTPase activity and Golgi m
em
brane dynam
ics 
Anglesio et al., 2004; 
Hollstein et al., 2015 
IFIH1 
Interferon-induced helicase C dom
ain-
containing protein 1 
Innate im
m
une receptor 
Rice et al., 2014 
KANK1 
KN m
otif and ankyrin repeat dom
ain-
containing protein 1 
Regulates cytoskeleton form
ation 
Roy et al., 2009 
KCNA2 
Potassium
 voltage-gated channel 
subfam
ily A m
em
ber 2 
Neuron developm
ent/synapse related 
Sybre et al., 2015; 
Helbig et al., 2016 
KIDINS220 
Kinase D-interacting substrate of  
220 kDa 
Neuron developm
ent/synapse related 
Iglesias et al., 2000; 
Arevalo et al., 2004; 
Josifova et al., 2016 
LYST 
Lysosom
al-trafficking regulator 
Endosom
al trafficking 
Shim
azaki et al., 2014 
M
T-ATP6 
ATP synthase subunit a 
M
itochondrial function 
Carrozzo et al., 2006; 
Vazquez-M
em
ije et al., 2009; 
Sgobbi de Souza et al., 2017 
M
T-ND4 
NADH-ubiquinone oxidoreductase chain 4 
M
itochondrial function 
Clarencon et al., 2006,  
Sgobbi de Souza et al., 2016 
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M
T-TI 
M
itochondrially encoded tRNA isoleucine 
M
itochondrial function 
Corona et al., 2002; 
Sgobbi de Souza et al., 2017 
M
T-CO3 
Cytochrom
e c oxidase subunit 3 
M
itochondrial function 
Tiranti et al., 2000,  
Sgobbi de Souza et al., 2016 
TPP1 
Tripeptidyl-peptidase 1 
Lysosom
al serine peptidase 
Golabeck et al., 2003 
VCP 
Transitional endoplasm
ic reticulum
 
ATPase 
Autophagy, endosom
al trafficking, ERAD 
W
ojcik et al., 2006; 
DeLaBarre et al., 2006; 
Tresse et al., 2010; 
Kirchner et al., 2013 
 Table 1.3. Putative function of each HSP. HSP genes are listed by spastic gait disease-loci (SPG), genes not part of the SPG classification system
 
are listed alphabetically. HSP form
s and putative protein function of each HSP gene product w
ere obtained from
 literature.  
Abbreviations: BM
P = bone m
orphogenetic protein; ERAD = ER-associated degradation. Adapted from
 Blackstone, 2012; Lo Giudice et al., 2014; 
Noreau, Dion and Rouleau, 2014.  
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Figure 1.1 
                Figure 1.1. Com
m
on functional m
odules identified in HSP seed proteins. Analysis of HSP seed proteins has led to the identification of som
e 
com
m
on pathogenic them
es w
hich link sets of HSP proteins to different function m
odules. The schem
atic representation of a corticospinal m
otor 
neuron, is annotated to show
 the m
ajor HSP functional m
odules identified to date. Adapted from
 Blackstone, 2012; Lo Giudice et al., 2014.
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1.5.1 Axon development/pathfinding 
 
In order to form a functional nervous system, neurons extend axons from the cell 
body (soma) toward specific target cells (axon outgrowth) to form synaptic 
connections. This neural network is crucial to the complex functioning of the nervous 
system, and hence both intrinsic and extrinsic factors, or molecular cues, are used to 
guide and control axonal outgrowth and direction (Chilton, 2006). 
 
Mutations in the L1 cell adhesion molecule (L1CAM) gene causes the rare X-linked 
recessive spastic paraplegia type 1 (SPG1) (Jouet et al., 1994). This gene encodes the 
neuronal cell adhesion molecule L1, an axonal glycoprotein of the immunoglobulin 
(Ig) superfamily involved in cell-to-cell adhesion processes in the CNS. L1CAM is an 
axonal guidance molecule, and plays an important role in the development of the 
nervous system, promoting neuronal migration, axon outgrowth and synapse 
formation (Kenwrick, Watkins and Angelis, 2000; Maness and Schachner, 2007). 
These important cellular events are facilitated by interactions with other L1CAM 
molecules and extracellular ligands, including other cell adhesion molecules (CAMs), 
integrins and proteoglycans, as well as intracellular proteins (Blackstone, 2012; Lo 
Giudice et al., 2014).  
 
Mutations in the fibronectin leucine-rich transmembrane protein 1 (FLRT1) gene 
cause autosomal recessive spastic paraplegia type 68 (SPG68) (Novarino et al., 2014). 
This gene encodes a member of the fibronectin leucine rich transmembrane (FLRT) 
proteins, which are involved in cell adhesion and receptor signalling (Lacy et al., 1999; 
Wheldon et al., 2010).  
 
Mutations in the RAB3 GTPase activating protein subunit 2 (RAB3GAP2) gene cause 
autosomal recessive spastic paraplegia type 69 (SPG69) (Novarino et al., 2014). This 
gene encodes the 150-kD non-catalytic subunit of the RAB3GAP protein, one of three 
proteins that regulate the activity of the RAB3 protein family, which are involved in 
the regulated exocytosis of neurotransmitters and hormones (Aligianis et al., 2006). 
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Mutations in the SLC16A2 gene cause X-linked hereditary spastic paraplegia (HSP) 
type 22 (SPG22), and this gene encodes the monocarboxylate transporter 8 (MCT8) 
protein (Schwartz et al., 2005), which is necessary for tri-iodo-thyronine transport 
into neurons, and axonal pathfinding (Blackstone, O’Kane and Reid, 2011). 
 
1.5.2 Myelination 
 
The myelin sheath is a highly extended, specialised plasma membrane that wraps 
around the nerve axon, in a process known as myelination (Raine, 1984). The 
membranes of the myelin sheath originate from Schwann cells in the peripheral 
nervous system (PNS), and oligodendroglial cells in the central nervous system (CNS) 
(Bunge, 1968). The myelin sheath acts as an electrical insulator, increasing axonal 
conduction speed which allows fast transmission of electrical signals over large 
distances (Fields, 2008).  
 
Demyelination is the loss or destruction of the myelin sheath, whilst the axon 
remains relatively unaffected. This is caused by diseases that damage myelin sheaths 
directly or the cells that form them, and is typically seen in neurodegenerative 
disorders such as multiple sclerosis (MS), one of the most well-known demyelinating 
diseases (Love, 2006; Streitberger et al., 2012). Myelin defects can be caused by 
several mechanisms including inflammatory, metabolic or genetic abnormalities, 
leading to nerve dysfunction from the slowed or blocked signal conduction, resulting 
in impaired information relay between the brain and body or within the brain (Love, 
2006). Dysmyelination on the other hand, is used to describe the defective structure 
and function of myelin sheaths (Cheon et al., 2002). Dysmyelinating diseases are 
characterised by abnormal myelination, which often occur as a result of hereditary 
mutations that affect myelin biosynthesis and formation, and include the missense 
mutations in the human proteolipid protein (PLP1) gene (Krämer-Albers et al., 2006). 
 
One of the main myelination defects associated with HSP is known to occur as a result 
of proteolipid protein (PLP1) gene mutation. This gene encodes the primary 
constituent of myelin in the CNS, proteolipid protein 1 (PLP1) and the spliced variant 
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DM20 (Weimbs and Stoffel, 1992), which are both integral membrane proteins 
involved in the compaction, stabilisation and maintenance of the myelin sheath 
(Jahn, Tenzer and Werner, 2009). The variability of genetic mutations results in a 
wide clinical spectrum of PLP1-related disorders, which include both pure and 
complicated forms of spastic paraplegia type 2 (SPG2), as well as the more severe 
Pelizaeus–Merzbacher disease (PMD), which typically involves DM20 abnormalities 
(Inoue, 2005). SPG2 is an X-linked recessive PLP1-related disorder characterised by 
dysmyelination of the central nervous system, caused by a variety of mutations in 
the PLP1 gene (Noetzli et al., 2014).  
 
Mutations in the myelin-associated glycoprotein (MAG) gene cause severe autosomal 
recessive spastic paraplegia type 75 (SPG75) (Novarino et al., 2014). This gene 
encodes a component of myelin that belongs to the immunoglobulin (Ig) superfamily 
of proteins and is involved in myelin maintenance and glial-axon interactions, where 
it is enriched in myelinating glial cells (Lopez, 2014; Lossos et al., 2015). 
 
Mutations in the fatty acid 2-hydroxylase (FA2H) gene cause severe autosomal 
recessive spastic paraplegia type 35 (SPG35) (Dick et al., 2008). This gene encodes a 
fatty acid 2-hydroxylase hydroxylase (FA2H), an integral ER membrane protein which 
catalyses the 2-hydroxylation of the major myelin lipids galactosylceramides (GalCer) 
and sulfatides (Uchida et al., 2007; Lamari et al., 2013). FA2H is required for the initial 
step in the incorporation of α-hydroxylated GalCer into myelin, which use free fatty 
acids as substrates (Alderson et al., 2004; Edvardson et al., 2008). It has been shown 
to be required for the long-term maintenance of myelin (Zoller et al., 2008).  
 
Mutations in the gap junction gamma-2 (GJC2/GJA12) gene which encodes the gap 
junction protein connexin47 (Cx47) was originally associated with an early-onset 
dysmyelinating disorder, Pelizaeus-Merzbacher-like disease (PMLD) of the CNS 
(Uhlenberg et al., 2004; Salviati et al., 2007; Henneke et al., 2008). However, a novel 
mutation in GJC2 (Cx47) was associated with causing complicated spastic paraplegia 
type 44 (SPG44) in which it was suggested that Cx47/Cx43 channels between 
astrocytes and oligodendrocytes were disrupted resulting in cell-cell communication 
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impairment, affecting maintenance of CNS myelin (Orthmann-Murphy et al., 2009). 
Additional PMLD disorders also associated with HSP, include mutations in the solute 
carrier family 16 member 2 (SLC16A2) gene which causes X-linked hereditary spastic 
paraplegia (HSP) type 22 (SPG22) (Vaurs-Barrière et al., 2009), and more recently 
mutations in the CYP2U1 gene which causes the autosomal recessive hereditary 
spastic paraplegia (HSP) type 56 (SPG56) (Minase et al., 2017).  
 
1.5.3 ER membrane modelling 
 
The endoplasmic reticulum (ER) is a multifunctional organelle present in all 
eukaryotic cells, primarily involved in the synthesis, modification, quality control and 
transport of integral membrane and secreted proteins. It is also critical for sterol 
synthesis, lipid synthesis and distribution, carbohydrate metabolism and calcium 
storage, release and signalling (Clapham, 2007; Fagone and Jackowski, 2009; 
Braakman and Hebert, 2013). The ER is the largest and one of the most distinctive 
organelles in the cell. It is a continuous, membranous system that includes the well-
defined morphologies of the nuclear envelope, peripheral flat sheet-like structures 
studded with ribosomes, and a network of interconnected, branched tubules, all of 
which enable the diverse functions of the ER (Blackstone, 2012; Schwarz and Blower, 
2016). The distinctive shape and distribution of the ER architecture is regulated by 
several integral membrane proteins, as well as dynamic interactions with the 
cytoskeleton and other organelles (Schwarz and Blower, 2016). These include, (i) ER-
shaping proteins of the DP1/Yop1p and reticulon families, which have a characteristic 
hydrophobic domain, which is thought to sit in the ER membrane as a hairpin loop, 
occupying more space in the outer leaflet of the phospholipid bilayer, thereby 
generating membrane curvature through ‘hydrophobic wedging’ - critical to the 
formation and stabilisation of high membrane curvature found at ER tubules and 
sheet edges (Collins, 2006; Voeltz et al., 2006; Hu et al., 2008); (ii) the atlastin family 
of GTPases, which also contain a hairpin domain, are required for correct formation 
of the tubular ER network, promoting the formation of three-way junctions through 
homotypic fusion of ER tubules (Hu et al., 2009); (iii) microtubule cytoskeletal 
regulators required for distribution of ER network (Park et al., 2010), including the 
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microtubule-severing ATPase spastin, which also localises to the ER and has a hairpin 
domain allowing direct interaction with atlastins (Connell et al., 2009; Park et al., 
2010), particularly important for neurons (Renvoisé and Blackstone, 2010) and 
finally, (iv) components of the early secretory pathway which control vesicle 
biogenesis (Renvoisé and Blackstone, 2010; Zanetti et al., 2011).  
 
In neurons, the ER is particularly important during the expansion of polarised 
membrane which occurs during axon and dendrite formation (Pfenninger, 2009; 
Renvoisé and Blackstone, 2010). It also has an important role as an intracellular 
calcium store, tightly integrated with pre- and post-synaptic signalling mechanisms 
(Collin, Marty and Llano, 2005; Verkhratsky, 2005). ER morphology changes have 
been linked to synaptic organisation (Spacek and Harris, 1997). 
 
Mutations that affect the endoplasmic reticulum (ER) architecture are common in 
HSP patients, with over 50 % of patients harbouring pathogenic mutations in 1 of 3 
genes ATL1 (SPG3A), SPAST (SPG4) and REEP1 (SPG31) encoding proteins (spastin, 
atlastin-1 and REEP1) involved in ER membrane shaping and re-modelling events 
(Salinas et al., 2008; Blackstone, O’Kane and Reid, 2011). Mutations also occur in 
other, less common ER-shaping proteins RTN2 (SPG12) and REEP2 (SPG72) which 
further support a role for abnormal ER morphogenesis in the pathogenesis of HSP. 
 
Mutations in the ATL1 gene cause autosomal dominant spastic paraplegia type 3A 
(SPG3A) (Zhao et al., 2001). This gene encodes atlastin-1, a member of the dynamin 
superfamily of GTPases (Zhao et al., 2001; Rismanchi et al., 2008). Atlastin-1 GTPase 
is predominantly localised to the tubular ER, where it mediates homotypic fusion of 
ER membranes, promoting the formation of three-way junctions (Hu et al., 2009; 
Orso et al., 2009). Atlastin-1 GTPase can also interact directly with the ATP-
dependent microtubule-severing protein, spastin (Evans et al., 2006; Sanderson et 
al., 2006), and the ER tubule-shaping reticulons and DP1/Yop1p/REEP protein family, 
through hydrophobic hairpin domains within the tubular ER (Hu et al., 2008, 2009), 
linking membrane and cytoskeletal remodelling proteins (Voeltz et al., 2006; Hu et 
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al., 2008). This provides evidence to suggest a role for atlastins in the formation and 
morphology of an interconnected tubular ER network. 
 
Mutations in the SPAST gene cause autosomal dominant spastic paraplegia type 4 
(SPG4), the most common cause of autosomal dominant HSP. SPAST encodes an ATP-
dependent microtubule-severing protein, spastin (Hazan et al., 1999). Spastin is a 
member of the AAA (ATPase Associated with diverse cellular Activities) protein family 
with various functions including roles in microtubule dynamics (Errico, Ballabio and 
Rugarli, 2002) and membrane trafficking (Reid et al., 2005). The two translation 
initiation codons in SPAST allows the synthesis of two isoforms: full-length M1, and 
the shorter isoform, M87 which lacks the first 86 amino acids (Claudiani et al., 2005). 
Spastin consists of an N-terminal microtubule-interacting and endosomal-trafficking 
(MIT) domain, a microtubule-binding domain (MTBD) and the C-terminal AAA 
catalytic domain. MIT and MTBD are required for association with the microtubule 
cytoskeleton and subsequent severing, thereby regulating microtubule dynamics 
(White et al., 2007). The full-length M1 spastin isoform has a longer N-terminal 
domain as it contains a hydrophobic region (HR), not present in the shorter M87 
spastin isoform (Blackstone, O’Kane and Reid, 2011). The hydrophobic region (HR) is 
predicted to insert into the ER and form a partially membrane-spanning hairpin loop 
(Park et al., 2010), localising M1 to the ER where it mediates interactions between 
M1 spastin and three ER-shaping proteins: atlastin-1 (Evans et al., 2006; Sanderson 
et al., 2006), REEP1 (Park et al., 2010) and RTN2 (Montenegro et al., 2012). M1 
spastin is predominantly located at structures of the early secretory pathway, 
endosomes (Evans et al., 2006; Sanderson et al., 2006) and lipid droplets 
(Papadopoulos et al., 2015). The shorter M87 spastin isoform is a cytoplasmic protein 
that can be recruited to endosomes, but not to the early secretory pathway (Connell 
et al., 2009; Blackstone et al., 2011).  
 
Atlastin-1 and M1 spastin also regulate lipid droplet (LD) formation (Klemm et al., 
2013; Papadopoulos et al., 2015) and BMP signalling (Tsang et al., 2009; Zhao and 
Hedera, 2013), common functional modules also important to HSP. 
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Mutations in the REEP1 gene cause autosomal dominant spastic paraplegia type 31 
(SPG31) (Züchner et al., 2006). This gene encodes the receptor expression-enhancing 
protein 1 (REEP1), a member of the DP1/Yop1p protein family involved in ER tubule-
shaping (Voeltz et al., 2006). REEP1 localises to the tubular ER where it interacts with 
both atlastin-1 and spastin through hydrophobic hairpin domains, to co-ordinate the 
shaping and remodelling of ER tubules (Park et al., 2010). Interestingly, like spastin, 
REEP1 is also able to mediate microtubule interactions with the tubular ER network 
(Park et al., 2010). Defects in tubular ER shaping and ER network interactions with 
the microtubule cytoskeleton seem to be important in the pathogenesis of HSP. 
REEP2 encodes the receptor expression-enhancing protein 2, a paralog of REEP1, 
which also localises to the ER and microtubules where it is thought to participate in 
ER-shaping (Esteves et al., 2014), possibly through insertion of its hydrophobic 
domain in the phospholipid bilayer as shown for family member, REEP1 (Beetz, Koch, 
et al., 2013).  
 
Mutations in the RTN2 gene cause autosomal dominant spastic paraplegia type 12 
(SPG12) (Montenegro et al., 2012). This gene encodes a member of the large, diverse 
reticulon (RTN) superfamily of ER membrane-shaping proteins (Yang and 
Strittmatter, 2007). RTNs have a key role in shaping intracellular membrane-bound 
organelles, especially the ER, where they are involved in generating regions of high 
membrane curvature found at tubules and ER sheet edges, through hydrophobic 
insertion (wedging) (Collins, 2006; Voeltz et al., 2006; Hu et al., 2008; Chiurchiù, 
Maccarrone and Orlacchio, 2014). RTNs are characterised by the conserved reticulon 
homology domain (RHD), located at the C-terminal, which contains two short 
hydrophobic domains which are thought to “double back” forming hairpin loops and 
generating membrane curvature by increasing the area of the cytoplasmic leaflet of 
the lipid bilayer (Oertle and Schwab, no date; Zurek, Sparks and Voeltz, 2011). RTN2 
localises to the ER, where it appears to interact with spastin M1 through the 
hydrophobic hairpin loop domain, which is only observed in the longer M1 isoform 
(Montenegro et al., 2012). Given that the conserved RHD is known to mediate 
interactions between reticulons and other ER morphogens, RTN2 is thought to 
participate in the hairpin loop-containing network of ER morphogens, which includes 
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atlastin-1, M1 spastin and REEP1, interacting through hydrophobic hairpin domains 
within the tubular ER to co-ordinate ER shaping and microtubule dynamics (Park et 
al., 2010; Montenegro et al., 2012). 
 
Mutations in the ZFYVE27 gene cause autosomal dominant spastic paraplegia type 
33 (SPG33), and encodes a member of the FYVE-finger family of proteins, protrudin 
(Mannan et al., 2006). Protrudin localises predominantly to the tubular ER where it 
interacts with ER-shaping proteins spastin, atlastin-1 and REEP1 through 
hydrophobic hairpin domains to co-ordinate ER membrane curvature, contributing 
to the formation of the tubular ER network (Mannan et al., 2006; Hashimoto et al., 
2014). 
 
Mutations in the tropomyosin-receptor kinase (Trk)-fused gene (TFG) cause 
autosomal recessive spastic paraplegia type 57 (SPG57) (Beetz, Koch, et al., 2013). 
This gene encodes a protein which functions at ER exit sites in the regulation of COPII 
vesicle secretion (Witte et al., 2011; Johnson et al., 2015). TFG is thought to be a key 
component of the early secretory pathway, regulating anterograde trafficking from 
ER (Johnson et al., 2015). Mutant TFG is unable to form a matrix at the interface 
between the ER and ER-Golgi intermediate compartments (ERGIC), critical to its 
function, altering ER protein secretion and subsequent ER morphology, disrupting ER 
tubule organisation and causing the ER network to collapse onto the underlying 
microtubule cytoskeleton (Beetz, Koch, et al., 2013). 
 
Mutations in the ADP-ribosylation-like factor 6-interacting protein 1 (ARL6IP1) gene 
cause autosomal recessive spastic paraplegia type 61 (SPG61) (Novarino et al., 2014). 
This gene encodes the ADP-ribosylation factor-like protein 6-interacting protein 1 
(ARL6IP1 or ARMER), an anti-apoptotic protein which localises to ER (Lui et al., 2003). 
ARL6IP1 localises to the ER where the short hairpin structures of the transmembrane 
domains are required for shaping the ER membrane, in a reticulon-like manner 
(Yamamoto et al., 2014). 
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1.5.4 ERAD pathway & Protein folding 
 
Newly synthesized proteins are translocated into the ER lumen, where if destined for 
secretion, they must undergo correct folding and modifications, such as 
glycosylation, with the assistance of numerous chaperones and modifying enzymes 
(Rapoport, 2007). However, even with numerous chaperones and other cellular 
factors, protein folding is still inefficient, and a significant proportion fail to acquire 
their native three-dimensional structure and end up misfolded (Hartl and Hayer-
Hartl, 2009). Cells have evolved protein quality control systems in the ER to detect 
and eliminate terminally misfolded proteins, the most well-characterised of these 
pathways is ER-associated degradation (ERAD). ERAD is a conserved multi-step 
pathway dedicated to the removal of misfolded proteins from the lumen or 
membrane of the ER, targeting them for ubiquitin-proteasome-mediated 
degradation (Hiller et al., 1996; Werner, Brodsky and McCracken, 1996). Recognition 
of misfolded proteins and subsequent clearance through the ERAD pathway needs 
to be tightly regulated so that normal cellular function is not affected (Ruggiano, 
Foresti and Carvalho, 2014).  
 
Mutations in the CCT5 gene cause autosomal recessive mutilating sensory 
neuropathy with spastic paraplegia (Bouhouche et al., 2005). This gene encodes 
subunit 5 of the chaperonin-containing TCP1 (T-complex polypeptide 1) complex, a 
complex comprised of two stacked rings, each containing 8 different subunits (Liou, 
Willison and Research, 1997). Molecular chaperones assist misfolded and nascent 
proteins into their native conformation or protect misfolded proteins from 
aggregation (Sergeeva et al., 2013). The chaperonin CCT complex is required for the 
proper folding of cytoskeletal proteins (actin and tubulin) whereby unfolded 
polypeptides enter the central cavity and are folded in an ATP-dependent manner 
(Lewis et al., 1996). 
 
ERLIN2 (SPG18) and its paralog ERLIN1 (SPG62) are members of the 
Stomatin/Prohibitin/Flotillin/HflK/C (SPFH) domain-containing family, and encode 
lipid raft-associated proteins localised to the endoplasmic reticulum and nuclear 
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envelope (Browman et al., 2006; Tian et al., 2016). Together, they form an ER 
membrane complex and mediate the ER-associated degradation (ERAD) of inositol 
1,4,5-triphophate (IP3) receptors (Pearce et al., 2009). 
 
Mutations in the VCP gene cause a progressive lower limb spasticity which has been 
associated with hereditary spastic paraplegia (de Bot et al., 2012). This gene encodes 
a member of the AAA (ATPases Associated with a variety of cellular Activities) family 
of proteins (DeLaBarre and Brunger, 2005; Pye et al., 2006), which is known to 
function in a range of cellular processes, including ERAD (Meyer, Bug and Bremer, 
2012). VCP/p97 acts as a ubiquitin-selective chaperone, using energy from ATP 
hydrolysis to re-translocate proteins from the ER to the cytosol during ERAD (Jarosch 
et al., 2002; Rabinovich et al., 2002; Christianson and Ye, 2014). 
 
1.5.5 Lipid metabolism 
 
The ER is not only where membrane-bound and secretory proteins are synthesised, 
but together with the Golgi apparatus it forms the endomembrane compartment, 
the major site of lipid synthesis (Fagone and Jackowski, 2009). The ER region close to 
the Golgi apparatus is known as the ER-Golgi intermediate compartment (ERGIC). 
This region is rich in vesicles and tubules and is where phospholipids, the major lipid 
components of all mammalian membranes, including glycerophospholipids and 
sphingolipids, are transferred and biochemically modified, together with proteins 
destined for the cell surface or transport to other organelles (Fagone and Jackowski, 
2009; Glick and Nakano, 2009). The structure closest to the ERGIC is the cis-Golgi 
structure leading to the trans-Golgi network (TGN), the site where budding vesicles 
are formed carrying newly synthesised secretory proteins (Fagone and Jackowski, 
2009; Schwarz and Blower, 2016). The TGN has traditionally been seen as the main 
cargo sorting hub, where proteins and lipids are sorted into transport carriers, which 
requires elaborate cargo sorting machineries allowing them to be transported to 
downstream destinations which include the plasma membrane and endosomal 
compartments (Guo, Sirkis and Schekman, 2014). 
 
 34 
Brain lipids consist of glycerophospholipids, sphingolipids and cholesterol, which are 
important structural components of cellular membranes (Korade and Kenworthy, 
2008). The brain is the most cholesterol-rich organ in the body (Björkhem and 
Meaney, 2004), where it is tightly regulated and has been shown to be essential for 
normal brain development (Orth and Bellosta, 2012). Cholesterol is required for 
synapse and dendrite formation (Goritz, Mauch and Pfrieger, 2005; Fester et al., 
2009) and axonal guidance (de Chaves et al., 1997), and as it is a major constituent 
of cell membranes, any defects associated with cholesterol metabolism can lead to 
a number of CNS diseases, including Huntington’s disease (Block et al., 2010) and 
Alzheimer’s disease (Di Paolo and Kim, 2011) to name a few. A number of proteins 
involved in HSP, play various roles in lipid metabolism, and so it is not surprising that 
a subset of HSPs are caused by disturbances in phospholipid, sphingolipid and fatty 
acid metabolism. For example, DDHD1 (SPG28) and DDHD2 (SPG54) are members of 
the mammalian intracellular phospholipase A1 family of proteins (Inoue et al., 2012), 
and neuropathy target esterase (PNPLA6/NTE, SPG39) has combined phospholipase 
A1 and A2 activity (Zaccheo et al., 2004).  
 
Mutations in the DDHD domain-containing protein 1 (DDHD1) gene cause autosomal 
recessive hereditary spastic paraplegia (HSP) type 28 (SPG28) (Tesson et al., 2012). 
This gene encodes a cytosolic phosphatidic acid (PA)-preferring phospholipase A1 
(PA-PLA1), also known as DDHD1 (Higgs et al., 1998; Inoue et al., 2012). DDHD1 is 
predominantly localised in the cytosol, with partial localisation in microsomes and 
mitochondria (Yamashita et al., 2010). DDHD1 is also thought to be involved in 
regulating mitochondrial dynamics, since mutant DDHD1 causes mitochondrial 
dysfunction, which is thought to occur as a result of the PA accumulation in 
mitochondria. Alterations in lipid metabolism may therefore affect mitochondrial 
bioenergetic function in HSP (Tesson et al., 2012). DDHD2 encodes a member of the 
phospholipase A1 family of proteins, a hydrolysing phospholipid that localise to the 
cis-Golgi and to the ER-Golgi intermediate compartment (ERGIC) (Morikawa et al., 
2009; Sato et al., 2010).  
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PNPLA6 encodes a neuropathy target esterase (NTE), which is involved in the de-
esterification of phosphatidylcholine, a major membrane phospholipid, into 
glycerophosphocholine and fatty acids, maintaining intracellular phospholipid 
homeostasis (Synofzik et al., 2014; Topaloglu et al., 2014).  
 
ELOVL4, FA2H (SPG35) and CYP2U1 (SPG53) are all involved in various aspects of fatty 
acid metabolism. Mutations in the ELOVL Fatty Acid Elongase 4 (ELOVL4) gene cause 
autosomal recessive conditions such as Sjӧgren-Larsson syndrome, in which spastic 
quadriplegia is associated with mental retardation and ichthyosis (Laurenzi et al., 
1996; Aldahmesh et al., 2011), and recently associated with HSP (Fink, 2013). This 
gene encodes a member of the ELO family, a membrane-bound fatty acid elongase 
essential for biosynthesis of fatty acids (Agbaga et al., 2008). FA2H (SPG35) catalyses 
the 2-hydroxylation of the major myelin lipids which can then be incorporated into 
myelin, using the free fatty acids as substrates (Alderson et al., 2004; Edvardson et 
al., 2008). CYP2U1 (SPG56) is a member of the cytochrome P450 superfamily of 
enzymes involved in fatty acid hydroxylation, catalysing the hydroxylation of 
arachidonic acid and related long-chain fatty acids (Chuang et al., 2004; Tesson et al., 
2012). 
 
The SPG20 gene encodes spartin, a multifunctional protein that associates with the 
surface of lipid droplets (LDs), interacting with TIP47 (tail-interacting protein of 47 
kDa), a peripheral membrane protein (Eastman, Yassaee and Bieniasz, 2009). LDs 
store neutral lipids and have important roles in lipid metabolism (Welte, 2007). These 
dynamic organelles are thought to be formed within ER membranes, before budding 
off and being transported along microtubules and mobilised for lipolysis, in response 
to metabolic changes (Brasaemle, 2007). The membrane layer on the surface of LDs 
has two main groups of proteins; enzymes important in lipid metabolism and 
membrane proteins of the perilipin (PAT) family which includes TIP47. TIP47 is 
involved in stabilising LDs (Thiele and Spandl, 2008). Spartin is involved in the 
regulation of lipid droplet turnover (Eastman, Yassaee and Bieniasz, 2009), acting as 
an adaptor protein, it activates and recruits atrophin-1 interacting protein 4 (AIP4)-
E3 ubiquitin ligase to lipid droplets, regulating the level of AIP4-mediated 
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ubiquitination of lipid droplet-associated proteins (Eastman, Yassaee and Bieniasz, 
2009; Milewska, McRedmond and Byrne, 2009; Hooper et al., 2010).  
 
Mutations in the BSCL2 gene cause autosomal dominant hereditary spastic 
paraplegia (HSP) type 17 (SPG17) (Windpassinger et al., 2004). This gene encodes the 
ER membrane protein seipin (BSCL2), which is involved in lipid droplet morphology 
and metabolism (Fei, Du and Yang, 2011). HSP-associated BSCL2 mutations (N88S 
and S90L), cause misfolded seipin to accumulate in the ER, leading to ER stress and 
enhance ubiquitination and degradation (Ito et al., 2008).  
 
In addition, the full-length spastin isoform M1 was recently found to be involved in 
lipid metabolism, regulating lipid droplet (LD) size and distribution (Papadopoulos et 
al., 2015). 
 
ERLIN1 (SPG62) and ERLIN2 (SPG18) have also been identified as novel ER regulators 
of Sterol Regulatory Element Binding Proteins (SREBPs), restricting SREBP activation 
in the ER and regulating cellular cholesterol homeostasis (Huber et al., 2013). 
 
1.5.6 Endosome dynamics & Vesicle formation 
 
Membrane trafficking involves a wide range of complex, highly regulated processes 
that are required for the movement of cargo (proteins etc.) using membrane-bound 
transport vesicles (Herrmann and Spang, 2015). Membrane trafficking can be divided 
into two pathways, exocytosis and endocytosis, based on the direction of travel. 
Exocytosis involves the movement of newly synthesised lipids, proteins or 
carbohydrates from the endoplasmic reticulum (ER) via the Golgi complex to plasma 
membrane or extracellular space. In contrast, the endocytic pathway involves the 
internalisation of cargo, such as receptors and transmembrane domains from the 
plasma membrane and extracellular environment to early endosomes, where they 
can be recycled back to plasma membrane, targeted to Golgi or transported to late 
endosomes and lysosomes for degradation (Mellman, 1996; Mellman and Warren, 
2000; Maxfield and McGraw, 2004).  
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The endosomal sorting complexes required for transport (ESCRT) machinery are 
composed of several cytosolic protein complexes, ESCRT-I to III, which are 
evolutionary conserved key components of the endocytic pathway that function in a 
number of cellular contexts to mediate receptor sorting, membrane remodelling and 
membrane scission (Hurley, 2010). The ESCRT proteins were originally identified as 
being involved in the biogenesis of multivesicular bodies (MVBs), late endosomal 
structures that fuse with lysosomes, leading to degradation of endocytosed proteins 
such as receptors and transmembrane proteins (Katzmann, Odorizzi and Emr, 2002; 
Metcalf and Isaacs, 2010). The ESCRT pathway is also involved in a number of 
membrane-scission events, including viral budding (Garrus et al., 2001) and 
cytokinesis (Carlton and Martin-Serrano, 2007). The endocytic pathway ensures 
cellular homeostasis and regulates cell-to-cell communication, controlling nutrient 
uptake, signalling and degradation of transmembrane and misfolded proteins 
(Huotari and Helenius, 2011). 
 
The endosomal system can provide mechanisms to overcome the spatial challenges 
presented as a result of the distinctive morphology of neurons, which enable 
signalling molecules to be trafficked throughout the neuron, and allow intracellular 
signals to be sustained over long distances (Cosker and Segal, 2014). The endosomal 
processes remain largely the same in neurons as in other cell types (Yap and 
Winckler, 2012), with many developmental processes dependent on endocytosis, 
endosomal recycling and degradation (Shilo and Schejter, 2011). The endocytic 
machinery is important in a number of neurodevelopmental processes (Yap and 
Winckler, 2012), particularly endosomes, which are crucial to neuronal signalling, 
regulating cell survival, axon outgrowth and guidance, dendritic branching and cell 
migration (Cosker and Segal, 2014). 
 
Adaptor protein complexes (AP1-5) are conserved heterotetrameric complexes that 
function in vesicle trafficking (Hirst, Irving and Borner, 2013). All APs function as coat 
proteins which are recruited onto membranes to mediate the formation of different 
types of vesicles and select cargo for inclusion into these vesicles (Abou Jamra et al., 
2011; Hirst, Irving and Borner, 2013). AP-4 and AP-5 both function independently of 
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clathrin and both are associated with spastic paraplegia (Hirst et al., 2011). AP-4 is 
thought to be important in brain function and development, it mediates anterograde 
vesicular trafficking between the trans-Golgi network (TGN) and an endosomal 
compartment of specific cargos, such as the amyloid precursor protein (APP) (Burgos 
et al., 2010). AP-4 deficiency has been linked with severe intellectual disability and 
progressive spastic paraplegia, with mutations identified in several of the AP-4 
subunits (Abou Jamra et al., 2011; Moreno-De-Luca et al., 2011). Interestingly, the 
AP-5 complex, which seems to be involved in endosomal trafficking, is also associated 
with progressive spastic paraplegia and is therefore likely to be crucial for neuronal 
development and homeostasis (Hirst et al., 2011; Hirst, Irving and Borner, 2013). 
 
Mutations in the AP5Z1 gene cause autosomal recessive spastic paraplegia type 48 
(SPG48) (Słabicki et al., 2010). This gene encodes the zeta-1 subunit of adaptor-
related protein complex 5 (AP5Z1) or KIAA0415, which was originally thought to 
function in DNA repair (Słabicki et al., 2010), but has since been identified as a 
subunit of the new adaptor protein complex, AP-5, where it localises to late 
endosomes and is involved in endosomal dynamics (Hirst et al., 2011). Like AP-4, AP-
5 is not associated with clathrin but instead interacts with spatacsin (SPG11) and 
spastizin (SPG15) in an emerging HSP-related complex related to endocytic trafficking 
(Słabicki et al., 2010; Hirst et al., 2011; Hirst, Irving and Borner, 2013). It is thought 
that due to structural features, spatacsin (SPG11) and spastizin (SPG15) may in fact 
act as accessory proteins in the formation of an AP-5-containing coat-like complex 
(Słabicki et al., 2010; Hirst et al., 2011). Spatacsin (SPG11) has predicted structures 
which are similar to clathrin heavy chains, suggesting a role for SPG11 as a membrane 
scaffold (Hirst et al., 2011), whereas spastizin (SPG15) may facilitate membrane 
docking through interaction with the endosomal lipid, phosphatidylinositol 3-
phosphate (PI3P), via its FYVE domain (Sagona et al., 2010; Park and Guo, 2014). 
 
As discussed previously, the ATP-dependent microtubule-severing protein spastin 
(SPG4) harbours an N-terminal microtubule-interacting and trafficking (MIT) domain. 
Through this domain spastin binds strongly with two endosomal sorting complex 
required for transport III (ESCRT-III) proteins, CHMP1B (charged multivesicular body 
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protein 1B) and IST1 (increased sodium tolerance 1), coupling microtubule severing 
with membrane scission (Reid et al., 2005; Agromayor et al., 2009). Specifically, 
interaction with IST1 is important for spastin recruitment to the midbody and 
subsequent participation in cytokinesis (Renvoisé and Blackstone, 2010). The MIT 
domain has been described in several other proteins that are known to have defined 
roles in endosomal trafficking (Ciccarelli et al., 2003), interacting with components 
of the endosomal sorting complexes required for transport (ESCRT) machinery, 
specifically MIT-interacting motifs (MIMs) of ESCRT-III proteins (Hurley and Yang, 
2008). The major membrane-remodelling component, ESCRT-III mediates a range of 
cellular membrane scission processes other than ESCRT-mediated endosomal sorting 
and multivesicular endosome (MVE) formation (Katzmann, Odorizzi and Emr, 2002), 
which include virus budding (Morita and Sundquist, 2004) and cytokinesis (Carlton 
and Martin-Serrano, 2007), a process in which both spastin (Connell et al., 2009) and 
spartin (Lind et al., 2011) are known to participate. Another cellular membrane 
scission process mediated by ESCRT-III includes the recruitment of spastin to regulate 
endosomal tubulation, following interaction with IST1, which promotes fission of 
recycling tubules from the endosome (Allison et al., 2013). Endosomal tubulation at 
early sorting endosomes is important for both recycling and endosome-to-Golgi 
pathways. In the recycling pathway, tubules traffic cargo directly or indirectly from 
the peripheral early endosome to the plasma membrane (Allison et al., 2013). In the 
endosome-to-Golgi pathway, the retromer complex is required for cargo-selective 
endosomal sorting (Seaman, 2004; Bonifacino and Hurley, 2008). 
 
Another HSP protein, strumpellin, is involved in the fission of endosomal tubules. 
Strumpellin, also known as WASH complex subunit 5 (WASHC5), is a component of 
the Wiskott Aldrich Syndrome Protein (WASP) and SCAR Homologue (WASH) 
complex (Derivery et al., 2009). The WASH complex is recruited to endosomes by the 
retromer complex, via interactions with the vacuolar protein sorting-associated 
protein 35 (VPS35), a component of the retromer complex (Harbour et al., 2010). The 
retromer complex is a crucial element of the endosomal protein recycling machinery 
which sorts cargo into the endosome-to-Golgi pathway (Gomez and Billadeau, 2009; 
Gomez et al., 2012; Seaman, 2012). 
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Mutations in the Vacuolar Protein Sorting 37A (VPS37A) gene, have also been 
associated with impaired endosomal trafficking in HSP, causing autosomal recessive 
spastic paraplegia type 53(SPG53) (Zivony-Elboum et al., 2012). This gene encodes 
subunit alpha of the ESCRT-I complex which is involved in vesicular trafficking and 
ubiquitination (Zivony-Elboum et al., 2012). 
 
Mutations in the neuronal KIF1C gene cause autosomal recessive spastic paraplegia 
type 58 (SPG58) (Dor et al., 2014; Novarino et al., 2014). This gene encodes a 
microtubule-dependent motor protein which is required for the retrograde transport 
of Golgi vesicles to the ER (Dorner et al., 1998). 
 
Mutations in the Ubiquitin Specific Peptidase 8 (USP8) gene cause autosomal 
recessive spastic paraplegia type 59 (SPG59) (Novarino et al., 2014). This gene 
encodes a deubiquitinating enzyme (DUB) known to associate directly with the early 
ESCRT-0 complex (Berlin et al., 2010), as well as with chromatin-modifying protein 
(CHMP) components of the late ESCRT-III machinery (Tsang et al., 2006; Row et al., 
2007). 
 
Mutations in the WD Repeat-Containing Protein 48 (WDR48) gene cause autosomal 
recessive spastic paraplegia type 60 (SPG60) (Novarino et al., 2014).This gene 
encodes an endosomal protein known to regulate deubiquitination, by forming 
stable complexes with multiple deubiquitinating enzymes (DUBs) including USP1, 
USP12 and USP46 (Cohn et al., 2009). Together with KIF1C and USP8, WDR48 has 
been implicated in the endosomal sorting complexes required for transport (ESCRT) 
pathway (Novarino et al., 2014). 
 
Mutations in the 33-kD acidic cluster protein (ACP33) gene have been associated with 
causing autosomal recessive hereditary spastic paraplegia (HSP) type 21 (SPG21), 
also known as Mast syndrome (Simpson et al., 2003). This gene encodes ‘maspardin’ 
(Mast syndrome, spastic paraplegia, autosomal recessive with dementia), which 
localises to intracellular endosomal/trans-Golgi vesicles, where it likely has a 
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functional role in the trans-Golgi network/endosomal pathway (Simpson et al., 2003; 
Hanna and Blackstone, 2009). 
 
As discussed previously, VCP is essential for autophagy, a process linked with 
endosomal trafficking (Ju and Weihl, 2010; Tresse et al., 2010). The VCP gene 
encodes a member of the AAA (ATPases Associated with a variety of cellular 
Activities) family of proteins (DeLaBarre and Brunger, 2005; Pye et al., 2006), and is 
known to function in a range of cellular processes. VCP is involved in the early steps 
of endosomal trafficking as it associates with the endocytic coat protein clathrin and 
the endosomal sorting factor, EEA1 (early endosome antigen 1) (Pleasure, Black and 
Keen, 1993; Ramanathan and Ye, 2012). VCP can affect the oligomeric state of EEA1, 
to regulate the size of early endosomes (Ramanathan and Ye, 2012).  
 
1.5.7 Autophagy 
 
Autophagy is the general term used to describe the regulated catabolic process in 
which cytosolic components, organelles and misfolded proteins are degraded in 
lysosomes and recycled (Levine and Kroemer, 2008; Klionsky, 2010). Based on the 
mechanism of cargo delivery to the lysosomes, there are 3 distinct types of 
autophagy: chaperone-mediated autophagy (CMA), micro-autophagy and macro-
autophagy (Cuervo, 2004). In micro-autophagy, lysosomal membrane invaginations 
directly engulf portions of the cytoplasm, whereas CMA involves the chaperone 
HSC70 and its co-chaperones which are able to recognise and unfold substrate 
proteins with the specific ‘KFERQ’ amino-acid motif. These substrates bind to the 
lysosomal protein LAMP-2A and are translocated across the lysosomal membrane for 
degradation (Nikoletopoulou, Papandreou and Tavernarakis, 2015). The main 
pathway is thought to be macro-autophagy, which differs from the other two 
pathways in that the cytoplasmic cargo is sequestered inside a double membranous 
structure known as the autophagosome. The autophagosome is then transported 
along microtubules to lysosomes, which they fuse with to form autolysosomes. 
Together, the cellular components and the inner membrane are degraded by 
lysosomal enzymes and recycled (Levine and Kroemer, 2008). 
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Neuronal autophagy is essential for the maintenance of neuronal homeostasis and 
neuronal survival (Liang and Jia, 2014). There is increasing evidence that autophagy 
dysfunction, which can lead to the accumulation and aggregation of proteins 
resulting in cellular toxicity, is involved in the pathogenesis of several 
neurodegenerative diseases, including Parkinson’s disease, Alzheimer’s disease, 
Huntington’s disease and other protein-misfolding disorders (Pan et al., 2008; Liang 
and Jia, 2014; Ciechanover and Kwon, 2015a).  
 
As already mentioned, mutations in the VCP gene cause progressive lower limb 
spasticity, which has been associated with hereditary spastic paraplegia (de Bot et 
al., 2012), but is not yet classified as such. VCP/p97 monomers form a homohexamer 
allowing the ATPase domains to orientate as two stacked rings to form a central pore 
(Zhang et al., 2000; DeLaBarre and Brunger, 2003). As one of the most abundant 
proteins, it functions in a range of independent cellular processes, and although it 
has a well-established role in proteasomal degradation, it is now also linked to the 
other cellular degradative system, the lysosome (Meyer, Bug and Bremer, 2012). VCP 
has been shown to function in both ubiquitin-controlled autophagy pathway (Tresse 
et al., 2010) and endolysosomal sorting (Ritz et al., 2011). Pathogenic VCP mutants 
have been identified in a number of different neurodegenerative disorders, including 
Parkinson’s disease, Huntington’s disease, and ALS (Kakizuka, 2008) increasing our 
confidence in its involvement in HSP. 
 
Mutations in the tectonin beta-propeller repeat containing 2 (TECPR2) gene cause 
autosomal recessive spastic paraplegia type 49 (SPG49) (Oz-Levi et al., 2012). This 
gene encodes the tectonin beta-propeller repeat-containing protein 2 (TECPR2), a 
positive regulator in intracellular autophagy pathways, regulating autophagosome 
formation and accumulation (Behrends et al., 2010).  
 
Additionally, autophagy/lysosomal dysfunction has also been associated with SPG11 
and SPG15, caused by SPG11 (spatacsin) and ZFYVE26 (spastizin) gene mutations 
(Stevanin et al., 2007; Hanein et al., 2008). Both spatacsin (SPG11) and spastizin 
(SPG15), are known to co-localise with vesicle, endosomal and ER markers (Murmu 
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et al., 2011) and are also thought to be involved with autophagic lysosome 
reformation and initiation of lysosome tabulation (Chang, Lee and Blackstone, 2014; 
Varga et al., 2015). 
 
The lysosomal trafficking regulator (LYST) gene was originally described as the 
causative gene for the rare autosomal recessive, Chédiak-Higashi syndrome (CHS) 
(Nagle et al., 1996). However, LYST mutations have now been associated with 
impaired autophagy (Rahman et al., 2012) in autosomal recessive hereditary spastic 
paraplegia (Shimazaki et al., 2014). This gene encodes the large, cytoplasmic 
lysosomal trafficking regulator protein, LYST (Barbosa et al., 1996; Nagle et al., 1996). 
Given that autophagic impairment is observed with the loss-of-function of other HSP-
related proteins, this highlights the importance of this function module in the 
pathogenesis of disease. 
 
1.5.8 Axonal transport 
 
Neurons have a unique morphology, as highly polarised cells with extended axons 
and dendrites, making them dependent on the active intracellular transport of 
proteins, RNA and organelles (cargo) along axons (Perlson et al., 2010). Axonal 
transport allows newly synthesised lipids and proteins to reach the distal synapse, 
whilst misfolded and aggregated proteins are removed from the axon and 
transported to the cell body (soma) for efficient degradation (Chevalier-Larsen and 
Holzbaur, 2006). Axonal transport is also important for intracellular neural 
transmission between the distal axon and the soma, allowing the neuron to respond 
efficiently to environmental changes (Perlson et al., 2010). Molecular motors, such 
as kinesin and dynein superfamily proteins, are required to drive long-distance 
axonal transport of cargo (membrane-bound organelles and vesicles) along the 
microtubule ‘rails’ of the cytoskeleton, using the energy released following ATP 
hydrolysis (Hirokawa, 1998; Perlson et al., 2010). Kinesins are thought to be the main 
molecular motors required for the intracellular transport of cargos along the 
microtubules ‘tracts’ in the anterograde direction (away from cell body) (Hirokawa 
et al., 1991), whereas cytoplasmic dynein complexes move in the opposite direction 
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(towards cell body), to drive retrograde microtubule-based transport (Hirokawa, 
1998; Goldstein and Yang, 2000).  
 
Axonal transport defects have emerged as a common factor in the pathogenesis of 
several neurodegenerative disorders including Alzheimer’s disease (Stokin et al., 
2005), Parkinson’s disease (Saha et al., 2004), Huntington’s disease (Gunawardena et 
al., 2003; Her and Goldstein, 2008) and amyotrophic lateral sclerosis (ALS) (Ligon et 
al., 2005; Perlson et al., 2010). Given the vulnerability of long motor neuron axons to 
changes in transport processes, it is not surprising that several HSP-associated genes, 
encoding proteins involved in axonal transport and intracellular trafficking, have 
been identified (Blackstone, 2012). 
 
Most pathogenic SPAST mutations affect the enzymatic activity of spastin, and as it 
is a microtubule-severing protein, mutations can cause a redistribution of the 
microtubule cytoskeleton, disrupting microtubule dynamics (Errico, Ballabio and 
Rugarli, 2002; McDermott et al., 2003). However, it has also been shown to be 
involved in axonal transport, as expression in cultured neurons of a short 
dysfunctional M1 polypeptide (but not a short dysfunctional M87) was found to 
dramatically inhibit fast axonal transport (FAT), possibly through the activation of 
specific kinases and phosphatases involved in the regulation of molecular motor 
proteins, thereby causing a defect in axonal transport (Solowska et al., 2008). As 
spastin regulates microtubule dynamics, and microtubules are essential in axonal 
transport, defects in axonal transport are likely to play some part in the pathogenesis 
of disease. 
 
Axonal transport impairments have also been associated with SPG10 caused by KIF5A 
gene mutation (Reid et al., 2002) and SPG30 caused by KIF1A gene mutation (Erlich 
et al., 2011), both of which encode microtubule-dependent motor proteins involved 
in vesicular anterograde axonal transport. More recently, SPG58 caused by KIF1C 
gene mutations has been identified (Dor et al., 2014; Novarino et al., 2014). KIF1C 
encodes a microtubule-dependent motor protein required for the retrograde 
transport of Golgi vesicles to the ER (Dorner et al., 1998).  
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Mutations in the BICD2 gene, have been associated with axonal transport 
impairments in autosomal recessive HSP patients (Oates et al., 2013). This gene 
encodes an evolutionary conserved Golgi-associated motor-adaptor protein involved 
in anterograde and retrograde transport (Splinter et al., 2010).  
 
The identification of genes that encode motor and motor-adaptor proteins involved 
in the pathogenesis of HSPs further supports the role of intracellular transport 
processes in the pathogenesis of hereditary axonopathies such as HSP. 
 
1.5.9 Mitochondrial function 
 
Mitochondria are unique, double membrane-bound organelles central to a number 
of cellular processes, including adenosine-5’-triphosphate (ATP) production through 
coupled electron transport chain and oxidative phosphorylation, intracellular Ca2+ 
homeostasis, steroid synthesis and the generation of reactive oxygen species (ROS) 
(Kann and Kovács, 2007). Consequently, mitochondrial dysfunction has serious 
implications for cells, with links to cancer, as well as to ageing, metabolic and 
neurodegenerative diseases (Wallace, 2005). 
 
The central nervous system (CNS) has an extremely high metabolic rate, with a single 
cortical neuron requiring up to 4.7 billion ATP molecules/second (Zhu et al., 2012). 
Constant ATP production is required for neuronal function and survival (Nicholls and 
Budd, 2000), as it supports synapse assembly (Lee and Peng, 2008), generating action 
potentials (Attwell and Laughlin, 2001), and for synaptic transmission (Verstreken et 
al., 2005). Since the majority of neuronal ATP is generated by oxidative metabolism, 
neurons are dependent upon mitochondrial function and oxygen supply (Erecinska, 
Cherian and Silver, 2004; Kann and Kovács, 2007) and are therefore sensitive to 
mitochondrial dysfunction (Fiskum, Murphy and Beal, 1999; Nicholls and Budd, 
2000). Mitochondrial dysfunction occurs when there is an inadequate number of 
mitochondria, an inability to supply substrates to mitochondria, or a dysfunction in 
their electron transport and ATP-synthesis machinery (Nicolson, 2014). As a result, 
these changes cause a reduced efficiency of oxidative phosphorylation and a 
 46 
reduction in the synthesis of high-energy molecules such as ATP, a feature observed 
in most chronic diseases (Reddy, 2008; Swerdlow, 2011; Nicolson, 2014). 
Mitochondrial dysfunction is a characteristic that is also observed in ageing and in 
age-related neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s 
disease, amyotrophic lateral sclerosis (ALS) and Huntington’s disease (Trushina and 
McMurray, 2007), as well as in cancer (Wallace, 2012) and diabetes (Reddy, 2008). 
Impaired mitochondrial function has also been implicated in the pathogenesis of 
several neurodegenerative diseases, including several HSPs.  
 
Frameshift mutations in the SPG20 gene have been associated with causing 
autosomal recessive hereditary spastic paraplegia (HSP) type 20 (SPG20), also known 
as Troyer syndrome (Patel et al., 2002). This gene encodes spartin, a multifunctional 
protein which is known to interact with multiple binding partners (Milewska, 
McRedmond and Byrne, 2009) and is associated with several intracellular organelles 
(Robay et al., 2006), including mitochondria (Lu, Rashid and Byrne, 2006). Spartin has 
been found to have a functional role in maintaining mitochondrial Ca2+ homeostasis 
via an interaction with cardiolipin, a major mitochondrial phospholipid (Joshi and 
Bakowska, 2011).  
 
Mutations in the C12orf65 gene have also been associated with mitochondrial 
dysfunction in HSP, causing autosomal recessive spastic paraplegia type 55 (SPG55) 
(Shimazaki et al., 2012). This gene encodes a soluble mitochondrial matrix protein 
which belongs to a family of four mitochondrial class I peptide release factors, all 
characterised by a ‘GGQ’ motif at the active site (Richter et al., 2010). C12orf65 
encodes a protein thought to be critical for the release of newly synthesised proteins 
from mitochondrial ribosomes (Antonicka et al., 2010). The C12orf65 nonsense 
mutation causes autosomal recessive SPG55, resulting in a premature stop codon. 
The truncated protein leads to a defect in mitochondrial protein synthesis and 
subsequent defects in respiratory complexes I and IV, leading to a reduction in the 
activity of the respiratory enzyme complex (Shimazaki et al., 2012). 
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Abnormal mitochondrial function has also been associated with SPG7 caused by PGN 
gene mutation (Casari et al., 1998) and SPG13 caused by heat-shock protein 60 
(HSPD1) gene mutation (Hansen et al., 2002). Paraplegin assembles with AFG3L2 to 
form the metalo-protease AAA (ATPase Associated with diverse cellular Activities) 
complex at the mitochondrial inner membrane, where it is essential for 
mitochondrial protein quality control (Atorino et al., 2003; Nolden et al., 2005), 
degrading misfolded proteins (Karlberg et al., 2009) and regulating ribosome 
assembly (Nolden et al., 2005; Koppen et al., 2007). Interestingly, homozygous 
mutations in the AFG3L2 gene cause autosomal dominant hereditary ataxia 
spinocerebellar ataxia type 28 (SCA28), identifying this gene as a novel cause of 
dominant neurodegenerative disease (Di Bella et al., 2010). HSPD1 is also involved in 
mitochondrial protein quality control, forming a double barrel chaperonin complex 
with its co-chaperone, 10 kDa heat shock protein (HSP10), to facilitate the correct 
folding of imported mitochondrial proteins (Nielsen and Cowan, 1998; Levy-Rimler 
et al., 2001; Bross and Fernandez-Guerra, 2016). 
 
Mutations in the IBA57 gene, have also been associated with mitochondrial 
dysfunction in HSP, causing autosomal recessive spastic paraplegia type 74 (SPG74) 
(Lossos et al., 2015). This gene encodes a mitochondrial iron-sulphur (Fe/S) protein 
assembly factor which is involved in the maturation of mitochondrial proteins 
(Sheftel et al., 2012).  
 
Finally, mutations in MT-ATP6 (Verny et al., 2011), MT-ND4 (Clarençon et al., 2006), 
MT-CO3 (Tiranti et al., 2000) or MT-TI (Corona et al., 2002) mitochondrial genes, are 
rare and easily overlooked, but they can contribute to both pure and complex forms 
of HSP.  
 
1.5.10 DNA repair & Nucleotide metabolism 
 
DNA damage is defined as any DNA modification that alters the chemical structure 
of DNA and changes its normal function in transcription or replication, or DNA coding 
properties (Lindahl, 1993; Rao, 1993). DNA damage can occur naturally following 
 48 
metabolic processes where DNA damaging compounds such as reactive oxygen 
species (ROS) and reactive nitrogen species (RNS) are released (Rao, 1993), or 
following hydrolytic processes involving X-rays, ultraviolet (UV) light or various 
chemicals (Friedberg, 2008; Tubbs and Nussenzweig, 2017). Given that the majority 
of daily DNA damage is caused by single-stranded DNA (SSD) breaks following 
oxidative damage during metabolism or base hydrolysis, it is not surprising that cells 
acquired enzymes during evolution that can repair DNA following damage, restoring 
genome integrity (Lindahl and Barnes, 2000; Friedberg, 2008). However, mutations 
in DNA repair genes have been associated with several different diseases including 
cancer (Hoeijmakers, 2001), aging (Lombard et al., 2005), and several 
neurodegenerative diseases (Rass, Ahel and West, 2007).  
 
Given the extreme sensitivity of the neuron genome, specifically the motor neuron 
genome, to ROS and RNS, which cause both single- and double-strand DNA breaks 
(Martin and Liu, 2002) and the particular vulnerability of neurons to mutations in 
DNA repair genes (Słabicki et al., 2010), it is unsurprising that neuronal DNA damage 
has been implicated in the pathogenesis of several neurological disorders, including 
amyotrophic lateral sclerosis (ALS), Alzheimer’s disease, Parkinson disease’s, and 
head trauma, to name a few (Martin, 2008).  
 
Mutations in the AP5Z1 gene, have been associated with abnormal DNA repair in 
HSP, causing autosomal recessive spastic paraplegia type 48 (SPG48) (Słabicki et al., 
2010). This gene encodes the zeta-1 subunit of adaptor-related protein complex 5 
(AP5Z1) or KIAA0415, which has both nuclear and cytoplasmic localisation. According 
to Slabicki et al., (2010), AP5Z1 is a putative helicase required for efficient 
homologous recombination-mediated DNA double-strand break (DSB) repair. 
Although DSBs are less frequent than SSBs, they are more dangerous (Tubbs and 
Nussenzweig, 2017). 
 
Purine nucleotide metabolism has previously been linked to several inherited 
neurological disorders including the X-linked recessive Lesch-Nyhan syndrome (LNS) 
and the autosomal recessive adenylosuccinate lyase (ASL) (Jinnah, Sabina and Van 
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Den Berghe, 2013), but never to HSP. However, AMPD2, ENTPD1 and NT5C2 are 
proteins involved in purine nucleotide metabolism, which have recently been 
implicated in HSP (Novarino et al., 2014). AMPD2 encodes one of three known 
adenosine monophosphate (AMP) deaminase enzymes involved in the deamination 
of AMP in the purine nucleotide cycle (Akizu et al., 2013). AMPD2 mutations have 
been associated with an early-onset neurodegenerative condition, a new 
pontocerebellar hypoplasia (PCH)-like syndrome (Akizu et al., 2013). ENTPD1 
encodes a plasma membrane ectonucleotidase which hydrolyses ATP and other 
nucleotides in the synaptic cleft, regulating purinergic transmission (Munkonda et 
al., 2007). NT5C2 encodes cytosolic a purine 5’-nucleotidase which catalyses the 
hydrolysis of cytoplasmic purine nucleotides such as AMP, releasing adenosine 
(Dursun et al., 2009).  
 
1.6    Treatment & Management 
 
Currently, there is no specific disease modifying cure or treatment that targets the 
underlying genetic defect in HSP. Instead, treatment involves targeting the main 
symptoms to reduce or manage muscle spasticity. Anti-spasticity drugs are often 
used to reduce muscle tightness, alongside regular physiotherapy which focuses on 
reducing muscle tone, maintaining muscle flexibility and improving range of motion 
and mobility (Fink, 2013). 
 
The identification of specific disease genes and their corresponding proteins is 
already providing major advances in our understanding of the pathogenesis of HSPs, 
and this will continue, contributing to the identification of common pathways 
targetable with drugs. There is also the potential for future personalised treatments, 
depending on the altered pathway(s) of a particular individual (Klebe, Stevanin and 
Depienne, 2015). 
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1.7    Protein-Protein Interactions (PPIs)  
 
Since the completion and release of high-quality sequencing of the human genome 
well over a decade ago (International Genome Sequencing Consortium, 2004), 
progress has been made in our understanding of the mechanisms that underlie 
human diseases, and in particular genetically inherited disorders, as our ability to 
assign genotypes to phenotypes has dramatically increased (Hamosh et al., 2004; 
Rolland et al., 2014). The actual causal mutations that connect genotype to 
phenotype are usually unknown, and this is especially true for complex trait loci and 
cancer-associated mutations. However, even when identified, how the causal 
mutation alters the function of the corresponding gene or gene product is often 
unclear (Rolland et al., 2014). 
 
Complex cellular systems are formed by interactions between genes and gene 
products located in the same cell, across cells, or even across organs, which appear 
to underlie most cellular functions, including most genotype-to-phenotype 
relationships (Vidal, Cusick and Barabási, 2011). A critical step towards unravelling 
the complex molecular relationships in living systems is the mapping of protein-
protein interactions, or interactome networks, to understand more about the 
mechanisms involved following network perturbation as a result of inherited or 
somatic disease susceptibilities (Rolland et al., 2014).  
 
1.7.1 Protein-Protein Interaction (PPI) networks 
 
Network construction and analysis is a relatively modern approach which has been 
used to investigate a number of diseases, including Alzheimer’s disease (Goñi et al., 
2008; Soler-Lopez et al., 2011), multiple sclerosis (Satoh, Tabunoki and Yamamura, 
2009), and cancer (Pujana et al., 2007; Su, Yoon and Dougherty, 2010). The disease 
networks were generated using experimental data, as well as protein interaction 
datasets from publicly available databases. 
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Disease networks are of particular interest as they not only increase our 
understanding of the molecular mechanisms involved in a disease process, but they 
can also help to identify potential disease drug targets, and in some diseases the 
identification of multiple targets is necessary if disease mechanisms bypass the 
inhibition of a single gene and instead target multiple genes (Schrattenholz, Groebe 
and Soskic, 2010). Moreover, it has been suggested that partial inhibition of 
multiple targets can be more efficient than complete inhibition of a single target 
(Csermely, Agoston and Pongor, 2005). Disease networks can also be used to 
characterise disease-related proteins, with some studies having shown a highly 
interconnected protein network with disease proteins compared with non-
essential proteins, and these disease-related proteins have also been shown to be 
important to the overall network structure (Gandhi et al., 2006; Jonsson and Bates, 
2006; Xu and Li, 2006). However, Goh et al. (2007) found that the majority of 
disease genes were in fact non-essential and were not more likely to be highly 
interconnected than non-disease genes (Goh et al., 2007). Other studies have also 
shown that disease-related proteins have a tendency to interact with proteins 
involved in the same disease (Barabási, Gulbahce and Loscalzo, 2011), like in the 
biological concept of “guilt by association”. This observation is important for the 
identification of potentially novel candidate proteins involved in disease 
progression and development. 
 
Additionally, interolog interactions are valuable datasets which can be used to 
predict human protein-protein interactions, and to prioritise interactions for 
further study. Walhout et al., (2000) introduced the concept of ‘interologs’, 
orthologous pairs of interacting proteins in different organisms, from which 
interaction annotation can be transferred from one organism to another (Walhout 
et al., 2000; Yu et al., 2004).  
 
1.7.2 Detecting binary and co-complex PPIs  
 
Experimental techniques used to detect protein-protein interactions (PPIs) can be 
divided into two major classes. The first include methods that are used to measure 
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direct physical interactions between a specific pair of proteins. These are known as 
“binary” methods, and include techniques such as yeast two-hybrid (Y2H) and 
membrane yeast two-hybrid (MYTH) (Rual et al., 2005; Suter, Auerbach and Stagljar, 
2006). The second class includes methods that are used to measure physical 
interactions between a tagged protein and a group of proteins without pairwise 
determination of protein pairs. These are known as “co-complex” or “non-binary” 
methods, because they are designed to identify proteins in stable complexes within 
a cellular context, and include techniques such as tandem affinity purification 
coupled to mass spectrometry (TAP-MS) or co-immunoprecipitation (Co-IP) 
(Berggård, Linse and James, 2007). Both of these methodologies can be used to 
detect protein-protein interactions in a high-throughput manner, producing different 
types of PPI data which can be used to generate large-scale interaction maps (Yu et 
al., 2008; De Las Rivas and Fontanillo, 2010). These protein-protein interaction 
network maps have nodes which represent proteins, and edges which represent a 
physical interaction between each pair of proteins (Vidal, Cusick and Barabási, 2011).  
 
1.7.3 Yeast two-Hybrid 
 
The yeast two-hybrid (Y2H) system, which was originally devised by Stanley Fields 
and Ok-kyu Song (1989), utilises the powerful genetic system of the model organism 
Saccharomyces cerevisiae (yeast) to detect protein-protein interactions between any 
two proteins, X and Y (Fields and Song, 1989). As shown in Figure 1.2, Y2H is based 
on the functional reconstitution of a yeast transcription factor (e.g. GAL4) and 
subsequent activation of a selective reporter gene. To test whether two proteins (X 
and Y) interact, two expression constructs are made so that: bait protein (X) is fused 
to the DNA-binding domain (BD), whilst prey protein (Y) is fused to the activation 
domain (AD) of a transcription factor (Fields and Song, 1989). The DNA-binding 
domain (BD) binds to an upstream activating sequence (UAS), whereas the activation 
domain (AD) recruits the RNA polymerase II complex to the transcriptional start site 
of the reporter gene (Fields and Song, 1989). Therefore, following direct interaction 
between bait and prey proteins, the reconstituted functional transcription factor 
(TF), binds onto an upstream activating sequence (UAS), resulting in the activation of 
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detectable downstream reporter genes that enable growth under selective 
conditions or a change in colour of yeast colonies (b-galactosidase assay) (Fields and 
Song, 1989; Brückner et al., 2009).  
 
Figure 1.2 
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Figure 1.2. Yeast two-hybrid (Y2H) system. The GAL4 transcription factor can be 
divided into two fragments: DNA-binding domain (Gal4 BD) and activation domain 
(Gal4 AD). The BD is responsible for binding to the UAS, whilst the AD is responsible 
for the activation of transcription. (A) To assess whether two proteins (X and Y) 
interact, fusion constructs can be co-expressed in yeast cells to produce BD-X and 
AD-Y. If X and Y interact the fragmented GAL4 transcription factor is functionally 
reconstituted, thereby driving the expression of reporter genes (e.g. HIS3, ADE2 or 
lacZ). (B) If X and Y do not interact, the GAL4 transcription factor BD and AD 
fragments remain in isolation, and transcription of the reporter gene does not occur.  
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Reporter genes must encode proteins whose function/phenotype can be easily 
assessed, and these include the more commonly used auxotrophic growth markers 
(e.g. LEU2, HIS3, ADE2, URA3, LYS2), whose activation enables yeast to grow on 
defined minimal media lacking specific amino acids, as well as the lacZ gene, which 
encodes the beta-galactosidase enzyme. Therefore, interactions between bait and 
prey proteins in yeast, can be translated into a transcriptional readout which results 
in growth of yeast on selective media and colour development when using a 
colorimetric substrate such as X-Gal in the b-galactosidase assay (Brückner et al., 
2009). Current Y2H screens usually assay two or more reporter genes in parallel, 
increasing stringency of the screen and the reliability of data. 
 
The Y2H system is efficient and easy to use, and as such it has become one of the 
most common and successfully used high-throughput methods to investigate binary 
protein interactions (Dreze et al., 2010). For large-scale screenings, there are two 
distinct, commonly used screening approaches: the matrix mating (or array) 
approach, in which baits are screened against an array of defined preys (pair-wise 
interaction analysis), and the library approach, in which baits are screened against 
high complexity prey cDNA libraries (cDNA library screening). In the matrix approach, 
various combinations of full-length or truncated open reading frames (ORFs) can be 
systematically tested through direct mating with a collection of defined bait and prey 
clones expressed in yeast with different mating types (e.g. mating type a for baits 
against type α for preys) (Brückner et al., 2009). This approach is easily automated 
and has been fundamental for global interactome studies. It was originally used to 
generate an overview of the yeast proteome, screening various combinations of the 
6,000 ORFs which were cloned into bait and prey vectors, identifying over 5,600 
interactions, a 70% coverage of the yeast proteome (Fields et al., 2000; Ito et al., 
2001). The defined bait position in a matrix allows quick identification of interacting 
preys without sequencing. In the ‘classical’ library approach, a defined bait is used to 
carry out a comprehensive screen of cDNA-libraries, which contain pools of random 
full-length and fragmented prey ORF clones, identifying large numbers of novel 
interaction partners for a given bait protein of interest (Brückner et al., 2009). 
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Several variations on the ‘classical’ Y2H system have since been devised, involving 
different DNA-binding domains derived from the Escherichia coli LexA protein, 
transcriptional activation domains derived from the herpes simplex virus VP16 
protein, and various reporter gene combinations (Brückner et al., 2009). 
 
1.7.3.1 Advantages and limitations of Y2H 
 
The yeast two-hybrid (Y2H) system is able to detect protein interactions in a cellular 
‘in vivo’ environment, and since it is a relatively simple, cost-effective technique 
which can be easily adapted for high-throughput studies, it is now considered one of 
the most widely and successfully used systems of choice for the detection of binary 
protein-protein interactions (Brückner et al., 2009). 
 
There are limitations associated with yeast two-hybrid (Y2H) methods which are 
imposed by the occurrence of false negative and false positive interactions. False 
negative interactions are true interactions that cannot be detected in the ‘classical’ 
Y2H screening methodology due to inherent technical limitations. These include 
interactions involving membrane proteins, proteins which require post-translational 
modifications, or self-activating proteins. False negative interactions can be caused 
by a number of factors: (i) failure in nuclear localisation – once bait and prey are 
expressed they must be able to enter or be stably expressed in the yeast nucleus in 
order to activate transcription of downstream reporter gene; (ii) incorrect folding of 
the fusion proteins – the BD or AD fusion moiety may obstruct the site of interaction, 
or cause steric hindrance which prevents protein interaction; (iii) co-factors or post-
translational modifications – may be different or lacking in yeast (host organism). 
Proper folding or post-translational protein modification may be required for certain 
protein interactions, particularly interactions between proteins of higher eukaryotes 
(Brückner et al., 2009; Rodríguez-Negrete, Bejarano and Castillo, 2014). 
 
False positive interactions detected in the context of the ‘classical’ Y2H methodology 
are non-specific interactions. These are not reproducible in any independent system 
and are therefore physiologically meaningless. Some of the possible reasons for the 
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occurrence of false positive interactions in yeast include: (i) overexpression of bait 
and prey proteins and their localisation in a ‘foreign’ environment. Human proteins 
in particular, are localised in a compartment which is not their natural environment, 
and this promotes the formation of non-specific interactions; (ii) self-activating bait 
protein – which can activate reporter gene transcription in the absence of prey; (iii) 
proteins that directly bind and activate reporter promoters – this can be reduced 
when two or more reporter genes are assayed increasing the stringency of the assay; 
(iv) proteins known to be intrinsically “sticky” or incorrectly folded can lead to 
formation of non-specific interactions (Brückner et al., 2009; Rodríguez-Negrete, 
Bejarano and Castillo, 2014). Regardless of the limitations highlighted above, the Y2H 
system remains a powerful tool for large-scale binary protein-protein interaction 
screening. 
 
The ‘classical’ Y2H system generated by Fields and Song (1989), has been used to 
develop several alternative variants to overcome the limitations associated with 
compartment and cell-type, increasing coverage and reliability associated with Y2H 
systems (Suter, Auerbach and Stagljar, 2006). Some of these variant Y2H 
methodologies are designed to detect interactions between membrane proteins 
(e.g. membrane yeast two-hybrid, MYTH), cytosolic proteins (e.g. split-TEV system), 
or even protein interactions in mammalian cells (e.g. mammalian protein-protein 
interaction trap, MAPPIT), some of which have been adapted for large-scale screens 
(Suter, Kittanakom and Stagljar, 2008). 
 
1.7.4 Membrane Yeast two-Hybrid (MYTH) 
 
Almost one-third of all genes across various organisms encode integral membrane 
and/or membrane-associated proteins (Stagljar and Fields, 2002). Integral 
membrane proteins are one of the most biologically important protein classes, with 
key roles in various cellular processes which includes cell signalling, molecular 
transport, metabolism and cell structure maintenance (Stagljar and Fields, 2002; 
Engel and Gaub, 2008; Cordwell and Thingholm, 2010). Many integral membrane 
proteins have been functionally linked to disease, making them particularly 
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significant as potential drug targets, with the majority of current therapeutics 
directed towards altering their function (Overington, Al-Lazikani and Hopkins, 2006). 
The identification and characterisation of membrane protein-protein interactions 
and subsequent ‘interactome’ maps, are key to gaining an insight into the function 
and mechanism of action associated with this class of proteins (Stagljar and Fields, 
2002; Suter, Kittanakom and Stagljar, 2008). Detection of membrane protein-protein 
interactions (PPIs) is particularly challenging due to their hydrophobic nature and 
non-nuclear localisation, making them difficult to analyse using conventional 
interaction detection methods (Stagljar et al., 1998). However, the biological and 
clinical importance of this class of proteins encouraged the development of the 
membrane yeast two-hybrid (MYTH) system, which allows the high-throughput 
identification of PPIs involving full-length integral membrane proteins and 
membrane-associated proteins in an in vivo setting inside cellular membranes, using 
the model organism Saccharomyces cerevisiae as a host (Stagljar et al., 1998; Iyer et 
al., 2005; Paumi et al., 2007). In contrast to the ‘classical’ Y2H system, there is no 
need for the bait and prey proteins, once expressed, to enter the nucleus.  
 
MYTH is a powerful tool which exploits the concept of ‘split-ubiquitin’, the notion 
that ubiquitin, a small and evolutionary conserved protein that functions as a tag, 
marking proteins for degradation by the 26S proteasome (Hershko, 2005), can be 
separated into two moieties: C-terminal (Cub) and N-terminal (Nub) fragments, that 
can spontaneously re-associate in vivo to form a full-length ‘pseudo-ubiquitin’ 
molecule due to their high affinity for one another (Figure 1.3 A). This strong affinity 
can be blocked though the introduction of an isoleucine 13 to glycine mutation, 
producing a mutated NubG fragment which has almost no affinity for Cub when co-
expressed in the same cell (Figure 1.3 B). As shown in Figure 1.3 C, the ‘split-ubiquitin’ 
principle is easily adapted for use as a protein-protein interaction ‘sensor’ (Johnsson 
and Varshavsky, 1994; Stagljar et al., 1998).  
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Figure 1.3 
 
 A         B                          C 
 
 
  
 
 
 
 
 
 
 
 
 
  
 
 
 
 
Figure 1.3. Principle of ‘split-ubiquitin’. (A) Wild-type ubiquitin can be split into N-
terminal (NubI, light green) and C-terminal (Cub, dark green) fragments, which can 
spontaneously re-associate. The ‘pseudo-ubiquitin’ molecule formed can be 
recognized by cytosolic deubiquitinating enzymes (DUBs) which releases the 
reporter. (B) A point mutation at position 13 from an isoleucine to glycine (NubG) 
prevents spontaneous re-association. Interacting proteins, X and Y, are fused to the 
NubG and Cub domains, respectively. If X and Y interact, NubG and Cub domains are 
brought into close proximity which causes partial re-association of ubiquitin, 
recognition by DUBs and release of reporter. Adapted from Fetchko and Stagljar, 
2004. 
 
In the ‘split-ubiquitin’-based membrane yeast two-hybrid (MYTH) system (Figure 
1.4), the membrane protein of interest (bait) is tagged at its N or C terminus to the 
C-terminal half of ubiquitin (Cub), along with an artificial transcription factor (TF) 
composed of the bacterial LexA DNA-binding domain (BD) and the herpes simplex 
virus VP16 transcriptional activation domain (AD), which is used as a cleavable 
reporter protein (Brückner et al., 2009). Membrane-bound or cytosolic interacting 
proteins (preys) are tagged at either their N or C terminus to the mutated N-terminal 
half of ubiquitin (Nub) fragment, NubG, so as to prevent spontaneous re-association 
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of the split-ubiquitin fragments. For high-throughput applications, prey NubG-fused 
cDNA libraries can also be generated and used to identify novel interaction partners 
for a given membrane protein of interest (bait) (Snider et al., 2010). 
 
Both bait and prey proteins are co-expressed in an S.cerevisiae host. Following a 
direct interaction between bait and prey proteins, the Cub and NubG fragments are 
brought into close proximity, allowing the reconstitution of the ‘pseudo-ubiquitin’ 
molecule which can be recognised by the cytosolic proteases, DUBs (Johnsson and 
Varshavsky, 1994; Stagljar et al., 1998; Snider et al., 2010). DUBs (deubiquitinating 
enzymes) are a class of proteases involved in the de-conjugation of ubiquitin from 
proteins targeted for degradation, through the hydrolysis of the amide bond 
between the protein and the C-terminal residue of ubiquitin (Love et al., 2007; Snider 
et al., 2010). As a result of this reaction, the artificial TF (LexA-VP16) is released from 
the membrane and translocates to the nucleus, where it activates reporter gene 
transcription (e.g. HIS3, ADE2 and lacZ) (Snider et al., 2010).  
 
Figure 1.4  
 
Figure 1.4. ‘Split-ubiquitin’ based membrane yeast two-hybrid (MYTH) system. Bait 
(red) and prey (purple) proteins are tagged with Cub-LexA-VP16 and NubG, 
respectively. Interaction between bait and prey proteins enables the NubG and Cub 
fragments to associate and form a ‘pseudo-ubiquitin’ which can be recognized by 
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cytosolic DUBs. DUBs cleave after the terminus of the Cub tag, releasing the LexA-
VP16 transcription factor (TF). The TF can enter the nucleus and activate the reporter 
system. Additionally, even though a membrane-bound prey protein is depicted in the 
figure above, the MYTH system is just as effective using preys with cytosolic 
localisation. Adapted from Snider et al., 2010.  
 
Reporter genes typically used in the MYTH screen are the same as those used in the 
‘classical’ Y2H system, which include the more commonly used auxotrophic growth 
markers (e.g. HIS3, and ADE2) as well as the lacZ gene, which encodes the beta-
galactosidase enzyme. Interactions between bait and prey proteins in yeast can 
therefore be translated into a transcriptional readout resulting in growth of yeast on 
selective media and yeast colour development in a b-galactosidase assay (Stagljar et 
al., 1998; Iyer et al., 2005; Paumi et al., 2007). 
 
This system has been successfully adapted for use in cDNA library screens (Thaminy 
et al., 2003; Wang et al., 2004) and large-scale matrix approaches (Pandey and 
Assmann, 2004; Miller et al., 2005) to identify and characterise binary protein-
protein interactions between integral membrane proteins, membrane-associated 
proteins and cytosolic proteins in their natural environment. MYTH is sensitive 
enough to be able to detect both transient and stable interactions of exogenously 
and endogenously expressed proteins (Snider et al., 2010).  
 
1.7.4.1 Advantages and limitations of MYTH  
 
The membrane yeast two-hybrid (MYTH) system is a powerful tool which, unlike the 
‘classical’ Y2H system, allows the investigation of protein-protein interactions 
involving full-length membrane proteins and/or membrane-associated proteins in 
vivo and in situ, as there is no need for nuclear localisation (Stagljar et al., 1998; Iyer 
et al., 2005; Paumi et al., 2007). There is however a requirement for membrane 
proteins to have their N and/or C terminus located in the cytosol (Snider et al., 2010). 
In addition, the MYTH system is relatively simple and can easily be adapted for high-
throughput studies, which include large-scale matrix and library screening 
applications, as well as smaller-scale interaction studies. Although it is not suitable 
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for use with cytosolic bait proteins, interactions involving both membrane-bound 
and cytosolic proteins can be detected (Snider et al., 2010). 
 
All yeast two-hybrid (Y2H) methods have limitations associated with the occurrence 
of false positive and false negative interactions, caused by a number of common 
factors. For example, false negative interactions can occur as a result of increased 
steric hindrance caused by either the Cub-LexA-VP16 tag on the bait protein in the 
MYTH system or the BD or AD fusion moiety in the ‘classical’ Y2H system, which 
affects certain protein-protein interactions (Brückner et al., 2009). Alternatively, 
false positive interactions can occur in both the MYTH system and the ‘classical’ Y2H 
system, if the bait protein can activate the reporter system in the absence of an 
interacting prey, it is known to ‘self-activate’. In the MYTH system, the level of ‘self-
activation’ can be assessed using the NubG/NubI control test. If a bait shows some 
level of ‘self-activation’ the stringency of the selective medium can be increased 
using the HIS3 competitive inhibitor 3-amino-1,2,4-triazole (3-AT), which, if used, 
must be consistent throughout the screening process (Snider et al., 2010). 
 
1.8       Aims 
 
Hereditary spastic paraplegias (HSPs) are a large, genetically diverse group of 
disorders characterised by progressive lower limb spasticity and pyramidal 
weakness. This defining clinical feature is thought to be length-dependent 
axonopathy affecting the distal ends of corticospinal tract axons, for which gene 
mutation is a major causative factor. However, the genetic basis of many cases of 
HSP and the factors that control age-of-onset or severity remain unclear. 
Identification of genetic mutations that contribute to inherited forms of HSP provides 
valuable insight into the molecular mechanisms and pathogenesis of this group of 
disorders, as well as improving our understanding of the cellular processes required 
for axonal maintenance or degeneration. 
 
Although increasing numbers of HSP-related genes are being identified, in many 
cases the underlying mechanistic changes that lead to an HSP phenotype remain 
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uncharacterised. We hypothesise that proteins that interact with known disease-
causing HSP proteins may in some cases also acquire mutations that contribute to 
specific HSP-related phenotypes. Therefore, identification of proteins that interact 
with known HSP proteins, or exist in common molecular complexes, may provide 
new insight into the molecular mechanisms fundamental to the pathogenesis of this 
group of disorders.  
 
To improve our understanding of the pathogenic mechanisms that contribute to the 
onset and progression of HSPs, we aim to perform a systematic investigation of HSP 
protein interactions. The net result will be an extended high-density map of the 
human HSP interactome, thereby providing a resource to guide future hypothesis-
driven research, as well as for the development of new strategies for therapeutic 
intervention.  
 
Specific aims of the project: 
1. To generate an initial high-density HSP interactome consisting of all known and 
predicted interaction partners. 
2. To selectively test a set of binary HSP:HSP interactions using the ‘classical’ yeast 
two-hybrid system.  
3. To selectively test a set of predicted binary HSP:RING E3 ligase and HSP:DUB 
interactions using the ‘classical’ yeast two-hybrid system to understand more 
about changes in ubiquitination in HSP.  
4. To generate a set of HSP disease-related mutant proteins which can be used to 
conduct high-throughput interaction profiling, in order to identify novel edgetic 
effects within the HSP interactome. 
5. To identify novel binary HSP interaction partners using the ‘classical’ yeast two-
hybrid library system.  
6. To identify novel binary protein-protein interactions involving full-length 
membrane and membrane-associated HSP proteins using the optimised 
membrane yeast two-hybrid library system.  
7. To integrate all binary HSP interaction data obtained, into an updated HSP 
interactome, which can then be used for bioinformatics analyses to predict areas 
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of interest and functional relevance, as well to guide future hypothesis-driven 
research. 
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Chapter 2: Materials & Methods  
 
2.1 Molecular Biology 
 
2.1.1 Reagents 
 
Custom DNA Primers, TRIzol® reagent (#15596026), SuperScript™ III Reverse 
Transcriptase (#18080093), SYBR® Safe DNA Gel Stain (#S33103), Gateway® BP 
clonase® II (#11789020) and LR clonase® II (#11791020) enzyme kits were all 
obtained from Invitrogen (paisley, UK). dNTP Set (100 mM, #28-4065-52) was 
purchased from GE Healthcare Life Sciences (Buckinghamshire, UK). KOD Hot Start 
DNA Polymerase (#71086-3) was from Novagen (distributed by Merck Chemicals Ltd, 
Nottingham, UK). BIOTAQ™ DNA Polymerase (#BIO-21060), Hyperladder™ 1kb 
(#BIO-33026), Agarose, Molecular Grade (#BIO-41025) and a-Select Competent 
Cells, Silver Efficiency (#BIO-85026) were all purchased from Bioline Reagents Ltd 
(London, UK). Tris-Borate-EDTA (TBE) buffer 10X (#10031223) was from Fisher 
Scientific (Loughborough, UK). Antarctic phosphatase (#M0289S) and all restriction 
endonucleases used, were obtained from New England Biolabs (Hertfordshire, UK). 
Wizard ® Plus SV Minipreps DNA Purification System (#A1460) and RQ1 RNase-Free 
DNase (#M6101) was from Promega (Southampton, UK) whilst HiSpeed Plasmid Maxi 
kits (#12662), QIAquick® Gel Extraction kit (#28704) and QIAquick® PCR Purification 
kit (#28104) were all from QIAGEN (Manchester, UK). Yeast Extract (#YEA03), D(+)-
Glucose Anhydrous (#GLU03), Tryptone (#TRP02) were all from Foremedium 
(Norfolk, UK), whilst the BioAgar (#400-050) was obtained from BioGene 
(Huntingdon, UK). All other reagents, unless otherwise stated, were obtained from 
Sigma-Aldrich (Dorset, UK). 
 
2.1.2 Amplification of a-Select Competent Cells  
 
The a-Select Competent Cells were initially purchased from Bioline and then 
amplified using the following protocol. A 5 µL aliquot of a-Select Competent Cells 
was grown in 5 mL SOC media (Table 2.1) at room temperature (RT), with gentle 
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rocking for 20 h or until the OD600 reached 0.6-0.8. Once grown, 200 µL of culture 
was used to inoculate 250 mL SOC media and grown at room temperature (RT) with 
gentle rocking, until the OD600 reached 0.6-0.8 (approx. 40 h). The culture was cooled 
and stored at 4 °C for 3 h prior to centrifugation at 2600 rpm, 4 °C for 15 min. 80 mL 
of the CCMB80 buffer, pH 6.4 (Table 2.2) was used to resuspend the bacterial pellet, 
and left on ice for 30 min prior to centrifugation at 2600 rpm, 4 °C for 15 min. 8 mL 
of the CCMB80 buffer was used to resuspend the bacterial pellet to achieve an OD600 
of 1.5-2.0, and left on ice for 15 min. Aliquots (100-200 µL) were flash-frozen in 
methanol cooled to -80 °C, and stored at -80 °C. 
 
Table 2.1 
Reagent  Final concentration 
KCl 2.5 mM 
NaCl  10 mM 
MgCl2 10 mM 
MgSO4 10 mM 
D-(+)-Glucose  20 mM 
Yeast Extract 0.5 % (w/v) 
Tryptone 2 % (w/v) 
 
Table 2.1. Constituents required to make SOC medium. Media was made up with 
double-distilled water and autoclaved.   
 
Table 2.2 
Reagent Final concentration 
KOAc (pH 7) 10 mM 
CaCl2.2H2O 80 mM 
MnCl2.4H2O 20 mM 
Glycerol 10 % (w/v) 
 
Table 2.2. Constituents required to make the CCMB80 buffer. Buffer was made up 
in double-distilled water and pH adjusted to 6.4. 
 
2.1.3 Agarose gel electrophoresis 
 
Agarose gels (0.6-1.0 % w/v) were prepared by adding molecular grade agarose to 
0.5X TBE buffer. The mixture was heated, allowing the agarose to dissolve 
completely. SYBR® Safe DNA Gel Stain (1:20,000) was added once cooled, the gel was 
poured and left at room temperature to set. DNA samples were made up in 1% 
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Orange G DNA loading buffer (5 % w/v glycerol, 0.05 % Orange G) and resolved in 
0.5X TBE buffer in a horizontal mini/midi-electrophoresis tank (Bio-Rad, 
Hertfordshire, UK) alongside Hyperladder™ 1kb standard (5 µL/well), at 120 V for 15 
min to 1 h. DNA bands were visualised using an ultraviolet (UV) light source. 
 
2.1.4 Sequencing 
 
Sequencing of all DNA constructs was performed by automated fluorescent DNA 
sequencing by GATC Biotech (Konstanz, Germany). Following purification, 
sequencing of the 5’ end of yeast colony PCR products was performed by automated 
fluorescent DNA sequencing by GATC Biotech (Konstanz, Germany). 
 
2.1.5 Bacterial glycerol stocks 
 
Glycerol stocks of transformed bacterial cells, containing sequence-verified 
constructs, were made from 10 mL 2X TY medium (Table 2.3) plus appropriate 
antibiotic culture which was previously inoculated with a single bacterial colony and 
grown at 37 °C, 220 rpm for 16 h. A 200 µL aliquot of overnight bacterial culture was 
combined with 80 µL sterile glycerol (80 % v/v) in a labelled 1.5 mL microcentrifuge 
tube, prior to storage at -80 °C. 
 
Table 2.3 
Reagent g/L 
NaCl 5 
Yeast Extract 10 
Tryptone 16 
BioAgar* 20 
 
Table 2.3. Constituents required to make 2X TY medium. All media was made up 
with double-distilled water and autoclaved. (*for solid media only) 
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2.1.6 RNA extraction and cDNA synthesis  
 
2.1.6.1 RNA extraction 
 
RNA was extracted from HEK293T, A549, HeLa and K-562 cell lines. RNaseZAP™ 
(Sigma-Aldrich) was used on all work surfaces, removing any RNase. To a 10 cm dish 
of confluent cells (80-100 %), 1 mL TRIzol® reagent (Invitrogen) was added and 
incubated at room temperature until all the cells had detached from the dish. Cells 
were transferred into a 1.5 mL microcentrifuge tube, with the help of a cell scraper. 
Next, 200 µL chloroform was added, and samples shaken vigorously for 15 sec. 
Samples were centrifuged at 13,000 rpm, RT for 15 min separating into three layers: 
a clear, aqueous phase (top), white precipitated DNA (middle) and a pink organic 
phase (bottom). The clear phase (top layer) was carefully transferred into a clean 1.5 
mL microcentrifuge tube and gently mixed with 500 µL isopropanol. Samples were 
incubated at room temperature for 10 min, followed by centrifugation at 13,000 rpm, 
RT for 10 min. The RNA pellet was washed with 1 mL 75 % ethanol solution, 
centrifuged at 7,000 rpm, RT for 5 min and washed again with 1 mL 75 % ethanol 
solution. Samples were kept on ice or stored at -20 °C. 
 
2.1.6.2 DNase treatment and cDNA synthesis 
 
Ethanol was removed, and RNA pellets left to air-dry for 10-20 min, before 30 µL 
DEPC-treated water was added and gently mixed. RNA concentration was estimated, 
using a spectrophotometer to measure the optical density at 260 nm. The DNase 
reaction mixture (Table 2.4 A) was set up in 0.2 mL PCR tubes and incubated at 37 °C 
for 30 min. Next, 1 µL RQ1 DNase Stop Solution was added and incubated at 60 °C 
for 15 min, inactivating the DNase and terminating the reaction. DNase treated RNA 
samples were placed on ice. The reaction mixture (Table 2.4 B) was set up using 
DNase-treated RNA from the previous step in clean 0.2 mL PCR tubes and incubated 
at 65 °C for 5 min. Samples were immediately placed on ice. These samples were 
used in the reaction mixture shown in Table 2.4 C and cycled in a thermocycler as 
described (Table 2.4 D). The RNA samples are now thought to be successfully 
converted into cDNA, which can be used immediately or stored at -20 °C. 
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Table 2.4 
A 
Reagent µL/reaction Final concentration 
RQ1 RNase-free DNase 1 - 
RQ1 DNase 10X reaction buffer  1 - 
RNA sample X (1.4 µg) 1X 
DEPC-treated H2O 8-X - 
TOTAL 10 - 
 
B 
Reagent µL/reaction Final concentration 
DNase-treated RNA 4 - 
Random hexamers (100 ng/µL) 2 14.29 ng/µL 
dNTPs (10 mM) 1 0.714 mM 
DEPC-treated H2O 7 - 
TOTAL 14 - 
 
C 
Reagent µL/reaction Final concentration 
DNase-treated RNA sample 14 - 
SuperScript™ III RT (200 U/µL) 1 10 U 
5X First-Strand Buffer 4 1X 
DTT (0.1 M) 1 5 mM 
TOTAL 20 - 
 
D 
Step Temperature (°C) Duration 
1 25 5 min 
2 50 60 min 
3 70 15 min 
4 4 Forever 
 
Table 2.4. Multi-step reaction mixtures and cycling parameters for cDNA synthesis. 
Reagents and volumes required for each of the following steps: (A) DNase treatment 
of RNA, (B) and (C) Reverse transcription of DNase-treated RNA. Thermal cycling 
parameters for cDNA synthesis (D).  
 
2.1.7 ORF cloning from cDNA and cDNA libraries 
 
Open reading frames (ORFs) were initially amplified from cDNA or cDNA libraries by 
polymerase chain reaction (PCR) using KOD Hot Start DNA polymerase and specific 
primers designed to the 5’ and 3’ end of the coding mRNA sequence (CDS) and 
 69 
containing the Gateway® attB recombination site sequences necessary for the 
subsequent BP reaction. These recombination sequences were: 
 
Forward primer:  
5’ GAATTCACAAGTTTGAAAAAAGCAGGCTGGATG [gene-specific sequence] 3’ 
Reverse primer:  
5’ GTCGACCACTTTGTACAAAGCTGGGTG [gene-specific sequence] 3’  
 
 A typical KOD PCR reaction is shown in Table 2.5. Following PCR amplification, a 
sample (10 µL) of the reaction was analysed by gel electrophoresis, for correct 
fragment size, before continuing with subsequent Gateway® cloning. 
 
Table 2.5 
A 
Reagent µL/reaction Final concentration 
Forward primer (10 µM) 0.5 0.2 µM 
Reverse primer (10 µM) 0.5 0.2 µM 
10X KOD buffer 2.5 1X 
MgSO4 (25 mM) 1.5 1.5 mM 
dNTPs (2 mM) 2.5 0.2 mM 
KOD polymerase 0.5 - 
cDNA/cDNA library X (280 ng) - 
Nuclease-free H2O 17-X - 
TOTAL 25 - 
 
B 
Step Cycles Temperature (°C) Duration 
1 1 95 2 min 
 
2 
 
 
30-40* 
 
95 30 s 
55-68** 1 min 
72 30 s/kb 
3 1 4 Forever 
 
Table 2.5. Master mix and cycling parameters for a typical KOD Hot Start DNA 
polymerase chain reaction. (A) Reaction master mix was set up in thin-walled PCR 
tubes, using reagents and volumes stated. (B) KOD PCR was cycled as indicated.  
*30 cycles for amplification from plasmid DNA, 40 cycles from cDNA.  
**Annealing temperatures vary depending on the predicted melting temperature 
(Tm) of the individual primers used.  
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2.1.8 Gateway® Cloning 
 
Gateway® Technology (Invitrogen) was employed as the main cloning strategy for 
the generation of the HSP constructs used in this study, which enables quick and easy 
shuttling of ORFs into a range of expression vectors.  
 
2.1.8.1  Gateway® BP reaction 
 
Following PCR amplification, in vitro recombination of ORFs containing attB sites and 
the donor vector pDONR223 (containing attP sites) was performed to generate entry 
clones, via a BP recombination reaction using the Gateway® BP clonase® II enzyme 
kit.  
 
The reactions were set up on ice as detailed in Table 2.6 and incubated at 25 °C for 
16 h. Following incubation, Proteinase K (0.5 µL) was added to each reaction and 
further incubated at 37 °C for 10 min, allowing the remaining clonase enzymes to be 
digested, before storing at -20 °C or immediately using in bacterial transformation.  
 
Table 2.6 
Reagent µL/reaction 
attB-PCR product 1.5 
attP donor vector (pDONR223) X (100 ng) 
BP clonase® II enzyme mix 1 
Nuclease-free H2O 2.5-X 
TOTAL 5 
 
Table 2.6. BP recombination reaction mixture. Reaction mixture was set up on ice, 
using reagents and volumes stated. 
 
2.1.8.2 Gateway ® LR reaction 
 
LR recombination reactions involve the in vitro recombination of entry clones 
(containing attL sites) and various destination vectors (containing attR sites), to 
generate expression clones, using the Gateway® LR clonase® II enzyme kit. The 
reactions were set up on ice, as detailed in Table 2.7, with equal amounts of entry 
clone and destination vector (100 ng). They were incubated at 25 °C for 16 h, 
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followed by Proteinase K (0.5 µL) addition and further incubation at 37 °C for 10 min, 
allowing the remaining clonase enzymes to be digested, before storing at -20 °C or 
immediately using in bacterial transformation. 
 
Table 2.7 
Reagent µL/reaction 
attL entry clone X (100 ng) 
attR destination vector  Y (100 ng) 
LR clonase® II enzyme mix 1 
Nuclease-free H2O 4-X-Y 
TOTAL 5 
 
Table 2.7. LR recombination reaction mixture. Reaction mixture was set up on ice, 
using reagents and volumes stated. 
 
2.1.9 Seamless Ligation Cloning Extract (SLiCE) 
 
The Seamless Ligation Cloning Extract (SLiCE) method, recently developed in the 
Motohashi lab (Kyoto, Japan), exploits the homologous recombination activities of E. 
coli cell lysates to assemble DNA fragments into a vector, and as such is a relatively 
novel seamless DNA cloning tool (Motohashi, 2015). SLiCE is a relatively simple, low-
cost homemade alternative to the many commercially available seamless DNA 
cloning kits. The primer sequences contain 15-21 bases homologous to the linear 
ends of the vector, followed by 18-21 bases homologous to the gene of interest. PCR 
reagents and cycling parameters are outlined in Table 2.5. 
 
2.1.9.1 SLiCE extract preparation 
 
The SLiCE extract can be prepared from any RecA (-) strain of bacteria, using the 
following protocol. 5 mL 2X LB media was inoculated (Table 2.8) with 5 µL RecA (-) 
bacterial strain (a-select competent cells) and incubated at 37 °C, 220 rpm for 16 h.  
 
 
 
 
 
 
 72 
Table 2.8 
Reagent g/L 
NaCl 20 
Yeast Extract 10 
Tryptone 20 
BioAgar* 20 
 
Table 2.8. Constituents required to make 2X LB medium. All media was made up 
with double-distilled water and autoclaved (*for solid media only). 
 
The culture was diluted with a further 45 mL 2X LB media, transferred to a 500 mL 
flask and incubated at 37 °C, 220 rpm for 3 h or until the OD600 reached 0.3 for a 1:10 
dilution sample. Bacteria were harvested by centrifugation at 4 °C, 4,300 rpm for 20 
min and supernatant discarded. Bacterial pellet was resuspended in 50 mL ice-cold 
sterile ddH2O before centrifugation at 4 °C, 4,300 rpm for 10 min. Again, supernatant 
was discarded, and pellet was resuspended in 1.2 mL 3 % (w/v) Triton X-100 in 50 
mM Tris-HCl (pH 8) and transferred to 2 mL microcentrifuge tube. The mixture was 
incubated at RT for 10 min, followed by centrifugation at 4 °C, 13,000 rpm for 5 min. 
Supernatant was transferred to a microcentrifuge tube and one volume of ice-cold 
80 % glycerol was added. Aliquots (50 µL) were flash-frozen in liquid nitrogen and 
stored at -80 °C. The SLiCE buffer was prepared as shown in Table 2.9, sterile filtered, 
and stored at -20 °C in 1 mL aliquots. 
 
Table 2.9 
Reagent Volume (mL) Final concentration 
1 M Tris-HCL, pH 7.5 5 500 mM 
1 M MgCl2 1 100 mM 
100 mM ATP 1 10 mM 
100 mM DTT 1 10 mM 
ddH2O 2 - 
 
Table 2.9. Constituents required to make the SLiCE buffer. 
 
2.1.9.2 SLiCE reaction 
 
The SLiCE reactions were set up on ice, as detailed in Table 2.10, and incubated at 37 
°C for 15-30 min, followed by immediate bacterial transformation or storage at -20 
°C.  
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Table 2.10 
Reagent µL/reaction 
PCR insert X (30 ng) 
Linearised vector  Y (10 ng) 
10X SLiCE buffer 1 
SLiCE extract 1 
Nuclease-free H2O 8-X-Y 
TOTAL 10 
 
Table 2.10. SLiCE reaction mixture. Reaction mixture was set up on ice, using 
reagents and volumes stated, and then incubated at 37 °C for 30 min. 
 
2.1.10 Transformation of chemically competent bacterial cells 
 
Gateway® BP and LR reactions were transformed into chemically competent a-select 
silver efficiency cells. a-select cells were thawed on ice and 25 µL aliquots were 
added to pre-cooled 2 mL microcentrifuge tubes. 2 µL BP or LR reaction mixture was 
added to the thawed cells and incubated on ice for 30 min. Cells were heat-shocked 
(42°C for 45 sec) in a water bath and immediately returned to ice for 2 min. SOC 
media (250 µL) was added to the cells followed by incubation at 37 °C, 220 rpm for 1 
h. 200 µL sample of the culture was plated onto 2X TY agar plates supplemented with 
the appropriate antibiotic, depending on the plasmid and incubated at 37 °C for 16 
h. 
 
2.1.11 Diagnostic bacterial colony PCR (BC-PCR) 
 
Diagnostic BC-PCR was performed to test Gateway® cloning reactions, and whether 
bacterial transformation of a DNA construct had been successful. All BC-PCR 
reactions were carried out using BIOTAQ™ DNA Polymerase using vector-specific 
primers (see Appendix 2.1). A typical BC-PCR reaction and cycle are shown in Table 
2.11. Following BC-PCR, samples were analysed by gel electrophoresis, for correct 
insert size. 
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Table 2.11 
A 
Reagent µL/reaction Final concentration 
Forward primer (10 µM) 0.7 0.7 µM 
Reverse primer (10 µM) 0.7 0.7 µM 
10X NH4 buffer 1.0 1X 
MgCl2 (50 mM) 0.4 2 mM 
dNTPs (25 mM) 0.25 0.625 mM 
BIOTAQ™ DNA polymerase 0.05 - 
Nuclease-free H2O 6.9 - 
TOTAL 10 - 
 
B 
Step Cycles Temperature (°C) Duration 
1 1 95 5 min 
 
2 
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95 1 min 
55-68* 1 min 
72 1 min/kb 
3 1 72 5 min 
4 1 4 Forever 
 
Table 2.11. Master mix and cycling parameters for a typical BC-PCR. (A) Reaction 
master mix was set up in thin-walled PCR tubes on ice, using reagents and volumes 
stated. Half of a bacterial colonies were picked with sterile toothpicks and 
resuspended in the BC-PCR reaction mixture. (B) BC-PCR was cycled as indicated.  
*Annealing temperatures vary depending on the predicted melting temperature 
(Tm) of the individual primers used. 
 
2.1.12 DNA plasmid purification 
 
Positive bacterial colonies were selected for subsequent plasmid DNA purification. 
The remainder of the bacterial colony was picked with a sterile toothpick and used 
to inoculate 9 mL 2X TY broth supplemented with appropriate antibiotic and grown 
at 37°C, 220 rpm for 16 h. Bacterial glycerol stocks were made from the overnight 
culture as described previously in section 2.1.5. The remainder of the bacterial 
culture was then pelleted by centrifugation (4000 rpm, 4 °C, 10 min), supernatant 
was removed, and DNA purified using the Wizard ® Plus SV Minipreps DNA 
Purification System (Promega) according to the manufacturer’s protocol. Following 
correct sequencing analysis, the glycerol stocks of the positive bacterial colonies 
were used to inoculate 2X TY broth supplemented with appropriate antibiotic and 
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overnight cultures were then used for DNA purification using the HiSpeed Maxiprep 
kit (QIAGEN). The concentration for both mini/maxi-prep DNA was estimated, by 
measuring the optical density at 260 nm, using a spectrophotometer. 
 
2.1.13 Site-directed mutagenesis 
 
To investigate the potential interaction profile changes caused by disease-specific 
mutations, mutants were made using a similar protocol (see Figure 2.1) to that 
developed for the QuickChange II Site-Directed Mutagenesis approach (Agilent 
Genomics). Reactions were set up using KOD Hot Start DNA polymerase (Table 2.12) 
with sequence-verified pDONR223-ORF constructs and two complementary primers 
carrying base substitutions in the centre of the primers.  
 
Table 2.12 
A 
Reagent µL/reaction Final concentration 
Forward primer (10 µM) 0.5 0.2 µM 
Reverse primer (10 µM) 0.5 0.2 µM 
10X KOD buffer 2.5 1X 
MgSO4 (25 mM) 1.5 1.5 mM 
dNTPs (2 mM) 2.5 0.2 mM 
KOD polymerase 0.5 - 
DNA X (10 ng) - 
Nuclease-free H2O 17-X - 
TOTAL 25 - 
 
B i 
Step Cycles Temperature (°C) Duration 
1 1 95 30 s 
 
2 
 
 
12-18 
 
95 30 s 
55-60* 1 min 
68 30 sec/kb 
3 1 4 Forever 
 
B ii 
Type of mutation Number of cycles 
Point mutation 12 
Single amino acid change 16 
Multiple amino acid insertions/deletions 18 
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Table 2.12. Master mix and cycling parameters for a typical KOD Hot Start DNA 
polymerase mutagenesis reaction. (A) Reaction master mix was set up in thin-walled 
PCR tubes, using reagents and volumes stated. (B i) Mutagenesis KOD PCR was cycled 
as indicated. (B ii) Step 2 of the cycling parameters changes according to mutation 
type desired. 
*Annealing temperatures vary depending on the predicted melting temperature 
(Tm) of the individual primers used. 
 
A sample of the PCR reaction mixture was analysed by gel electrophoresis to check 
that the whole plasmid had been amplified. Following successful amplification, 
reactions were incubated with 1 µL DpnI and incubated at 37 °C for 1 h. DpnI, a 
restriction endonuclease, was added to digest any of the original DNA template as it 
recognizes methylated adenine in the short DNA sequence GATC. DNA replicated in 
bacteria, like the original template, will be methylated unlike products synthesized 
in vitro, therefore the original product will be digested leaving the mutated DNA 
construct. A sample of the digest mixture was analysed by gel electrophoresis to 
check the digest had worked. The remainder was purified using a PCR purification kit 
(QIAGEN), according to the manufacturer’s protocol, followed by bacterial 
transformation (see section 2.1.10). Following diagnostic BC-PCR, positive colonies 
were selected for plasmid DNA purification (see section 2.1.12) and sequenced to 
check that the mutagenesis had worked. 
 
2.1.14 Restriction endonuclease assays 
 
Restriction enzymes and buffers from New England Biolabs (NEB), were used for 
restriction digests according to the manufacturer’s protocol. An initial diagnostic 
digest was performed for 1 h, digesting 1 µg DNA in a total volume of 10 µL. For 
cloning reactions, 2-5 µg DNA was digested in a total volume of 50 µL for 2-4 h. An 
excess of enzyme, equating to no more than 10 % of the total volume, was used. 
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Figure 2.1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.1. Overview of the site-directed mutagenesis method. Complementary 
primer pairs were designed with the appropriate base substitutions and used to 
amplify the mutant strand using the original as a template. DpnI digestion of the 
template DNA was performed prior to bacterial transformation of the mutant. 
(Adapted from Agilent Genomics) 
 
2.2 Yeast two-Hybrid clone generation and matrix mating 
 
2.2.1 Reagents and media 
 
The yeast two-hybrid strain PJ69-4A (MATa trp1-901 leu2-3, 112 ura3-52, his3-200 
gal4D gal80D LYS2::GAL1-HIS3 GAL2-ADE2 met2::GAL7-lacZ), was used as the bait 
strain for all Y2H matrix mating assays (provided by Phil James, University of 
Wisconsin, USA). The PJ69-4A strain carries three independent GAL4-responsive 
reporter genes and was used to create the switched mating-type strain PJ69-4a, a 
suitable mating partner with an identical genotype.  
*
*
*
*
DpnI digest
Transformation
*
*
*
*
PCR
mutant	strand	synthesis
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PJ69-4a (provided by Phil James) was used as the prey strain for all Y2H matrix mating 
assays. Yeast Extract (#YEA03), D(+)-Glucose Anhydrous (#GLU03), Tryptone 
(#TRP02), Peptone (#PEP03) and Yeast Nitrogen Base without Amino Acids 
(#CYN0405) were all from Foremedium (Norfolk, UK), whilst the BioAgar (#400-050) 
was obtained from BioGene (Huntingdon, UK). Adenine hemisulphate salt (#A9126), 
DMSO (#D8418), Sodium hydroxide solution (#3574), Lithium acetate dehydrate 
(LiOAc, #L4158), Poly(ethylene) glycol (PEG 3350, #202444), Deoxyribonucleic acid, 
single stranded from salmon testes (#D7656), 3-Amino-1,2,4-triazole (3-AT, #A8056) 
and all amino acids were from Sigma-Aldrich (Dorset, UK). Custom DNA Primers, 
SYBR® Safe DNA Gel Stain (#S33103) were from Invitrogen (paisley, UK). dNTP Set 
(100 mM, #28-4065-52) was purchased from GE Healthcare Life Sciences 
(Buckinghamshire, UK). KOD Hot Start DNA Polymerase (#71086-3) was from 
Novagen (distributed by Merck Chemicals Ltd, Nottingham, UK). BIOTAQ™ DNA 
Polymerase (#BIO-21060), Hyperladder™ 1kb (#BIO-33026) and Agarose, molecular 
grade (#BIO-41025) were all purchased from Bioline Reagents Ltd (London, UK). Tris-
Borate-EDTA (TBE) buffer 10X (#10031223) was from Fisher Scientific 
(Loughborough, UK). 5-bromo-4-chloro-3-indoyl-b-D-galactoside (X-GAL, #7240906) 
was from Melford Laboratories Ltd (Suffolk, UK). All plastic ware was from STARLAB 
(Milton Keynes, UK) except for the plastic plates which were from Greiner Bio-One 
(Gloucester, UK). All other reagents, unless otherwise stated, were obtained from 
Sigma-Aldrich (Dorset, UK). 
 
Media required for yeast two-hybrid clone generation and matrix matings were 
prepared in-house (Table 2.13-19). Table 2.13 provides an overview of the various 
media used in these studies. 
 
Table 2.13 
Media Description Function 
YPAD Nutrient rich Yeast Extract Peptone Adenine Dextrose Routine yeast growth 
SD-W Synthetic Defined Deficient in tryptophan 
pGBAE-B (bait) selection and 
growth 
SD-L Deficient in leucine pACTBE-B (prey) selection and growth 
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SD-U Deficient in uracil pGBDU (bait) selection and growth 
SD-W,LA Deficient in tryptophan, low adenine MATa (bait) selection and growth 
SD-L,LA Deficient in leucine, low adenine MATa (prey) selection and growth 
SD-WA Deficient in tryptophan and adenine 
Testing for the auto-activation 
of pGBAE-B (bait) constructs SD-WH 
(3-AT) 
Deficient in tryptophan and 
histidine, supplemented with 3-AT 
SD-UA Deficient in uracil and adenine 
Testing for the auto-activation 
of pGBDU-GW (bait) constructs SD-UH 
(3-AT) 
Deficient in uracil and histidine, 
supplemented with 3-AT 
SD-LA Deficient in leucine and adenine Testing for the auto-activation 
of pACTBE-B (prey) constructs SD-LH 
(3-AT) 
Deficient in leucine and histidine, 
supplemented with 3-AT 
SD-WL Deficient in tryptophan and leucine 
Selection and growth of diploid 
clones pGBAE-B (bait) and 
pACTBE-B (prey) 
SD-UL Deficient in uracil and leucine 
Selection and growth of diploid 
clones pGBDU-GW (bait) and 
pACTBE-B (prey) 
SD-WLA Deficient in tryptophan, leucine and adenine Triple selection, used to select 
positive protein interactions 
between pGBAE-B (bait) and 
pACTBE-B (prey) clones SD-WLH 
(3-AT) 
Deficient in tryptophan, leucine and 
histidine, supplemented with 3-AT 
SD-ULA Deficient in uracil, leucine and adenine Triple selection, used to select 
positive protein interactions 
between pGBDU-GW (bait) and 
pACTBE-B (prey) clones SD-ULH 
(3-AT) 
Deficient in uracil, leucine and 
histidine, supplemented with 3-AT 
 
Table 2.13. Summary of all yeast media and their uses. All media could be made into 
solid media by the addition of BioAgar (20 g/L).  
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Table 2.14 
YPAD 
Reagent g/L 
Peptone 20 
D-(+)-Glucose 20 
Yeast extract 10 
Adenine hemisulphate 0.3 
BioAgar* 20 
 
Table 2.14. Constituents required to make YPAD medium. YPAD is required for basic 
MATa and MATa yeast growth. All media was made up with double-distilled water 
and autoclaved. *for solid media only. 
 
Table 2.15 
SD-X 
Reagent g/L 
Yeast nitrogen base w/o AA 6.7 
D-(+)-Glucose 20 
Amino acid supplement mix X 
BioAgar* 20 
 
Table 2.15. Constituents required to make Synthetic Defined (SD-X) media. All 
media was made up with double-distilled water and autoclaved. *for solid media 
only. 
 
Table 2.16 
A/H/L/W/U DO mix 
Amino acid g/100 L 
Arginine 2 
Isoleucine 3 
Lysine 3 
Methionine 2 
Phenylalanine 5 
Threonine 20 
Tyrosine 3 
Valine 15 
 
Table 2.16. Constituents required to make the amino acid dropout (DO) mix. The 
DO mix was added to all SD-X media with the addition of amino acids according to 
the selection required (Table 2.17-19).  
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Table 2.17 
Amino 
acid 
SD-X mix (g/10 L) 
-L -W -U -L, LA -W, LA 
Adenine hem. (A) 0.6 0.6 0.6 0.06 0.06 
Histidine (H) 0.2 0.2 0.2 0.2 0.2 
Leucine (L) - 1.0 1.0 - 1.0 
Uracil (U) 0.2 0.2 - 0.2 0.2 
A/H/W/U DO mix 5.3 5.3 5.3 5.3 5.3 
Total (g/L) 0.63* 0.73 0.71* 0.58* 0.68 
 
Table 2.17. Amino acid supplement mix for SD-X media for bait and prey yeast gap-
repair and transformation. 
* post-autoclaving, supplement media with filter-sterile tryptophan to a final 
concentration of 20 mg/L. 
 
Table 2.18 
Amino 
acid 
SD-X mix (g/10 L) 
-LA -LH -WA -WH -UA -UH 
Adenine hem. (A) - 0.6 - 0.6 - 0.6 
Histidine (H) 0.2 - 0.2 - 0.2 - 
Leucine (L) - - 1.0 1.0 1.0 1.0 
Uracil (U) 0.2 0.2 0.2 0.2 - - 
A/H/W/U DO mix 5.3 5.3 5.3 5.3 5.3 5.3 
Total (g/L) 0.57* 0.61*** 0.67 0.71** 0.65* 0.69*** 
 
Table 2.18. Amino acid supplement for SD-X media for the detection of auto-
activating bait and prey constructs.  
* post-autoclaving, supplement media with filter-sterile tryptophan to a final 
concentration of 20 mg/L.  
**supplement with 3-amino-1,2,4-triazole (3-AT) to a final concentration of 2.5 mM.  
***supplement media with 3-AT and tryptophan. 
 
Table 2.19 
Amino 
acid 
SD-X mix (g/10 L) 
-WL -WLA -WLH -UL -ULA -ULH 
Adenine hem. (A) 0.6 - 0.6 0.6 - 0.6 
Histidine (H) 0.2 0.2 - 0.2 0.2 - 
Leucine (L) - - - - - - 
Uracil (U) 0.2 0.2 0.2 - - - 
A/H/W/U DO mix 5.3 5.3 5.3 5.3 5.3 5.3 
Total (g/L) 0.63 0.57 0.61** 0.61* 0.55* 0.59*** 
 
Table 2.19. Amino acid supplement for SD-X media for the detection of protein-
protein interactions.  
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* post-autoclaving, supplement media with filter-sterile tryptophan to a final 
concentration of 20 mg/L. 
**supplement with 3-AT to a final concentration of 2.5 mM.  
***supplement media with 3-AT to a final concentration of 2.5 mM and tryptophan. 
 
2.2.2 Yeast vectors 
 
Conventional Y2H vectors encode either GAL4 Activation Domain (AD) or DNA-
binding domain (BD) at the 5’ or 3’ end of the recombination site, however pGBAE-B 
(bait) and pACTBE-B (prey) are frame-shift vectors. These frame-shift vectors have 
both GAL4 domain sequences and maintain an open reading frame with the cloning 
site. Instead of a multiple cloning site (MCS), pGBAE-B and pACTBE-B vectors have a 
synthetic DNA fragment containing a BamHI restriction site flanked by attB1 and 
attB2 sequences (Figure 2.2). The addition of one base pair insertion between the 
recombination sequences, allows a frame-shift and stop codon insertion, following 
homologous recombination of an ORF by gap-repair (Semple et al., 2005).  
 
Figure 2.2 
 
 
 
 
 
 
 
 
 
Figure 2.2. Schematic representations of the yeast two-hybrid vectors. pACTBE-B 
prey vector based on pACT2 encodes the GAL4 Activation Domain (AD), whereas 
pGBAE-B bait vector based on pGBD-C1 and pGBDU-GW bait vector based on pGBT9 
GAL4 BDGAL4 ADPADH1 TADH1
attB1 BamHI attB2
2! oriAmpr LEU2
pACTBE-B
ori
GAL4 ADGAL4 BDPADH1 TADH1
attB1 BamHI attB2
2! ori Ampr ori TRP1
pGBAE-B
GAL4 BDPADH1 TADH1
attR1 ccdB attR2
2! oriAmpr URA3
pGBDU-GW
ori
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encode the GAL4 DNA-binding domain (BD). They all utilize the modified, enhanced 
ADH1 promoter giving rise to moderate expression levels. 
 
The addition of a stop codon causes a disruption in GAL4 function which fails to 
activate the ADE2 reporter gene. Consequently, this enables the identification of 
successfully transformed yeast clones as there is a production of red-pigmented 
colonies for clones that contain an insert, and this can be observed on selective 
media containing low amounts of adenine. Empty pGBAE-B and pACTBE-B vectors 
express the GAL4 BD and AD as one in-frame fusion protein, activating the ADE2 
reporter gene and thereby allowing the growth of healthy, white yeast colonies on 
low adenine media. In contrast, pGBDU-GW is a Gateway® converted vector based 
on pGBT9. The attR1 and attR2 recombination sites, enable any ORF to be easily and 
quickly inserted by LR recombination cloning (see section 2.1.8.2). 
 
As a large proportion of WT and all mutant HSP ORFs generated were lacking a stop 
codon, they were put into pACTBE-B (prey) and/or pGBAE-B (bait) vectors. The prey 
E3 RING ligases (pACTBE-B) and the bait DUBs (pGBDU-GW), had been previously 
generated within the laboratory, and were used in subsequent interaction studies 
discussed in Chapter 5. 
 
2.2.3 Proof-reading KOD PCR from pDONR223 
 
Due to sequence variation between the Gateway® attB recombination site 
sequences flanking ORFs in pDONR223 and those in yeast required for in vivo 
homologous recombination, primers were designed which allowed both the 
amplification of any ORF from pDONR223 and yeast homologous recombination.  
 
The primers, shown below, contain bases from the yeast sequence (blue), pDONR223 
sequence (green) and sequence present in both (black). 
 
pDONR223 gap repair F:    5’ GAATTCACAAGTTTGTACAAAAAAGCAGGAATG 3’ 
pDONR223 gap repair R:    5’ GTCGACCACTTTGTACAAGAAAGCTGGG 3’ 
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Sequence-verified pDONR223-ORFs were amplified (using primers above) and 
combined with linearised pGBAE-B (bait) or pACTBE-B (prey) Y2H vector to transform 
yeast. Following PCR amplification, a sample (10 µL) of the reaction was analysed by 
gel electrophoresis, for correct fragment size, before continuing with gap-repair 
cloning. 
 
2.2.4 Gap-repair homologous recombination 
 
pGBAE-B and pACTBE-B vectors were linearized prior to use via restriction digest with 
BamHI restriction enzyme, as described in section 2.1.14. MATa and MATa yeast 
glycerol stocks were streaked onto YPAD agar (Table 2.14) plates and grown at 30 °C 
for 3-5 days. A single MATa or MATa colony was used to inoculate 2 mL YPAD broth 
and grown at 30 °C, 200 rpm for 16 h. An additional 8 mL YPAD broth was added to 
the culture and further incubated at 30 °C, 200 rpm for 5 h. 
 
Yeast were harvested by centrifugation at 2,300 rpm, RT for 5 min and supernatant 
discarded. The yeast pellet was resuspended in 5 mL 100 mM LiOAc. 1.5 mL aliquots 
of LiOAc-yeast mixture (each enough for 10 reactions) was added to 2 mL 
microcentrifuge tubes and pelleted as above. Supernatant was discarded, and the 
pellet was resuspended in 230 µL 50 % (w/v) PEG 3350, 45 µL sterile ddH2O, 35 µL 1 
M LiOAc, 9 µL 10.5 mg/mL heat-denatured salmon testes DNA and 20 ng BamHI-
linearized Y2H vector. The yeast suspension was mixed before transferring 32 µL into 
individual 0.2 mL PCR tubes, followed by 4 µL of a specific gap-repair KOD PCR and 
gentle mixing. As a negative control 4 µL ddH2O was added to 32 µL yeast suspension, 
to assess the level of background growth of red and white colonies. All samples were 
incubated in a thermocycler at the following conditions: 30 °C for 30 min, 42 °C for 
25 min and 30 °C for 1 min. All the reaction mixture was plated out onto appropriate 
low adenine media lacking vector selection marker (Table 2.17), and incubated at 30 
°C for 3-5 days, allowing yeast colonies to grow. Homologous recombination (gap 
repair) between the linearized plasmid and the amplified bait or prey constructs 
occurs in the transformed yeast, which results in recombinant vector construction. 
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The production of red colonies is indicative of positive yeast transformation and ORF 
insertion, and as such a number of red colonies are selected for diagnostic yeast 
colony PCR (YC-PCR) and auto-activation testing (see Figure 2.3 A).  
 
2.2.5 Diagnostic yeast colony PCR (YC-PCR) 
 
To establish whether the correct ORF was inserted into the correct bait and/or prey 
Y2H vector during gap-repair cloning, diagnostic YC-PCR was performed. Several red 
colonies were picked and lysed in 5 µL 20 mM NaOH in 0.2 mL PCR tubes and 
incubated at RT for 20 min. Following incubation, 3 µL NaOH-yeast lysate suspension 
was added to 12 µL of the YC-PCR mix (see Table 2.20 A) and incubated in a 
thermocycler as described in Table 2.20 B. A 5 µL sample of the PCR product was 
analysed by gel electrophoresis, for correct fragment size. Positive colonies were 
taken through to the auto-activation assay. 
 
Table 2.20 
A 
Reagent µL/reaction Final concentration 
Forward primer (10 µM) 0.75 0.5 µM 
Reverse primer (10 µM) 0.75 0.5 µM 
10X NH4 buffer 1.5 1X 
MgCl2 (50 mM) 0.75 2.5 mM 
dNTPs (25 mM) 0.45 750 µM 
BIOTAQ™ polymerase 0.15 - 
DMSO 0.3  
Nuclease-free H2O 7.35 - 
NaOH yeast lysate suspension 3.0  
TOTAL 15 - 
 
B 
Step Cycles Temperature (°C) Duration 
1 1 95 5 min 
 
2 
 
 
40 
 
95 1 min 
55-68* 1 min 
72 1 min/kb 
3 1 72 5 min 
4 1 4 Forever 
 
Table 2.20. Master mix and cycling parameters for a typical YC-PCR. (A) Reaction 
master mix was set up in thin-walled PCR tubes on ice, using reagents and volumes 
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stated. Yeast colonies were lysed in 20 mM NaOH before the addition of YC-PCR 
reaction mixture. (B) YC-PCR was cycled as indicated.  
*Annealing temperatures vary depending on the predicted melting temperature 
(Tm) of the individual primers used. 
 
2.2.6 Auto-activation testing 
 
False positive interactions can occur in Y2H screens if an ORF, when inserted into bait 
or prey Y2H expression vector, causes constitutive activation of reporter genes HIS3, 
ADE2 and/or lacZ, in the absence of a positive interacting protein. This is also known 
as “auto-activation”. To test for auto-activation in yeast clones, the remainder of the 
YC-PCR positive bait and prey yeast colonies were picked from gap-repair 
transformation plates and resuspended in 20 µL ddH2O. The yeast suspension was 
spotted onto double dropout media lacking vector selection marker and one of the 
biosynthetic reporter nutrients (Table 2.18). ADE2 and HIS3 are two of the three 
GAL4-independent reporter genes assayed for auto-activation. Yeast colonies were 
left to grow at 30 °C for up to 14 days, and any colony growth on the double dropout 
media (i.e. auto-activated) were discarded and not taken any further. Those that did 
not auto-activate were used to make glycerol stocks, pooled and used in subsequent 
studies.  
 
2.2.7 Yeast glycerol stocks 
 
In S. cerevisiae, almost all mutations that inhibit GAL4 function are found in the 
region of the gene that encodes the DNA-binding domain (Johnston and Dover, 
1987), and so false negatives may arise from spontaneous mutations within this 
region. Therefore, only pooled glycerols stocks of positive colonies will be used for 
subsequent experimentation, to try and counterbalance any possible spontaneous 
mutations which may arise. 
 
Glycerol stocks of transformed yeast strains were made in synthetic deficient (SD) 
medium lacking appropriate nutrients (SD-X). Yeast colonies were grown for 3 days, 
post-transformation on SD-X agar plates. Following successful YC-PCR, positive 
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colonies were used to inoculate SD-X liquid medium (200 µL) and grown at 30 °C, 220 
rpm for 24 h. Overnight cultures were combined with 80 % (v/v) sterile glycerol (80 
µL) in a 1.5 mL microcentrifuge tube and mixed, prior to storage at -80 °C. Pooled 
glycerol stocks were made from glycerol aliquots of up to 4 positive yeast clones to 
a total volume of 200 µL in a 1.5 mL microcentrifuge tube and stored at -80 °C. 
 
2.2.8 Yeast two-Hybrid matrix mating 
 
2.2.8.1 Matrix mating protocol 
 
A summary of the yeast two-hybrid matrix mating protocol can be seen in Figure 2.3. 
Yeast glycerol stocks for each clone to be mated, were spotted onto appropriate 
selective media (Table 2.17) and grown at 30 °C for 3-5 days. Individual yeast clones 
were then picked and resuspended in 4 µL ddH2O x number of individual constructs 
to be mated against (e.g. to screen a bait construct against a 96-well plate of different 
prey yeast clones, the bait would be resuspended in a total volume of 384 µL ddH2O). 
The bait and prey suspensions used in each screen were of similar opacity (assessed 
by eye) and this was dependent on the amount of individual bait and prey yeast 
picked. 3 µL of the bait yeast suspension, was spotted in a 96-array plate format onto 
YPAD agar in 150 mm, triple vented sterile plates, and allowed to dry. 3 µL of the 
individual prey yeast suspension was spotted on top of the dried bait spot and 
allowed to dry before incubating at 30 °C for 24 h to allow the mating of the MATa 
and MATa yeast. The newly mated yeast was then replicated using sterile velvet 
cloths, onto 2 double dropout media (SD-WL) plates to select for diploid yeast 
containing both bait and prey vectors, before incubating at 30 °C for 48 h. One diploid 
yeast plate was used for the b-Galactosidase (b-Gal) assay (see below Section 
2.2.8.2). The second diploid plate was used to further replicate onto triple dropout 
media (Table 2.19) plates, first the more stringent SD-WLA followed by the less 
stringent SD-WLH(3-AT). The order is important for the reduction of background 
growth on the less stringent SD-WLH(3-AT) media. The triple dropout plates were 
incubated at 30 °C for 14 days allowing the selective growth of potential positive 
interactions between specific bait-prey pairs. Images were taken, and positive yeast 
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growth was scored every 3-4 days. Interaction scoring criteria were as follows; 0-5 
colonies: background growth (0), 5-20 colonies: weak growth (+), 20-100 colonies: 
medium growth (++), full plaque: strong growth (+++). 
 
Figure 2.3 
 
Figure 2.3. Schematic representation of yeast two-hybrid clone generation and 
matrix mating. (A) PCR product containing flanking sequences homologous to the 
vector enables in vivo recombination between linearised plasmid and PCR product in 
yeast, resulting in the growth of red colonies. (B) Red colonies were selected for 
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diagnostic YC-PCR, followed by auto-activation testing and production of yeast 
glycerol stocks of positive hits. (C) Matrix mating protocol comparing the original and 
improved b-Galactosidase assay. 
 
2.2.8.2 b-Galactosidase assay – colony filter lift assay 
 
The b-Galactosidase (b-Gal) assay was used to measure the level of the lacZ reporter 
construct expression, using the diploid yeast plate not used for further replication 
and selection (see above). Equal amounts of yeast from diploid array plates were 
transferred onto a Whatman® filter paper, diam. 150 mm and freeze-thawed twice 
by submersion in liquid nitrogen for 10 seconds, to lyse yeast cells. Following this, 
the filter paper was placed yeast side up onto two Whatman® filter papers which had 
been placed in a 150 mm petri dish and saturated in b-gal reagent (6 mL b-gal Z-
buffer (60 mM Na2HPO4, 40 mM Na2H2PO4, 10 mM KCl, 1 mM MgSO4), 1.6 mg/mL X-
Gal reagent (100 mg/mL X-Gal in N,N-dimethylforamide) and 11 µL b-
mercaptoethanol). The plate was sealed and incubated at 37 °C for up to 12 h to 
allow for the blue colour change to occur in lysed yeast, indicative of the presence of 
b-galactosidase and therefore a positive protein-protein interaction (see Figure 2.3). 
Images were taken and scored every 30 min based on the intensity of blue colour 
change appearing on the filter paper. Scoring criteria were as follows; white colonies 
(0), light blue colonies: weak growth (+), light-dark blue colonies: medium growth 
(++), dark blue colonies: strong growth (+++). 
 
2.2.9  Yeast two-hybrid matrix mating with improved b-Gal assay 
 
2.2.9.1 Matrix mating protocol 
 
A summary of the yeast two-hybrid matrix with improved b-Gal assay can be seen in 
Figure 2.3. The original matrix mating method was used, as previously described 
(2.2.8.1). 
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2.2.9.2 b-Galactosidase assay – agar overlay assay 
 
The improved b-Galactosidase (b-Gal) assay was used to assess lacZ activity using the 
second diploid plate which was instead used to replicate onto SD-WLH(3-AT)/-ULH(3-
AT) + X-Gal plates. SD-WLH(3-AT)/-ULH(3-AT) media containing agar was prepared, 
as previously described. After autoclaving, media was allowed to cool before adding 
1/10th volume of sterile sodium phosphate solution (493 mM sodium phosphate 
dibasic, 250 mM sodium phosphate monobasic in ddH2O) followed by X-Gal reagent 
(100 mg/mL in N,N-dimethylforamide) up to a final concentration of 80 µg/mL. The 
triple dropout plates containing X-Gal were incubated at 30 °C for 10 days allowing 
the selective growth of potential positive protein-protein interactions. Images were 
taken and scored every 3-4 days based on the intensity of blue colour change of the 
yeast colonies as described in section 2.2.8.2.  
 
2.3 Yeast two-Hybrid library screens 
 
2.3.1 Matchmaker® yeast two-hybrid system  
 
2.3.1.1 Reagents and media 
 
Traditional Matchmaker® Yeast two-hybrid cDNA library was from Clontech 
Laboratories Inc. (distributed by Takara Bio Europe, France). All other reagents are 
listed in section 2.2.1. 
 
2.3.1.2 Initial mating 
 
Initially, several pGBAE-B HSP bait proteins were screened against the K-562 pACT2 
prey cDNA library. HSP bait yeast glycerol stocks were streaked onto SD-W agar 
plates and grown at 30 °C for 3-5 days. Two colonies were used to inoculate 2 x 25 
mL SD-W broth and grown at 30 °C, 200 rpm for 16-20 h or until the OD600 reached 
0.8. Following this, yeast cultures were harvested by centrifugation at 2,300 rpm, RT 
for 5 min and supernatant discarded before re-suspending each pellet in 500 µL YPAD 
and combining both. The bait suspension was mixed with 300 µL prey Matchmaker 
Y2H library, plated onto YPAD agar in 150 mm, triple vented sterile plates and 
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incubated at 30 °C for 6 h to allow the mating of the prey library and bait HSP yeast. 
Following incubation, newly mated yeast cells were harvested using 5 mL sterile 
ddH2O and a cell scraper, transferring the yeast suspension to a 15 mL Falcon tube 
and repeating the process with another 1 mL sterile ddH2O. To assess the mating 
efficiency, a 2 µL sample of the yeast suspension was used to make 10-2, 10-3 and 10-
4 serial dilutions and 100 µL plated onto SD-WL agar plates (90 mm) and incubated 
at 30 °C for 3-5 days. The remaining yeast suspension was plated equally onto 16 x 
SD-WLA agar in 150 mm, triple vented sterile plates and incubated at 30 °C for 14 
days. 
 
2.3.1.3 Diagnostic YC-PCR 
 
Colonies growing on SD-WLA agar, are diploid colonies containing both bait and prey 
clones which are also able to activate the ADE2 reporter gene and as such are 
representative of a potential protein-protein interaction. As such, up to 2 x 96 
colonies were selected for diagnostic YC-PCR and reconfirmation mating. Colonies 
from SD-WLA library plates were resuspended in 20 µL H2O, spotted (4 µL) onto fresh 
SD-WLA agar plates and incubated at 30 °C for 3-5 days. Once grown, yeast colonies 
were subjected to diagnostic YC-PCR, amplifying the prey clone with the use of the 
following primers:  
 
Forward primer: 
5’ GAATTCACAAGTTTGTACAAAAAAGCAGGCTGGATGGCTTACCCATACGATGTTCC 3’ 
 
Reverse primer: 
5’ GTCGACCACTTTGTACAAGAAAGCTGGTTTTTCAGTATCTACGATTCATAG 3’ 
 
These primers contain flanking sequences (shown in green) which allow amplification 
of the prey clone and in vivo yeast homologous recombination (gap repair) into 
pACTBE-B prey vector for reconfirmation mating of positive clones. 
In brief, a small amount of yeast was lysed in 5 µL 20 mM NaOH in 0.2 mL PCR tubes 
and incubated at RT for 20 min. Following lysis, 25 µL of the YC-PCR mixture (Table 
2.21 A) was added to each sample and incubated in a thermocycler as described in 
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Table 2.21 B. The PCR product was analysed by gel electrophoresis, as described 
previously, to identify insert size for each clone. Positive colonies were taken through 
to the gap repair and reconfirmation stage. 
 
Table 2.21 
A 
Reagent µL/reaction Final concentration 
Forward primer (10 µM) 1.5 0.5 µM 
Reverse primer (10 µM) 1.5 0.5 µM 
10X NH4 buffer 3 1X 
MgCl2 (50 mM) 1.5 2.5 mM 
dNTPs (25 mM) 0.9 750 µM 
BIOTAQ™ polymerase 0.3 - 
DMSO 0.6  
Nuclease-free H2O 15.7 - 
NaOH yeast lysate suspension 5  
TOTAL 30 - 
 
B 
Step Cycles Temperature (°C) Duration 
1 1 95 5 min 
 
2 
 
 
40 
 
95 1 min 
58 1 min 
72 1 min/kb 
3 1 72 5 min 
4 1 4 Forever 
 
Table 2.21. Master mix and cycling parameters for a library diagnostic YC-PCR. (A) 
Reaction master mix was set up in thin-walled PCR tubes on ice, using reagents and 
volumes stated. (B) YC-PCR was cycled in as indicated.  
 
2.3.1.4 Library Gap Repair  
 
Library colonies were amplified with the intention of performing in vivo 
recombination (gap repair) of prey library hits into the pACTBE-B prey vector to carry 
out a reconfirmation mating. pACTBE-B, as described previously, is a frame-shift 
vector allowing the easy identification of successfully transformed yeast colonies 
through the production of red-pigmented colonies. 
 
MATa yeast strain glycerol stock was streaked onto YPAD agar and grown at 30 °C 
for 3-5 days. A single MATa colony was used to inoculate 4 mL YPAD broth and grown 
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at 30 °C, 200 rpm for 16 h. An additional 16 mL YPAD broth was added to the culture 
and further incubated at 30 °C, 200 rpm for 5 h. Yeast were harvested by 
centrifugation at 2,300 rpm, RT for 5 min and supernatant discarded. The yeast pellet 
was resuspended in 5 mL 100 mM LiOAc and pelleted as above. Supernatant was 
discarded, and the pellet was resuspended in 1100 µL 50 % (w/v) PEG 3350, 170 µL 
sterile ddH2O, 167 µL 1M LiOAc, 40 µL 10.5 mg/mL heat denatured salmon testes 
DNA and 50 ng BamHI linearized pACTBE-B vector. The yeast suspension was mixed 
and 8 µL was added to each well of a sterile 96-well PCR plate, followed by 2 µL of a 
specific YC-PCR reaction (from above) and gentle mixing. As a negative control 2 µL 
H2O was added to 8 µL yeast suspension, to assess the level of background growth 
of red and white colonies. All samples were incubated in a thermocycler at the 
following conditions: 30 °C for 30 min, 42 °C for 25 min and 30 °C for 1 min. Each 
reaction mixture was spotted 3 µL at a time, onto SD-L, low adenine media, allowing 
the spots in between. The plates were then incubated at 30 °C for 3-5 days, allowing 
yeast colonies to grow.  
 
2.3.1.5 Reconfirmation mating 
 
To distinguish between false positives and genuine positive interactions it was 
important to re-confirm the interactions using the original bait and a negative bait 
control, thereby eliminating any auto-activating or non-specific prey clones. Unlike 
the initial mating, the reconfirmation mating will involve utilising all three GAL4-
independent reporter genes (HIS3, ADE2 and lacZ), and only interactions that 
activate all three will be considered genuine positive interactions. The negative bait 
control used in the reconfirmation matings was LSM2, due to its specificity for other 
LSM proteins. 
 
The successful gap repair of prey clones into the pACTBE-B vector was observed by 
the growth of red-pigmented colonies. Several red colonies from each spot were 
picked, resuspended in 20 µL H2O in a sterile 96-well mating plate and 3 µL spotted 
onto SD-L agar plate. At the same time 3 µL of the original bait and LSM2 bait clone 
were spotted onto SD-W agar plates and all yeast colonies were grown at 30 °C for 
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3-5 days. Prey colonies were resuspended in 20 µL ddH2O, whilst the bait (original 
and LSM2) were each resuspended in 384 µL ddH2O (enough to screen against for 96 
prey clones). The bait and prey suspensions used in each screen were of similar 
opacity (assessed by eye), dependent on the amount of individual bait and prey yeast 
picked. Next, 3 µL of the bait yeast suspension (original or LSM2), was spotted in a 
96-array plate format onto YPAD agar in 150 mm, triple vented sterile plates, and 
allowed to dry. Following this, 3 µL of the individual prey yeast suspension was 
spotted on top of the dried bait spot and allowed to dry before incubating at 30 °C 
for 24 h to allow mating to occur. The newly mated yeast was then replicated using 
sterile velvet cloths, onto 2 X SD-WL agar plates to select for diploid yeast, before 
incubating at 30 °C for 48 h. One SD-WL yeast plate was used for the b-Galactosidase 
(b-Gal) assay as described previously in section 2.2.8.2. The second plate of diploid 
yeast was used to replicate onto triple dropout media SD-WLA followed by SD-
WLH(3-AT). These plates were incubated at 30 °C for 14 days allowing the selective 
growth of potential positive interactions between specific bait-prey pairs. Images 
were taken, and positive yeast growth was scored every 3-4 days as described in 
section 2.2.8.2.  
 
2.3.1.6 Yeast prey sequencing 
 
Colonies grown on all three reporter assays with the original bait and not the 
negative control were selected for DNA sequencing analysis. The remaining 20 µL of 
the diagnostic YC-PCR product was sent to GATC Biotech (Konstanz, Germany), for 
purification followed by sequencing by automated fluorescent DNA sequencing. 
Sequence information was analysed using the NCBI Basic Local Alignment Search Tool 
(BLAST) tool (McGinnis and Madden, 2004) to identify prey interactors. 
 
2.3.2 Matchmaker® Gold Yeast two-Hybrid System 
 
2.3.2.1 Reagents and media 
 
Matchmaker® Gold Yeast two-hybrid cDNA library system was from Clontech 
(distributed by Takara Bio Europe, France). The yeast host strain Y2HGold (MATa 
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trp1-901 leu2-3, 112 ura3-52, his3-200 gal4D gal80D LYS2::GAL1UAS-Gal1TATA-His3, 
GAL2UAS-Gal2TATA-Ade2 URA3::MEL1UAS-Mel1TATA AUR1-C MEL1), was used as the bait 
strain for all Y2H matrix mating assays. The Y2HGold yeast strain is a derivative of the 
PJ69-2A strain (James et al., 1996) and carries four independent GAL4-responsive 
reporter genes. The yeast host strain Y187 (MATa ura3-52, his3-200, ade2-101, trp1-
901, leu2-3, 112, gal4D,  gal80D, met1, URA3::GAL1UAS-Gal1TATA-LacZ, MEL1) was used 
as the prey library strain and carries two independent GAL4-responsive reporter 
genes. All other reagents and media are stated in section 2.2.1.  
 
2.3.2.2 Matchmaker® Gold yeast vectors  
 
Matchmaker® Gold Y2H vectors encode either GAL4 Activation Domain (AD) or DNA-
binding domain (BD) at the 5’ or 3’ end of the recombination site, like most other 
conventional Y2H vectors. The bait protein is expressed as a fusion to the GAL4 DNA-
binding domain (BD) using the DNA-BD cloning vector pGBKT7, whilst the library of 
prey proteins are expressed as fusions to the GAL4 activation domain (AD) using the 
AD cloning vector, pGADT7 (Figure 2.4). 
 
Figure 2.4 
 
 
 
 
 
 
 
 
 
Figure 2.4. Schematic representations of Matchmaker® Gold yeast two-hybrid 
vectors. pGBKT7 bait vector encode the GAL4 DNA-binding domain (BD), whereas 
pGADT7 prey vector encodes the GAL4 Activator domain (AD). They all utilize the 
modified, enhanced ADH1 promoter giving rise to moderate expression levels. 
 
 
 
 
GAL4 BDPADH1 TADH1
EcoRI MCS    BamHI
pGBKT7
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2! ori Kanr oriTRP1
GAL4 ADPADH1 TADH1
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2.3.2.3 pGBKT7 bait generation 
 
An overview of the SLiCE cloning method, used to generate pGBKT7 bait constructs 
used in the Matchmaker® Gold yeast two-hybrid system, is presented in Figure 2.5.  
 
Primers were designed to enable seamless DNA cloning of the desired bait ORF, in-
frame with the GAL4 DNA-binding domain of the pGBKT7 plasmid. The primers 
included 15-21 bases from the pGBKT7 vector, followed by 18-21 bases homologous 
to the bait (see Figure 2.5 A). Sequence-verified pDONR223-ORFs were amplified 
using these specifically designed primers and combined with the pGBKT7 vector, via 
a SLiCE reaction (see section 2.1.9.2). The pGBKT7 vector is linearized prior to use via 
restriction digest with BamHI and EcoRI restriction enzymes, as described in section 
2.1.14. Following PCR amplification, a sample (10 µL) of the reaction was analysed by 
gel electrophoresis for correct fragment size before continuing with bacterial 
transformation, BC-PCR and sequencing. 
 
Figure 2.5 
A  
 
 
 
 
 
B 
 
 
 
 
 
 
 
 
 
 
SLiCE
37 ∘C 
15 min
Plasmid recovery 
& Sequencing
Bait
ORF
PCR
ORF
Linearised
vector
BanHI
+EcoRI
digest
pGBKT7
iiii
ii
GBKT7_F:
5’ catggaggccgaattcXXX222333444555666777888 3’
GBKT7_RS:
5’ gcaggtcgacggatccYYY222333444555666777888 3’
Homologous 
recombination
ORF
ORF
 97 
Figure 2.5. Matchmaker® Gold pGBKT7 bait generation. (A) Primer design for use 
with pGBKT7 bait vector. Primer sequences contain a 16bp sequence that is 
homologous to the ends of the linearised pGBKT7 vector, together with a 24bp region 
that is homologous to the required bait protein. XXX = first codon of the bait, YYY = 
reverse complement of the last codon of the bait protein. (B) Schematic diagram 
showing the strategy for cloning bait inserts into the linearised pGBKT7 bait vector 
by homologous recombination, using the Seamless Ligation Cloning Extract (SLiCE) 
method. (i) The gene of interest (bait) is first amplified using the primers with 
recombination compatible flanking sequences. (ii) The bait cDNA inserts flanked by 
vector homologous sequences are mixed with linearised vector and E.Coli cell lysates. 
(iii) The SLiCE method uses the homologous recombination activities in E.Coli cell 
lysates to assemble the bait insert into the pGBKT7 vector. Following in vitro 
assembly, all plasmids were amplified, and sequence verified before use in 
matchmaker Y2H library screens. 
 
2.3.2.4 Auto-activation and toxicity testing 
 
An overview of the auto-activation testing method, used for Matchmaker® pGBKT7 
bait validation, is shown in Figure 2.6. Y2HGold yeast glycerol stocks were streaked 
onto YPAD agar plates and grown at 30 °C for 3-5 days. A single Y2HGold colony was 
used to inoculate 10 mL YPAD broth and grown at 30 °C, 200 rpm for 16 h. A 5 mL 
culture sample was discarded and 45 mL YPAD broth was added to the remaining 
culture and further incubated at 30 °C, 200 rpm for 90 min or until the OD600 reached 
0.4-0.5. Yeast were harvested by centrifugation at 2,300 rpm, RT for 5 min and 
supernatant discarded. The yeast pellet was resuspended in 30 mL ddH2O and 
pelleted as above. Supernatant was discarded, and the pellet resuspended in 1.5 mL 
LiOAc/TE solution (Table 2.22) before transferring the yeast suspension into two 1.5 
mL microcentrifuge tubes and centrifugation at high speed for 15 s. 
 
Table 2.22 
Reagent  Volume (mL) 
10X Tris EDTA buffer (pH 7.5) 1.1 
1M Lithium acetate 1.1 
ddH2O 7.8 
 
Table 2.22. Constituents required to make LiOAc/TE solution. Vortex thoroughly 
and prepare just before use.  
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Supernatant was discarded, and each pellet was resuspended in 600 µL LiOAc/TE 
solution. To pre-cooled 1.5 mL microcentrifuge tubes 50 µL cell suspension, 100 ng 
sequence-verified plasmid DNA (or 100 ng empty pGBKT7 as a negative control) and 
500 µL PEG/LiOAc solution (Table 2.23) were added and mixed gently. The 
transformation mixture was incubated at 30 °C for 30 min, gently vortexing every 10 
min, followed by the addition of 20 µL DMSO. The solution was mixed before 
incubating at 42 °C for 15 min, gently vortexing every 5 min, followed by 
centrifugation at high speed for 15 s. Supernatant was discarded and pellet was 
resuspended in 1 mL YPD Plus broth and grown at 30 °C, 200 rpm for 1 h. Yeast was 
harvested by centrifugation at high speed for 15 s, supernatant discarded and pellet 
resuspended in 1 mL 0.9 % (w/v) NaCl. 
 
Table 2.23 
Reagent  Volume (mL) 
50 % (v/v) PEG 3350 12 
1M Lithium acetate 1.5 
10X Tris EDTA buffer (pH 7.5) 1.5 
 
Table 2.23. Constituents required to make PEG/LiOAc solution. Vortex thoroughly 
and prepare just before use.  
 
To assess bait auto-activation, 100 µL of a 1/10 and 1/100 dilution of the 
transformation mixture was plated onto SD-W, SD-W/X-a-Gal and SD-W/X-a-
Gal/AbA agar plates (90 mm) and incubated at 30 °C for 3-5 days. 
 
Expected results: 
SD-W White, 2mm colonies 
SD-W/X-a-Gal White/blue, 2mm colonies 
SD-W/X-a-Gal/Aba No colony growth 
 
To assess bait toxicity, 100 µL of a 1/10 and 1/100 dilution of the transformation 
mixture containing plasmid DNA or empty pGBKT7 vector was plated onto SD-W agar 
plates (90 mm) and incubated at 30 °C for 3-5 days. If bait is toxic to the yeast, 
colonies may appear smaller than those containing empty vector. Those pGBKT7 bait 
constructs that were not toxic to yeast and did not auto-activate, were used to make 
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yeast glycerol stocks (see section 2.2.7) for use in subsequent Matchmaker® Gold 
interaction studies. 
 
Figure 2.6 
A  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
B 
 
 
 
 
Figure 2.6. Matchmaker® Gold pGBKT7 bait validation. (A) For each bait, auto-
activation tests are first performed to confirm that the bait does not activate reporter 
genes in the Y2HGold yeast strain, in the absence of prey proteins. (i) sequence-
verified pGBKT7 baits are transformed into Y2HGold yeast cells and plated onto SD-
W plates or SD-W plates supplemented with either X-!-Gal alone, or X-!-Gal plus 
Aureobasidin A (AbA). (ii) Example of results from a successful, non-auto activating 
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bait (top row), or from an unsuccessful auto-activating bait (bottom row). (B) List of 
pGBKT7 baits which passed auto-activation and toxicity tests and were subsequently 
taken through to the library screening. 
 
2.3.2.5 Yeast two-Hybrid library screen: Initial mating 
 
Several pGBKT7-HSP bait proteins were screened against the Matchmaker® human 
brain pGADT7 prey cDNA library. HSP bait yeast glycerol stocks were streaked onto 
SD-W agar plates and grown at 30 °C for 3-5 days. A single colony was used to 
inoculate 5 mL SD-W broth and grown at 30 °C, 220 rpm for 8 h. The culture was 
diluted with a further 45 mL SD-W broth, transferred to a 500 mL flask and incubated 
at 37 °C, 220 rpm for 16 h or until the OD600 reached 0.8. Following this, yeast cultures 
were harvested by centrifugation at 2,300 rpm, RT for 5 min, supernatant discarded 
and pellet resuspended in 1 mL 2X YPAD. The bait suspension was mixed with 1 mL 
prey Matchmaker Gold Human Brain Y2H library, plated onto YPAD agar in 150 mm, 
triple vented sterile plates and incubated at 30 °C for 5 h to allow the mating of the 
prey library and bait HSP yeast. Following incubation, newly mated yeast cells were 
harvested using 4 mL 0.5X YPAD broth (with 50 µg/mL kanamycin) and a cell scraper, 
transferring the yeast suspension to a Falcon and repeating the process with another 
0.5 mL 0.5X YPAD/Kan liquid medium. To assess the mating efficiency, a 4 µL sample 
of the yeast suspension was used to make 10-2, 10-3 and 10-4 serial dilutions and plate 
100 µL of each onto SD-W, -L and -WL agar plates (90 mm) and incubated at 30 °C 
for 3-5 days. The remaining yeast suspension was plated equally onto 16 x SD-
WL/AbA agar in 150 mm, triple vented sterile plates and incubated at 30 °C for 3-5 
days. 
 
2.3.2.6 Diagnostic YC-PCR 
 
Colonies growing on SD-WL/AbA agar, are diploid colonies containing both bait and 
prey clones and are therefore representative of a potential protein-protein 
interaction. As such, up to 2 x 96 colonies were selected for diagnostic yeast YC-PCR 
and reconfirmation mating. Colonies from SD-WL/AbA library plates were 
resuspended in 100 µL 0.9 % (w/v) NaCl, spotted (3 µL) onto SD-WLAH and SD-
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WLAH/X-a-Gal/AbA agar plates and incubated at 30 °C for 3-5 days. Once grown, 
yeast colonies which were shown to activate all four reporter genes (i.e. blue colonies 
on WLAH/X-a-Gal/AbA agar plates) were subjected to diagnostic YC-PCR, amplifying 
the prey clone with the following primers:  
 
pGADT7.F primer:     5’ CGACTCACTATAGGGCGAGC 3’ 
pGADT7.R primer:     5’ GATGGTGCACGATGCACAG 3’ 
 
These primers allow amplification of the prey clone and in vivo yeast homologous 
recombination (gap repair) back into the pGADT7 prey vector for reconfirmation 
mating of positive clones. In brief, a small amount of yeast was lysed in 5 µL 20 mM 
NaOH in 0.2 mL PCR tubes and incubated at RT for 20 min. Following lysis, 25 µL of 
the YC-PCR mixture (Table 2.21 A) was added to each sample and incubated in a 
thermocycler as described in Table 2.21 B. The PCR product was analysed by gel 
electrophoresis, as described previously, to identify correct insert size for each clone 
with positive colonies taken through to the gap repair and reconfirmation stage. 
 
2.3.2.7 Gap Repair homologous recombination 
 
Positive YC-PCR library colonies were amplified with the intention of performing in 
vivo recombination (gap repair) of prey library hits back into the pGADT7 prey vector 
for the reconfirmation mating of positive interactions. Y187 yeast glycerol stock was 
streaked onto YPAD agar and grown at 30 °C for 3-5 days. Two Y187 colonies were 
used to inoculate 10 mL YPAD broth and grown at 30 °C, 200 rpm for 16 h. 5 mL 
culture was discarded and 45 mL YPAD broth was added to the remaining culture and 
further incubated at 30 °C, 200 rpm for 90 min. Yeast were harvested by 
centrifugation at 2,300 rpm, RT for 5 min and supernatant discarded. The yeast pellet 
was resuspended in 30 mL ddH2O and pelleted as above. Supernatant was discarded, 
and the pellet resuspended in 1.5 mL LiOAc/TE solution (Table 2.22) before 
transferring suspension into two 1.5 mL microcentrifuge tubes and centrifugation at 
high speed for 15 s. Again, discard supernatant and resuspend each pellet in 1100 µL 
50 % (v/v) PEG 3350, 170 µL sterile ddH2O, 167 µL 1M LiOAc, 40 µL 10.5 mg/mL heat 
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denatured salmon testes DNA and 60 ng NcoI linearized pGADT7 vector. The yeast 
suspension was mixed and 8 µL was added to each well of a sterile 96-well PCR plate, 
followed by 4 µL of a specific YC-PCR reaction (from above) and gentle mixing. As a 
negative control 4 µL sterile ddH2O was added to 8 µL yeast suspension, to assess 
the level of background growth of red and white colonies. All samples were 
incubated in a thermocycler at the following conditions: 30 °C for 30 min, 42 °C for 
25 min and 30 °C for 1 min. Each reaction mixture was spotted onto SD-L agar in 150 
mm, triple vented sterile plates, 4 µL at a time, allowing the spots to dry before 
spotting out again. The plates were then incubated at 30 °C for 3-5 days, allowing 
yeast colonies to grow. 
 
2.3.2.8 Yeast two-Hybrid library screen: reconfirmation mating 
 
To distinguish between false positives and genuine positive interactions it was 
important to re-confirm the interactions using the original pGBKT7 bait and a 
negative bait control (empty pGBKT7), thereby eliminating any auto-activating or 
non-specific prey clones. The successful gap repair of prey clones into the pGADT7 
vector was observed by the growth of colonies within each spot. Several colonies 
from each spot were picked, resuspended in 20 µL sterile ddH2O in a sterile 96-well 
mating plate and 3 µL spotted onto SD-L agar plate. At the same time 3 µL of the 
original pGBKT7 bait and empty pGBKT7 were spotted onto SD-W agar plates and all 
yeast colonies were grown at 30 °C for 3-5 days. Prey colonies were resuspended in 
20 µL sterile ddH2O, whilst the bait (original and empty) were each resuspended in 
384 µL sterile ddH2O (enough to screen against for 96 prey clones). The bait and prey 
suspensions used in each screen were of similar opacity (assessed by eye), dependent 
on the amount of individual bait and prey yeast picked. Next, 3 µL of the bait yeast 
suspension (original or empty), was spotted in a 96-array plate format onto YPAD 
agar in 150 mm, triple vented sterile plates, and allowed to dry. Following this, 3 µL 
of the individual prey yeast suspension was spotted on top of the dried bait spot and 
allowed to dry before incubating at 30 °C for 24 h to allow mating to occur. The newly 
mated yeast was then replicated using sterile velvet cloths, onto SD-WL agar plate to 
select for diploid yeast, before incubating at 30 °C for 48 h. The SD-WL diploid yeast 
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plate was used to replicate onto double dropout media SD-WL/X-a-Gal and 
quadruple dropout media SD-WLAH/X-a-Gal/Aba. These plates were incubated at 30 
°C for 14 days allowing the selective growth of potential positive interactions 
between specific bait-prey pairs. Images were taken every 3-4 days.  
 
Expected results: 
Genuine positive 
pGBKT7 bait + 
candidate prey 
SD-WL/X-a-Gal Blue, 2mm colonies 
SD-WLAH/X-a-Gal/Aba Blue, 2mm colonies 
Empty pGBKT7 + 
candidate prey 
SD-WL/X-a-Gal White, 2mm colonies 
SD-WLAH/X-a-Gal/Aba No colony growth 
 
False positive 
pGBKT7 bait + 
candidate prey 
SD-WL/X-a-Gal Blue, 2mm colonies 
SD-WLAH/X-a-Gal/Aba Blue, 2mm colonies 
Empty pGBKT7 + 
candidate prey 
SD-WL/X-a-Gal Blue, 2mm colonies 
SD-WLAH/X-a-Gal/Aba Blue, 2mm colonies 
 
2.3.2.9 Yeast prey sequencing 
 
Colonies grown on all four reporter assays with the original bait and not the negative 
control were selected for DNA sequencing analysis. The remaining 20 µL of the 
diagnostic YC-PCR product was sent to GATC Biotech (Konstanz, Germany), for 
purification followed by sequencing by automated fluorescent DNA sequencing. 
Sequence information was analysed using the NCBI Basic Local Alignment Search Tool 
(BLAST) tool (McGinnis and Madden, 2004) to identify prey interactors. 
 
2.4 Membrane Yeast two-Hybrid (MYTH) library screens 
 
2.4.1 Reagents and media 
 
The NMY51 yeast strain, MYTH empty plasmids, control plasmids and human 
embryonic, whole brain cDNA library used was obtained from Igor Stagljar (University 
of Toronto, Canada), whilst all other reagents are stated in section 2.2.1. 
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2.4.2 MYTH vectors 
 
When using the MYTH Y2H system, the bait must be cloned in-frame with the Cub-
LexA-VP16 tag of an appropriate vector. Vector choice is dependent upon membrane 
topology of the bait (protein of interest). At present, there are several MYTH Y2H 
vectors available (Figure 2.7), allowing for both N- and C-terminal tagging. C-terminal 
vectors pCMBV4, pAMBV4 and pTMBV4 (BAIT- Cub-LexA-VP16) are used to generate 
baits under the control of CYC1 (weak), ADH1 (strong) and TEF1 (very strong) 
promoters, respectively. N-terminal vectors pTLB1 and pBT3N (LexA-VP16- Cub-BAIT) 
generate baits under the control of TEF1 and CYC1 promoters, respectively.  
 
Figure 2.7 
A  
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Figure 2.7. Schematic representations of the Membrane yeast two-hybrid (MYTH) 
vectors. (A) Commonly used C- and N-terminal MYTH bait vectors. (B) N-terminal 
MYTH prey vector. 
 
2.4.3 Bait Generation 
 
2.4.3.1 Proof-reading KOD PCR from pDONR223 
 
Forward and reverse primers were designed such that they contained 35-40 bases 
homologous to the linear ends of each bait vector in-frame with 18-21 bases 
homologous to the cDNA reading frame of the bait (shown below). These primers 
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allowed the amplification of the desired ORF from pDONR223 and in vivo 
homologous recombination in yeast. Examples shown below: 
 
AMBV_F: 5’ AGCATTGCTGCTAAAGAAGAAGGGGTATCTTTGGATAAAXXX 3’ 
AMBV_R: 5’ CGACGGTATCGATAAGCTTGATATCGAATTCCTGCAGATYYY 3’ 
 
BT3N_F:  5’ ACGGTATCGATAAGCTTGATATCGAATTCCTGCAGGGCCXXX 3’ 
BT3N_RS: 5’ TGACGTCAGCGCTCCGCGGTTAGCTACTTACCATGGGGCYYY 3’ 
 
XXX = first codon of the bait, 
YYY = reverse complement of last codon of the bait (for N-terminal tagging this is a 
stop codon). 
 
Sequence-verified pDONR223-ORFs were amplified using KOD Hot Start DNA 
polymerase and bait-specific MYTH primers (designed as shown above). Typical KOD 
PCR master mix and cycling parameters in Table 2.5. Following PCR amplification, a 
sample (10 µL) of the reaction was analysed by gel electrophoresis, for correct 
fragment size. PCR products were stored at -20 °C. 
 
2.4.3.2 Generation of MYTH baits by Gap Repair 
 
An overview of the homologous recombination method used to generate MYTH bait 
clones, is shown in Figure 2.8. pAMBV and pBT3N vectors were linearized prior to use 
via restriction digest with SfiI restriction enzyme, as described in section 2.1.14. 
NMY51 yeast glycerol stocks were streaked onto YPAD agar plates and grown at 30 
°C for 3-5 days. A single NMY51 colony was used to inoculate 5 mL YPAD broth and 
grown at 30 °C, 200 rpm for 16 h. An additional 45 mL YPAD broth was added to the 
culture to an OD600 of ~0.15 and further incubated at 30 °C, 200 rpm for 3-4 h until 
an OD600 of ~0.6 was reached. Yeast were harvested by centrifugation at 2,300 rpm, 
RT for 5 min and supernatant discarded. The yeast pellet was resuspended in 25 mL 
sterile ddH2O and pelleted as above. Supernatant was discarded, and the pellet was 
resuspended in 1 mL sterile ddH2O. To a 1.5 mL microcentrifuge tube: 100 µL yeast 
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cell suspension, 300 µL PEG/LiOAc solution (Table 2.23), linearised MYTH vector (50 
fmol) and KOD PCR product (250-500 fmol) was added and gently mixed.  
 
Figure 2.8  
A  
 
 
 
 
 
 
 
 
B 
 
 
 
 
 
 
 
Figure 2.8. Generation of Membrane Yeast Two-Hybrid (MYTH) bait constructs. (A) 
Forward and reverse Primers designed for in vivo recombination cloning into pAMBV 
(C-terminal tagging) and pBT3N (N-terminal tagging) MYTH bait vectors. Primers are 
designed to contain a 39 base region of homology to the linear ends of the respective 
target vectors, together with 18-21 bait specific nucleotides. (XXX = first codon of the 
bait and YYY = reverse complement of last codon of the selected bait. For N-terminal 
tagging, this is always a stop codon). (B) Schematic diagram of the homologous 
recombination method used to generate MYTH bait clones by the in vivo gap repair 
process. (i) Bait cDNA clones were amplified using the primers shown in (A). (ii) The 
NMY51 MYTH reporter yeast strain was then transfected with a combination of the 
bait, flanked by vector specific homologous recombination sequences (PCR product) 
and linearised vector. (iii) In vivo homologous recombination facilitates in-frame 
insertion of the bait into the selected bait vector. Following sequence verification, 
bait construct is transformed back into MYTH reporter strain, NMY51. 
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These were incubated at 30 °C for 30 min followed by heat-shock at 42 °C for 60 min, 
before centrifugation at 2,300 rpm, RT for 5 min. Supernatant was discarded and 
pellet resuspended in 200 µL sterile ddH2O and reaction mixture was plated onto SD-
L agar plates and grown at 30 °C for 2-4 days. Bait plasmid DNA was isolated from 
the yeast cell pellet using a commercial miniprep kit (Promega). The manufacturer’s 
bacterial miniprep protocol was modified for yeast plasmid rescue, adding a small 
volume of 0.5 mm soda lime glass beads to the initial resuspension, followed by 5 
min high vortex to ensure sufficient yeast cell lysis. Isolated yeast plasmid DNA was 
transformed into a-Select competent cells to obtain higher quality, pure plasmid in 
sufficient quantities for use in subsequent sequencing and analyses. Bait plasmid 
DNA was isolated from transformed bacterial cells before sequencing construct to 
confirm proper bait plasmid construction. Sequence-verified bait plasmid DNA was 
transformed back into NMY51, using the protocol described above, substituting the 
linearised plasmid and PCR product for the bait plasmid DNA. Yeast glycerol stocks 
were made as described in section 2.2.7. 
 
2.4.4 Bait Validation – NubG/ NubI control test 
 
An overview of the NubG/ NubI control test used for MYTH bait validation, is shown in 
Figure 2.9. It is necessary to make sure that the bait does not activate the reporter 
system alone or in the presence of non-interacting preys (i.e. ensure the bait is not 
auto-activating). The NubG/I control test is used to assess whether a bait an auto-
activator, as it is transformed with interacting (positive) and non-interacting 
(negative) control preys, and growth assessed on selective media. The following 
control prey constructs were used: pOST1-NubI, pFUR4-NubI (positive) and pOST1-
NubG, pFUR4-NubG (negative). OST1 and FUR4 are commonly used control preys. 
OST1, a component of the N-oligosaccharyl transferase complex, is an integral 
endoplasmic reticulum (ER) membrane protein (Wilson and High, 2007), whilst FUR4, 
a uracil permease, is a multi-spanning protein of the plasma membrane in yeast (Silve 
et al., 1991).  
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MYTH bait yeast glycerol stocks were streaked onto SD-L agar plates and grown at 30 
°C for 3-5 days. A single colony was used to inoculate 5 mL SD-L broth and grown at 
30 °C, 200 rpm for 16 h. An additional 45 mL SD-L broth was added to the culture to 
an OD600 of ~0.15 and further incubated at 30 °C, 200 rpm for 3-4 h until an OD600 of 
~0.6 was reached. Yeast were harvested by centrifugation at 2,300 rpm, RT for 5 min 
and supernatant discarded. 
 
Figure 2.9 
 
 
Figure 2.9. Membrane Yeast Two-Hybrid (MYTH) bait validation. (A) Schematic 
showing the required stages of a MYTH NubG/NubI control test. (i) MYTH bait clones, 
generated as shown in Figure 2.8, were transformed with either NubI (positive 
control) or NubG (negative control) prey plasmids before being plated onto SD-WL 
plates to select for co-transformed yeast. Positive yeast colonies were then picked 
and re-spotted onto both SD-WL and a series of SD-WLAH plates supplemented with 
increasing amounts (0-10 mM) of 3-aminotriazole (3-AT). (ii) Results from a positive 
(top panel) and negative (bottom panel) NubG/NubI control test are shown. Each row 
of spotted yeast represents a bait transformed with either a negative NubG (top row) 
or positive NubI (bottom row) control prey clone. Spots from left to right represent 
increasing dilutions (100, 10-1, 10-2 and 10-3) of yeast. (B) List of MYTH baits which 
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passed the NubG/NubI control tests and were subsequently taken through to MYTH 
library screening. 
 
The yeast pellet was resuspended in 25 mL sterile ddH2O and pelleted as above. 
Supernatant was discarded, and the pellet was resuspended in 1 mL sterile ddH2O. 
To a 1.5 mL microcentrifuge tube: 100 µL yeast suspension, 300 µL PEG/LiOAc 
solution (Table 2.23), 7 µL 10.5 mg/mL heat-denatured salmon testes DNA and 200 
ng control prey plasmid was added and gently mixed. These were incubated at 30 °C 
for 30 min followed by heat-shock at 42 °C for 60 min, before centrifugation at 2,300 
rpm, RT for 5 min. Supernatant was discarded and pellet resuspended in 200 µL 
sterile ddH2O and reaction mixture was plated onto SD-WL agar plates and grown at 
30 °C for 2-4 days. Following diploid colony growth, single colonies from each 
transformation were resuspended in 100 µL sterile ddH2O, and used to make 10-2, 
10-3 and 10-4 serial dilutions. Spot 5 µL of undiluted and diluted cells onto SD-WL, SD-
WLH±3-AT and SD-WLAH±3-AT (1-10 mM 3-AT) agar plates and grown at 30 °C for 2-
4 days. 
 
2.4.5 Large-scale transformation of human embryonic whole brain cDNA prey 
library with MYTH bait yeast 
 
The initial large-scale transformation step of library screening protocol was 
performed as described in the DUALmembrane manual (Dualsystems Biotech). Fresh 
MYTH bait yeast glycerol stocks were streaked onto SD-L agar plates and grown at 30 
°C for 3-5 days. Two-three colonies were used to inoculate 10 mL SD-L broth and 
grown at 30 °C, 200 rpm for 8 h. 100 mL fresh SD-L broth was inoculated with the 10-
mL culture and grown at 30 °C, 200 rpm for 16 h. Following incubation, a 1 mL aliquot 
of culture was pelleted by centrifugation at 2,300 rpm, RT for 5 min and resuspended 
in 1 mL H2O. The OD600 of the sample was measured and the amount of culture 
required for 30 OD600 units was transferred to a 50-mL Falcon tube and harvested at 
2,300 rpm, RT for 5 min. The yeast pellet was resuspended in 10 mL pre-warmed 2X 
YPAD broth and transferred to a 1 L flask. The Falcon was rinsed with a further 40 mL 
pre-warmed 2X YPAD broth to recover any remaining cells. An additional 150 mL pre-
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warmed 2X YPAD broth (200 mL total volume) was added to the culture resulting in 
an OD600 of ~0.15. The culture was further incubated at 30 °C, 220 rpm for 3-5 h until 
an OD600 of ~0.6 was reached. 
 
The 200 mL yeast culture was divided into four 50 mL Falcon tubes and harvested at 
2,300 rpm, RT for 5 min and supernatant discarded. The yeast pellets were each 
resuspended in 30 mL sterile ddH2O and pelleted as above. Supernatant was 
discarded, and each pellet resuspended in 1 mL LiOAc/TE solution (Table 2.22), 
transferred to a 1.5 mL microcentrifuge tube and pelleted as above. Supernatant was 
discarded, and the pellet was resuspended in 600 µL LiOAc/TE solution. Four 50 mL 
Falcon tubes were set up and to each the following was added: 600 µL yeast cell 
suspension, 2.5 mL PEG/LiOAc solution (Table 2.23), 100 µL 10.5 mg/mL heat 
denatured salmon testes DNA and 8 µg human adult, whole brain pPR3N (prey) cDNA 
library. The transformation mixture was incubated at 30 °C for 45 min, gently 
vortexing every 15 min, followed by addition of 160 µL DMSO. The solution was 
mixed (by inverting) before incubating at 42 °C for 20 min, followed by centrifugation 
at 2,300 rpm, 4 °C for 5 min. Each pellet was resuspended in 3 mL 2X YPAD and 
samples pooled before incubating at 30 °C, 150-200 rpm for 90 min. Yeast were 
harvested by centrifugation at 2,300 rpm, 4 °C for 5 min and supernatant discarded. 
The yeast pellet was resuspended in 4.9 mL 0.9 % (w/v) NaCl. To calculate the 
transformation efficiency, a 100 µL of the yeast suspension was used to make 10-2, 
10-3 and 10-4 serial dilutions and 100 µL was plated onto SD-WL agar plates (90 mm) 
and incubated at 30 °C for 2-3 days. The remaining yeast suspension was plated 
equally onto 24 x SD-WLAH (±3-AT depending on control test) agar in 150 mm, triple 
vented sterile plates and incubated at 30 °C for 3-5 days. Subsequent steps leading 
to prey identification had to be optimised due to facilities available in the lab (for 
more details see Appendix 2.2) 
 
2.4.6 Diagnostic YC-PCR 
 
Colonies growing on SD-WL are diploid colonies containing both bait and prey 
plasmids. Additionally, colony growth on SD-WLAH±3-AT agar plates, indicates 
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activation of both HIS3 and ADE2 reporter genes following successful bait-prey 
interaction. Up to 2 x 96 colonies from SD-WLAH±3-AT library plates were 
resuspended in 100 µL 0.9 % (w/v) NaCl, 3 µL spotted onto SD-WLAH and SD-
WLAH/X-Gal agar plates and incubated at 30 °C for 3-5 days. Once grown, yeast 
colonies which could activate all three reporter genes (i.e. blue colonies on WLAH/X-
Gal agar plates) were selected for diagnostic YC-PCR using the following primers:  
 
NubGX seq F primer:   5’ GTCGAAAATTCAAGACAAGG 3’ 
pPR3N seq R primer:   5’ AAGCGTGACATAACTAATTAC 3’  
 
These primers allow amplification of the prey clone and in vivo yeast homologous 
recombination (gap repair) back into the pPR3N prey vector for reconfirmation 
mating of positive clones. 
 
In brief, a small amount of yeast was lysed in 5 µL 20 mM NaOH in 0.2 mL PCR tubes 
and incubated at RT for 20 min. Following lysis, 25 µL of the YC-PCR mixture (Table 
2.21 A) was added to each sample and incubated in a thermocycler as described in 
Table 2.21 B. The PCR product was analysed by gel electrophoresis, as described 
previously, to identify insert size for each clone. Positive colonies were taken through 
to the reconfirmation stage. 
 
2.4.7 Reconfirmation gap repair/co-transformation 
 
To distinguish between false positives and genuine positive interactions, prey 
plasmids are re-transformed with either the original MYTH bait or a negative control. 
Only those preys which activate all three reporter genes when co-expressed with the 
original bait only, are considered true positives. The negative bait control used is the 
empty vector used to construct the MYTH bait. Positive YC-PCR library colonies were 
amplified with the intention of performing in vivo recombination (gap repair) of prey 
library hits back into the pPR3N prey vector. This was performed simultaneously to 
the co-transformation of recovered prey and original/control bait, protocol 
described below. 
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NMY51 yeast glycerol stocks were streaked onto YPAD agar plates and grown at 30 
°C for 3-5 days. A single NMY51 colony was used to inoculate 5 mL YPAD broth and 
grown at 30 °C, 200 rpm for 16 h. An additional 45 mL YPAD broth was added to the 
culture to an OD600 of ~0.15 and further incubated at 30 °C, 200 rpm for 3-4 h until 
an OD600 of ~0.6 was reached. Yeast were harvested by centrifugation at 2,300 rpm, 
RT for 5 min and supernatant discarded. The yeast pellet was resuspended in 25 mL 
sterile ddH2O and pelleted as above. The pellet was resuspended in 1100 µL 50 % 
(v/v) PEG 3350, 170 µL sterile ddH2O, 167 µL 1M LiOAc, 40 µL 10.5 mg/mL heat 
denatured salmon testes DNA. To a 1.5 mL microcentrifuge tube: 8 µL yeast cell 
suspension/reaction (i.e. 96x8=768 µL), 5 ng original/control bait/reaction (i.e. 
96x5=480 ng) and 5 ng SfiI linearised pPR3N prey vector were added and gently 
mixed. The yeast suspension was mixed and 8 µL was added to each well of a sterile 
96-well PCR plate, followed by 4 µL of a specific YC-PCR reaction (from above) and 
gentle mixing. As a negative control 4 µL H2O was added to 8 µL yeast suspension, to 
assess the level of background growth. All samples were incubated in a thermocycler 
at the following conditions: 30 °C for 30 min, 42 °C for 25 min and 30 °C for 1 min. 
Each reaction mixture was spotted onto SD-WL, low adenine media (Table 2.17) 3 µL 
at a time, allowing the spots to dry before spotting out again. The plates were then 
incubated at 30 °C for 3-5 days, allowing yeast colonies to grow. Following diploid 
colony growth, yeast were replicated onto SD-WLAH±3-AT (same as library) and SD-
WLAH±3-AT+X-Gal agar plates and grown at 30 °C for 2-4 days, allowing for the 
selection of positive protein-protein interactions. 
 
2.4.8 Yeast prey sequencing 
 
Only those yeast clones that selectively activate all three reporters (ADE2, HIS3 and 
lacZ) with the original bait and not the empty bait vector were selected for DNA 
sequencing analysis. The remaining 20 µL of the diagnostic YC-PCR product was sent 
to GATC Biotech (Konstanz, Germany), for purification followed by sequencing by 
automated fluorescent DNA sequencing. Sequence information was analysed using 
the NCBI Basic Local Alignment Search Tool (BLAST) tool to identify prey interactors. 
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2.5 Network construction and analysis 
 
It is extremely important to minimise error when dealing with high-throughput data 
by, accurately collating and storing data. All tested Y2H interactions, both positive 
and negative, were recorded in Excel spreadsheets (Microsoft, California, USA). 
 
2.5.1 Network construction: database curation 
 
There are many different pathway and molecular databases that have been built to 
try and collate and store the vast range of interaction network information available 
in the literature, as well as that being generated in high-throughput, large-scale 
experiments. There is not one database which provides a fully comprehensive 
dataset of all published protein-protein interaction data, and soit is necessary to 
integrate information from several databases to try and increase the coverage of 
reported interactions.  
 
An ‘In-house’ interactome network was previously generated by Dr Russell Hyde and 
Dr Jonathan Woodsmith, combining interaction data collected from several public 
databases (BioGRID, Human Protein Reference Database (HPRD) and IntAct) as well 
as interactome data from the Vidal group. This interactome was updated with the 
most up-to-date version of each database, in combination with experimental 
interaction data from the Human Integrated Protein-Protein Interaction Reference 
(HIPPIE) and Biophysical Interactions of ORFeome-based complexes (BioPlex), 
increasing interaction coverage and providing a final dataset containing both binary 
(direct) and non-binary (indirect) protein-protein interaction data from which to 
generate a final network. All identifiers were converted into Entrez Gene IDs to 
standardise interaction reporting, with the primary gene symbol annotated as a 
secondary label. This allowed the removal of duplicate interactions, generating an 
interaction dataset with the highest density and coverage possible at the time of 
analysis. 
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2.5.2 Network generation: Cytoscape 
 
Publically available bioinformatics resources such as the Database for Annotation, 
Visualisation and Integrated Discovery (DAVID) and the Protein ANalysis THrough 
Evolutionary Relationships (PANTHER) were used on all protein-protein interaction 
data collated via the final network as well as integrating experimental data 
generated. Protein-protein interaction data was visualised as complex networks 
using the open source software platform, Cytoscape (Lopes et al., 2010). Cytoscape 
allows the integration of networks with any type of attribute data. Figures were 
generated using Cytoscape version 2.8.2 and will be discussed in more detail in 
Chapters 3 and 6. 
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Chapter 3: Constructing a Hereditary Spastic Paraplegia protein-protein 
interaction (PPI) network 
 
3.1        Introduction 
 
Hereditary spastic paraplegia (HSP or SPG) was first described in the late 1800s 
(Seeligmüller, 1876; Strümpell, 1880) and has since become a term used to describe 
this relatively large, clinically and genetically diverse group of inherited 
neurodegenerative or neurodevelopmental disorders. HSP is characterised by a 
progressive lower limb spasticity and pyramidal weakness (Harding, 1983; 
Blackstone, O’Kane and Reid, 2011). Since the identification of the first HSP locus in 
1986 (Kenwrick et al., 1986), more recent advances in molecular genetics has led to 
the identification of over 75 HSP disease-loci with over 60 corresponding genes 
(Klebe, Stevanin and Depienne, 2015; de Souza et al., 2016). The identification of 
genes involved in HSP and the functions associated with corresponding proteins, has 
so far provided a more detailed understanding of the molecular pathways and 
mechanisms required for axonal maintenance and motor neuron function 
(Sanderson et al., 2005). 
 
Complex cellular systems are formed by interactions between genes and gene 
products, located in the same cell, across cells, or even across organs, which appear 
to underlie most cellular functions, including most genotype-to-phenotype 
relationships (Vidal, Cusick and Barabási, 2011). A critical step towards unravelling 
the complex molecular relationships in living systems is the mapping of protein-
protein interactions, also known as interactome networks (Rolland et al., 2014). 
Proteins with similar functions and cellular localisations tend to cluster together 
within these networks, with the majority sharing at least one function (Vazquez et 
al., 2003; Chua, Sung and Wong, 2006). Given the inter- and intracellular connectivity 
within networks, a disease phenotype is rarely the outcome of a specific genetic 
abnormality in a single gene product, but rather a reflection of the various 
pathobiological processes that interact within a complex network (Barabási, 
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Gulbahce and Loscalzo, 2011). Therefore, identifying proteins that either directly or 
indirectly interact with known HSP proteins, may identify new candidate genes for 
genetic screening, whilst also providing insights into the molecular mechanisms of 
HSP pathology. It is therefore important to generate an extended high-confidence 
human HSP interactome network. 
 
The main aim of the work presented in this section was to prepare a set of tools that 
would be used to study HSPs systematically. This would be done by: (i) Compiling a 
comprehensive, up-to-date list of identifiers of all putative human HSPs by literature 
and database curation; (ii) Using a universal, high-throughput cloning strategy; (iii) 
Acquiring as many HSP ORFs as possible, and producing expression constructs for use 
in further studies; (iv) Constructing a predicted HSP PPI network, which can be used 
to inform interaction predictions, new hypotheses and prioritization of targets for 
further functional investigation. 
 
3.2        Human HSP ORF library generation 
 
3.2.1 Literature curation 
 
When this study started, there were over 50 spastic gait disease-loci, (“SPastic 
parapleGia” [SPG] 1-56) identified, with 38 corresponding spastic paraplegia genes 
(Fink, 2013). This rapidly evolved, and in less than a year, following whole-exome 
sequencing (WES) and network analysis, there were over 70 different disease-loci 
(SPG1-71) and a further 16 spastic paraplegia genes identified, as well as other 
causative genes not yet in the SPG classification (Lo Giudice et al., 2014; Novarino et 
al., 2014). For this study, information was gathered from a number of literature-
based sources including the above-mentioned studies, which were used to acquire 
Entrez Gene IDs (Maglott et al., 2007) for a total of 58 genes that encode HSP-related 
proteins (shown in Table 3.1), and are referred to as ‘HSP seed 1’.  
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3.2.2 Obtaining HSP gene identifiers (IDs)  
 
Entrez Gene is an open-access gene-specific database at the National Centre for 
Biotechnology Information (NCBI, https://www.ncbi.nlm.nih.gov), which generates 
identifiers (Gene IDs) for individual genes and loci. These unique identifiers 
correspond to annotated and curated gene-specific information which includes 
nomenclature, chromosomal localization, protein interactions and phenotypes 
(Maglott et al., 2011). As such, Entrez Gene IDs were acquired for HSPs identified in 
section 3.2.1. To maintain consistency throughout this study, HSPs will be annotated 
and referred to by their gene symbols assigned by Entrez Gene, regardless of any 
other aliases in use.  
 
Table 3.1 
SPG Gene Gene ID Protein Referencesa 
SPG1 L1CAM 3897 Neural cell adhesion molecule L1 Jouet et al., 1994 
SPG2 PLP1 5354 Myelin proteolipid protein Saugier-Veber et al., 1994 
SPG3 ATL1 51062 Atlastin 1 Zhao et al., 2001 
SPG4 SPAST 6683 Spastin Hazan et al., 1999 
SPG5A CYP7B1 9420 25-hydroxycholesterol 7-alpha-hydroxylase Tsaousidou et al., 2008 
SPG6 NIPA1 123606 Magnesium transporter NIPA1 Rainier et al., 2003 
SPG7 SPG7 6687 Paraplegin Casari et al., 1998 
SPG8 WASHC5 9897 WASH complex subunit strumpellin Valdmanis et al., 2007 
SPG10 KIF5A 3798 Kinesin heavy chain isoform 5A Reid et al., 2002 
SPG11 SPG11 80208 Spatacsin Stevanin et al., 2007 
SPG12 RTN2 6253 Reticulon-2 Montenegro et al., 2012 
SPG13 HSPD1 3329 60 kDa heat shock protein, mitochondrial Hansen et al., 2002 
SPG15 ZFYVE26 23503 Zinc finger FYVE domain-containing protein 26 Hanein et al., 2008 
SPG17 BSCL2 26580 Seipin Windpassinger et al., 2004 
SPG18 ERLIN2 11160 Erlin-2 Alazami et al., 2011 
SPG20 SPART 23111 Spartin Patel et al., 2002 
SPG21 SPG21 51324 Maspardin Simpson et al., 2003 
 118 
SPG22 SLC16A2 6567 Monocarboxylate transporter 8 Schwartz et al., 2006 
SPG28 DDHD1 80821 Phospholipase DDHD1 Tesson et al., 2012 
SPG30 KIF1A 547 Kinesin-like protein KIF1A Erlich et al., 2011, Klebe et al., 2012 
SPG31 REEP1 65055 Receptor expression-enhancing protein 1 Zuchner et al., 2006 
SPG35 FA2H 79152 Fatty acid 2-hydroxylase Dick et al., 2010 
SPG39 PNPLA6 10908 Neuropathy target esterase Rainier et al., 2008 
SPG42 SLC33A1 9197 Acetyl-coenzyme A transporter 1 Lin et al., 2008 
SPG44 GJC2 57165 Gap junction gamma-2 protein 
Orthmann-Murphy et 
al., 2009 
SPG47 AP4B1 10717 AP-4 complex subunit beta-1 Abou Jamra et al., 2011 
SPG48 AP5Z1 9907 AP-5 complex subunit zeta-1 Slabicki et al., 2010 
SPG49 TECPR2 9895 Tectonin beta-propeller repeat-containing protein 2 Oz-Levi et al., 2012 
SPG50 AP4M1 9179 AP-4 complex subunit mu-1 Verkerk et al 2009 
SPG51 AP4E1 23431 AP-4 complex subunit epsilon-1 
Abou Jamra et al., 
2011,  
Moreno-De-Luca et al., 
2011 
SPG52 AP4S1 11154 AP-4 complex subunit sigma-1 
Abou Jamra et al., 
2011 
SPG53 VPS37A 137492 Vacuolar protein sorting-associated protein 37A 
Zivony-Elboum et al., 
2012 
SPG54 DDHD2 23259 Phospholipase DDHD2 Schuurs-Hoeijmakers et al., 2012 
SPG55 C12orf65 91574 
Probable peptide chain 
release factor C12orf65, 
mitochondrial 
Shimazaki et al., 2012 
SPG56 CYP2U1 113612 Cytochrome P450 2U1 Oz-Levi et al., 2012 
SPG58 KIF1C 10749 Kinesin-like protein KIF1C Novarino et al., 2014,  Dor et al., 2014 
SPG59 USP8 9101 Ubiquitin carboxyl-terminal hydrolase 8 Novarino et al., 2014 
SPG60 WDR48 57599 WD repeat-containing protein 48 Novarino et al., 2014 
SPG61 ARL6IP1 23204 
ADP-ribosylation factor-like 
protein 6-interacting protein 
1 
Novarino et al., 2014 
SPG62 ERLIN1 10613 Erlin-1  Novarino et al., 2014 
SPG63 AMPD2 271 AMP deaminase 2 Novarino et al., 2014 
SPG64 ENTPD1 953 Ectonucleoside triphosphate diphosphohydrolase 1 Novarino et al., 2014 
SPG65 NT5C2 22978 Cytosolic purine 5'-nucleotidase Novarino et al., 2014 
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SPG66 ARSI 340075 Arylsulfatase I Novarino et al., 2014 
SPG67 PGAP1 80055 GPI inositol-deacylase Novarino et al., 2014 
SPG68 FLRT1 23769 
Leucine-rich repeat 
transmembrane protein 
FLRT1 
Novarino et al., 2014 
SPG69 RAB3GAP2 25782 
Rab3 GTPase-activating 
protein non-catalytic 
subunit 
Novarino et al., 2014 
SPG70 MARS 4141 Methionine--tRNA ligase, cytoplasmic Novarino et al., 2014 
SPG71 ZFR 51663 Zinc finger RNA-binding protein Novarino et al., 2014 
- AFG3L2 10939 AFG3-like protein 2 Koppen et al., 2007,  Di Bella et al., 2010 
- ALS2 57679 Alsin Eymard-Pierre et al., 2002  
- ATP6 4508 Protein bicaudal D homolog 2 Verny et al., 2011 
- CCT5 22948 T-complex protein 1 subunit epsilon Bouhouche et al., 2006 
- ELOVL4 6785 Elongation of very long chain fatty acids protein 4 
Aldahmesh et al., 2011 
Fink, 2013 
- GAD1 2571 Glutamate decarboxylase 1 McHale et al., 1999,  Lynex et al., 2004 
- GJA1 2697 Gap junction alpha-1 protein Paznekas et al., 2003 
- KANK1 23189 KN motif and ankyrin repeat domain-containing protein 1 Novarino et al., 2014 
- VCP 7415 Transitional endoplasmic reticulum ATPase De Bot et al., 2012 
 
Table 3.1. List of ‘HSP seed 1’ loci and genes. HSP genes are listed by spastic gait 
disease-loci (SPG), numbered sequentially based on the order of locus discovery 
(Fink, 2013). HSP genes not part of the SPG classification system are listed 
alphabetically. Entrez Gene IDs were obtained from the NCBI database (Maglott et 
al., 2007) and are the most updated identifiers for the corresponding genes at the 
time of submission.  
a Locus/gene discovery association with HSP 
 
3.2.3 DNA sequence collection  
 
The NCBI Reference Sequence (RefSeq) database (Pruitt, Tatusova and Maglott, 
2005) is an open-access, non-redundant and comprehensive collection of well-
annotated sequences, including genomic DNA, transcripts and proteins in which 
Entrez Gene IDs were used to obtain a Reference Sequence (RefSeq) for each HSP. 
Some HSP genes have more than one variant annotated in the RefSeq database, only 
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those variants that encode the longest isoform were selected. RefSeq sequences are 
continually updated and annotated with newer versions often including longer 5’ and 
3’ untranslated regions (UTR), however the protein coding sequence generally 
remains the same, and as such the complementary DNA (cDNA) sequence 
information of the selected HSPs were acquired for primer design and cloning 
purposes.  
 
The ‘HSP seed 1’ genes were subjected to a set of exclusion criteria, removing those 
insufficiently annotated or those that were unlikely to be expressed, leaving only 
well-annotated sequences for cloning. The exclusion criteria include: (i) any evidence 
suggesting that they are a pseudogene (i.e. non-coding); (ii) any sequences which are 
poorly annotated (i.e. no known ORF start/stop site), and (iii) any genes that encode 
ORFs larger than 3 kb, as large ORFs will be difficult to clone from cDNA and encoded 
proteins are unlikely to function properly in yeast (Shulga et al., 2000).  
 
Following application of the exclusion criteria, size exclusion was the only relevant 
criteria and was used to exclude 14 HSPs (Table 3.2) from the ‘HSP seed 1’ list, leaving 
a total of 44 HSPs to be followed up. 
 
Table 3.2 
SPG Gene ORF size Exclusion criteria 
SPG1 L1CAM 3773 
ORF size > 3,000 bp 
SPG8 WASHC5 3479 
SPG10 KIF5A 3098 
SPG11 SPG11 7331 
SPG15 ZFYVE26 7619 
SPG30 KIF1A 5375 
SPG39 PNPLA6 4127 
SPG49 TECPR2 4235 
SPG51 AP4E1 3413 
SPG58 KIF1C 3311 
SPG59 USP8 3356 
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SPG69 RAB3GAP2 4181 
SPG71 ZFR 3224 
- ALS2 4973 
 
Table 3.2. Excluded HSPs. HSP genes excluded from further investigation due to 
large ORF size. 
 
3.3        Cloning protocol 
 
Having acquired all the DNA sequencing information for the 44 ‘HSP seed 1’ ORFs, 
the Gateway® cloning strategy was used to generate expression constructs for 
subsequent experimental studies. 
 
3.3.1 Gateway® cloning 
 
An overview of Gateway® cloning can be seen in Figure 3.1. The Gateway® 
Technology (Invitrogen) is a universal cloning method used to accelerate the cloning 
of ORFs into a range of different expression vectors. This technology takes advantage 
of the lambda recombination system which allows the quick and easy shuttling of 
DNA sequences between vectors, as long as DNA sequences are flanked by specific 
recombination sequences (Hartley, Temple and Brasch, 2000).  
 
HSP ORFs were amplified from cDNA using ‘Gateway’ gene-specific primers, these 
were designed so that the 5’ and 3’ end of the ORF was followed with attB1 and attB2 
sequence overhangs, respectively. All Gateway primers, contain the ORF native start 
and stop codons. Once an attB-PCR product is generated this can be used in a BP 
recombination reaction (termed BP reaction), in which the PCR product is 
recombined, in vitro, with the Gateway® donor vector pDONR223. The donor vector 
has attP1 and attP2 sites which flank the ccdB gene (expression of which is lethal to 
E. coli). The BP reaction results in the recombination of the attB-PCR product with 
the attP-donor vector in which the ccdB gene is flipped out and replaced by the HSP 
ORF to create an attL-flanking HSP ORF pDONR223 entry clone. 
 
 
 122 
Figure 3.1 
 
A 
 
 
 
 
B 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1. The Gateway® system. (A) Primer design includes the Gateway® attB 
recombination site sequences (blue), XXX = first gene-specific codon after ATG and 
YYY = reverse complement of last gene-specific codon. (B) ORFs are amplified using 
Gateway primers (as in A), resulting in attB1 and attB2 overhangs (blue). The attB 
sites allow the PCR product to be recombined with the attP1 and attP2 sites (orange) 
of a donor vector, producing an attL-containing entry clone, in what is called a BP 
reaction. This entry clone can undergo further recombination with the attR1 and 
attR2 sites (yellow) of various destination vectors, in what is called an LR reaction, 
generating attB-containing bacterial, yeast and mammalian expression clones. 
 
ORF orientation is important, and by using this system this can be maintained as the 
attB1 site only recombines with the attP1 site (likewise for attB2 and attP2). 
Following E. coli transformation, only pDONR223 entry clones can grow as the ccdB 
gene is no longer be expressed in the recombined vector. The Gateway® pDONR223 
Gateway_F:
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vector contains a spectinomycin resistance marker (Rual et al., 2004) allowing for the 
selection of positively transformed colonies on spectinomycin-containing agar 
plates.  
 
Generated entry clones contain attL1 and attL2 sites which allows ORFs to be 
shuttled into other expression vectors (destination vectors), in a similar 
recombination reaction as the BP reaction. The destination vector contains attR1 and 
attR2 and with an attL-entry clone, can be used to undergo a LR recombination 
reaction (termed LR reaction). Following E. coli transformation, transformants are 
selected for growth using antibiotic-containing media (elective towards the 
destination vector. 
 
3.3.2 Yeast two-Hybrid cloning 
  
The primary aim was to investigate the interaction profiles of HSPs, to provide new 
insight into the molecular mechanisms of the disease and identify new candidate 
genes for screening. Initially, the GAL4 yeast two-hybrid (Y2H) system (reviewed in 
Chapters 1 and 4) was used for this analysis. HSP ORFs were successfully cloned into 
the Y2H bait vector pGBAE-B and the Y2H prey vector pACTBE-B for use in 
‘conventional’ yeast two-hybrid screens (discussed further in Chapters 4 and 5).  
 
Several HSPs were known to have transmembrane domains (see Figure 3.2), which, 
due to their hydrophobic nature can be problematic for ‘traditional’ Y2H and so the 
split-ubiquitin membrane yeast two-hybrid (MYTH) system was employed (reviewed 
in Chapters 1 and 6). HSP ORFs were successfully cloned into MYTH bait vectors 
pAMBV or pBT3N, for use in MYTH library screens (discussed further in Chapter 6).  
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Figure 3.2  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.2. Dendrogram of all putative HSP proteins (HSP seed 3) and the 
representation of transmembrane proteins within the group. Proteins are ordered 
by their primary sequence using ClustalOmega, a multiple protein sequence 
alignment tool. Sequence alignment was used to generate a phylogenetic tree using 
iTOL (Letunic and Bork, 2007). The transmembrane-domain containing proteins are 
highlighted in green. The position of each transmembrane domain is shown. 
Abbreviations: TM = transmembrane domain. 
 
3.4        HSP-related proteins interact within a network 
 
For the purpose of network analysis, an annual literature curation was conducted to 
acquire the most up-to-date list of Entrez Gene IDs for gene entries that encode HSP-
related proteins (see Figure 3.3). Ultimately, this resulted in a total of 99 bona fide 
gene entries, corresponding to 83 HSP-related proteins (as shown in Table 1.1), which 
include 78 spastic gait disease-loci (SPG1-78) and 63 corresponding spastic 
paraplegia genes, as well as those genes involved in complex forms not referred to 
as HSP, such as mitochondrial genes MT-ATP6 (Verny et al., 2011) and MT-TI (Corona 
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et al., 2002), or other causative genes not yet part of the SPG classification system, 
such as LYST (Shimazaki et al., 2014) and CCT5 (Bouhouche et al., 2005).   
 
3.4.1 HSP protein-protein interaction (PPI) network construction: HSPome 
 
As many cellular processes are mediated by protein-protein interactions, including 
signal transduction and enzyme activity, large protein-protein interaction networks 
have often facilitated the identification of common biological pathways and gene 
function annotation (Vallabhajosyula et al., 2009). 
 
Early in the project, Novarino et al. (2014) generated a predicted HSP interactome 
network (Novarino et al., 2014). They initially created an expanded global proteome 
network, combining interaction data from multiple sources which included, 
iREFINDEX (Razick, Magklaras and Donaldson, 2008), ConsensusPath DB (Kamburov 
et al., 2009), HumanNet (Lee et al., 2011), literature-curated interactions from 
STRING (Franceschini et al., 2013) and the Y2H pre-publication dataset (HI-2012) 
from the Human Interactome Database website 
(http://interactome.dfci.harvard.edu/H_sapiens/). Following a network 
propagation-based approach (Vanunu et al., 2010), they were then able to extract 
already published HSP mutated genes (seeds), candidate HSP genes they identified 
through whole-exome sequencing of families displaying AR-HSP and their 
interactors, to derive their HSPome. This ‘one-step’ subnetwork was composed of 
589 proteins. The authors did not make their HSPome freely available and so prior to 
performing a large-scale targeted Y2H analysis, it was important to generate our own 
comprehensive predicted HSP interactome network. To achieve this, a global protein 
network consisting of interaction data from several public databases (BioGRID, HPRD 
and CCSB), our ‘In-house’ interactome network (as described in section 2.5.1) and 
literature-based interaction data was curated. This was used to extract known HSP 
genes (seeds) and their proximal interactors, creating a ‘one-step’ HSP subnetwork. 
Due to the continual discovery of disease-loci and corresponding spastic paraplegia 
genes, the HSP seed list was updated regularly throughout this project and is shown 
by the three subnetworks generated (Figure 3.3 A).  
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Finally, interaction data from several updated public databases, in combination with 
experimental interaction data from the Human Integrated Protein-Protein 
Interaction rEference (HIPPIE) and Biophysical Interactions of ORFeome-based 
complexes (BioPlex) was merged with the global network generated to maximise 
interaction coverage. This ‘expanded’ global network, consisted of 22,932 proteins 
(nodes) and 422,357 interactions(edges), was used to extract the most recent set of 
known HSP genes (HSP seed 3) and their proximal interactors, creating a ‘one-step’ 
HSP subnetwork, termed the ‘HSPome’ (Figure 3.3 B).  
 
Many of the public interaction databases assign annotations such as a “direct” or 
“physical” association which can often be confusing. For example, a “physical” 
association describes molecules in a physical complex, identifying both direct binding 
partners or indirect protein associations. It was therefore important that in this study 
all PPIs were annotated according to method of discovery. An interaction was termed 
“known direct” if discovered via binary methods such as Y2H, whereas a “known 
indirect” interaction would have been discovered by other techniques such as 
affinity-capture western or co-immunoprecipitation and finally “predicted 
direct/indirect” interactions would be assigned to an interolog accordingly. 
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Figure 3.3 
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Figure 3.3. Generation of a high-density predicted HSPome network. (A) HSP ‘one-
step’ subnetworks were generated from a combined global human and orthologue 
network, consisting of interaction data derived from each of the listed databases. 
Incremental expansion in the number of HSP-associated seed nodes (HSP seed 1 to 
3), over the timeline of this project is shown by comparison of the three subnetworks 
generated, respectively. (B) Final HSP ‘one-step’ network (HSPome) containing 
recent data from the HIPPIE, BioPlex and BioGRID databases. 
 
HSP seeds and candidate proteins identified by Novarino et al., (2014) and similarly 
those identified in the predicted HSPome generated in this study were found to have 
some degree of overlap (as shown in Figure 3.4). Of the proximal interactors 
identified by Novarino at al. 6 have since been identified as novel HSP proteins, 
highlighting the importance and relevance of network analysis. 
 
Figure 3.4 
 
 
 
 
 
 
 
 
 
 
Figure 3.4. Relative expansion of the human ‘HSPome’. The degree of overlap 
between sets of HSP genes previously identified by Novarino et al. (2014) was 
compared with those in the predicted ‘HSPome’ generated in this study. Of the 589 
genes identified by Novarino et al. (2014), 6 have since been identified as novel HSP 
proteins and are shown in the box. 
 
3.4.2 Identifying ‘hubs’ in the HSPome network 
 
Analysis of the topological pattern of interactions observed in large PPI networks 
often reveals a common feature, the presence of ‘hubs’ or nodes (proteins) that are 
highly connected to other nodes within the network. Large networks characterised 
Predicted	
‘HSPome’
Novarino	
et	al.,	2014	
ATP13A2,	BICD2,	CAPN1
MAG,	REEP2,	ZFYVE27
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by the presence of ‘hubs’ often possess the ‘scale-free’ property i.e. the nodal degree 
distribution of the network is a power-law distribution (Barabasi and Albert, 1999). 
Even though this property does not identify any degree ‘scale’, it has become 
common practice to use an informal threshold or degree scale when analysing 
protein interaction networks, so that all nodes (proteins) that have a degree higher 
that the ‘threshold’ scale are considered special ‘hub’ nodes (Vallabhajosyula et al., 
2009). 
 
Following topological analysis of the HSPome network, ‘hub’ HSP nodes (proteins) 
were defined as those most highly connected. The top 10 most highly connected HSP 
nodes were defined as HSP ‘hub’ nodes (see Figure 3.5 A). The HSPome network was 
used to extract these ‘hub’ HSP nodes and their proximal interactors to create the 
‘one-step’ HSPome degree-based subnetwork as shown in Figure 3.5 B. 
 
Figure 3.5 
A 
Gene ID Symbol No. of interactors No. of HSP interactors 
7415 VCP 698 7 
3329 HSPD1 413 5 
22948 CCT5 235 2 
2697 GJA1 169 0 
10342 TFG 165 2 
9101 USP8 151 0 
823 CAPN1 133 0 
57599 WDR48 126 0 
4141 MARS 117 0 
11160 ERLIN2 110 1 
 
 
 
 
 
 
 
 130 
8412
8672
55432
26191
84649
51143
811
4751
54431
797112146
6185 10109
6188
5530
10277
23397
4287
9774
2293056997
850500
9230
557688424656897
55610
551392475
55971
1797
10112
3998
51552
9373
16765891
91319
56259
83743
57617
1838
9894
9700
51322
2975
400091544
80173
107242
55829
197320
7158
6130
641
51035
7993
835423059
25897
51663
642851477
7429
3003
6310
55204
8352
55968
55766
9024
556666262
391282
5495
87
5431
130617
10629
6184
1026
9919
220042
10953
23637
51780
23235
7979 6599
29979
6811
50813
258010
5685
8471
7165
25828
9181
8714
857
5983
550
5886
572 7150
682
81
23256
80344
10623
80700
2703401
2531
57650
8968
23543
653789
5445
10564
2720
7314
637
9474
6955
569021706225507
64342
8161
57122
5683
23141
5701
79609
90268
5243
1852
8189
3021
23195
23165
84364
55275
55646
121504
28973
10971
25820
51465
2060
3315
5339
5287
2155
79660
987
9217
83858
4794 92305
85456
2906
79039308
10043
10040 5824
260608358
5682
6494681892340273
15068451719
2554 13788610284
55775 8099
25949 9026
3925
5303
5518
2335
1984
4790
55602
6045
8353
920
57154
3688
3178
113389636
847906612
4171
10273
5261
3320
135228
581
3303
5315
2631
5894
7157
3187
60
10238
74127277 6613
10376
80335 5165
23363
23524
3676
6175
10383
7283
1019
5594
1615
1938
4836
5859
5687
5515983
9641
5516
9128
10575
31
6780
6195
155971
908
5567
1445
842
8350
7203
6446
5071
301
23352
8775
170954
290554
84923
10466
3281
23332
833974678
23160
127733
23512
260006156
6233
259042011
29109
55127
919
5580
6152
11198 179554
9616
114049
12534
65125
9891
9873
8647
440093
51361
7917
83667
84000
8503
4869
85440
6230
6238
9125
11316
775
221927
418955114
338
102062733922858
55183
9100
51667
6651
5710
7342
6714
5705
4438
846
84823
5708
7534
347733
5695
1974
26168
1917
3091
1937
5713
170572
2316
476
9293
25824
10093
4719
10052
4856
1213
11045
80035
54859 1514
6217
9413
568935052
3009
7082
801
6708
291
16275578
4734
559811043
6647
6176
5216
51699
8359
2492
231
1981
353174
3956
3646
6813
4701
829
2697
5582
11041
4942
51474
9382
4713
3690
23581
2717
4597
824
128077
1281
4361
2189
214910763
55325 6586
5770
9531
2339
1075
598
1892
80258
18943552
2799
3827
166
54850
6774 70
2175
2744
2150
5664
445
6450
5730
3631
84290
867
10459
3895
2904
23517
8804
57223
22897
9446
345222
6100
92483
51659
2620
4124
1827
5910
83692
1674
64785
79587
2176
4779
114609
11104
3184
5184
1277
823
4741
1936
2844
163882
6155
1800 7417
4747
7001 2700
5630
2023
4907
6812
26262
729454
1824
10935 23646
9688
5831
79716
27352
57192707
83795
2702
10617
1072
7385
33
2771
5906
5901
6336
11270
3359
61811634
4001
55630
1453
3030
9146 22998
55898 6271846175270
5478
483
10382
72965592
10092
5579
79188
51144
830
25978
5923
3615
27005
22824
19417
9588
5718
8370
2066
57159
83940
1039
3891
9402
9958
75608
140679
285053
23326
6337
440587
8366
9493
8363
1098523048
91782
9308
23390
79648
6696
55929
8360
12488
375743
737510399
10714
2960
6192
57646
54503
7329
2034
554313
54874
9871
8365
5929
8673
6338
9837 795899632
84675
6594
79643 7326
8338
10449
8522
83617874
8367
10193
8364
22627
10049
3783
4174
4077
80746
2810
8362
64219
7324
6340
10808
8027
1005657448
9525
7884
8368
22848
8294
8653
6778
7155
6522079591
389
92421
253782
10133
26052
23063
2317
6010
5962
10381
25782
6207207
162494
26018
29970
902557511
6251
3189
7818
7268
4793
81567
5244
614227250
25930
26128
204219
7189
23307
54882
10807
6139
3156821
9218
84447
3638
23197
6520
5887
23291
1027
27338
4848
80343
81624
102547533
6202
234357531
7529
1729
6205
5296
8467
790
51141
128866
79139
80124
284942
26232
10972
27429
10016
1994
915
3708
7879
7353
8689
9101
5320
781
4670 2949
23322
91304
132320
23385
67490
5713229082 796006048 2191
27243
51510
1226156334
57463
64210
10211
90550
5862
81790
4771
8880
5777
25890
25836
80204
54344
11030
10980
9499
2130
2319
55226
1965
54165
14679608
1434
807958477
79152
9131 51026
153642
7184
4791
3308
3881
3305
525
5162
55611
3735
3306
84676267
1500
5728
74861460
1956
526
6830
3106
1080367
51366
331055165
1211
25871
8329
1400
8065
87247706
76816
6232
3841
3396
11345
8349
2058
51807
84687
338917
8939
22872 8570
23077
8450
4773
10009
10486
10409
96398667
8339
219333
10635
5436 60487
5479
1457
23382
7443
9212
81631
57599
23710
54994738
55850
11337
55832
343069
55128
200728
9500
9737
116447
4458158991
27237
341208
8969
2237
80114
10403 23281
147409
1410
391123
10802
5610
11161
7187
10476
10015
5295
6274
84331
90293
11217
29086
55048
6396
219287
9685
6278
9875
6777
3185
535114928
11005
3500
57222
84282
129531
6342
1478
1315785300
5154081552
51324
66037
3428
10171
5317
23617
196463
1964
2139
254102
8031
941213470193487
47365462251230 9798
57562311
6124
113189401036
517658615544879577
6453
553115
5359
26233
388646
729852
284677
11072
4851232398565
58513
159090834451184
6417551193
6301201176
10197
64854
5313
23194
64135
8346
55100
10491
8666
79915
1314
2177
3018556078342
837375438 8970
6894
728689
10497
440689
79368347
1762
9991
22976
55677
8340
85236
6949
56252
264355651
386681
7419
84324
10363
760
10944
8661
7416
61351004
79089
55362
488
6720
91445
67809
91147
11236
19345
19386
6929
385579885
55851
1639
1095212166
57003 841
145508
51107
83590
6721 55288
5663
1845
10456
242785 2588
10613
7153
51652 337867
685815119
8153922937
221092
55033
1201
92609
55291
11064
55920 57019
9647
6878
9255
5970
2673
3035
5564
55660
2997
1407
38
6157
155030
51605
200081
591779165
7511
51520
10342
7975116870
115708
95217407
7327
7138
8793
7965
11100
55290
3099
6386
2998
8573
25766
511262617
9943
10755
1670913627
11160
9945
8343
8345
91833
9861
3017
4772
509
23210
92345
7398
23246
55843
57621
128312
9682
104871736
8663
866810525
255626
6794
55164
8348
51720
26985
8665
55505
5111
23035
4607
23345
5505420637
2539
2342
23649
55748
4817 79728
2274
10236
83939
831
5198
885155970
6711
10492
9118
64129
3958
339390
9368
26057
123355
3846
51031
196394
25996
2272
6199
25895
988
1020
10494
552122938120892
14688
8139
1454
6576
6472
64689
27161
5213
5921
10598 217
5869
578
839
2836005631
5763
5661680167
2068
8536
5336
59344
2282710640
4343
64858
51666
9258
5340
55090
940975888
6628 10426
5161
140858
55626
79072
3959
1386 1643
5105
10110
991
55159 8816
29888
5522
3065
9924
10951
25956
16565
79968
8518
16706
29915
12468
11335
23468
68653
192670
1025066317
10681
11035
79657892
6897
653333
3654
83983 29110
642725886
55220
12464
5082 10534
4956
93436
118813
7297
54464
1069
1155
67857
54903
22697755605
79871
55622
71924
557027514
5524
10190
17246 54475
51503
23030
27077
28969
9320
51547
5613
2318
226
5581
3921
2875
22948
840
4792
6189
56647
3313
58
7428
84321
5191
10097
59345
10569
17997
55339
12462
7284
80005
9709
11034
5571
2315410956
3691
79886
6683
124930
10963
1518522888
7975211140
115106
2074
135138
5595
5562
23061
8508
10694
8945
6927
3336
2521 3190
6517
5885
4843
5566
2923
5568292
10574
2597
6470
3326
3836
8764
6218
3029349
7086
3070
5774
4926
29842
4831
79879
51068
23042
51434
10735
1781
23223 5265
2570395250
4141
67375954
7431
6709
409
382
10419
6146
55072
834815604
9040
8290
23062
130773
79058
70675
25814
165324
9330
9354
3105
4763
6400
91012
9908
84464
8356
7024
9927
54982
3692
1977
55004
2783
523
19052
6745
5689
81929
121441
5356
25843
111378841
221120
51298
22144
3476
6223
826
7430
103733
88
726084078
29966
67561
3014
6000
12461 34913668776468
631151548 5513591801
25879 9184
79026 23588
59
8195 8439
780
1246979735
84292
5531
83992
107995
64326
2782
10989564205520
5195
6801
2784
76843
94186
9352
7015
55844
10693
80342
26523
351
2512
3157
64087
84275
51106 7059
84532
26094
5464
285367
10614
9615
211
26995
81890
3914
2936
3363
387867
158219 5160
54948
203427
2731
9722
388677
284427
64064
5211 8985
2103
6611
11331
51073
25793
132001
84445
11252
2232
378374684706
7468
25
64431
10884
112937212
64581
23897
23410
4087
708
140462
5681
57172
10059 55577 7517125115860181876
29083
645455
23111
5214 66468
3675
5424
254013
238
92106
952010945
55687
586
79828
10352
639
6789
836
85451
54880
7096
10521
8834
7919
23203
2341129925219541
9391 9911
23409
115290
70925
8854
2078
29763
216
54994
79709
677770
149041
123096
5597
80139
5019
1933
63932
56288
60314
28951
39121719
29115
373156
5771
2110
153328
26164
129868
383
1459
4170
5893
57805
3181
79913
3276 64745
25821
11014
75786
154075
951475
51067 79018
10801
55366
27235
2
587
11321
23786
4512
386682
10768
9918
8726
10482
8175
3421
6790
3845
950
7064
9524
128989
54675
1191
2752
1327
1018
6901
2908
79922
11015
551991608
5550
4357
2629
55572
80321
1743
512535621
220
999
515 156
27122
5500
26015
23678
201456
5106
3329
384
814
6497
219
374291
4193
10014
9337
6307
5034
9768
9820
8451
2099
3725
26270
83987
7341
3309
506
5603
4914
2885
84557
4215
10537
55868411
7532
10013
3064
7030
4163
6137
80198
49856
6788
6418
8453
8454
8266
154
10155
55215
10987
3312
10576
7846
7316
6950
84525684
672
1017
55781
1025
10075
1408
4214
3376
2634
26260
4609
3611
387082
1452
11345726415
1432
8517
1127148428
29904
112858
5537
10397
8533
7190
11235
55658
79603
1406296319
8355
653604
23190
2583923580
5347
26088
5576
10979
55210
647099
6772
26043
8626
5690
161
63924
6440
1734
3020
404734
3069
79649
335
6191
9532
8613
55869
83932
10425
4363
9554
6194
10890
5800
7415
84708
26121
10844
5903
25989
53371
23636 56888887
6128
23534
10469
6147
570051009
85302
55093
1161
741411124
57679
6314
8513375245
342538
51649
79989
6767
64423
230908
7014
3417
94239
3188
26058
51726
100133240
1312
5501
993
57614112002203
56888
5780 89758826
118
6203
7844 5693
5985
26960
87298648
6132
1111
10728
9328
1982
3123
10196
10856
162
55147
88455
8100
402643
4905
5928
8220
8214
5743
9657
7272
981810712
310
260135704
1495 996
203068
7251
6257
1047
9295
338692
171558
51608
9047
84993
5538
1832
2703399
11135
3717
7411
147841
5832
29956
79876
284695
84984
813
8496
23542
6133
55161
6500
MARS USP8
ERLIN1
WDR48
ZFYVE27
CCT5
CAPN1
VCP
RAB
ALS2
ERLIN2
GJA1
HSPD1
IFIH1
SPG21
SPG 0
ZFR
TFG
FA2H 
SPAST
B 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.5. Degree-based hubs within the current HSPome. (A) Nodes within the 
HSPome were ranked to identify the top 10 most highly connected nodes, defined as 
‘hub’ nodes (proteins). The number of total interactors compared to interactions 
with other HSP proteins is shown. (B) These ‘hub’ proteins (in bold) were then used 
to generate the HSPome degree-based subnetwork. Colours represent different 
functional modules as shown in the key.  
 
3.4.3 Transmembrane HSP subnetwork: construction 
 
Membrane proteins are involved in diverse processes including molecular transport, 
metabolism and the maintenance of cell structures, with many involved in functions 
linked to disease (Snider et al., 2010). The identification of membrane protein 
interactions, and subsequent network generation, would enable a greater 
understanding of how this class of proteins is able to carry out various cellular roles. 
However, due to their hydrophobic nature, the use of conventional assays is often 
difficult or unsuitable (Stagljar and Fields, 2002).  
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In ‘traditional’ Y2H, the bait and prey are fused to split-transcription factor 
components and so to activate the reporter genes, the interacting proteins must 
relocate, with the newly fused transcription factor, to the nucleus (Stagljar and Fields, 
2002). This can be considerably difficult for proteins with a high hydrophobic nature 
such as those with transmembrane domains, and so the split-ubiquitin membrane 
yeast two-hybrid (MYTH) system was developed for use in such circumstances. Prior 
to performing a large-scale targeted Y2H analysis, it was therefore important to 
identify those HSPs with transmembrane domains and use the appropriate technique 
for further investigation.  
 
Following identification of membrane HSP proteins (Table 3.3), the HSPome network 
was used to extract HSPs with or without transmembrane domains and their 
proximal interactors, creating two ‘one-step’ HSPome subnetworks as shown in 
Figure 3.6.  
 
Figure 3.6 
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Figure 3.6. Generation of high-density predicted HSPome subnetworks. Lists of 
HSPs with (37) or without (46) transmembrane domains were used to generate ‘one-
step’ subnetworks from the HSPome network, respectively. 
 
The subnetworks revealed a bias in the number of proteins (nodes) and interactions 
(edges), more specifically “direct” binary interactions (Table 3.3) identified for non-
membrane associated HSP proteins. This in part is reflected in the difficulty 
membrane proteins pose in the more conventional techniques, and as such the 
MYTH system was employed for the high-throughput investigation of membrane HSP 
proteins. 
 
Table 3.3 
SPG Symbol Gene ID No. of TM domains Known Direct Interactions 
SPG1 L1CAM 3897 1 14 
SPG2 PLP1 5354 4 5 
SPG3 ATL1 51062 2 1 
SPG4 SPAST 6683 1 3 
SPG6 NIPA1 123606 9 0 
SPG7 SPG7 6687 2 23 
SPG12 RTN2 6253 2 1 
SPG17 BSCL2 26580 2 8 
SPG18 ERLIN2 11160 1 1 
SPG22 SLC16A2 6567 12 0 
SPG26 B4GALNT1 2583 1 1 
SPG31 REEP1 65055 2 0 
SPG33 ZFYVE27 118813 3 2 
SPG35 FA2H 79152 4 3 
SPG39 PNPLA6 10908 1 1 
SPG42 SLC33A1 9197 11 0 
SPG43 C19orf12 83636 1 2 
SPG44 GJC2 57165 4 0 
SPG49 CYP2U1 113612 5 0 
SPG61 ARL6IP1 23204 3 41 
SPG62 ERLIN1 10613 1 4 
SPG64 ENTPD1 953 2 1 
SPG67 PGAP1 80055 7 0 
SPG68 FLRT1 23769 1 0 
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SPG72 REEP2 51308 2 1 
SPG73 CPT1C 126129 2 0 
SPG75 MAG 4099 1 13 
SPG78 ATP13A2 23400 12 45 
- AFG3L2 10939 2 5 
- ELOVL4 6785 7 0 
- FAM134B 54463 4 2 
- GJA1 2697 4 7 
- KCNA2 3737 6 6 
- KIDINS220 57498 4 6 
- MT-ATP6 4508 6 1 
- MT-ND4 4538 11 10 
- MT-CO3 4514 7 6 
 
Table 3.3. List of all transmembrane domain-containing HSPs. HSP genes are listed 
by spastic gait disease-loci (SPG), those not part of the SPG classification system are 
listed alphabetically. Entrez Gene IDs were obtained from the NCBI database 
(Maglott et al., 2007). Information regarding transmembrane domains was obtained 
from UniProt. The number of known direct interactors was identified following 
analysis of the transmembrane HSPome subnetwork shown in Figure 3.6. 
 
Following identification of membrane HSP proteins, the HSPome network was used 
to extract HSPs with or without transmembrane domains and their proximal 
interactors, creating two ‘one-step’ HSPome subnetworks as shown in Figure 3.6. The 
subnetworks revealed a bias in the number of proteins (nodes) and interactions 
(edges), more specifically “direct” binary interactions (Table 3.3) identified for non-
membrane associated HSP proteins. This in part is reflected in the difficulty 
membrane proteins pose in the more conventional techniques, and as such the 
MYTH system was employed for the high-throughput investigation of membrane HSP 
proteins. 
 
3.5        Discussion 
 
For the analysis of a given protein family, or in this case a genetically diverse group 
of disorders, generating a collection of ORFs is a powerful tool to enable a more 
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systematic, global approach for studying interaction profiles, subcellular localisation 
or biochemical properties of such proteins. 
 
This chapter describes the process required to generate as complete a set of human 
HSP ORFs as possible. An initial list of all human putative HSP genes and their 
corresponding proteins (HSP seed 1) were identified, and all appropriate genetic 
information extracted following literature-based, and publicly available 
bioinformatics database searches. The data from several published studies (Fink, 
2013; Lo Giudice et al., 2014; Novarino et al., 2014) was extracted so that the initial 
number of putative HSPs, at the beginning of this study, was set at 58. After removal 
of 14 HSPs due to their large ORF size, the original 58 was reduced and a new list of 
44 human HSPs was compiled and this became the initial ORF acquisition target. DNA 
sequences representing 41 of the 44 HSPs were acquired, 11 of which were not 
successfully cloned into the Gateway system, setting the number of genes 
represented within our collection at 30, and included spastin (SPG4) and its two 
isoforms (M1 and M87). The majority of HSPs used in this study were full-length and 
these can be used as a template for the production of truncated ORFs for specific 
analysis of individual domains separate from the full-length protein. Finally, DNA 
sequences representing several of the larger ORF-containing HSPs were also used to 
generate fragments which were successfully cloned into the Gateway® system, for 
L1CAM and WASHC5, setting the number of genes represented within our collection 
at 32. 
 
The main aim of this project was to analyse the interaction profiles of human HSPs 
by Y2H, and so a collection of HSP ORFs in yeast expression vectors had to be 
successfully constructed. The techniques and reagents for Y2H analysis will be 
discussed in Chapter 2, and the data generated is compiled in Chapters 4-5. Integral 
membrane and membrane-associated HSPs were cloned into alternative membrane 
yeast two-hybrid (MYTH) expression vectors, in the hope to overcome the paucity of 
data regarding biological function of some of these HSPs, due to the hydrophobic 
nature of transmembrane domains. The techniques and reagents for membrane Y2H 
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analysis were discussed in Chapter 2, and data generated will be discussed further in 
Chapter 6.  
 
Additionally, to further our understanding of HSPs and the biological processes 
underpinning these disorders, it was essential to generate an initial high coverage 
protein-protein interaction (PPI) network, which can be continually enriched with 
experimental data, providing further interaction predictions, as well as annotations 
with information from literature and other bioinformatics databases, which can 
serve as a basis for the generation of new hypotheses and prioritization of targets for 
further investigation.  
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Chapter 4: Systematic analysis of binary HSP:HSP interactions &  
the ‘edgetic’ effect of HSP genetic mutations 
 
4.1       Introduction 
 
Large-scale interactome mapping projects have been successfully used to provide 
new insight into the composition and organisation of biological processes in several 
model organisms (Fromont-Racine, Rain and Legrain, 1997; Walhout et al., 2000). 
Interactome network mapping relies on high-throughput experimental data 
generated from various methodologies, including yeast two-hybrid (Y2H), which 
tests direct or ‘binary’ interactions (Chien et al., 1991; Braun, 2012), or affinity 
purification and mass spectrometry (AP-MS), which normally involves the isolation 
of protein complexes, composed of direct and indirect protein interactions (Gingras 
and Raught, 2012; Walzthoeni et al., 2013). Initially used to investigate the functional 
relationship of proteins in several model organisms, binary protein-protein 
interaction mapping can be highly informative (Fromont-Racine, Rain and Legrain, 
1997; Walhout et al., 2000), and has since been used to provide insights into a range 
of human diseases, which result from perturbations in network connectivity (Goh et 
al., 2007). The approach of systematic protein-protein interaction screening has been 
successfully used to identify potential interaction partners, as well as to functionally 
annotate uncharacterised proteins, based on the biological principle known as ‘guilt 
by association’. Interacting proteins usually function within the same molecular 
machinery or cellular pathway (Schauer and Stingl, 2009).  
 
Yeast two-hybrid is one of the most well-established techniques used to map protein-
protein interactions (Walhout and Vidal, 2001), and the use of large-scale high 
throughput Y2H screens has been the source of most binary protein interaction data 
currently available (Parrish, Gulyas and Finley, 2006). The Y2H system, as described 
in Chapter 1, is one of the most standardised in vivo techniques used to study 
protein-protein interactions as it is a relatively simple assay that was originally 
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developed for high-throughput analyses in the late 1980s (Fields and Song, 1989; 
Chien et al., 1991).  
 
There are some well-documented examples of HSP:HSP protein interactions 
reported, which include direct interactions between REEP1, spastin and atlastin-1, all 
of which are linked to the tubular ER network (Park et al., 2010). However, to date 
there has not been a systematic investigation of all possible HSP:HSP protein 
interactions. Therefore, the main aim of the research presented in this chapter was 
to use the Y2H system to perform an unbiased systematic screen of all possible binary 
HSP:HSP protein interactions. Data generated from these screens was compared to 
all available published HSP:HSP protein interaction data, to define novel partner 
interactions and assess the reproducibility of previously defined interactions. Finally, 
all reproducible binary HSP:HSP interaction profiles were analysed to assess 
associated protein functions and/or cellular pathways or processes in which these 
proteins may act. 
 
Genotype-to-Phenotype: 
Genome-wide associated studies and next-generation sequencing has evolved 
rapidly, generating ever-increasing amounts of genotypic information, which can be 
used to explore the functional consequences of distinct disease-associated 
mutations (Karchin and Nussinov, 2016). Genotype-to-phenotype relationships are 
far more complicated than the original paradigm of ‘one-gene/ one-enzyme/ one-
function’ of the 1940s (Beadle and Tatum, 1941; Sahni et al., 2013), with different 
mutations affecting the same gene but often leading to clinically diverse phenotypes 
(Zhong et al., 2009). Additionally, genes and gene products rarely function alone, 
instead they tend to interact with each other to function as molecular machines, 
which form part of highly interconnected complex cellular networks, often 
represented in ‘interactome’ network models (or graphs) with nodes corresponding 
to proteins, and edges representing either physical or biochemical interactions 
(Barabási and Oltvai, 2004; Zhong et al., 2009; Vidal, Cusick and Barabási, 2011).  
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Missense mutations are some of the most common mutations in Mendelian 
disorders, accounting for more than half of all reported mutations in the Human 
Gene Mutation Database (HGMD) (Stenson et al., 2014). Missense mutations may 
have no functional consequence, however the majority of disease-associated 
missense mutations cause a complete loss of protein function, through protein 
misfolding or instability, leading to ‘node removal’, or alternatively, edge-specific 
genetic or ‘edgetic’ perturbations, which can lead to the loss or gain of specific 
interactions within the network (see Figure 4.1, panel A), giving rise to a host of 
clinically diverse phenotypes (Zhong et al., 2009; Sahni et al., 2015).  
 
‘Edgetic’ interaction network studies are emerging as a powerful tool, which can be 
used to facilitate our understanding of the mechanistic connection between 
genotype and phenotype (Zhong et al., 2009). Changes in network topology resulting 
from disease-associated mutations can confer different pathological phenotypes, 
and a strategy known as ‘Edgotyping’ can reveal how the loss or gain of specific 
interactions (edges), can be used to interpret complex genotype-to-phenotype 
relationships (as shown in Figure 4.1, panel B), allowing improved diagnosis and 
prognostic prediction (Sahni et al., 2013). 
 
Identification of genetic mutations that contribute to inherited forms of HSP could 
therefore provide valuable insight into the potential molecular mechanisms involved 
in the pathogenesis of this group of disorders, which may also improve our 
understanding of the cellular processes required for axonal maintenance or 
degeneration. Although there have been many HSP disease-associated mutations 
identified, to date there has not been any systematic ‘edgetic’ interaction network 
studies, investigating the effects of disease-associated mutations on particular 
interactions as well as on the overall HSP network topology. Therefore, the second 
aim of the work presented in this chapter was to investigate the ‘edgetic’ effects of 
HSP disease-associated mutations on binary wild-type HSP:HSP interactions, in an 
unbiased systematic method using the Y2H system. 
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Figure 4.1 
 
A               B 
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Figure 4.1. Characterisation of disease-associated HSP mutations. (A) Disease-
associated missense mutations have the potential to impose changes in protein 
folding/stability and protein-protein interactions, which in turn may confer a loss or 
gain of function, leading to phenotypic variation. (B) Changes in network topology 
resulting from disease-associated mutations can confer different pathological 
phenotypes. ‘Edgotyping’ reveals the loss or gain of specific interactions (edges), 
which can be used to interpret complex genotype-to-phenotype relationships, 
allowing improved diagnosis and prognostic prediction (Sahni et al., 2013). (C) 
Experimental workflow for the characterisation of ‘edgetic’ changes caused by 
known HSP-associated mutations. Abbreviations: WT (wild-type), mut (mutation).  
(Adapted from Sahni et al., 2015) 
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4.2        Targeted Yeast two-Hybrid Screens 
 
4.2.1 Yeast two-Hybrid assay 
 
In this study, the GAL4 Y2H system was employed. For bait and prey construct 
transfection the PJ69-4A (MATa) and the switched mating-type PJ69-4a (MATa) host 
strains were used, respectively (James, Halladay and Craig, 1996; Semple et al., 
2005). These host strains carry three independent GAL4-responsive reporter genes: 
HIS3, ADE2 and lacZ, each driven by a different promoter (GAL1, GAL2 and GAL7 
respectively). The promoter sequences are similar, but not identical, and thus allows 
for the removal of false positives from promoter-specific reporter activation (Bram, 
Lue and Kornberg, 1986; Walhout and Vidal, 2001). All three reporter genes can be 
assayed in parallel, increasing the stringency of Y2H screens (James, Halladay and 
Craig, 1996; Brückner et al., 2009).  
 
The HIS3 reporter gene encodes the enzyme, imidazoleglycerol-phosphate 
dehydratase, which is required for the biosynthesis of histidine (Walhout and Vidal, 
2001). Reporter activation allows yeast growth on medium lacking histidine. This 
reporter gene is very sensitive to low levels of activation, as it has a ‘leaky’ expression 
in most yeast strains (Feilotter et al., 1994; James, Halladay and Craig, 1996). Basal 
levels of expression are conventionally inhibited with the use of 3-aminotriazole (3-
AT), a competitive inhibitor of the HIS3 gene product, increasing stringency and 
reducing non-specific background growth (James, Halladay and Craig, 1996). The 
amount of 3-AT used can be titrated depending on the stringency level required, and 
this is largely dependent on the yeast strain (Van Criekinge and Beyaert, 1999). 
Previous studies within our laboratory have shown that 2.5 mM 3-AT is the optimal 
concentration (stringency) required to capture true interactions, whilst preventing 
false positives. This concentration was used throughout this study, unless stated 
otherwise. 
 
Activation of the ADE2 reporter gene allows yeast growth on medium lacking 
adenine. This reporter gene encodes the enzyme, AIR-carboxylase which is required 
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for the purine biosynthetic pathway under both specific adenine control and the 
general amino acid control system (Robert Dorfman, 1969; Gedvilaite and 
Sasnauskas, 1994).  
 
The lacZ gene was first cloned from the lac operon in E. coli (Lederberg, 1948) and 
encodes the enzyme, beta-galactosidase (b-Gal), which is required for the hydrolysis 
of b-galactosides (lactose) into monosaccharides (glucose and galactose). The lacZ 
reporter gene is generally more stringent but less sensitive than HIS3 (Tirode et al., 
1997). Yeast colonies can be easily assayed for lacZ activity (b-Galactosidase assay) 
using the colorimetric substrate, X-Gal (5-bromo-4-chloro-3-indolyl-β-D-
galactopyranoside) (Brückner et al., 2009). X-Gal is hydrolysed by b-Gal which forms 
galactose and 5-bromo-4-chloro-3-hydroxyindole, which following spontaneous 
dimerization, oxidises to form a bright blue insoluble pigment (5,5'-dibromo-4,4'-
dichloro-indigo) (Suter et al., 2012).  
 
Upon protein-protein interaction, reporter genes are activated resulting in growth of 
yeast on selective media and blue colour development in b-Galactosidase assays. 
Each biosynthetic/enzymatic assay was repeated at least twice and results from each 
were recorded. Only reproducible interactions were considered to be ‘true’ 
interactions.  
 
4.2.2 Generation of HSP Y2H bait and prey constructs 
 
To test binary interactions of HSP proteins, a set of HSP Y2H bait and prey clones 
were assembled (as described in Chapter 3), resulting in a Gateway® entry clone 
library consisting of 34 HSP ORFs representing 30 human HSPs. These ORFs were then 
used to generate corresponding Y2H bait and prey clones for each candidate HSP 
protein. HSP ORFs were successfully cloned into Y2H expression vectors, pGBAE-B 
(bait) and pACTBE-B (prey). The pGBAE-B vector contains the TRP1 gene whilst the 
pACTBE-B vector contains the LEU2 gene, both controlled by the ALDH1 promoter, 
which has been modified to allow moderate expression and stringent selection of N-
terminally tagged GAL4-fusion proteins (pGBAE-B and pACTBE-B) on synthetic 
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defined agar plates lacking tryptone (SD-W) or leucine (SD-L), respectively (see 
Section 2.2). It should be noted that due to problems generating full-length CDS 
clones for WASHC5 (SPG8) and L1CAM (SPG1) proteins, fragmented domains of each 
protein was generated in Y2H expression vectors. All Y2H bait and prey clones were 
tested for auto-activation, resulting in a final collection of 33 HSP Y2H bait clones and 
24 HSP Y2H prey clones, representing 29 and 22 human HSPs respectively. This 
collection of HSP constructs were used to perform systematic Y2H matrix interaction 
assays. 
 
4.2.3 Generation of HSP disease-associated mutants  
 
To characterise the effect of HSP genetic mutations on the binary HSP network, a set 
of HSP disease-associated mutants had to be generated. Due to the vast number of 
known disease-associated HSP proteins, those involved in intracellular trafficking 
processes were prioritised, resulting in a Gateway® entry clone library of 23 mutant 
HSP ORFs, representing 10 human HSPs. These mutant HSP ORFs were then 
transferred into bait and prey Y2H vectors. An outline of the experimental workflow 
used to investigate HSP ‘edgetic’ interaction profiles, is shown in Figure 4.1, panel C. 
Mutant HSP ORFs were successfully cloned into Y2H expression vectors, pGBAE-B 
(bait) and pACTBE-B (prey). However, many of the pACTBE-B constructs showed signs 
of auto-activation and were therefore removed from further analysis. For the 
purposes of this study only pGBAE-B (bait) constructs were used, resulting in 16 
mutant HSP Y2H bait clones, representing 9 HSPs as shown in Table 4.1.  
 
Table 4.1 
SPG Gene Gene ID Protein Protein  change 
Effect on 
protein 
SPG4 SPAST  (M87) 6683 Spastin 
p.E112K Missense 
p.R115C Missense 
p.F124D Missense 
p.V162I Missense 
p.N184T Missense 
p.L195V Missense 
SPG8 WASHC5 9897 WASH complex subunit 5  p.I226T Missense 
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p.N471D Missense 
p.L619F Missense 
p.V620A Missense 
p.V626F Missense 
p.G696A Missense 
SPG20 SPART 23111 Spartin p.F24D Missense 
SPG21 SPG21 51324 Maspardin p.S109A Missense 
SPG50 AP4M1 9179 AP-4 complex subunit mu-1 
p.F255A Missense 
p.R283D Missense 
SPG53 VPS37A 137492 Vacuolar protein sorting-associated protein 37A p.K382N Missense 
SPG57 TFG 10342 Protein TFG p.R106C Missense 
SPG61 ARL6IP1 23204 
ADP-ribosylation factor-
like protein 6-interacting 
protein 1 
p.K193FfsX Frameshift 
SPG62 ERLIN1 10613 Erlin-1 
p.R55X Nonsense 
p.G50V Missense 
p.del288-
289YQ Frameshift 
- CCT5 22948 T-complex protein 1 subunit epsilon p.H174R Missense 
 
Table 4.1. Selection of known HSP disease-associated mutations. List of mutations 
found in some of the HSP proteins involved in intracellular transport and ER-
associated processes. Only successfully cloned, sequence-verified mutants are 
shown. Red boxes highlight mutant clones that were successfully cloned into 
pDONR223 but auto-activated when cloned into either bait (pGBAE-B) or prey 
(pACTBE-B) yeast vectors. The remainder were successfully cloned into Y2H pGBAE-
B bait vector. 
 
4.3        Identification of binary HSP:HSP interactions  
 
4.3.1 Targeted Y2H assay reveals 15 binary HSP:HSP interactions 
 
An outline of the targeted Y2H matrix mating methodology used in the HSP:HSP 
interaction screen is shown in Figure 4.2. As described in Chapter 2, MATα haploid 
yeast transfected with HSP prey constructs were spotted onto rich medium (YPAD) 
agar plates, in a 96-well format. MATa haploid yeast cells transfected with HSP bait 
constructs were spotted on top of prey clones and left for 24 hours to mate. Diploid 
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yeast were then selected following initial velvet replication onto SD-WL agar plates, 
followed by a second replication onto SD-WLA and SD-WLH(3-AT) agar plates, to 
select for positive protein-protein interactions. The lacZ reporter activity (β-Gal 
assays) was also performed on diploid yeast cells, followed by evaluation of blue 
colouration in a colony filter lift assay as described in Chapter 2. Images were taken 
every 3-4 days and interactions were annotated as either weak, medium or strong 
growth. A known positive control was included in every assay to check for efficient 
mating. All screens were repeated twice, and only interactions observed in both 
screens were annotated as positive. 
 
Figure 4.2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.2. Targeted Y2H matrix mating protocol. In the GAL4 Y2H system, MATa 
yeast were transfected with pGBAE-B bait constructs while MATα yeast were 
transfected with pACTBE-B prey constructs and resulting transformants were 
selected for on –W (pGBAE-B) or –L (pACTBE-B) selective plates respectively. All bait 
and prey clones were then individually tested for auto-activation (Section 2.2.6) prior 
to use in subsequent protein-protein interaction assays. Preys were spotted onto 
non-selective rich media (YPAD), in a 96-well format, and selected baits were spotted 
on top of each individual prey. Mating on rich medium allowed the growth of diploid 
yeast, which were selected for on SD-WL medium (-WL). Following diploid selection, 
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yeast was replicated from SD-WL onto both SD-WLH(3-AT) and SD-WLA triple 
dropout plates, for the selection of positive protein-protein interactions. The 
activation of a third reporter, lacZ was also analysed using the β-Gal assay on diploid 
yeast. The level of reporter activation (*) based on yeast colony growth, and growth 
time (days) for each stage is shown. 
 
In total, a possible 792 binary interactions were tested between 33 HSP bait clones 
and 24 HSP prey clones (Figure 4.3), and the 15 reproducible positive binary HSP:HSP 
interactions are presented in Table 4.2. As a general rule, true positive Y2H 
interactions should be observed on both SD-WLA and SD-WLH(3-AT) selective media, 
or on the less stringent SD-WLH(3-AT) selection alone. Interactions only detected on 
SD-WLA, were considered to be false positives and were therefore excluded from the 
final list of positive interactions in this study. In addition, results from corresponding 
β-Gal assays (lacZ reporter activity assays) were incorporated with those from the 
biosynthetic reporter assays and the final list of positive binary interactions includes 
7 interactions seen on all three reporters, 5 interactions seen on two reporters and 
3 interactions seen on only one reporter. In addition, 3 of the 15 positive HSP:HSP 
interactions had previously been identified as ‘direct’ or binary interactions and are 
highlighted (green) in Table 4.2, leaving 12 novel binary HSP:HSP interactions. 
  
Table 4.2 
BAIT 
Gene ID 
BAIT 
Symbol 
PREY 
Gene ID 
PREY 
Symbol HIS3 ADE2 lacZ 
7415 VCP 7415 VCP +++ +++ ++ 
10613 ERLIN1 11160 ERLIN2 +++ +++ ++ 
9179 AP4M1 10717 AP4B1 +++ ++ +++ 
51324 SPG21 10342 TFG +++ ++   
137492 VPS37A 137492 VPS37A +++ +++ +++ 
51324 SPG21 137492 VPS37A +++ +++ ++ 
23204 ARL6IP1 11160 ERLIN2 ++ + + 
22948 CCT5 137492 VPS37A ++ + ++ 
51324 SPG21 51324 SPG21 +++ ++   
51324 SPG21 23111 SPG20 ++ ++   
83636 C19orf12 23111 SPG20 ++ +   
6683 SPAST (M1) 11160 ERLIN2 +++   ++ 
11160 ERLIN2 11160 ERLIN2 +++     
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51324 SPG21 11160 ERLIN2 ++     
10717 AP4B1 3897 L1CAM (NT) +     
 
Table 4.2. Summary of positive binary HSP:HSP interactions detected in targeted 
Y2H matrix interaction screens. Entrez Gene IDs and symbols for bait and prey HSPs 
that showed evidence of positive binary interactions are listed, along with an 
indication of the relative strength of interaction, as indicated by relative colony 
growth or intensity of blue signal: strong (+++), medium (++) or weak (+) as defined 
in Figure 4.2. Previously defined known direct interactions are highlighted in green. 
Entrez Gene IDs and symbols were obtained from the NCBI database (Maglott et al., 
2007). 
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Figure 4.3. Summary of all binary HSP:HSP interactions tested in targeted Y2H 
matrix interaction assays. A) Matrix showing results of all tested binary HSP:HSP 
interactions. HSP genes are listed by spastic gait disease-loci (SPG), genes that are 
not part of the SPG classification system are listed alphabetically. (B) Shows the 
percentage of positive Y2H interactions observed at each level of reporter stringency. 
Stringency scoring is ranked as follows: His/Ade/ β-Gal (Dark Blue) > His/Ade (Light 
Blue) > His/β-Gal (Dark Green) > His (light Green). Corresponding colours are also 
used to represent relative stringency of individual positive interactions in panel (A). 
BOLD = Transmembrane protein. 
 
4.3.2 Reconfirmation of previously defined interactions 
 
Interaction data from published interaction studies is often manually and/or 
automatically curated and deposited into publicly available databases such as 
BioGRID and HPRD. As described in Chapter 3, several of these databases, in 
combination with our ‘in house’ interactome data were used to produce the 
Expanded Global protein interaction network (Figure 3.3). The Expanded Global 
network (Chapter 3) was used to extract the 58 HSP proteins (using ‘seed 1’ list), 
together with their interaction partners, to create the HSP seed 1 ‘one-step’ 
subnetwork shown in Figure 4.4 A. All previously defined known (direct and indirect) 
and predicted HSP:HSP interactions were extracted from this global subnetwork, to 
create the HSP:HSP ‘one-step’ subnetwork (Figure 4.4 B). A union of HSP:HSP ‘one-
step’ subnetwork and the data generated in this study is presented in Figure 4.4 C. 
Compared to the initial HSP:HSP ‘one-step’ subnetwork (Figure 4.4 B), the new 
‘combined’ HSP:HSP subnetwork is composed of 47 interactions between 34 HSP 
nodes, representing a 10 % increase in the number of HSP nodes and a 31 % increase 
in the number of interactions (edges) observed.  
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Figure 4.4 
A Expanded Global seed 1 ‘one-step’ subnetwork  
 
      Total nodes: 2,334 
      Total edges: 3,314 
 
 
 
 
 
 
 
B HSP:HSP subnetwork 
 
      Total nodes: 31 
      Total edges: 36 
 
 
 
 
 
 
 
 
 
C Combined HSP:HSP subnetwork 
 
               Total nodes: 34 
                Total edges: 47 
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Figure 4.4. Generation of an HSP:HSP protein interaction network. (A) HSP seed 1 
‘one-step’ subnetwork was extracted from the expanded global network (shown in 
Figure 3.3 B), using the HSP seed 1 list (58), as core nodes. All non-HSP nodes and 
adjacent edges were removed from the network shown in panel A, to generate the 
HSP:HSP ‘one-step’ subnetwork (B). (C) The HSP:HSP ‘one-step’ subnetwork shown 
in panel (B) with the additional binary interactions identified in this study 
(represented as bold lines) represented as a network. New HSP partners are shown 
as purple nodes. 
 
Of the 31 previously known (direct and indirect) HSP:HSP interactions, 16 were re-
tested in this study and 4 were reconfirmed. Additionally, 4 of the 16 re-tested known 
interactions were previously identified as ‘direct’ or binary interactions, and 75% 
(3/4) were reconfirmed in this study, compared with 8% (1/12) of the re-tested 
‘indirect’ interactions (from non-Y2H experiments), as presented in Table 4.3. This 
was the well-defined ERLIN1 (SPFH1) and ERLIN2 (SPFH2) interaction (Pearce et al., 
2009; Christianson et al., 2011). The remainder of the re-tested ‘indirect’ interactions 
were not found to be positive binary interactions when re-tested in this study. 
 
Table 4.3 
Interaction Direct Indirect 
Known 14 17 
Re-tested 4 12 
Reconfirmed 3 1 
Reconfirmation rate 75% 8% 
 
Table 4.3. Re-tested HSP:HSP protein interactions. Known direct and indirect human 
HSP:HSP interactions previously defined, were extracted from the expanded global 
HSP seed 1 ‘one-step’ subnetwork (Figure 4.4 A), and interaction reconfirmation 
rates were determined. 
 
4.3.3 Common HSP:HSP protein interaction partners  
 
The combined HSP:HSP subnetwork was analysed for common binding partners and 
cellular pathways in which these proteins might act (Figure 4.5). In the known 
HSP:HSP ‘one-step’ subnetwork (Figure 4.4, panel B), SPG20 (spartin) is reported to 
have one indirect interacting partner, HSPD1 (Milewska, McRedmond and Byrne, 
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2009). In our study, SPG20 was shown to interact with SPG21 and C19orf12 (Figure 
4.4 C). SPG20 (spartin) is a multifunctional protein with roles in endosomal trafficking 
(Renvoisé et al., 2010), mitochondrial and ER protein folding and degradation of lipid 
droplet-associated proteins (Milewska, McRedmond and Byrne, 2009). HSPD1 
encodes a mitochondrial chaperone protein involved in mitochondrial protein quality 
control, which also functions as a signalling molecule in the immune system 
(Landstein, Ulmansky and Naparstek, 2015). C19orf12, encodes a mitochondrial 
membrane protein (Hartig et al., 2011) which localises to mitochondria and ER 
(Venco et al., 2015), however not much else is known. Through its interaction with 
SPG20, and the proteins involved in this subnetwork, C19orf12 could have a role in 
regulating intracellular trafficking processes or protein quality control.  
 
Figure 4.5 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.5. Functional annotation of the combined HSP:HSP subnetwork. The nodes 
(proteins) of the combined HSP:HSP subnetwork (Figure 4.4 C) were functionally 
annotated based on the previously identified HSP functional modules for which they 
are predicted to be involved in, as discussed in Chapter 1 (Figure 1.1).  
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In the HSP:HSP ‘one-step’ subnetwork as presented in Figure 4.4 B, SPG21 
(maspardin) has only two direct interaction partners, TFG and ARL6IP1 (Rolland et 
al., 2014). SPG21 was initially thought to function as a negative regulatory factor 
involved in CD4-dependent T-cell activation, due to its interaction with CD4 
(Zeitlmann et al., 2001). However, localisation studies showed enrichment at the 
trans-Golgi, late endosomes and lysosomes, suggesting a functional role for SPG21 
in the trans-Golgi network/endosomal pathway (Hanna and Blackstone, 2009). 
ARL6IP1 encodes an ER-shaping protein, required for ER and mitochondrial network 
organisation (Fowler and O’Sullivan, 2016), whilst TFG is a conserved regulator of 
protein secretion from the ER, where it facilitates the assembly of the COPII coat 
complex at the interface between ER and ER-Golgi intermediate compartments, to 
enable the rapid movement of secretory vesicles (Witte et al., 2011; Beetz, Johnson, 
et al., 2013; Hanna et al., 2017).  
 
Interestingly, in our study ERLIN2, a regulator of the ERAD pathway (Pearce et al., 
2007), interacts with both SPG21 and ARL6IP1 as shown in Figure 4.5. ERLIN2 was 
also shown to interact with SPAST (spastin). Spastin is a microtubule-interacting and 
trafficking (MIT) domain-containing AAA ATPase (Evans et al., 2005), and the larger 
isoform, M1 is known to localise and interact with the tubular ER membrane of 
corticospinal neurons, co-ordinating ER-shaping and microtubule dynamics (Park et 
al., 2010). Spastin interacts with CHMP1B, a ESCRT-III complex-associated endosomal 
protein (Reid et al., 2005). Moreover, we identified an interaction between SPG21 
and VPS37A. VPS37A encodes a subunit of the endosomal sorting complex required 
for transport I (ESCRT-I) system (Zivony-Elboum et al., 2012). The ESCRT system is 
important for intracellular trafficking, maturation of multivesicular bodies (MVB) and 
regulation of vesicular transport of ubiquitinated cargo proteins for lysosomal 
degradation (Raiborg and Stenmark, 2009; Lee and Gao, 2012). ESCRT dysfunction 
has been associated with several human diseases, including neurodegenerative 
diseases, disrupting neuronal endosomal trafficking and protein degradation 
(Saksena and Emr, 2009). These findings further demonstrate a potential role for 
SPG21 in vesicle-mediated trafficking and protein sorting, including ESCRT, providing 
further evidence to support the idea that defects in intracellular trafficking events 
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are potentially significant in the pathogenesis of neurodegenerative diseases such as 
HSP. 
 
4.4        Mutational analysis of HSP ‘edgetic’ interaction profiles  
 
4.4.1 Y2H analysis of disease-associated mutations on HSP:HSP interaction profiles 
 
An outline of the targeted Y2H matrix mating with improved β-Gal assay 
methodology, is described in Figure 4.6. As described in Chapter 2, mating arrays 
were set up on rich medium (YPAD) agar plates, in a 96-well format and left for 24 h 
at 30 °C, allowing for the mating of MATa and MATa yeast (Chapter 2). Diploid yeast 
were selected following sequential growth and replication onto SD-WL, followed by 
SD-WLA and SD-WLH(3-AT) agar plates, to select for positive protein-protein 
interactions. In this study assessment of lacZ reporter activity (β-Gal assay) was 
changed from the colony lift assay to an agar overlay assay, in which diploid yeast 
were replicated onto SD-WLH(3-AT) +X-Gal agar plates, as described in Chapter 2. 
Both methods rely on successful colony transfer and evaluation of blue coloration. 
We found the agar overlay assay to be more successful in yeast transfer and colour 
visualisation. Therefore, this approach was adopted for the remainder of the yeast 
work carried out in this project. As in the conventional Y2H assay, images were taken 
every 3-4 days and interactions were scored to reflect weak, medium or strong yeast 
colony growth on selective plates. Again, a known positive control was always 
included, to check for efficient mating. The interaction screen was repeated twice, 
and only interactions observed in both screens were annotated as positive. 
 
All 16 mutant HSP Y2H bait clones were screened against 24 HSP Y2H prey clones. 
384 possible binary interactions were tested (Figure 4.7), and the 29 reproducible 
positive binary interactions are presented in Table 4.4. As before, true positive Y2H 
interactions should be observed on both SD-WLA and SD-WLH(3-AT) or the less 
stringent SD-WLH(3-AT) selection alone, and interactions detected only on SD-WLA 
selection media, were considered to be false positives and were removed.  
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Figure 4.6 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
Figure 4.6. Improved targeted Y2H matrix mating procedure. In the GAL4 Y2H 
system, MATa yeast were transfected with pGBAE-B bait constructs while MATα 
yeast were transfected with pACTBE-B prey constructs and resulting transformants 
were selected for on –W (pGBAE-B) or –L (pACTBE-B) selective plates respectively. 
All bait and prey clones were then individually tested for auto-activation (Section 
2.2.6) prior to use in subsequent protein-protein interaction assays. Preys were 
spotted onto non-selective rich media (YPAD), in a 96-well format, and the selected 
bait was spotted on top of each individual prey. Mating on rich medium allowed the 
growth of diploid yeast, which were selected for on SD-WL medium (-WL). Following 
the diploid selection, yeast was replicated from SD-WL onto SD-WLA, SD-WLH(3-AT) 
and SD-WLH(3-AT) +X-Gal triple dropout plates, for the selection of positive protein-
protein interactions. The activation of a third reporter, lacZ was also analysed using 
the β-Gal assay on diploid yeast. The level of reporter activation (*) based on yeast 
colony growth, and growth time (days) for each stage is shown. 
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The results obtained from the β-Gal assays were incorporated with those from the 
biosynthetic reporter assays are presented in Table 4.4. The final list of positive 
binary interactions includes 1 interaction seen on all three reporters, 19 seen on two 
reporters and 9 seen on one reporter. 
 
Table 4.4 
BAIT  
Gene ID 
BAIT  
Symbol 
PREY  
Gene ID 
PREY  
Symbol HIS3 ADE2 lacZ 
6683 SPAST (M87) N184T 
3897 L1CAM (NT) + +  
6683 SPAST (M87) + +  
11160 ERLIN2 + + ++ 
23111 SPG20 F24D 
3329 HSPD1 +++ +++  
10342 TFG +   
51324 SPG21 S109A 
6683 SPAST (M1) + +  
3329 HSPD1 ++ ++  
137492 VPS37A + +  
10342 TFG ++   
9179 
AP4M1 
F255D 
6683 SPAST (M1) + +  
3329 HSPD1 +++ +++  
137492 VPS37A + +  
AP4M1 
R283D 
6683 SPAST (M1) + +  
3329 HSPD1 +++ +++  
137492 VPS37A K382N 3329 HSPD1 +++ +++  
10342 TFG R106C 
3329 HSPD1 +++ +++  
23111 SPG20 ++   
23204 ARL6IP1 K193FfsX 
3897 L1CAM (NT) ++   
6683 SPAST (M1) ++ +  
3329 HSPD1 +++ +++  
11160 ERLIN2 ++   
10613 
ERLIN1 
G50V 
3897 L1CAM (NT) ++   
3329 HSPD1 +++ +++  
11160 ERLIN2 ++   
ERLIN1 
R55X 
3897 L1CAM (NT) ++ +  
6683 SPAST (M1) +   
3329 HSPD1 +++ +++  
11160 ERLIN2 +++   
22948 CCT5 H147R 3329 HSPD1 +++ +++  
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Table 4.4. Summary of disease-associated ‘edgetic’ changes on the binary HSP:HSP 
protein interactions detected in targeted Y2H matrix screens. Entrez Gene IDs and 
symbols for selected mutant HSP bait (pGBAE-B) and wild-type HSP preys (pACTBE-
B) that showed evidence of positive binary interactions are listed, along with an 
indication of the relative strength of interaction: strong (+++), medium (++) or weak 
(+), as defined previously. 
 
4.4.2 Effect of genetic mutations on HSP:HSP networks 
 
Proteins must be folded correctly to enable correct organelle localisation and protein 
function, and inherited mutations can affect the folding and subcellular localisation 
of proteins, resulting in the accumulation of misfolded, non-functional proteins 
(Valastyan and Lindquist, 2014; Oakes and Papa, 2015). To prevent the toxic build-up 
of misfolded proteins and protect cells from the damaging effects, cellular responses, 
including the ER stress response, are activated (Dobson and Ellis, 1998; Kaufman, 
1999; Dobson, 2003). However, excessive amounts of misfolded proteins can 
overwhelm the ‘quality control’ system and impairs the protective mechanisms of 
the UPR, leading to ER stress-induced organelle dysfunction and cell death (Rao and 
Bredesen, 2004). ER stress-mediated cell dysfunction and cell death has been 
implicated in the pathogenesis of human chronic disorders including 
neurodegenerative disorders such as Parkinson’s disease (PD), Alzheimer’s disease 
(AD) and Amyotrophic Lateral Sclerosis (ALS) (Taylor, Hardy and Fischbeck, 2002; 
Ross and Poirier, 2005).  
 
Interestingly, Figure 4.7 shows that the edgetic mutation S109A in SPG21 completely 
abolished interactions with SPG20 and ERLIN2, whilst maintaining interactions with 
VPS37A and TFG. Both SPG20 and ERLIN2 are involved in protein degradation, so a 
loss of interaction could result in increased levels of aberrant proteins, leading to ER 
stress. SPG21 S109A interacts with both SPAST and VPS37A. SPAST is known to 
interact with two ESCRT-III complex-associated proteins CHMP1B and IST1 (Reid et 
al., 2005; Allison et al., 2013), whilst VPS37A is also associated with the ESCRT 
complex, as a component and regulator of ESCRT-I (Zivony-Elboum et al., 2012). 
More recently, extracellular vesicles formed and released by the ESCRT system have 
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been identified as important factors for the spread of neurodegenerative disorders 
(Budnik, Ruiz-Cañada and Wendler, 2016). These findings support the idea that 
SPG21 could be involved in the ESCRT system, and its involvement in 
neurodegeneration could provide a link between SPG21 dysfunction and HSP.  
 
Figure 4.7  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.7. Analysis of disease-associated ‘edgetic’ changes in HSP:HSP interaction 
profiles. Comparative analysis of wild-type HSP-wild-type HSP or mutant HSP-wild-
type HSP partner interaction profiles. Wild-type or mutant HSP bait (pGBAE-B) 
proteins and wild-type HSP prey (pACTBE-B) Entrez gene ID/symbols are arranged by 
HSP gene loci. Stringency scoring is ranked as follows: His/Ade/ β-Gal (Dark Blue) > 
His/Ade (Light Blue) > His/β-Gal (Dark Green) > His (light Green), with corresponding 
colours used to represent relative stringency of individual positive interactions 
shown in the table. ‘Edgetic’ changes are highlighted by green (gain of interaction) or 
red (loss of interaction) boxes respectively.  
BOLD = Wild-type protein. 
 
Additionally, having shown previously that SPG21 is able to form a dimer (Figure 4.3), 
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loss of dimerization could help explain the loss of interactions leading to a loss-of-
function phenotype that is observed with mutant SPG21 S109A.  
 
Furthermore, SPG21 S109A was also shown to interact with HSPD1, a highly 
conserved protein initially identified as a mitochondrial chaperone (Quintana and 
Cohen, 2011). However, upon exposure to stress stimuli, HSPD1 functions as a 
signalling molecule in the immune system, activating both adaptive and innate 
immune responses (Landstein, Ulmansky and Naparstek, 2015).  
 
Interestingly, CCT5 H174R and VPS37A K382N both have abolished interactions with 
VPS37A, however they both also interact with HSPD1. As the ESCRT system is 
essential for protein degradation, loss of function could lead to ER stress and so the 
involvement of HSPD1 may provide a link between ER stress and immune response 
signalling pathways. 
 
Loss-of-function mutations 
One example of loss-of-function observed in our study is provided by mutant SPG50 
(AP4M1). AP4M1 is a subunit of the heterotetrameric adaptor protein 4 (AP-4) 
complex, which is important in vesicular transport. The AP-4 complex is involved in 
the recognition and sorting of cargo proteins from trans-Golgi network (TGN) to 
endosomal-lysosomal system, and all AP-4 subunits have been classified as HSP 
genes (Hirst, Irving and Borner, 2013). The AP-4 phenotype includes early onset, 
autosomal-recessive complicated form of hereditary spastic paraplegia (HSP), with 
severe intellectual disability (Hirst, Irving and Borner, 2013). In our study, we 
observed a loss-of-interaction between both AP4M1 HSP disease-associated mutants 
F255D and R283D, and SPG47 (AP4B1), which would suggest a loss-of function of the 
AP-4 complex and this may account for the phenotype observed. Given the 
importance of the AP-4 complex in vesicular transport and protein sorting, if the AP-
4 complex was non-functional there could be a build-up of proteins in the TGN, which 
could lead to an increase in ER stress, a common feature of neurodegenerative 
diseases as already mentioned.  
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Gain-of-function mutations 
One example of gain-of-function observed in our study is provided by SPG57 (TFG) 
R106C mutant. TFG is a regulator of ER protein secretion, regulating ER-derived COPII 
vesicle secretion, as well as ER morphology (Witte et al., 2011; Beetz, Johnson, et al., 
2013). Our study identified a gain-of-interaction with SPG20 (spartin). SPG20 is 
thought to be involved in regulating endosomal trafficking and mitochondrial 
function (Renvoisé et al., 2010) and is mutated in Troyer syndrome. Troyer syndrome 
is an early childhood-onset, autosomal-recessive complicated form of HSP, with 
additional neurological features including intellectual disability and muscular 
dystrophy (Proukakis et al., 2004). A gain-of-function mutation could result in an 
altered protein conformation, which can cause dominant toxic phenotypes 
(Valastyan and Lindquist, 2014). Previous studies have already identified that the TFG 
R106C mutant demonstrated a defect in its ability to self-assemble into an oligomeric 
complex, required for normal TFG function, and inhibition of TFG in cell lines revealed 
slower ER protein secretion and altered ER morphology, causing a collapse of the ER 
network (Beetz, Johnson, et al., 2013). During endosomal maturation and trafficking, 
endosomes are bound to the ER, causing changes to ER morphology (Friedman et al., 
2013), therefore the probable altered protein conformation of TFG which interacts 
with SPG20, likely affecting ER architecture and endosomal trafficking. Given the 
function of TFG and SPG20, dysfunctional TFG may cause an accumulation of 
aberrant proteins in the ER, which are unlikely to be degraded, contributing to an 
increase in ER stress and possible cell death. 
 
4.5        Discussion 
 
Although there are over 75 HSP disease-loci, about 70% of individuals are affected 
by autosomal dominant mutations (Salinas et al., 2008), most of which affect 
organelle dynamics, and in particular the endoplasmic reticulum (ER) and ER 
architecture (Beetz, Johnson, et al., 2013). SPAST, ATL1, and REEP1 (spastin, atlastin-
1, and REEP1 proteins, respectively) are some of the most well-characterised HSP 
genes, which together with reticulons, also implicated in HSP (Saito et al., 2004), 
regulate ER-shaping and network distribution (Park et al., 2010).  
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In this study we identified 12 novel binary HSP:HSP interactions, which when 
integrated with current known HSP interactome data, reveal several functional 
modules, which are thought to be involved in the pathophysiology of HSPs. These 
include HSP proteins implicated in endoplasmic reticulum (ER) membrane 
remodelling (SPAST, ARL6IP1), ER-associated degradation (ERAD) pathway (ERLIN2) 
and protein folding (CCT5), as well as endosome-associated HSP genes (AP4 complex, 
VPS37A). ERLIN2 and SPG21, not only interact with each other but they also interact 
with proteins known to function in each of the functional modules as highlighted in 
Figure 4.5. Given the recent reports of endosomal involvement in ER dynamics, it is 
likely that all three functional modules act together as part of the overall dynamics 
of the ER network.   
 
Interestingly, there are proteins involved in ER network shaping and distribution, 
which are mutated in HSP and other neurodegenerative disorders, suggesting that 
correct ER organisation is important for axonal maintenance (Renvoisé and 
Blackstone, 2010; Beetz, Johnson, et al., 2013), thereby providing a clear link 
between ER network organisation and neurodegeneration (Beetz, Johnson, et al., 
2013). 
  
The ER is a multifunctional organelle involved in a range of processes including 
protein synthesis, trafficking, and quality control (English, Zurek and Voeltz, 2009). 
The ER also has an important role in lipid synthesis and distribution, and as a major 
intracellular calcium store (Matus, Glimcher and Hetz, 2011). Its varied functionality 
is reflected in its complex architecture (Schwarz and Blower, 2016). The ER is a 
continuous network of branched tubules and peripheral sheet-like cisternae 
distributed throughout the cytoplasm, and include the nuclear envelope (Renvoisé 
and Blackstone, 2010; Beetz, Johnson, et al., 2013). There are a variety of different 
ER membrane proteins that mediate interactions with other organelles and 
components of the cytoskeleton, which are thought to be integral to ER shape and 
distribution (Schwarz and Blower, 2016). These include, (i) ER membrane-bending 
proteins of the REEP and reticulon families (Voeltz et al., 2006); (ii) the atlastin family 
of GTPases required for tubular ER network formation (Hu et al., 2009); (iii) 
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microtubule cytoskeletal regulators required for distribution of ER network (Park and 
Blackstone, 2010), particularly important for neurons (Renvoisé and Blackstone, 
2010) and (iv) components of the early secretory pathway (Renvoisé and Blackstone, 
2010; Zanetti et al., 2011). In recent studies, the importance of an endosomal 
complex regulating nuclear envelope reformation was demonstrated (Olmos et al., 
2015; Vietri et al., 2015), suggesting a potential role for ESCRT-III in ER dynamics 
(Schwarz and Blower, 2016).  
 
The ER is the main site for localised protein synthesis, and even with specific 
chaperone proteins and enzymes which assist in protein folding, the success rate is 
low, with less than 20% of proteins translocated into the ER lumen undergo proper 
folding events, to create a stable and functional protein (Hartl and Hayer-Hartl, 2009; 
Oakes and Papa, 2015; Schwarz and Blower, 2016). Environmental and genetic 
factors can disrupt ER function, affecting protein folding processes in the ER lumen. 
This can cause an imbalance between protein synthesis and the processing of newly 
synthesised proteins in the ER, leading to an accumulation of misfolded and/or 
unfolded proteins in the ER lumen, a condition known as ER stress (Oslowski and 
Urano, 2011). In response to ER stress, cells induce the Unfolded Protein Response 
(UPR), a highly conserved, adaptive cellular response, which acts to reduce stress and 
restore protein homeostasis (Malhotra and Kaufman, 2007; Oslowski and Urano, 
2011). The UPR is a group of intracellular signal transduction pathways, monitoring 
conditions in the ER (Walter and Ron, 2011). The UPR is initiated by three major ER 
transmembrane proteins: inositol requiring kinase 1α (IRE1α), activating 
transcription factor 6 (ATF6), and protein kinase RNA-like ER kinase (PERK), which 
function as signal transducers of ER stress (Oslowski and Urano, 2011; Walter and 
Ron, 2011). Initiation of the UPR is regulated by the ER chaperone, immunoglobulin 
binding protein (BiP), as it is able to directly interact with each signal transducing 
sensor (Bertolotti et al., 2000; J. Li et al., 2008). This physical interaction stabilises 
these ER transmembrane proteins, as they remain in an inactive state. Following 
increased protein synthesis or abnormal protein folding, there is an increased 
demand for chaperone-mediated protein stabilisation and so BiP dissociates from 
the sensors, rendering them active (Bertolotti et al., 2000; Oslowski and Urano, 
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2011). The activation of each of the ER stress sensors initiates signalling cascades, 
resulting in transcriptional and translational changes in an attempt to reduce cellular 
stress, whilst simultaneously inducing protein quality control mechanisms in an 
attempt to reduce protein misfolding (Sprenkle et al., 2017). In mammalian cells, the 
UPR adaptive response includes: (i) increased gene transcription of ER-resident 
chaperones – increase protein folding and handling efficiency, (ii) decreased protein 
translation - decreasing ER workload and preventing further accumulation of 
misfolded proteins and (iii) increased ERAD and autophagy components to promote 
protein clearance and maintain quality control (Anelli and Sitia, 2008; Oslowski and 
Urano, 2011). Through, ER-associated degradation (ERAD), misfolded proteins are 
transported back to the cytosol where they undergo ubiquitin-proteasome system 
(UPS)-dependent degradation (Menendez-Benito et al., 2005; Smith, Ploegh and 
Weissman, 2011). The UPS is the main pathway responsible for the degradation of 
cytosolic proteins, however if its function is disrupted this can also lead to ER stress 
(Ciechanover and Brundin, 2003; Korhonen and Lindholm, 2004). In more severe 
cases, excessive amounts of misfolded proteins can overwhelm the ‘quality control’ 
system leading to ER stress-induced organelle dysfunction and cell death (Rao and 
Bredesen, 2004; Kim, Xu and Reed, 2008). ER stress-mediated cell dysfunction and 
cell death has been implicated in the pathogenesis of several human 
neurodegenerative disorders which include Parkinson’s disease (PD), Alzheimer’s 
disease (AD) and Amyotrophic Lateral Sclerosis (ALS) (Taylor, Hardy and Fischbeck, 
2002; Ross and Poirier, 2005). 
 
ER stress in neurodegenerative diseases 
The accumulation and aggregation of misfolded proteins is a common feature among 
neurodegenerative diseases such as Alzheimer’s disease (AD), Parkinson’s disease 
(PD), Huntington’s disease (HD) and amyotrophic lateral sclerosis (ALS) (Kopito and 
Ron, 2000; Taylor, Hardy and Fischbeck, 2002; Selkoe, 2003; Soto and Estrada, 2008). 
These can also be referred to as protein conformation disorders or proteinopathies 
(Soto, 2003). The presence of misfolded proteins triggers cellular stress responses 
which includes the initiation of the UPR, an adaptive cellular response of the ER, 
which protects cells against the toxic build-up of misfolded proteins, maintaining 
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biological processes within the brain during cellular stress (Kopito, 2000; Dobson, 
2003; Rao and Bredesen, 2004). Accumulation of misfolded proteins in excessive 
amounts can overwhelm the ‘cellular quality control’ system and the prolonged 
stress observed in neurodegenerative diseases is thought to disrupt the protective 
mechanisms of the UPR, which ultimately leads to organelle dysfunction and cell 
death through the activation of inflammation and apoptotic pathways (Rao and 
Bredesen, 2004; Sprenkle et al., 2017). 
 
Examples in hereditary spastic paraplegia include, the missense mutations in the 
BSCL2 gene, which encodes the ER transmembrane protein seipin (BSCL2), causes 
hereditary spastic paraplegia (HSP) type 17 (SPG17) (Windpassinger et al., 2004). 
Seipin is involved in lipid droplet morphology and metabolism (Fei et al., 2008). HSP-
associated BSCL2 mutations (N88S and S90L), cause misfolded seipin to accumulate 
in the ER, leading to ER stress and enhance ubiquitination and degradation (Ito et al., 
2008).  
 
More recently, reticulon-like-1 (Rtnl1), the Drosophila orthologue of the Hereditary 
Spastic Paraplegia gene reticulon 2, was found to be important in ER organisation and 
function. Loss of Rtnl1 caused an expansion of the ER sheets which contributed to 
the overall reorganisation of the ER and significantly increased the ER stress 
response. Abnormalities within distal motor axons, including disruption of smooth 
ER (SER), microtubule cytoskeleton and mitochondria, was also observed, linking the 
pathogenesis of HSP proteins involved in ER morphogenesis and mitochondrial 
dysfunction (O’Sullivan et al., 2012). 
 
The tropomyosin-receptor kinase fused gene (TFG) has been implicated in several 
hereditary neurological disorders which include hereditary spastic paraplegia (Beetz, 
Johnson, et al., 2013), Charcot-Marie-Tooth (CMT) disease type 2 (CMT2) (Tsai et al., 
2014)and the hereditary motor and sensory neuropathy with proximal dominant 
involvement (HMSN-P) (Ishiura et al., 2012). Each TFG mutation is thought to cause 
a different disorder, affecting several distinct pathological pathways associated with 
ER dysfunction (Yagi, Ito and Suzuki, 2016). In cell lines, TFG inhibition slows protein 
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secretion from the ER and disrupts ER morphology, affecting peripheral ER tubular 
organisation and the subsequent collapse of the ER network, thereby providing a link 
between altered ER morphology and neurodegeneration (Beetz, Johnson, et al., 
2013). More recently, TFG was shown to function as an inhibitory regulator in the 
ubiquitin-proteasome system (UPS) and overexpression of wild-type TFG was found 
to increase ubiquitination of ER-resident protein Seipin, resulting in ER stress (Yagi, 
Ito and Suzuki, 2014). Furthermore, mutant TFG (P285L), causes autosomal-
dominant type of HMSN-P, exhibiting an enhanced inhibitory effect on the UPS and 
the level of ER stress (Yagi, Ito and Suzuki, 2014). 
 
Data from this study show that disease-related mutations of human HSP proteins 
may re-structure HSP protein interaction networks, which may have the potential to 
effect ER function and associated cellular processes, this could in turn lead to 
increased levels of ER stress. ER stress has been suggested to be involved in several 
human neurodegenerative diseases. Understanding more about the role of ER stress 
in neurodegenerative diseases, may reveal novel insight into disease mechanisms 
involved in the progressive axonal degeneration observed in HSPs and other 
neurodegenerative diseases may be possible, as well as identifying potentially novel 
therapeutic strategies for these disorders.  
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Chapter 5: Identification of potential RING E3 ligase and DUB regulators 
of HSP proteins & the ‘edgetic’ effect of HSP genetic mutations 
 
5.1. Introduction 
 
The ubiquitin-proteasome system (UPS) is the main pathway for the removal of 
short-lived, damaged and misfolded proteins in the nucleus and cytoplasm (Dantuma 
and Bott, 2014). The UPS consists of two distinct and successive steps: ubiquitination 
and proteasomal degradation (Wilkinson, 1997; Hershko and Ciechanover, 1998).  
Ubiquitination is a post-translational modification, whereby ubiquitin, a highly 
conserved 76-amino acid peptide (Goldknopf and Busch, 1977), is covalently 
attached to a specific substrate protein via its C-terminal glycine to either the ε-
amino group of lysine (Lys) residues or, the less common, amino (N) terminus of the 
substrate protein itself, forming an isopeptide bond (Pickart, 2001). Ubiquitination is 
an ATP-dependent process which is catalysed by the sequential action of three 
enzymes: ubiquitin-activating enzymes (E1), ubiquitin-conjugating enzyme (E2) and 
ubiquitin ligases (E3) (Ciechanover, 1998; Hershko and Ciechanover, 1998). Initially, 
the E1 or ubiquitin-activating enzyme, activates ubiquitin using ATP to form a 
ubiquitin-adenylate intermediate, after which, ubiquitin is transferred to the cysteine 
residue of the E1 active site, resulting in a thioester linkage between ubiquitin C 
terminus and the catalytic cysteine on the E1. The activated ubiquitin is then 
transferred to the cysteine residue of one of the many ubiquitin-conjugating E2 
enzymes. Finally, an isopeptide bond is formed between a Lys residue of the target 
protein and the C-terminal glycine of ubiquitin, with the co-ordination of a ubiquitin 
ligase E3 which can interact with both E2 and substrate (Ciechanover, 1998; Pickart, 
2001). E3s can identify specific protein domains capable of binding the E2-Ub 
complex, as well as a substrate-specific domain for binding target protein (Bernassola 
et al., 2008; Deshaies and Joazeiro, 2009). Ubiquitin E3 ligases are a large family 
which are currently classified into one of three main types based on the presence of 
specific active and structural domains, and on the mechanism by which ubiquitin is 
transferred to a substrate protein, and include the Homologous to E6-AP Carboxyl 
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Terminus (HECT) domain-containing E3s, the Really Interesting New Gene (RING) 
finger domain-containing E3s, and the RING-between RING-RING (RBR) E3s, 
analogous to HECT E3s (Morreale and Walden, 2016). The E3 ligases of the HECT 
domain family, like the RBR E3s, catalyse a two-step ubiquitin transfer reaction where 
ubiquitin is first transferred to a catalytic cysteine on the E3, and then to the 
substrate protein, whilst the RING E3s, mediate a direct transfer of ubiquitin, 
functioning as a scaffold to orient the E2-Ub complex with respect to the substrate 
protein and stimulating ubiquitin transfer (Metzger, Hristova and Weissman, 2012; 
Spratt, Walden and Shaw, 2014). 
 
The ubiquitination process can be reversed, by a family of ubiquitin-specific 
proteases, termed de-ubiquitinating enzymes (DUBs). DUBs can cleave conjugated 
ubiquitin residues on mono- or poly-ubiquitinated proteins (Wilkinson, 1997; Sun, 
2008). DUBs not only reverse ubiquitination to prevent protein degradation, but they 
can also regulate different cellular pathways. By editing ubiquitin chain linkage and 
length during ubiquitin chain formation, DUBs can target proteins to specific cellular 
pathways (Todi and Paulson, 2011).  
 
Ubiquitination is required for many cellular processes, and once ubiquitinated the 
structural conformation, cellular location and biological function of the target protein 
will change, and following multiple rounds of ubiquitination, a polyubiquitin chain of 
four or more ubiquitin moieties at Lys 48 can serve as a signal for degradation, which 
occurs in the 26S barrel-like complexes known as proteasomes (Ciechanover, 1998; 
Hershko and Ciechanover, 1998; Cao and Mao, 2011). Most ubiquitinated proteins 
are in fact destined for degradation by the 26S proteasome, a large, multi-protein 
complex consisting of one 20S core particle and two 19S regulatory particles (Cao 
and Mao, 2011). The proteasome unfolds substrates, threading polypeptide chains 
through the inner channel, where they can be cleaved into short peptides 
(Bhattacharyya et al., 2014). These short peptides are released from the barrel-like 
structure of the proteasome, rapidly processed rapidly into amino acids and recycled 
(Reits et al., 2003). 
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UPS-dependent protein degradation is initiated when chaperones and ubiquitin 
ligases recognise abnormalities in protein folding (Ravid and Hochstrasser, 2008). 
There are several ubiquitin E3 ligases which mediate the ubiquitination of misfolded 
proteins, and this includes the yeast S.cerevisiae, RING finger E3 ligase Ubr1, which, 
with assistance from chaperones, is responsible for the targeting of misfolded 
cytosolic proteins to proteasomal degradation (Eisele and Wolf, 2008; Ciechanover 
and Kwon, 2015b).  
 
Given that the ubiquitin-proteasome system (UPS) is the main pathway for selective 
protein degradation, it is thought to be a contributing factor in the aetiology of 
neurodegenerative disorders and in particular those associated with the 
accumulation or aggregation of misfolded proteins (Dennissen, Kholod and van 
Leeuwen, 2012). In fact, there are many neurodegenerative diseases, which include 
AD, PD, HD and ALS, for which the pathogenesis of disease has been associated with 
the downregulation of the UPS (Hegde and Upadhya, 2011; Dennissen, Kholod and 
van Leeuwen, 2012). Aging and protein aggregation are two major risk factors 
associated with reduced UPS activity. Studies have shown that proteasomal activity 
gradually decreases with age, thereby reducing its ability to degrade misfolded 
proteins which results in the formation of pathological protein aggregates (Keller, 
Huang and Markesbery, 2000; Tydlacka et al., 2008). The presence of protein 
aggregates, on the other hand, can impair proteasome activity, and other UPS 
components. For example, in Alzheimer’s disease, there is an accumulation of 
hyperphosphorylated and ubiquitinated tau in the brain (Morishima-Kawashima et 
al., 1993; Cripps et al., 2006), as well as an accumulation of proteasomes and 
chaperones which suggests that tau aggregation leads to impaired proteolysis, 
consistent with dysfunction of the UPS (Keck et al., 2003; Tai et al., 2012).  
 
The accumulation and aggregation of misfolded proteins within affected neurons and 
the surrounding environment, is now a recognised feature among many 
neurodegenerative diseases, with UPS dysfunction reported in many cases (Ross and 
Poirier, 2004; Atkin and Paulson, 2014; Ciechanover and Kwon, 2015b). To date, 
there is very little known about the potential involvement of the UPS in HSP. 
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Understanding the molecular mechanisms and components responsible for changes 
in ubiquitination in neurodegenerative diseases, and in particular HSP, may provide 
valuable insight into the molecular mechanisms involved in the pathogenesis of this 
group of disorders, as well as potentially identifying novel therapeutic strategies. All 
of which may improve our understanding of the cellular processes required for 
axonal maintenance or degeneration.  
 
To do this, we targeted specific components of the ubiquitination process, in 
particular ubiquitin E3 ligases, which determine the selectivity of the ubiquitination 
process, and DUBs, direct antagonists of ubiquitin E3 ligases, which together regulate 
the level and activity of protein substrates and thus cell homeostasis.     
 
The main aim of the research presented in this chapter was to use the Y2H system to 
perform an unbiased systematic screen of binary HSP:RING E3 ligase or HSP:DUB 
protein interactions. The second aim was to investigate the ‘edgetic’ effects of HSP 
disease-associated mutations on any detected binary wild-type HSP:RING E3 ligase 
or HSP:DUB interactions, in an unbiased systematic method using the Y2H system.  
All data generated was compared to all available published data, to assess the 
reproducibility of previously defined interactions and identify potentially novel 
regulators of HSP protein function. Finally, all reproducible data was analysed and 
used to predict protein function as well as possible cellular pathways/processes in 
which potential HSP interaction partners may act. 
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5.2. Use of targeted Y2H assay to investigate binary HSP:RING E3 ligase 
interactions 
 
5.2.1. The RING E3 ligase prey collection used in this study 
 
The RING E3 ligases constitute the largest type of ubiquitin ligases, with over 600 
predicted human E3 ubiquitin ligase genes identified so far, and approximately 300 
E3 ligase proteins are currently annotated at RINGs (W. Li et al., 2008). RING E3s can 
be characterised by the presence of a zinc-binding domain called RING (Really 
Interesting New Gene) or by a U-box domain, and can function as monomers, 
homodimers or heterodimers (Morreale and Walden, 2016).  
 
Previous research in our laboratory used a collection of RING E3 ligases, sub-cloned 
into Y2H prey vectors (pACTBE-B/pACTBD-B), to investigate protein-protein 
interactions between RING E3 ligases/ RING E3 ligases (Woodsmith, Jenn and 
Sanderson, 2012) and E2 conjugating enzymes/RING E3 ligases (Markson et al., 
2009). The collection consisted of 177 RING E3 ligase genes as presented in Figure 
5.1, and a list of all RING E3 ligase genes used was assembled in Appendix 5.1). There 
were 138 full-length ORF clones and 39 transmembrane (TM) domain-containing 
RING E3 ligases. As transmembrane domain-containing proteins can be problematic 
for the ‘traditional’ Y2H assay, these clones had been previously truncated to 
generate ORFs encoding the full cytoplasmic RING domain (CRD). These were sub-
cloned into the Y2H prey vector (pACTBE-B) generating a collection of TM-RING-E3 
proteins (Robert Jenn, University of Liverpool, unpublished data). 
 
5.2.2. The HSP bait collection used in this study 
 
To test binary interactions between human HSP proteins and the set of RING E3 ligase 
Y2H prey clones, a set of HSP Y2H bait constructs had to be generated. In total, 34 
HSP ORFs were sub-cloned into the pGBAE-B (bait) Y2H vector, resulting in 33 HSP 
Y2H bait clones (Chapter 4, section 4.2.2).  
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Figure 5.1 
 
Figure 5.1. RING E3 ligases tested by Y2H. All 177 human RING E3 ligases-domain 
containing proteins were aligned using ClustalOmega, a multiple protein sequence 
alignment tool. Sequence alignment was used to generate the phylogenetic tree 
using iTOL (Letunic and Bork, 2007). TM-RING-E3 ligases are highlighted in green.  
 
 
5.2.3. The HSP disease-associated mutant bait collection used in this study  
 
To test the ‘edgetic’ effects on the binary interactions between human HSP proteins 
and the set of RING E3 ligase Y2H prey clones, a set of mutant HSP Y2H bait constructs 
had to be generated. In total, 23 mutant HSP ORFs were sub-cloned into the pGBAE-
B (bait) Y2H vector, resulting in 16 mutant HSP Y2H bait clones (Chapter 4, section 
4.2.3). 
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5.3. Identification of binary HSP:RING E3 ligase interactions  
 
5.3.1. Y2H screens reveals 88 binary HSP:RING E3 ligase interactions 
 
The improved targeted Y2H matrix mating methodology was used in the HSP:RING 
E3 ligase interaction screen, as described in Chapter 2. Briefly, MATα haploid yeast 
cells transfected with RING E3 ligase prey constructs were spotted onto rich medium 
(YPAD) agar plates, in a 96-well format. MATa haploid yeast cells transfected with 
the desired HSP bait construct was spotted on top of preys, and they were left for 24 
hours to mate. Diploid yeast was selected for following velvet replication onto SD-
WL agar plates and left to grow after which yeast cells were replicated onto the SD-
WLA and SD-WLH(3-AT) agar plates, to select for positive protein-protein 
interactions. The lacZ reporter activity (β-Gal assay) was altered from the colony lift 
assay to the agar overlay assay. Diploid yeast was also replicated onto SD-WLH(3-AT) 
+X-Gal agar plates, as described in Chapter 2, and images taken every 3-4 days. 
Interactions were annotated as weak, medium or strong according to the relative 
degree of yeast colony growth on selective plates (see Figure 5.2). A known positive 
control was always included in each matrix mating assay, to check for efficient 
detection of interaction. The interaction screen was repeated twice, and only 
interactions observed in both screens were annotated as positive. 
 
All 33 HSP bait constructs were systematically screened against 177 RING E3 ligase 
prey constructs, which included 39 TM-RING-E3 proteins. 5,841 possible binary 
interactions were tested, and the 88 reproducible positive binary HSP:RING E3 ligase 
interactions are presented in Figure 5.3. Additionally, there were 2 previously 
defined HSP:RING E3 ligase interactions which were also identified in this study, 
leaving 86 potentially novel binary HSP:RING E3 ligase interactions. All true positive 
interactions should be observed on either SD-WLA and SD-WLH(3-AT) or the less 
stringent SD-WLH(3-AT) alone, interactions detected on SD-WLA alone are 
considered false positive interactions and were excluded from the final list of positive 
interactions.  
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Figure 5.2 
 
Figure 5.2. HSP:RING E3 ligase interaction data. (A) pGBAE-B-CCT5, (B) pGBAE-B-
SPG21 and (C) pGBAE-B-DDHD1 transfected MATa yeast was mated against MATα 
yeast transfected with either pACTBE-B-TM-RING E3 (panel A) or the full-length 
pACTBE-B-RING E3 ligase collection (panels B and C), in a matrix array format. Yeast 
growth was scored on both SD-WLA (most stringent) and SD-WLH(3-AT) (least 
stringent) agar plates on day 14, shown above. *not E3 RING ligases. 
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Results obtained from the β-Gal assays were incorporated with those from the 
biosynthetic reporter assays and presented in Table 5.1, and the final list of positive 
binary interactions includes: 9 interactions seen on all three reporters, 56 
interactions seen on two reporters and 23 interactions seen on one reporter.  
 
Table 5.1 
BAIT  
Gene ID 
BAIT 
Symbol 
PREY  
Gene ID 
PREY 
Symbol HIS3 ADE2 lacZ 
7415 VCP 267 AMFR +++ +++   
22948 CCT5 4287 ATXN3 ++ +++   
51324 SPG21 330 BIRC3 +++ +++   
51324 SPG21 23624 CBLC +++ +++ + 
80821 DDHD1 23624 CBLC +     
23204 ARL6IP1 65989 DLK2 +++ +++   
6683 SPAST (M1) 65989 DLK2 +++ +++   
5354 PLP1 65989 DLK2 ++ +   
6785 ELOVL4 65989 DLK2 ++     
2571 GAD1 65989 DLK2 ++     
2697 GJA1 65989 DLK2 ++     
51324 SPG21 65989 DLK2 ++     
51062 ATL1 65989 DLK2 ++     
118813 ZFYVE27 65989 DLK2 ++     
10342 TFG 196403 DTX3 + + ++ 
51324 SPG21 196403 DTX3 +++ ++   
80821 DDHD1 196403 DTX3 ++     
51324 SPG21 9666 DZIP3 +++ +++ ++ 
51324 SPG21 2783 GNB2 ++ +++   
22948 CCT5 54708 MARCH5 +++ +++   
9179 AP4M1 54708 MARCH5 ++ +++   
9179 AP4M1 10299 MARCH6 +++ +++   
22948 CCT5 10299 MARCH6 ++ +++   
80821 DDHD1 84108 PCGF6 +     
51324 SPG21 5192 PEX10 +++ ++ ++ 
2571 GAD1 5192 PEX10 +++ +++   
2697 GJA1 5192 PEX10 +++ +++   
6683 SPAST (M1) 5192 PEX10 +++ +++   
83636 C19orf12 5192 PEX10 +++ ++   
5354 PLP1 5192 PEX10 + +   
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80821 DDHD1 51533 PHF7 +++     
51324 SPG21 9867 PJA2 +++ +++   
22948 CCT5 10213 PSMD14 + +   
51324 SPG21 10213 PSMD14 +     
80821 DDHD1 25898 RCHY1 ++ +++   
9897 KIAA0196 (NT) 55159 RFWD3 +     
137492 VPS37A 55658 RNF126 ++ ++ ++ 
6683 SPAST (M1) 9781 RNF144A +++ +++   
6785 ELOVL4 9781 RNF144A +++ +++   
5354 PLP1 9781 RNF144A ++ +   
2697 GJA1 9781 RNF144A +++     
2571 GAD1 9781 RNF144A ++   + 
51324 SPG21 9781 RNF144A ++     
51324 SPG21 115992 RNF166 + +   
6683 SPAST (M1) 91445 RNF185 +++ +++   
23204 ARL6IP1 91445 RNF185 +++ +++   
5354 PLP1 91445 RNF185 + +   
51324 SPG21 91445 RNF185 ++ ++   
51062 ATL1 91445 RNF185 + +   
118813 ZFYVE27 91445 RNF185 +     
22948 CCT5 25897 RNF19A +++ +++ ++ 
22948 CCT5 127544 RNF19B ++ +++   
6683 SPAST (M1) 127544 RNF19B ++     
23111 SPG20 727800 RNF208 ++     
51324 SPG21 140545 RNF32 +++ +++   
23204 ARL6IP1 6048 RNF5 +++ +++   
6683 SPAST (M1) 6048 RNF5 +++ +++   
5354 PLP1 6048 RNF5 + +   
51062 ATL1 6048 RNF5 ++     
2697 GJA1 6048 RNF5 ++     
6785 ELOVL4 6048 RNF5 +     
2571 GAD1 6048 RNF5 +     
9179 AP4M1 10206 TRIM13 ++ +++ +++ 
51324 SPG21 10206 TRIM13 +++ +++   
22948 CCT5 11074 TRIM31 + +   
51324 SPG21 11074 TRIM31 ++     
51324 SPG21 53840 TRIM34 +++ +++   
22948 CCT5 23087 TRIM35 +++ +++   
80821 DDHD1 90933 TRIM41 +++   +++ 
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51324 SPG21 85363 TRIM5 +++ ++ ++ 
6683 SPAST (M1) 84675 TRIM55 ++   + 
51324 SPG21 378108 TRIM74 ++ +++ +++ 
80821 DDHD1 81603 TRIM8 +++ +++   
51324 SPG21 114088 TRIM9 +++ ++   
80821 DDHD1 114088 TRIM9 +     
10342 TFG 55905 RNF114 ++ +   
23204 ARL6IP1 55905 RNF114 + +   
22948 CCT5 55905 RNF114 + +   
10613 ERLIN1 55905 RNF114 + +   
23111 SPG20 55905 RNF114 + +   
80821 DDHD1 55905 RNF114 + +   
51062 ATL1 55905 RNF114 + +   
6683 SPAST (M87) 55905 RNF114 + +   
83636 C19orf12 55905 RNF114 + +   
10717 AP4B1 55905 RNF114 + +   
11154 AP4S1 55905 RNF114 + +   
9897 KIAA0196 (NT) 55905 RNF114 + +   
51324 SPG21 55905 RNF114 + +   
 
Table 5.1. HSP:RING E3 ligase interaction summary. Gene IDs and Gene Symbols are 
indicated for HSP (pGBAE-B) bait and RING E3 ligase (pACTBE-B) preys that showed 
reproducible positive interactions in two independent matrix interaction assays. In 
each case interactions were scored as strong (+++), medium (++) or weak (+), as 
defined in Chapter 2. 
 
A graphical representation of the data compiled in Table 5.1 is presented in Figure 
5.4. HSPs and RING E3 ligases were arranged by degree (number of interactions) 
using interaction data generated from this screen. This degree sorting results in a 
cluster of highly-connected HSPs and RING E3 ligases in the top left corner 
(highlighted by a red box in Figure 5.4). Interestingly, highly connected HSPs do not 
always interact with highly connected RING E3 ligases, and although there are many 
interactions formed between HSPs and RING E3 ligases, there still appears to be a 
high degree of specificity. For example, DDHD1 and CCT5 are highly connected HSPs, 
yet they do not interact with some of the most highly connected RING E3 ligases. 
 176 
Figure 5.4 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.4. Degree clustering of observed HSP:RING E3 ligase protein interaction 
profiles. Bait HSPs (horizontal) and prey RING E3 ligases (vertical) were sorted by 
degree, resulting in a highly-connected subset of HSPs and RING E3 ligases 
highlighted in the top left of the table (red box). 
 
5.3.2. Reconfirmation of previously defined interactions 
 
The Expanded Global network (Figure 3.4 B) was used to extract the 177 RING E3 
ligase proteins used in this study, together with their proximal interaction partners, 
to create an expanded global RING E3 ligase ‘one-step’ subnetwork shown in Figure 
5.5 A. All previously defined known (direct and indirect) and predicted HSP:RING E3 
ligase interactions were extracted from this global subnetwork, to create the 
HSP:RING E3 ligase ‘one-step’ subnetwork (Figure 5.5 B). A union of the HSP:RING E3 
ligase ‘one-step’ subnetwork and the data obtained from this study is presented in 
Figure 5.5 C. Compared to the HSP:RING E3 ligase ‘one-step’ subnetwork (Figure 5.5 
B), this new ‘combined’ HSP:RING E3 ligase interaction network (Figure 5.5 C) 
contains 156 interactions (edges) between 35 HSPs and 65 RING E3 ligases (nodes), 
representing a 52 % increase in the number of HSP interactors and a 59 % increase 
in the number of RING E3 ligase interactors (nodes), which resulted in a 140 % 
increase in the overall total number of interactions (edges) identified.  
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Figure 5.5. Generation of an HSP:RING E3 ligase binary protein interaction 
subnetwork (A) An initial ‘one-step’ RING E3 ligase network was extracted from the 
expanded global network (Figure 3.4 B) using the 177 RINGs used in this study as core 
nodes. (B) An HSP:RING E3 ligase ‘one-step’ subnetwork was then derived from the 
expanded global RING E3 ‘one-step’ network (shown in A) using the 83 ‘HSP seed 3’ 
genes as core nodes. A union network was then generated from the HSP:RING E3 
ligase ‘one-step’ subnetwork (shown in B) and all interactions observed in this study 
(bold line) to generate a combined network (C). Newly identified HSPs are highlighted 
in purple. 
 
Of the 58 previously known (direct and indirect) HSP:RING E3 ligase interactions, 39 
were re-tested in this study, and 2 were reconfirmed. Additionally, 6 of the 39 re-
tested known interactions were previously identified as ‘direct’ or binary 
interactions, and 33% (2/6) were reconfirmed in this study. These include the well-
characterised interaction between VCP and AMFR, which was initially discovered via 
indirect methods (Zhong et al., 2004), but was later confirmed by Y2H to be a direct 
interaction (Grelle et al., 2006), and the less well-defined SPG21 and TRIM9 
interaction (Rolland et al., 2014). None of the retested ‘indirect’ interactions, were 
found to be positive binary interactions when tested in this study (Table 5.2). 
 
Table 5.2 
Interaction Direct Indirect 
Known 14 44 
Re-tested 6 33 
Reconfirmed 2 0 
Reconfirmation rate 33 % - 
 
Table 5.2. Re-tested HSP:RING E3 ligase protein interactions. Previously defined 
known direct and indirect human HSP:RING E3 ligase interactions, were extracted 
from the expanded global RING E3 ligase ‘one-step’ subnetwork (Figure 5.5 A), and 
interaction reconfirmation rates were determined by comparing them to the results 
observed in this study.  
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5.3.3. Common functions of HSP:RING E3 ligase pairs 
 
The Database for Annotation, Visualisation and Integrated Discovery (DAVID, 
https://david.ncifcrf.gov/home.jsp) is an open-access bioinformatics resource which 
enables large gene/protein lists to be analysed and the biological/functional 
information to be extracted, in a high-throughput manner. The DAVID Functional 
Annotation tool was used to analyse the HSP:RING E3 ligase interaction data 
generated, in combination with the previously defined HSP:RING E3 ligase 
interactions as presented in Figure 5.5 C. The RING E3 ligases identified were 
analysed for gene-GO term enrichment, highlighting the most enriched and 
statistically significant GO terms associated with the overall list of RING E3 ligase 
genes.  
 
The Functional Annotation Clustering feature is a novel algorithm, based on the 
hypothesis that similar gene members have similar annotations thereby clustering 
similar annotations together. This feature was used to analyse the RING E3 ligase 
genes, allowing them to be assigned to specific annotation groups/clusters. 
Following analysis, two clusters which were found to be significantly enriched; 
Cluster 1: Immune response mechanisms, which included IFN and NF-κB signalling 
pathways (blue) and, Cluster 2: UPR-associated processes, which included ERAD and 
protein ubiquitination (green) pathways, as presented in Figure 5.6. This type of 
analysis allows similar annotations to be grouped together, making the biology 
clearer and more focused. Following analysis, interacting HSPs were also grouped 
into functional Clusters 1 and/or 2. All of the functional information gathered was 
used to annotate the combined HSP:RING E3 ligase network, and is presented in 
Figure 5.7. 
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Figure 5.6 
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B    Cluster 2 
 
 
 
 
 
 
 
 
 
 
Figure 5.6. Functional annotation of the HSP:RING E3 protein interaction 
subnetwork. DAVID functional GO term enrichment analysis performed on the HSP 
interactors (RINGs) identified in the combined HSP:RING E3 ligase subnetwork 
(Figure 5.5 C). This analysis revealed two significantly enriched (EASE score p £ 0.05) 
clusters: Cluster 1, highlights partners involved in Immune response mechanisms, 
such as IFN and NF-κB signalling pathways (A, blue) and Cluster 2, highlights 
interaction partners involved in unfolded protein response (UPR)-related processes 
(B, green). The percentage of interactors assigned to each given GO category within 
each cluster are indicated. 
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Figure 5.7. Functional annotation of the HSP:RING E3 ligase subnetwork. The RING 
E3 ligases identified in the combined HSP: RING E3 ligase subnetwork (Figure 5.5 C) 
were functionally annotated according to whether they were involved in either of 
the assigned GO term enrichment analysis (see Figure 5.6). Cluster 1: Immune 
response mechanisms, including IFN and NF-κB signalling pathways (blue) and/or 
Cluster 2: UPR-related processes (green). HSP nodes were also annotated following 
literature-based curation.  
 
To determine whether there was an inherent bias for RING E3 ligases to naturally 
cluster within these two functional groups, our collection of 177 human RING E3 
ligase-domain containing proteins were analysed using the same DAVID Functional 
Annotation Clustering feature. The collection of 177 RING E3 ligase that were found 
to be enriched in several functional clusters (see Figure 5.8), the most significantly 
enriched being previously identified Cluster 1: Immune response mechanisms, 
including IFN and NF-κB signalling pathways (blue) and Cluster 2: UPR-associated 
processes (green). However, comparison with the HSP interactors from the 
combined HSP:RING E3 ligase subnetwork (Figure 5.5 C) revealed interactor-specific 
enriched GO terms within these clusters which are specific to the RING E3 ligases 
identified as potentially novel HSP interactors in this study, suggesting a potential 
role for those RING E3 ligases which specifically interacted with HSP proteins, in the 
immune response system and the ubiquitin-proteasome system (UPS).  
 
Figure 5.8 
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 184 
0 1 2 3 4 5 6 7 8 9
ERAD	pathway
Protein	K48-linked	ubiquitination	
ER-associated	ubiquitin-dependent	protein	catabolic	process
Ubiquitin	protein	ligase	activity	involved	in	ERAD	pathway
Ubiquitin-specific	protease	binding	
B    Cluster 2 
 
 
 
 
 
 
 
 
Figure 5.8. RING E3 ligase GO term enrichment analysis. DAVID functional GO term 
enrichment analysis performed on all 177 RING E3 ligases (grey) used in this study 
compared with the HSP protein interactors (RINGs) from the combined HSP:RING E3 
ligase subnetwork (Figure 5.5 panel C) shown as blue/green bars. This analysis also 
identified enrichment of previously identified Cluster 1: Immune response 
mechanisms, including IFN and NF-κB signalling pathways (A, blue) and Cluster 2: 
UPR-related processes (B, green). The number of interactors assigned to each given 
GO category within each cluster are indicated, with interactor-specific enrichment 
highlighted. 
 
5.4. Mutational analysis of HSP ‘edgetic’ interaction profiles 
 
5.4.1. Y2H analysis of HSP disease-associated mutations on HSP:RING E3 ligase 
interaction profiles 
 
The improved targeted Y2H matrix mating methodology was used to investigate the 
‘edgetic’ effects of HSP disease-associated mutations on the binary HSP:RING E3 
ligase protein interaction summary.  
 
All 16 mutant HSP bait constructs (Table 4.1) were systematically screened against 
177 RING E3 ligase prey constructs (including 39 TM-RING-E3 proteins). 2,832 binary 
interactions were tested, and the 30 reproducible positive binary interactions are 
presented in Figure 5.9. As before, all true positive interactions should be observed 
on either SD-WLA and SD-WLH(3-AT) or the less stringent SD-WLH(-AT) alone, 
interactions detected on SD-WLA alone are considered false positive interactions and 
were excluded from the final list of positive interactions.  
 
The number of genes (from the initial query list) 
assigned to each specific GO-term category 
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Figure 5.9  
    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
     
                 Figure 5.9. Analysis of m
utant induced ‘edgetic’ changes in HSP:RING E3 ligase interaction profiles. Com
parative analysis of W
T HSP-W
T RING 
E3 ligases or m
utant HSP-W
T RING E3 ligases partner interaction profiles. W
T or m
utant HSP bait (pGBAE-B) Entrez gene ID/sym
bols are ordered 
according to HSP loci, w
hilst W
T RING E3 ligase prey (pACTBE-B) clones are arranged alphabetically. Stringency scoring is ranked as follow
s: 
His/Ade/ β-Gal (Dark Blue) > His/Ade (Light Blue) > His/β-Gal (Dark Green) > His (light Green), w
ith corresponding colours used to represent 
relative stringency of individual positive interactions show
n in the table. ‘Edgetic’ changes are highlighted by green (gain of interaction)
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or red (loss of interaction) boxes respectively. BOLD = wild-type protein 
 
Results obtained from the β-Gal assays were incorporated with those from the 
biosynthetic reporter assays and presented in Table 5.3, and the final list of positive 
binary interactions includes: 11 interactions seen on all three reporters, 16 
interactions seen on two reporters and 3 interactions seen on one reporter.  
 
Table 5.3 
BAIT 
Gene ID 
BAIT 
Symbol 
PREY 
Gene ID 
PREY 
Symbol HIS3 ADE2 lacZ 
6683 
SPAST (M87) 
E112K 10206 TRIM13 +++ +++ ++ 
SPAST (M87) 
R115C 10206 TRIM13 +++ +++ +++ 
SPAST (M87) 
V162I 10206 TRIM13 +++ +++ +++ 
SPAST (M87) 
N184T 
10206 TRIM13 +++ +++ +++ 
51136 RNFT1 + + + 
55905 RNF114 + + + 
10616 RBCK1 ++ ++  
SPAST (M87) 
L195V 
10206 TRIM13 ++ ++ +++ 
25897 RNF19A + +  
23111 SPG20 F24D 55905 RNF114 + +  
51324 SPG21 S109A 
10299 MARCH6 ++ ++ ++ 
140545 RNF32 ++ ++ +++ 
10206 TRIM13 + + +++ 
53840 TRIM34 +++ ++  
22888 UBOX5 ++ ++  
55905 RNF114 ++ ++  
79102 RNF26 +  ++ 
127544 RNF19B ++   
10293 TRAIP +   
9179 
AP4M1 
F255D 55905 RNF114 + +  
AP4M1 
R283D 55905 RNF114 + +  
137492 VPS37A K382N 55905 RNF114 + +  
23204 ARL6IP1 K193FfsX 
65989 DLK2 +++ +++ + 
55905 RNF114 ++ ++  
91445 RNF185 ++ +  
6048 RNF5 + +  
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9781 RNF144A +   
10613 
ERLIN1 
G50V 55905 RNF114 + +  
ERLIN1  
R55X 55905 RNF114 + +  
22948 CCT5 H147R 55905 RNF114 + +  
 
Table 5.3. HSP disease-associated ‘edgetic’ changes on the binary HSP:RING E3 
ligase protein interaction summary. Entrez Gene IDs and symbols for selected 
mutant HSP bait (pGBAE-B) and RING E3 ligase preys (pACTBE-B) that showed 
evidence of positive binary interactions are listed, along with an indication of the 
relative strength of interaction: strong (+++), medium (++) or weak (+), as defined 
previously. 
 
5.4.2. Effect of genetic mutations on HSP:RING E3 ligase networks 
 
Misfolded proteins trigger cellular stress responses, including the adaptive cellular 
response of the ER, the UPR, which protects cells against the toxic build-up of 
misfolded proteins during cellular ER stress (Kopito, 2000; Dobson, 2003; Rao and 
Bredesen, 2004). Accumulation of misfolded proteins in excessive amounts can 
overwhelm the ‘cellular quality control’ system (ERAD and the UPS) and the 
prolonged stress observed in neurodegenerative diseases is thought to disrupt the 
protective mechanisms of the UPR, which ultimately leads to organelle dysfunction 
and cell death through the activation of inflammation and apoptotic pathways (Rao 
and Bredesen, 2004; Sprenkle et al., 2017). 
 
As a critical regulator of protein homeostasis, the UPS has received particular 
attention in the study of neurodegenerative disorders (Ciechanover and Brundin, 
2003). USP dysfunction has been reported in several neurodegenerative diseases 
including Alzheimer's disease (AD), Parkinson's disease (PD), Amyotrophic Lateral 
Sclerosis (ALS), and Huntington's disease (HD) (Keller, Huang and Markesbery, 2000; 
Bence, Sampat and Kopito, 2001; McNaught et al., 2003; Seo, Sonntag and Isacson, 
2004; Lonskaya et al., 2013). We therefore decided to investigate the potential 
‘edgetic’ effects of HSP disease-associated mutations on RING E3 ligase interactions, 
as key components of ubiquitination and the UPS. 
 188 
Interestingly, we notice that many HSP disease-associated mutants interact with 
RNF114, similarly to that observed with the hereditary spastic paraplegia protein, 
HSPD1 (SPG13). HSPD1 has a dual role as it is involved in the induction and 
propagation of autoimmune diseases, activating both innate and adaptive immune 
responses, but it can also activate immunoregulatory pathways which leads to 
suppression of these diseases (Quintana and Cohen, 2011; Landstein, Ulmansky and 
Naparstek, 2015). RNF114, also known as zinc-finger protein 313 (ZNF313), binds to 
K48- and K63-linked polyubiquitin chains both in vitro and in vivo, and was recently 
shown to be involved in the regulation of NF-kB activity contributing to the T cell-
mediated immune response signalling pathways (Rodriguez et al., 2014).  
 
Additionally, the edgetic mutations E112K, R115C, F124D, V162I and L195V of SPAST 
(M87) completely abolished interactions with RNF114. Moreover, most SPAST (M87) 
mutants (E112K, R115C, V162I, N184T and L195V) formed interactions with TRIM13, 
whereas the remainder of the HSP disease-associated mutants did not interact with 
TRIM13, and in the case of AP4M1, F255D and R283D both abolished interactions 
with TRIM13. TRIM13 is an ER-anchored E3 ligase involved in ERAD substrate 
degradation via proteasome and autophagy degradation pathways (Lerner et al., 
2007; Tomar et al., 2012). TRIM13 induced autophagy is crucial in the regulation of 
ER stress-induced cell death (Tomar et al., 2013). More recently, TRIM13 was shown 
to be involved in the regulation of NF-kB activity (Tomar and Singh, 2014). 
 
5.5. Use of targeted Y2H assay to investigate HSP:DUB interactions 
 
5.5.1. Analysis of binary HSP:DUB protein interaction profiles 
 
Deubiquitinating enzymes (DUBs) are an essential component of ubiquitin signalling, 
regulating ubiquitin homeostasis. Almost 100 putative human DUBs have been 
identified so far, and over 60% remain uncharacterised (Nijman et al., 2005; Hutchins 
et al., 2013). Previous research in our laboratory resulted in the generation of a 
library of 63 DUB ORFs representing 59 human DUBs (a list of all DUB genes used is 
shown in Appendix 5.2). These DUBs were sub-cloned into Y2H bait vector (pGBDU-
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GW), and used to investigate the protein-protein interactions between DUBs and 
RING E3 ligases (Sebastian Hayes, University of Liverpool, unpublished data). 
 
5.5.2.  The HSP bait collection used in this study 
 
To test binary interactions with the set of DUB Y2H bait clones, a set of HSP Y2H prey 
constructs was generated as described in Chapter 4. In total, 34 HSP ORFs were sub-
cloned into the pACTBE-B (prey) Y2H vector, resulting in 24 HSP Y2H prey clones. 
However, due to a lack of pACTBE-B (prey) mutant HSP constructs, a targeted Y2H 
screen against the pGBDU-GW (bait) DUB collection was not possible. 
 
5.6. Identification of binary HSP:DUB interactions  
 
5.6.1. Targeted Y2H matrix screens reveal 15 binary HSP:DUB interactions 
 
The improved targeted Y2H matrix mating methodology was used in the HSP:RING 
E3 ligase interaction screen, as described in Chapter 2. Briefly, MATa haploid yeast 
cells transfected with DUB bait constructs were spotted onto rich medium (YPAD) 
agar plates, in a 96-well format. MATα haploid yeast cells transfected with the 
desired HSP prey construct was spotted on top of preys, and they were left for 24 
hours to mate. Diploid yeast was then selected following velvet replication onto SD-
UL agar plates, and left to grow before colonies were further replicated onto the SD-
ULA and SD-ULH(3-AT) agar plates, to select for positive protein-protein interactions. 
The lacZ reporter activity (β-Gal assay) was also assessed using the agar overlay 
assay. As in the conventional Y2H assay, images were taken every 3-4 days and 
interactions were annotated as weak, medium or strong activators of reporter 
expression, based on yeast colony growth (see Figure 5.10). A known positive control 
was always included, to check for efficient mating and selective growth. The 
interaction screens were repeated twice, and only interactions observed in both 
screens were annotated as positive. 
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Figure 5.10  
 
Figure 5.10. HSP:DUB interaction data. (A) pACTBE-B-SPG20, (B) pACTBE-B-VPS37A 
and (C) pACTBE-B-VCP transfected MATα yeast was mated against Mata yeast 
transfected with our pGBDU-GW-DUB collection (top panel), in a matrix array format. 
Yeast growth was scored on both SD-ULA (most stringent) and SD-ULH(3-AT) (least 
stringent) agar plates on day 14, as shown above.  
 
In total, 24 HSP prey constructs were systematically screened against 59 DUB bait 
constructs, resulting in the analysis of 1,416 potential binary interactions. Following 
repeat screening, 15 reproducible positive binary HSP:DUB interactions were 
detected (Figure 5.11), of which only 2 of the 15 HSP:DUB interactions were 
previously identified, leaving 13 potentially novel binary HSP:DUB interactions. All 
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true positive interactions should be observed on either SD-WLA and SD-WLH(3-AT) 
or the less stringent SD-WLH(3-AT) alone, interactions detected on SD-WLA alone are 
considered false positive interactions and were excluded from the final list of positive 
interactions. 
 
Results obtained from the β-Gal assays were incorporated with those from the 
biosynthetic reporter assays and presented in Table 5.4. The final list of positive 
binary interactions includes: 3 interactions seen on all three reporters, 7 interactions 
seen on two and 5 interactions seen on only one reporter.  
 
Table 5.4 
BAIT  
Gene ID BAIT Symbol 
PREY  
Gene ID PREY Symbol HIS3 ADE2 lacZ 
55432 YOD1 7415 VCP +++ +++ +++ 
55432 YOD1 23111 SPG20 +++ +++   
80124 VCPIP1 7415 VCP +++ +++ ++ 
80124 VCPIP1 9897 KIAA0196 (NT) ++     
80124 VCPIP1 6683 SPAST (M87) ++     
9099 USP2 137492 VPS37A +++ +++   
9099 USP2 7415 VCP +++     
9099 USP2 23111 SPG20 +     
84669 USP32 137492 VPS37A +++ +++   
10713 USP39 23111 SPG20 ++ ++   
78990 OTUB2 23111 SPG20 +++ +++   
78990 OTUB2 9897 KIAA0196 (NT) +     
10980 COPS6 137492 VPS37A +++ +++ + 
56957 OTUD7B 23111 SPG20 +++ +++   
7128 TNFAIP3 23111 SPG20  ++ ++   
 
Table 5.4. HSP:DUB interaction summary. Gene IDs and Gene Symbols are indicated 
for DUB (pGBDU-GW) bait and HSP (pACTBE-B) preys that showed reproducible 
positive interactions in two independent matrix interaction assays. In each case 
interactions were scored as strong (+++), medium (++) or weak (+).  
 
 
 
192 
Figure 5.11  
   A  
                    B 
Figure 5.11. Sum
m
ary of all tested binary HSP:DUB interactions. (A) M
atrix show
ing all tested Y2H binary 
interaction profiles for DUB bait (pGBDU-GW
) and HSP prey (pACTBE-B) clones. HSP prey clones are arranged by 
spastic gait disease-loci (SPG), those not part of the SPG classification system
 and are listed alphabetically as are 
the DUB bait clones. (B) Percentage of positive Y2H interactions observed at each level of reporter stringency. 
Corresponding colours are also used to represent relative stringency of individual positive interactions in panel (A). 
BO
LD = Transm
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brane protein.
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5.6.2. Reconfirmation of previously defined interactions 
 
The Expanded Global network (Figure 3.4 B) was used to extract the 59 DUB proteins 
used in this study, together with their proximal (one-step) interaction partners, to 
create an expanded global DUB ‘one-step’ subnetwork (Figure 5.12 A). All previously 
defined known (direct and indirect) and predicted HSP:DUB interactions were then 
extracted from this global subnetwork, to create the HSP:DUB ‘one-step’ subnetwork 
(Figure 5.12 B). A union of the HSP:DUB ‘one-step’ subnetwork and the data obtained 
from this study is presented in Figure 5.12 C. Compared to the HSP:DUB ‘one-step’ 
subnetwork (Figure 5.12 B), this new ‘combined’ HSP:DUB interaction network 
contains 43 interactions (edges) between 17 HSPs and 28 DUBs (nodes), representing 
a 31 % increase in the number of HSP interactors and a 22 % increase in the number 
of DUB interactors (nodes), which resulted in a 39 % increase in the overall total 
number of interactions (edges) identified. 
 
Of the 30 previously known (direct and indirect) HSP:DUB interactions contained in 
this subnetwork, 8 were re-tested in this study (see Table 5.5). Significantly, 2 of the 
8 re-tested known interactions were previously identified as ‘direct’ or binary 
interactions, and both were reconfirmed in this study. HSP:DUB interactions 
reconfirmed in this study include the well-characterised interaction between VCP 
and VCPIP1 (Sowa et al., 2009; Totsukawa et al., 2011), as well as the VCP and YOD1 
interaction (Ernst et al., 2009). None of the retested ‘indirect’ interactions, were 
found to be positive binary interactions when tested in this study. 
 
Table 5.5 
Interaction Direct Indirect 
Known 4 26 
Re-tested 2 6 
Reconfirmed 2 0 
Reconfirmation rate 100 % - 
 
Table 5.5. Re-tested HSP:DUB protein interactions. Previously defined direct and 
indirect human HSP:DUB interactions were extracted from the global DUB ‘one-step’ 
subnetwork (Figure 5.12 A), and interaction reconfirmation rates were determined 
by comparing them to the results identified in this study.  
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A Expanded Global DUB subnetwork 
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C Combined HSP:DUB subnetwork 
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Figure 5.12. Generation of an HSP:DUB binary protein interaction subnetwork. (A) 
An initial global ‘one-step’ DUB network was extracted from the expanded global 
network (shown in Figure 3.4 B) using the 59 DUBs used in our Y2H matrix mating 
screen, as core nodes. (B) An HSP:DUB ‘one-step’ subnetwork was then derived from 
the global DUB ‘one-step’ network shown in (A) using the 83 ‘HSP seed 3’ genes as 
core nodes. A union of the HSP:DUB ‘one-step’ subnetwork shown in (B) and all 
interactions observed in this study (bold line), was used to generate (C). Newly 
identified DUB partners, identified in this study are shown as purple nodes.  
 
5.6.3. Common functions of HSP:DUB ligase pairs 
 
The DAVID Functional Annotation tool was used to analyse the newly expanded 
HSP:DUB interaction network. The DUBs identified were analysed for gene-GO term 
enrichment, unsurprisingly protein deubiquitination was one of the most relevant 
GO terms associated with the list of DUBs. However, more interestingly, another 
enriched GO term associated with these DUBs was the ‘negative regulation of 
IkappaB kinase/NF-kappaB signalling’. As this term was also related to Cluster 1: 
Immune response mechanisms, which was identified following analysis of binary 
HSP:RING E3 ligase interactions, we were interested to know whether any of the 
DUBs listed were known to be involved in either of the processes highlighted 
previously. As the DAVID functional annotation tool only highlights enriched terms 
associated with a specific gene list, we manually annotated the known functional 
associations of each of the DUBs identified. Following literature-based searches, 
DUBs were annotated according to their involvement in either of the previously 
identified clusters: Immune response mechanisms, including IFN and NF-κB signalling 
pathways (blue) and/or UPR-associated processes (green). We identified DUBs that 
were contained in each of the clusters, as well as three that were identified as having 
roles in both functional groups/clusters (Figure 5.13).  
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Figure 5.13 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.13. Functional annotation of the HSP:DUB protein interaction subnetwork. 
The DUBs identified in the combined HSP:DUB subnetwork (Figure 5.12, panel C) 
were functionally annotated according to whether they were involved in either of 
the assigned GO term enrichment analysis (see Figure 5.6). Cluster 1: Immune 
response mechanisms, including IFN and NF-κB signalling pathways (blue) and/or 
Cluster 2: UPR-related processes (green). The HSP nodes were also annotated 
following literature-based curation. 
 
As both the HSP interacting RING E3 ligases and DUBs seem to fall into these two 
functional clusters, it is possible that there may be a link between altered patterns of 
ubiquitination and changes in immune response mechanisms. Therefore, it is 
possible that over time changes in these processes may contribute to some forms of 
neurodegeneration.  
 
5.7. Discussion 
 
In this study, we identified a number of novel binary HSP:RING E3 ligase (86) and 
HSP:DUB (12) interactions, identifying a number of potential HSP regulators. Upon 
further investigation, two functional clusters appeared to be particularly enriched 
Cluster 1
Cluster 2
Key:
 197 
within each set of interactions, Cluster 1: Immune response mechanisms, and Cluster 
2: unfolded protein response (UPR)-related processes, with a particular emphasis on 
regulation of NF-kB signalling and protein K48-linked ubiquitination, respectively.  
 
UPR and the immune system 
The unfolded protein response (UPR) has traditionally been viewed as an adaptive 
cellular response to ER stress, activated by an accumulation of unfolded or misfolded 
proteins, which is aimed at reducing cellular stress and restoring ER homeostasis by 
co-ordinating the expression of ER stress response signal transducers during ER stress 
(Oslowski and Urano, 2011; Walter and Ron, 2011). This results with the initiation of 
several signalling cascades, resulting in transcriptional and translational changes, 
reducing cellular stress, whilst simultaneously inducing protein quality control 
mechanisms to reduce protein misfolding (Sprenkle et al., 2017). However, the UPR 
is also able to mediate inflammatory pathways, essential for an innate immune 
response.  
 
Inflammation is part of the non-specific immune response of the innate immune 
system to infection or tissue injury, and this initial response under normal conditions 
is self-limiting. However, prolonged or chronic inflammation is damaging and can 
lead to a host of diseases which includes: arthritis, diabetes, cardiovascular disease 
and even cancer (Shacter and Weitzman, 2002; Hansson and Libby, 2006; Rosenfeld, 
2013). The UPR is able to activate several primary inflammatory signalling proteins 
which include the Mitogen Activated Protein Kinase (MAPK) family proteins: c-Jun N-
terminal kinase (JNK) and p38, and the Nuclear Factor-kappa-light-chain-enhancer of 
activated B cells (NF-kB) (Sprenkle et al., 2017). NF-kB is a transcription factor with a 
crucial role in the inflammatory response, regulating the expression of many 
inflammatory cytokine genes, as well as in biological processes including cell survival, 
innate and adaptive immune responses (Wang et al., 2006; Ghosh and Hayden, 2008; 
Baltimore, 2009). In the absence of harmful stimuli, NF-kB resides in the cytoplasm 
where it is bound to a member of the family of inhibitors of NF-kB (IkB), which are 
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constitutively expressed, and thus NF-kB remains in an inactive state (Zhang and 
Kaufman, 2008).  
 
NF-kB activation pathways can be subdivided into two kinase-dependent pathways, 
the canonical/classical pathway and the non-canonical/alternative pathway (Bonizzi 
and Karin, 2004). Ubiquitin-mediated protein degradation activates both canonical 
and non-canonical NF-kB pathways. In the canonical pathway, NF-kB activation is 
initiated by the signal-induced IkB kinase (IKK) complex activation and subsequent 
IkB phosphorylation (Israel, 2010) by various stimuli. Phosphorylated IkBs undergo 
proteasome-mediated degradation which frees NF-kB exposing its nuclear-
localisation signal, allowing NF-kB dimers to translocate to the nucleus where it binds 
to κB promoter sites to activate transcription of NF-kB target genes (Ghosh and 
Hayden, 2008; Baltimore, 2009). The non-canonical NF-κB pathway involves the 
processing of NF-κB precursors (p100) by the proteasome (Pomerantz and Baltimore, 
2002). Ubiquitination has an important role in regulating signal transduction in the 
NF-κB pathways, it not only controls IkB degradation and the processing of NF-kB 
precursors (p100) via the proteasome, but it also regulates IkB kinase (IKK) 
activation, an important regulatory step in NF-kB regulation, via proteasomal-
independent mechanisms (Liu and Chen, 2011; Tam et al., 2012).  
 
NF-kB can be activated by a number of different stimuli which include infection, 
inflammatory signals: tumour necrosis factor alpha (TNFα), interleukin-1 (IL-1) and 
lipopolysaccharide (LPS), and also various cellular stresses, including DNA damage 
(Hayden and Ghosh, 2004) and ER stress. ER-associated NF-κB activation can occur 
as a result of the oxidative stress from excessive protein folding and/or ER-stress-
mediated leakage of calcium, increasing levels of cytosolic calcium (Pahl and 
Baeuerle, 1996; Tabary et al., 2006; Deniaud et al., 2008). Abnormal NF-kB activation 
occurs in many pathological conditions such as auto-inflammatory diseases (Iwai, 
2012). NF-kB provides an important link between the UPR and the immune system, 
and any changes in the UPR or ubiquitination may well have significant effects on the 
immune response. 
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Immune system and neurodegenerative diseases 
Inflammation is an initial protective response of the immune system, carried out by 
different immune and inflammatory cells, which include T-cells, neutrophils, 
macrophages etc., to repair, regenerate and remove damaged tissues/cells and 
harmful stimuli from the body (Kulkarni et al., 2016).  
 
Microglia are the main innate immune cells of the brain, that serve to constantly 
review the microenvironment. Under physiological conditions, they remain in an 
‘inactive’ state, associated with the production of anti-inflammatory and 
neurotrophic factors (Streit and Kincaid-Colton, 1995). However, in response to 
pathogens or tissue damage, they become ‘active’, thereby promoting an 
inflammatory response, also known as neuroinflammation (Glass et al., 2010). 
Neuroinflammation is the initial protective response mechanism of the CNS, carried 
out by microglia and the inflammatory mediators they release, to restore damaged 
glial cells and neuronal cells (Shabab et al., 2017). However, sustained or chronic 
inflammation, can be extremely damaging, resulting in the production of 
neuroinflammatory and neurotoxic factors, which include activation of MAPKs and 
NF-kB (Prinz and Priller, 2014; Sofroniew, 2015). Interestingly, a direct inflammatory 
response has been associated with Alzheimer’s disease (AD) for over 20 years 
(Akiyama, 1994), and subsequent neurodegenerative diseases such as Parkinson’s 
disease (PD), Multiple Sclerosis (MS) and amyotrophic lateral sclerosis (ALS) have 
documented inflammatory components (Glass et al., 2010). Although inflammation 
is not usually an initiating factor, sustained inflammatory responses are thought to 
be a crucial factor in the onset and progression of disease, as well as neuronal cell 
loss in neurodegenerative disease (Glass et al., 2010; Chen, Zhang and Huang, 2016; 
Kempuraj et al., 2016). 
 
Ubiquitination has an important role in regulating signal transduction in NF-κB 
pathways, and the RING E3 ligases and DUBs identified in this study may function as 
regulators of NF-κB signalling. As such abnormalities in UPR-mediated inflammatory 
pathways may lead to sustained neuroinflammation in hereditary spastic paraplegias 
(HSPs), contributing to the onset and progression of disease. 
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Chapter 6: Identification of novel interaction partners of HSP proteins 
 
6.1 Introduction 
 
HSPs are characterised by progressive lower limb spasticity and pyramidal weakness 
(Harding, 1983), a defining clinical feature which is thought to be caused by length-
dependent axonopathy affecting the distal ends of corticospinal tract axons (Harding, 
1983; DeLuca, Ebers and Esiri, 2004), for which gene mutation is a major causative 
factor. Recent advances in molecular genetics has led to the identification of over 75 
HSP disease-loci with over 55 corresponding genes (Klebe, Stevanin and Depienne, 
2015; de Souza et al., 2016). The identification of disease-loci/genes implicated in 
HSPs, has been critical to our understanding of the clinical and pathological features 
of this group of disorders, as well as improving our understanding of the cellular 
processes required for axonal maintenance or degeneration (Blackstone, O’Kane and 
Reid, 2011).  
 
We hypothesize that, proteins that interact with known disease-causing HSP 
proteins, could in some cases also acquire mutations, which may contribute to 
specific HSP-related phenotypes. It is therefore important to generate high-density 
protein-protein interaction (PPI) data of human HSP-related proteins, as 
identification of proteins that interact with known HSP proteins or exist in common 
molecular complexes may provide detailed insight into the molecular mechanisms 
that are fundamental to the pathogenesis of this group of disorders.  
 
The main aim of the work presented in this section was to identify novel interaction 
partners of HSP proteins by performing systematic unbiased cDNA library screens. 
This chapter describes the various Y2H library screens performed, with a particular 
focus on the membrane yeast two-hybrid (MYTH) system, which was optimised and 
used to screen integral membrane HSP proteins. All data generated was compared 
to all PPI data available in public databases to assess the confidence of each of the 
Y2H systems employed, as well as the reproducibility of any previously observed 
interactions. The resulting data was then incorporated, with additional data gathered 
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throughout this study, to generate an updated HSPome which can be used for 
bioinformatics analyses to predict areas of interest and functional relevance, as well 
as for future hypothesis-driven research. 
 
6.2 Matchmaker ® Yeast two-Hybrid library screens 
 
6.2.1 Matchmaker® yeast two-hybrid system 
 
In this study, the GAL4-based Y2H system was employed, using the PJ69-4A (MATa) 
and the switched mating-type PJ69-4a (MATa) host strains (James, Halladay and 
Craig, 1996; Semple et al., 2005) for pGBAE-B bait and pACT2 prey K562 cDNA library 
transfection, respectively. The K-562 cDNA library is derived from the human K562 
chronic myelogenous leukaemia (CML) cell-line (Lozzio and Lozzio, 1975). As 
previously described, the host strain carries three independent GAL4-responsive 
reporter genes: HIS3, ADE2 and lacZ, each driven by a different promoter (GAL1, 
GAL2 and GAL7, respectively), and all three reporter genes can be assayed in parallel, 
increasing the stringency of Y2H screens (James, Halladay and Craig, 1996; Brückner 
et al., 2009). To increase confidence of the interactions identified in the Y2H screens 
performed, all library hits were re-confirmed by performing an in vivo recombination 
(gap repair) of prey library hits into the frame-shift prey vector pACTBE-B, followed 
by a reconfirmation mating with the original and a negative control bait clone. The 
reconfirmation ‘gap repair’ facilitates the removal of false positive, non-specific 
background colonies, through a red/white selection protocol (Semple et al., 2005). 
The reconfirmation mating allows the confirmation of genuine positive clones, whilst 
allowing the removal of any auto-activating or non-specific prey clones. 
 
6.2.2 The HSP bait collection used in this study 
 
To identify novel HSP interaction partners, a set of HSP Y2H bait constructs had to be 
generated and individually screened against the K-562 cDNA prey library containing 
a random collection of ORFs and ORF fragments. In total, 34 HSP ORFs were sub-
cloned into the pGBAE-B (bait) Y2H vector, resulting in 33 HSP Y2H bait clones (see 
Chapter 4, section 4.2.2).  
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6.2.3 Matchmaker® Y2H library screen reveals 51 potentially novel HSP interactors 
 
A schematic depiction of the Matchmaker® Y2H library screening methodology used 
to identify novel interaction partners of HSP proteins, is shown in Figure 6.1. In Brief, 
MATa haploid yeast cells transfected with a HSP bait construct were mated against 
the K-562 cDNA prey library, pre-transformed into MATα haploid yeast cells, on a rich 
medium (YPAD) agar plate and incubated for 6 hours. The mated yeast suspension 
was then plated onto SD-WLA agar plates and left to grow for up to 14 days, to select 
for positive diploid colonies. To increase confidence of the interactions identified 
from these library screens, all prey library hits identified were re-confirmed. The 
library prey inserts were amplified from diploid colonies and cloned into the frame-
shift pACTBE-B prey vector for reconfirmation mating with the original or negative 
control (empty vector) bait. Only those that selectively activate all three reporters 
(ADE2, HIS3, lacZ) with the original bait and not the negative control bait, were 
selected for DNA sequencing to identify the encoded prey proteins. 
 
In total, 9 HSP bait clones were successfully screened against the K-562 cDNA prey 
library (Clontech), identifying a total of 51 potentially novel HSP interactors. The 
identification of a previously known interaction provides confidence in the other 
novel interactors identified. The successfully reconfirmed interaction partners 
identified in each individual library screen, are presented in Table 6.1. The function 
and subcellular localisation was manually curated from the literature a well as web 
sources such as UniProt, which provided functional context to partner interactions. 
 
The interaction between CCT5 and TCP1, was previously identified by affinity 
capture-MS techniques and as such was annotated as a non-direct interaction 
(Gingras et al., 2005). However, following identification in the Matchmaker® Y2H 
library screens, this interaction can now be annotated as a binary or direct 
interaction.  
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Figure 6.1 
                  Figure 6.1. Schem
atic representation of ‘traditional’ M
atchm
aker® yeast tw
o-hybrid library screening. pGBAE-B bait construct w
as m
ated 
against the K-562 prey cDNA library on YPAD rich m
edia for 6 h, before plating onto triple selection plates (SD-W
LA) for 14 days. Up to 2 x 96 
diploid colonies w
ere selected for am
plification of prey insert by YC-PCR and subsequent gap repair cloning into linearised pACTBE-B vector. Red 
colonies (prey clones) w
ere picked and re-m
ated w
ith the original bait (positive control) or LSM
2 bait (negative control), on YPAD m
edia. Diploid 
yeast w
ere selected on SD-W
L m
edium
, before replication onto higher stringency interaction selection plates (SD-W
LA/-W
LH(3-AT)) or filter 
paper for b-Galactosidase (b-Gal) assay. Only yeast clones that selectively activate all three reporters (ADE2, HIS3 and lacZ) w
ith the original and 
not the negative control bait, w
ere selected for DNA sequencing and prey identification via NCBI BLASTN. 
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Table 6.1 
 
SPG2/	PLP1
Plasm
a	m
em
brane
Gene
Protein	Nam
e	(UniProt)
Function
Localisation	(UniProt)
APLP2
Am
yloid-like	protein	2
M
em
ber	of	the	Am
yloid	Precursor	Protein	(APP)	fam
ily.	W
orks	w
ith	APP	in	roles	such	as	neurom
uscular	transm
ission,	spatial	learning	and	
synaptic	plasticity
M
em
brane,	Nucleus
CD63
CD63	antigen
Cell	surface	glycoprotein	know
n	to	com
plex	w
ith	integrins,	and	is	involved	in	various	cellular	signalling	cascades
-
CD81
CD81	antigen
Cell	surface	glycoprotein	know
n	to	com
plex	w
ith	integrins,	m
ay	be	involved	in	signal	transduction
Extracellular,	Plasm
a	m
em
brane
DCTN2
Dynactin	subunit	2
Involved	in	a	num
ber	of	cellular	functions,	including	axonogenesis,	ER-to-Golgi	transport	and	the	m
ovem
ent	of	lysosom
es	and	endosom
es
Cytoplasm
,	M
em
brane
DDA1
DET1-	and	DDB1-associated	protein	1
M
ay	be	involved	in	the	ubiquitination	and	proteasom
al	degradation	of	target	proteins
M
CM
2
DNA	replication	licensing	factor	M
CM
2
Com
ponent	of	the	m
ini-chrom
osom
e	m
aintenance	(M
CM
)	com
plex,	w
hich	is	involved	in	the	initiation	of	eukaryotic	genom
e	replication
RNF5
E3	ubiquitin-protein	ligase	RNF5
ER	m
em
brane-bound	ubiquitin	ligase.	Regulates	antiviral	response	and	cell	m
otility.
SPG12/	RTN2
ER
Gene
Protein	Nam
e	(UniProt)
Function
Localisation	(UniProt)
DCTN2
Dynactin	subunit	2
Involved	in	a	num
ber	of	cellular	functions,	including	axonogenesis,	ER-to-Golgi	transport	and	the	m
ovem
ent	of	lysosom
es	and	endosom
es
Cytoplasm
,	M
em
brane
ELF1
ETS-related	transcription	factor	Elf-1
Regulates	transcription	for	various	genes,	acting	as	enhancer	and	repressor.	Involved	in	T-cell-receptor-m
ediated	activation	of	HIV-2	gene	
expression
Nucleus
SPG21
Cytosol,	Golgi	app.,	endosom
es
Gene
Protein	Nam
e	(UniProt)
Function
Localisation	(UniProt)
ARIH2
E3	ubiquitin-protein	ligase	ARIH2
E3	ubiquitin-protein	ligase,	polyubiquitinating	proteins	tagging	them
	for	degradation
Nucleus,	Cytoplasm
C12orf10
UPF0160	protein	M
YG1,	m
itochondrial
-
Nucleus,	M
itochondrion
C7orf50
Uncharacterized	protein	C7orf50
-
-
CDV3
Protein	CDV3	hom
olog
-
Cytoplasm
COX6C
Cytochrom
e	c	oxidase	subunit	6C
Subunit	of	cytochrom
e	c	oxidase,	the	term
inal	enzym
e	of	the	m
itochondrial	respiratory	chain.	M
ay	also	function	in	the	regulation	and	
assem
bly	of	the	com
plex.	
M
itochondrion
NOTCH1
Neurogenic	locus	notch	hom
olog	protein	1
M
em
ber	of	the	NOTCH	fam
ily	of	proteins.	Notch	signalling	is	a	conserved	intracellular	signalling	pathw
ay	regulating	interactions	betw
een	
physically	adjacent	cells.
Cell	m
em
brane
LSR
Lipolysis-stim
ulated	lipoprotein	receptor
M
ay	be	involved	in	the	rem
oval	of	triglyceride-rich	lipoprotein	from
	blood
Cell	m
em
brane
NLRP2
NACHT,	LRR	and	PYD	dom
ains-containing	protein	2
Im
portant	regulator	of	im
m
une	responses,	interacting	w
ith	com
ponents	of	IKK	com
plex	and	regulating	caspase-1	and	NF-kB	activity
Cytoplasm
NQ
O2
Ribosyldihydronicotinam
ide	dehydrogenase	[quinone]
Q
uinone	reductase.	M
utations	have	been	associated	w
ith	neurodegenerative	diseases
Cytoplasm
PSM
D8
26S	proteasom
e	non-ATPase	regulatory	subunit	8
Com
ponent	of	26S	proteasom
e	w
hich	participates	in	num
erous	cellular	processes
Cytosol,	Extracellular,	Nucleus
RBM
X
RNA-binding	m
otif	protein,	X	chrom
osom
e
RNA-binding	protein	involved	in	the	regulation	or	pre-	and	post-transcriptional	processes
Nucleus
RBM
X2
RNA-binding	m
otif	protein,	X-linked	2
-
-
SDHB
Succinate	dehydrogenase	[ubiquinone]	iron-sulfur	subunit,	
m
itochondrial
Subunit	of	Com
plex	II	of	the	respiratory	chain,	w
here	it	is	involved	in	the	oxidation	of	succinate.
M
itochondrion
SLC26A8
Testis	anion	transporter	1
DIDS-sensitive	anion	transporter
M
em
brane
SPECC1
Cytospin-B
Belongs	to	cytospin-A	fam
ily.	It's	involvem
ent	in	chrom
osom
al	translocation	m
ay	be	a	cause	of	juvenile	m
yelom
onocytic	leukaem
ia
Nucleus
SRPX2
Sushi	repeat-containing	protein	SRPX2
M
ay	be	involved	in	the	developm
ent	of	speech	and	language	centres	in	the	brain.	M
ay	also	be	involved	in	angiogenesis
Cytoplasm
TRIM
56
E3	ubiquitin-protein	ligase	TRIM
56
E3	ubiquitin-protein	ligase,	w
hich	plays	a	key	role	in	innate	im
m
unity.
Cytoplasm
This	is	the	m
ajor	m
yelin	protein	from
	the	central	nervous	system
.	It	plays	an	im
portant	role	in	m
yelin	form
ation	and	m
aintenance.
Required	for	proper	generation	of	tubular	ER.	M
ay	be	involved	in	intracellular	vesicular	transport.
M
ay	act	as	a	negative	regulatory	factor	in	CD4-dependent	T-cell	activation
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Table 6.1. continued 
                          SPG28/	DDHD1
Cytoplasm
,	M
itochondrion
Gene
Protein	Nam
e	(UniProt)
Function
Localisation	(UniProt)
C1Q
BP
Com
plem
ent	com
ponent	1	Q
	subcom
ponent-binding	protein,	
m
itochondrial
M
ultifunctional	and	m
ulticom
petent	protein	involved	in	a	num
ber	of	processes	including;	apoptosis	regulation,	ribosom
e	biogenesis	and	
inflam
m
ation	and	infection	processes
M
itochondrion,	Cell	m
em
brane,	Nucleus,	
Cytoplasm
EEF1G
Elongation	factor	1-gam
m
a
Subunit	of	EF-1	com
plex	responsible	for	enzym
atic	delivery	of	am
inoacyl	tRNAs	to	the	ribosom
e,	m
ay	also	be	involved	in	anchoring	the	
com
plex	to	other	cellular	com
ponents
Cytoplasm
,	cytosol,	M
em
brane,	Nucleus
FLOT2
Flotillin-2
Caveolae-associated	m
em
brane	protein,	w
hich	m
ay	be	involved	in	neuronal	signalling
Cell	m
em
brane,	Endosom
e
POLR2G
DNA-directed	RNA	polym
erase	II	subunit	RPB7
Com
ponent	of	RNA	polym
erase	II	transcriptional	m
achinery,	w
hich	synthesises	m
RNA	precursors	and	non-coding	RNAs
Nucleus
PRAM
E
M
elanom
a	antigen	preferentially	expressed	in	tum
ours
Transcriptional	repressor	inhibiting	retinoic	acid	signalling
Nucleus,	Cell	m
em
brane
RPAIN
RPA-interacting	protein
Involved	in	the	translocation	of	RPA,	and	therefore	its	function	in	DNA	m
etabolism
Nucleus,	Cytoplasm
RPL7
60S	ribosom
al	protein	L7
Com
ponent	of	the	60S	ribosom
al	subunit,	has	a	regulatory	role	in	the	translation	apparatus
Cytoplasm
,	M
em
brane,	Nucleus
TAF10
Transcription	initiation	factor	TFIID	subunit	10
TFIID	is	a	protein	com
plex	involved	in	the	initiation	of	transcription	by	RNA	polym
erase	II
Nucleus
TOR3A
Torsin-3A
Novel	interferon	response	gene
Cytoplasm
,	ER
SPG43/	C19orf12
ER,	M
itochondrion
Gene
Protein	Nam
e	(UniProt)
Function
Localisation	(UniProt)
FUS
RNA-binding	protein	FUS
Com
ponent	of	the	hnRNP	com
plex.	M
ay	be	involved	in	the	regulation	of	gene	expression	and	m
aintenance	of	genom
ic	integrity
Nucleus
HNRNPH3
Heterogeneous	nuclear	ribonucleoprotein	H3
Belongs	to	hnRNP	subfam
ily,	and	is	involved	in	the	splicing	process	and	early	heat	shock-induced	splicing	arrest
Nucleus
PLIN3
Perilipin-3
Interacts	w
ith	m
annose	6-phosphate	receptors,	transporting	them
	from
	the	endosom
es	to	trans-Golgi	netw
ork	(TGN)	
Cytoplasm
,	Endosom
e,	Lipid	droplet
RPL7
60S	ribosom
al	protein	L7
Com
ponent	of	the	60S	ribosom
al	subunit,	has	a	regulatory	role	in	the	translation	apparatus
Cytoplasm
,	M
em
brane,	Nucleus
RUFY2
RUN	and	FYVE	dom
ain-containing	protein	2
-
Nucleus
SPG47/	AP4B1
Golgi	apparatus,	M
em
brane
Gene
Protein	Nam
e	(UniProt)
Function
Localisation	(UniProt)
TK1
Thym
idine	kinase,	cytosolic
Cytosolic	enzym
e	involved	in	the	first	step	in	the	biosynthesis	of	dTTP,	com
ponent	required	for	DNA	replication
Cytoplasm
SPG48/	AP5Z1
Cytoplasm
,	Nucleus
Gene
Protein	Nam
e	(UniProt)
Function
Localisation	(UniProt)
COPS5
COP9	signalosom
e	com
plex	subunit	5
Protease	subunit	of	COP9	signalosom
e	com
plex	(CSN)	involved	in	cellular	and	developm
ental	processes.
Cytoplasm
,	Cytoplasm
ic	vesicles,	Nucleus
SPG55/	C12orf65
M
itochondrion
Gene
Protein	Nam
e	(UniProt)
Function
Localisation	(UniProt)
DIAPH1
Protein	diaphanous	hom
olog	1
M
ay	be	involved	in	regulating	actin	polym
erisation	in	hair	cells	of	the	inner	ear
Cytoplasm
,	Cell	m
em
brane
HM
GA1
High	m
obility	group	protein	HM
G-I/HM
G-Y
Involved	in	a	num
ber	of	processes	including	gene	transcription	regulation
Nucleus
ADGRL1
Adhesion	G	protein-coupled	receptor	L1
M
em
ber	of	latrophilin	subfam
ily	G-protein	coupled	receptors	(GPCR),	involved	in	cell	adhesion	and	signal	transduction
Cell	m
em
brane
M
RPS18A
39S	ribosom
al	protein	S18a,	m
itochondrial
28S	ribosom
al	subunit	protein	of	the	ribosom
al	protein	S18P	fam
ily
M
itochondrion
NUBP2
Cytosolic	Fe-S	cluster	assem
bly	factor	NUBP2
Com
ponent	of	the	cytosolic	Fe/S	protein	assem
bly	(CIA)	m
achinery
Nucleus,	Cytoplasm
TIM
M
13
M
itochondrial	im
port	inner	m
em
brane	translocase	subunit	Tim
13
Functions	as	a	chaperone,	im
porting	proteins	from
	cytoplasm
	to	the	m
itochondrial	inner	m
em
brane
M
itochondrion
TUBA1B
Tubulin	alpha-1B	chain
M
ajor	constituent	of	m
icrotubules
Cytoplasm
Subunit	of	a	adaptor	protein	com
plex	5,	w
hich	m
ay	be	involved	in	endosom
al	transport.
M
itochondrial	m
atrix	protein,	directing	the	peptide	chain	term
ination	in	the	m
itochondrial	translation	m
achinery.
Cytosolic	protein,	preferentially	hydrolyses	phosphatidic	acid.	Som
e	m
itochondrial	localisation,	w
here	it	is	thought	to	play	a	role	in	the	regulation	of	m
itochondrial	dynam
ics.
Subunit	of	adapter-like	com
plex	4,	involved	in	targeting	protein	from
	trans-Golgi	netw
ork	(TGN)	to	endosom
al-lysosom
al	system
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Table 6.1 continued 
 
Table 6.1. M
atchm
aker® K-562 cDNA yeast tw
o-hybrid library screen results. Refined list of potential interaction partners identified from
 
M
atchm
aker® K-562 Y2H library screens, function and localisation established for each using UniProt and NCBI. Previously identified interactions 
are highlighted in green (know
n indirect).
CCT5
Cytoskeleton,	Cytosol,	Extracellular,	Nucleus
Gene
Protein	Nam
e	(UniProt)
Function
Localisation	(UniProt)
BCCIP
BRCA2	and	CDKN1A-interacting	protein
M
ay	prom
ote	cell	cycle	arrest.	M
ay	be	required	for	repair	follow
ing	DNA	dam
age.
Nucleus
C12orf10
UPF0160	protein	M
YG1,	m
itochondrial
-
Nucleus,	M
itochondrion
CCT5
T-com
plex	protein	1	subunit	epsilon
M
olecular	chaperone,	involved	in	the	folding	of	proteins	follow
ing	ATP	hydrolysis	(Inc.	actin	and	tubulin)
Cytoskeleton,	Cytosol,	Extracellular,	Nucleus
PRPF8
Pre-m
RNA-processing-splicing	factor	8
Acts	as	a	scaffold	in	the	assem
bly	of	spliceosom
al	proteins	and	snRNAs
Nucleus
TCP1
T-com
plex	protein	1	subunit	alpha
M
olecular	chaperone,	involved	in	the	folding	of	proteins	follow
ing	ATP	hydrolysis	(Inc.	actin	and	tubulin)
Cytoplasm
M
olecular	chaperone	involved	in	the	folding	of	proteins	follow
ing	ATP	hydrolysis	(including	actin	and	tubulin)
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6.2.4 Functional relevance of Matchmaker® Y2H library hits 
 
The interaction data generated from these Matchmaker® K-562 cDNA library screens 
was analysed to gain a better understanding of the novel interactions identified and 
their functional relevance.  
 
PLP1(SPG2): 
The Y2H library screens identified a total of 7 binary PLP1 (SPG2) interaction partners, 
all of which were novel. RNF5 was identified as an interactor of PLP1, which 
interestingly was also identified as a relatively weak PLP1 partner in our targeted 
RING E3 ligase Y2H matrix screens (Chapter 5). 
 
DCTN2, encodes a subunit of dynactin, a multiprotein complex which works with the 
cytoplasmic dynein-1 motor (dynein) transporting cargo along the microtubule 
cytoskeleton (Gill et al., 1991; Urnavicius et al., 2015), and was also identified as an 
interactor of PLP1. In neurons, dynein is involved in retrograde axonal transport 
(Hirokawa et al., 1990) and more interestingly, disruption of dynein/dynactin was 
found to inhibit axonal transport in motor neurons with the onset of progressive 
motor neuron degeneration (LaMonte et al., 2002). The interaction between PLP1 
and RTN2 was also recently identified through affinity capture-MS (Huttlin et al., 
2017), and interestingly we identified DCTN2 as a novel binary interactor for both 
PLP1 (SPG2) and RTN2 (SPG12). Therefore, the identification of a common interactor 
demonstrates a potential cellular function/pathway in which these proteins might 
act. 
 
SPG21:  
The Y2H library screens identified in total 17 binary SPG21 interaction partners, all of 
which were novel. ARIH2, an E3 ubiquitin ligase protein, was identified as an 
interactor of SPG21 and interestingly, it was also previously identified as a weak 
interactor of SPG21 following the targeted RING E3 ligase Y2H matrix screens but was 
not annotated as a positive hit at the time, as it was only observed once. 
Reconfirmation of this interaction would indicate that this is a true positive 
interaction.  
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NQO2, also known as quinone reductase 2 (QR2), is another SPG21 interaction 
partner. It is a cytosolic flavoenzyme which catalyses substrate-specific reduction and 
enhances the production of damaging activated quinone and reactive oxygen species 
(ROS) (Benoit et al., 2010). NQO2 expression was observed ubiquitously in brain and 
is particularly enriched in the neurons of the hippocampus and cortex (Hashimoto 
and Nakai, 2011). High levels of ROS are associated with age-related learning and 
memory deficits, as well as in Alzheimer’s disease (Serrano and Klann, 2004; Benoit 
et al., 2010). Moreover, significantly higher levels of NQO2 were identified in the 
hippocampus of Alzheimer’s disease patients compared to control (Hashimoto and 
Nakai, 2011), whilst NQO2 knock-out mice, demonstrated enhanced cognitive 
behaviour (Benoit et al., 2010). 
 
NLRP2, is a cytoplasmic protein which inhibits NF-κB activation (Bruey et al., 2004), 
it was more recently shown to associate with ASC and caspase-1, forming a functional 
inflammasome, in human astrocytes. Inflammasomes are essential for the activation 
of caspase-1 and the production of pro-inflammatory cytokines, following CNS injury. 
The NLRP2 inflammasome is now recognised as an important component of the CNS 
inflammatory response (Minkiewicz, de Rivero Vaccari and Keane, 2013).  
 
Another SPG21 interaction partner, TRIM56, regulates innate immune responses by 
associating with and promoting the ubiquitination of STING (stimulator of interferon 
genes), an ER transmembrane protein that functions as an innate immune signalling 
adaptor, enhancing cytosolic dsDNA-induced IFN production (Shen et al., 2012).  
 
C19orf12 (SPG43): 
Y2H library screens identified 5 binary C19orf12 (SPG43) interaction partners, all of 
which were novel. Perilipin-3 (PLIN3) was identified as an interactor of C19orf12, 
following successful library screening. PLIN3 is required for mannose-6-phosphate 
receptor (MPR) transport from endosomes to the trans-Golgi network (TGN) (Díaz 
and Pfeffer, 1998). We previously identified SPG20, an endosome-associated, 
multifunctional protein known to be involved in regulating endosomal trafficking 
(Renvoisé and Blackstone, 2010), as an C19orf12 (SPG43) interaction partner in our 
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targeted HSP:HSP Y2H matrix screens (Chapter 4). As very little is known about the 
function of C19orf12, it is interesting that these findings demonstrate a potential role 
for C19orf12 in endosomal trafficking, providing further evidence to support the idea 
that defects in intracellular trafficking events are potentially significant in the 
pathogenesis of neurodegenerative diseases such as HSP. 
 
The RNA-binding protein FUS (FUsed in Sarcoma), was also identified as an interactor 
of C19orf12. Interestingly, mutations in the FUS protein are known to be either 
causative or risk factors for several neurodegenerative diseases, including 
amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD) and essential 
tremor (Vance et al., 2009; Chen et al., 2011; Merner et al., 2012). Abnormal FUS 
protein aggregates may also suggest a potentially important role for FUS in 
neurodegenerative diseases (Deng, Gao and Jankovic, 2014).  
 
Unfortunately, many of the 33 Y2H HSP bait constructs used in this study were 
unsuccessful in the Matchmaker® Y2H library screens and did not yield any true-
positive prey interactions when screened against the prey K-562 cDNA library. There 
are a couple of factors that may contribute to the high failure rate, which need to be 
considered. First, the yeast cell viability of the prey library aliquots may have 
decreased over time, affecting library screening quality. Second, there are several 
HSPs that are known to have transmembrane domains (see Chapter 3) and because 
of their hydrophobic nature, this can often prove to be problematic for use in 
‘traditional’ Y2H systems.  
 
Given all of the above, a new commercial pre-transformed Matchmaker® Gold Y2H 
library system was bought and optimised for use with HSP proteins which do not 
have transmembrane domains. Additionally, the membrane yeast two-hybrid 
(MYTH) (provided by Dr Igor Stagljar, University of Toronto, Canada) was set-up and 
optimised for use with HSP proteins that encode one or more transmembrane 
domain. 
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6.3 Matchmaker® Gold Yeast two-Hybrid  
 
6.3.1 Matchmaker® Gold yeast two-hybrid system 
 
Again, the GAL4 Y2H system was employed, such that the bait protein was expressed 
as a fusion to the GAL4 DNA-binding domain (BD) using the DNA-BD cloning vector, 
pGBKT7, whilst the library of prey proteins were expressed as fusions to the GAL4 
activation domain (AD) using the AD cloning vector, pGADT7 (Fields and Song, 1989; 
Chien et al., 1991). When the bait and library prey proteins interact, the DNA-BD and 
AD are brought into close proximity to each other, which in the Matchmaker® Gold 
Y2H system, results in the transcription of four independent reporter genes (HIS3, 
ADE2, MEL1 and AUR1-C). 
 
In this study, the Y2HGold and Y187 host strains, were used for bait and prey library 
transfection, respectively. The Y187 library host strain carries two reporter genes: 
lacZ and MEL1, each driven by a different promoter (GAL1 and MEL1, respectively). 
Whilst the Y2HGold host strain, a derivative of PJ69-2A (James, Halladay and Craig, 
1996), carries four reporter genes: HIS3, ADE2 and MEL1/AUR1-C, under the control 
of three distinct GAL4-responsive promoter elements (GAL1, GAL2 and MEL1 
respectively).  
 
MEL1 encodes the enzyme, a-galactosidase (a-Gal), which is required for the 
hydrolysis of the terminal alpha-galactosyl moiety of melibiose into glucose and 
galactose (Buckholz and Adams, 1981; Liljeström, 1985). Yeast colonies can be 
assayed for MEL1 activity (a-Gal assay), without the need to lyse cells, using the 
chromogenic substrate, X-a-Gal (5-bromo-4-chloro-3-indolyl-a-D-
galactopyranoside) (Aho et al., 1997). X-a-Gal can be detected with significantly 
higher sensitivity than b-Gal (Lazo, Ochoa and Gascón, 1978). Secretion of the a-
galactosidase, in response to GAL4 activation, leads to the hydrolysis of X-a-Gal to 
yield a blue precipitate, and so interaction detection and strength can be easily 
assessed. The Y2HGold yeast strain is unable to synthesise histidine or adenine and 
is therefore unable to grow on media lacking these essential amino acids. Upon 
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protein-protein interaction, reporter genes are activated resulting in growth of yeast 
on selective media and blue colour development in the a-Gal assay.  
 
AUR1, on the other hand, encodes the essential yeast enzyme, inositol phosphoryl 
ceramide synthase, which can be inhibited be Aureobasidin A (AbA), a potent yeast 
antibiotic known to kill S. cerevisiae at low concentrations (Takesako et al., 1993). 
The dominant mutant AUR1-C, encodes a mutant enzyme which confers resistance 
to AbA (Hashida-Okado et al., 1996), which can be used as an effective selectable 
yeast marker. Reporter activation allows yeast to grow on media supplemented with 
AbA, with extremely low background as AbA kills sensitive cells as opposed to slowing 
growth, and so AbA-based selection favours the growth of genuinely positive 
interactions. 
 
The protein-binding sites within the three promoters are different, except for the 
short protein binding sites in the upstream activation sequence (UAS), which are 
recognised and specifically bound by the GAL4 BD (Giniger, Varnum and Ptashne, 
1985; Giniger and Ptashne, 1988). All four reporter genes, each under the control of 
different promoters, can be assayed in parallel and the high stringency screening 
protocols of the Matchmaker® Gold Y2H system is designed to decrease the 
incidence of false positives. In addition, to increase confidence of the interactions 
identified in the Matchmaker® Gold Y2H screens, all library hits were also re-
confirmed by performing an in vivo recombination (gap repair) of prey library hits 
back into the pGADT7 prey vector, followed by a reconfirmation mating with the 
original bait clone and a negative control (empty pGBKT7). This reconfirmation ‘gap 
repair’ facilitates the removal of non-specific background colonies. In addition, 
reconfirmation mating allows the confirmation of genuine positive clones, whilst 
removing auto-activating/ non-specific prey (false positive) clones. 
 
6.3.2 Generation of HSP Matchmaker® Gold Y2H bait constructs 
 
To identify additional novel HSP interaction partners, a set of HSP Matchmaker® Gold 
Y2H bait constructs had to be generated and individually screened against the 
 212 
Matchmaker® Gold human brain cDNA prey library. Due to time constraints, we 
prioritised those HSP proteins known to be involved in intracellular transport and 
degradation processes.  
 
As described in Chapter 3, the cloning efforts ultimately resulted in the generation of 
a Gateway® entry clone library representing 30 human HSPs, from which HSPs 
involved in intracellular trafficking processes were prioritised resulting in the 
selection of 16 HSP ORFs. The HSP ORFs were cloned in-frame with the GAL4 DNA-
binding domain of the pGBKT7 bait vector, followed by transformation into the Y2H 
Gold yeast strain (Chapter 2, section 2.3.2). The pGBKT7 vector contains the TRP1 
gene under the control of the modified ALDH1 promoter, which allows moderate 
expression and stringent selection of the N-terminal tagged GAL4-fusion bait 
proteins on synthetic defined agar plates lacking tryptone (SD-W). It should be noted 
that fragmented domains of SPG8 (WASHC5) were also cloned into the pGBKT7 Y2H 
bait expression vector. HSP pGBKT7 bait constructs which showed signs of auto-
activation or toxicity in yeast were removed, resulting in 9 HSP pGBKT7 bait clones 
representing 8 human HSPs: full-length and spectrin domain of SPG8 (WASHC5 and 
WASHC5-SD), SPG18 (ERLIN2), SPG20, SPG21, SPG52 (AP4S1), SPG57 (TFG), SPG59 
(USP8) and CCT5. 
  
6.3.3 Matchmaker® Gold Y2H library screen reveals 34 potentially novel HSP 
interactors 
 
An outline of the Matchmaker® Gold Y2H library screen methodology used is 
described in Figure 6.2. In brief, Y2HGold yeast cells transfected with a HSP bait 
construct was mated against Y187 yeast cells transfected with the Matchmaker® 
Gold human brain cDNA library, on a rich medium (YPAD) agar plate. Following a 5-
hour incubation, mated yeast were plated onto low stringency (SD-WL/AbA) plates 
and left to grow for 3-5 days to select for positive diploid colonies. These colonies 
were then transferred onto higher stringency (SD-WLAH/X-!-Gal/AbA) plates and 
left to grow for up to 14 days. To increase confidence of the interactions identified 
from these screens, all prey library hits were re-confirmed. The library prey inserts 
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were amplified from diploid colonies and cloned back into the pGADT7 prey vector 
for reconfirmation mating with the original or negative control (empty vector) bait. 
Only those that selectively activate all four reporters (ADE2, HIS3, MEL1 and AUR1-
C) with the original and not the negative control bait were selected for DNA 
sequencing.  
 
Unfortunately, 6 HSP pGBKT7 bait clones were unsuccessful in the Matchmaker® 
Gold Y2H library screens and did not yield any true-positive prey interactions when 
screened against the human brain cDNA library. In total, 3 HSP pGBKT7 bait clones 
were successfully screened against the Matchmaker® Gold human brain cDNA prey 
library (Clontech), identifying a total of 34 potentially novel HSP interactors. The 
successfully reconfirmed interaction partners identified in each individual library 
screen and are presented in Table 6.2. The function and subcellular localisation was 
manually curated from literature and web sources such as UniProt, again to provide 
functional context to partner interactions.  
 
AKIRIN2 and TCF4 are both known binary interactors of SPG21 (Rual et al., 2005; 
Rolland et al., 2014), whilst TFG (SPG57) and CEP126 are both known binary 
interactors of TFG (Stelzl et al., 2005), and all of these were also identified in the 
Matchmaker® Gold Y2H library screens. The identification of previously known 
interactions provides confidence in other novel binary/direct interactors identified in 
these screens. Moreover, the interactions between SPG21 and PSMD8, as well as 
CCT5 and CCT5, were both previously identified as novel binary interactions in the 
Matchmaker® K-562 cDNA library (Figure 6.3). The identification of interactions 
previously identified in other Y2H screens, provides additional confidence in the 
overall data generated from the Y2H library screens. 
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Figure 6.2 
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er stringency interaction selection m
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ith the original bait (positive control) or em
pty bait vector (negative control), on YPAD m
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on SD-W
L plates, before replication onto higher stringency interaction selection plates (SD-W
LAH/X-!-Gal/AbA). Yeast clones that activated all 
four reporters (ADE2, HIS3, M
EL1 and AUR1-C) w
ith the original bait and not negative control, w
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Table 6.2 
                       
SPG21
Cytosol,	Golgi	app.,	endosom
es
Gene
Protein	Nam
e	(UniProt)
Function
Localisation	(UniProt)
kd
AKIRIN2
Akirin-2
Im
portant	for	the	innate	im
m
une	response
Nucleus
ATP5O
ATP	synthase	subunit	O,	m
itochindrial
M
itochondrial	F-type	ATP	synthase,	m
ay	be	involved	in	transm
ission	of	conform
ational	changes	or	proton	conductance
Extracellular,	M
itochondrion,	Nucleus,	Plasm
a	
m
em
brane
COG1
Conserved	oligom
eric	Golgi	com
plex	subunit	1	
Com
ponent	of	the	Golgi-localized	com
plex	(COG)	involved	in	m
em
brane	trafficking.	It	is	also	required	for	norm
al	Golgi	m
orphology	and	
function	
Golgi	app.
COQ
3
Ubiquinone	biosynthesis	O-m
ethyltransferase,	m
itochondrial
Catalyzes	the	2	O-m
ethylation	steps	in	the	ubiquinone	(coenzym
e	Q
)	biosynthetic	pathw
ay
M
itochondrion
ERCC3	
TFIIH	basal	transcription	factor	com
plex	helicase	XPB	subunit
ATP-dependent	DNA	helicase	involved	in	nucleotide	excision	repair	(NER)	of	DNA	
Nucleus
FAM
104B
Protein	FAM
104B
-
Nucleus
GPM
6B
Neuronal	m
em
brane	glycoprotein	M
6-b	
Proteolipid	protein	thought	to	be	involved	in	m
em
brane	trafficking	and	cell-to-cell	com
m
unication
Plasm
a	m
em
brane
LDHB
L-lactate	dehydrogenase	B	chain	
Catalyzes	the	interconversion	of	pyruvate	and	lactate	w
hilst	sim
ultaneously	catalysing	the	interconversion	of	NADH	and	NAD+	in	a	post-
glycolysis	process
Cytosol,	Extracellular,	M
itochondrion
M
AGT1
M
agnesium
	transporter	protein	1	
Associates	w
ith	N-oligosaccharyl	transferase	and	m
ay	therefore	be	involved	in	N-glycosylation
Plasm
a	m
em
brane,	ER
PSM
D8
26S	proteasom
e	non-ATPase	regulatory	subunit	8
Com
ponent	of	26S	proteasom
e	w
hich	partcipates	in	num
erous	cellular	processes
Cytosol,	Extracellular,	Nucleus
PUM
1
Pum
ilio	hom
olog	1
RNA-binding	protein	involved	in	various	post-transcriptional	processes
Cytosol
kd
TCF4
Transcription	factor	4
Involved	in	the	initiation	of	neuronal	differentiation	and	m
ay	play	a	role	in	the	nervous	system
	developm
ent	
Nucleus
SPG57/	TFG
Cytosol,	Golgi	apparatus,	Extracellular
Gene
Protein	Nam
e	(UniProt)
Function
Localisation	(UniProt)
ABCG2
ATP	binding	cassette	sub-fam
ily	G	m
em
ber	2
A	m
em
brane-associated	ATP-binding	cassette	(ABC)	transport	protein	
Nucleus,	Plasm
a	m
em
brane
ANKRD36
Ankyrin	repeat	dom
ain-containing	protein	36A
-
Nucleus
ATL1
Atlastin	1
GTPase	and	Golgi	body	transm
em
brane	protein.	Functions	in	ER	tubular	netw
ork	biogenesis,	m
ay	also	regulate	Golgi	biogenesis	and	
axonal	developm
ent	
ER,	Golgi	apparatus
CEP126
Centrosom
al	protein	of	126kDa
Participates	in	cytokinesis.	Necessary	for	m
icrotubules	and	m
itotic	spindle	organization	Involved	in	prim
ary	cilium
	form
ation
Cytoplasm
,	Cytoskeleton,	Centrosom
e
FAM
13A
Protein	FAM
13A	
M
ay	be	involved	in	GPCR	and	Rho	GTPase	signalling	pathw
ays
Cytosol
FAM
13B	
Protein	FAM
13AB
M
ay	be	involved	in	GPCR	and	Rho	GTPase	signalling	pathw
ays
Cytosol
GLM
N
Glom
ulin
Essential	for	norm
al	developm
ent	of	the	vasculature.	M
ay	function	as	a	m
em
brane	anchoring	protein
Cytosol
HHLA3
HERV-H	LTR-Associating	3
-
Nucleus
HNRNPC	
Heterogeneous	Nuclear	Ribonucleoprotein	C1/C2
Binds	to	pre-m
RNAs	and	is	involved	in	the	assem
bly	of	40S	hnRNP	particles	
Cytosol,	Extracellular,	Nucleus
KIAA1755
uncharacterised	protein	KIAA1755
-
NAP1L2
Nucleosom
e	Assem
bly	Protein	1	-Like	2
Nucleosom
e	Assem
bly	Protein	(NAP)	m
em
ber	w
hich	interacts	w
ith	chom
atin	to	regulate	neuronal	cell	proliferation
Nucleus
PARG
Poly(ADP-Ribose)	Glycohydrolase
M
ajor	enzym
e	responsible	for	the	catabolism
	of	poly(ADP-ribose),	a	reversible	covalent-m
odifier	of	chrom
osom
al	proteins
M
itochondrion,	Nucleus
POLR2C
DNA-directed	RNA	Polym
erase	II	Subunit	RPB3
Synthesizes	m
RNA	precursors	and	m
any	functional	non-coding	RNAs
Cytoskeleton,	Nucelus
RPL27A
60S	Ribosom
al	Protein	L27a
A	com
ponent	of	the	60S	ribosom
al	subunit
Cytosol
RSL24D1
Probable	ribosom
e	biogenesis	protein	RLP24	
Involved	in	the	biogenesis	of	the	60S	ribosom
al	subunit
Cytosol,	Nucleus
SNRPG
Sm
all	Nuclear	Ribonucleoprotein	G.	
Com
ponent	of	the	spliceosom
al	U1,2,4	and	5	snRNPs	-	playing	a	role	in	the	splicing	of	cellular	pre-m
RNAs	
Cytosol,	Nucleus
TANK
TRAF	fam
ily	m
em
ber	Associated	NF-κB	activator
Adapter	protein	involved	in	I-kappa-B-kinase	(IKK)	regulation-role	in	innate	im
m
unity.	Negatively	regulates	NF-κB	signaling	and	cell	
survival	after	DNA	dam
age
Cytosol
TFG
Protein	TFG
Plays	a	role	in	the	norm
al	function	of	the	ER	and	its	associated	m
icrotubules,	m
ay	be	involved	in	the	NF-κB	pathw
ay
Cytosol,	Golgi	apparatus,	Extracellular
SNX6
Sorting	Nexin	6.	
Soritng	nexin	fam
ily	m
em
ber	involved	in	several	stages	of	intracellular	trafficking,	including	endosom
e-to-trans-Golgi-netw
ork	retrograde	
transport
Endosom
e
USO1
General	vesiclar	transport	factor	p115
Peripheral	m
em
brane	protein	required	for	intercisternal	transport	in	the	Golgi,	transcytotic	fusion	and/or	binding	of	vesicle	to	target	
m
em
brane
Cytosol,	Golgi	apparatus,	Nucleus
YBX1
Nuclease-sensitive	elem
ent-binding	protein	1
Functions	as	both	a	DNA	and	RNA	binding	protein	and	has	been	im
plicated	in	num
erous	cellular	processes	including	regulation	of	
transcription	and	translation
Extracellular,	Nucleus
ZNF251
Zinc	finger	protein	251
M
ay	be	involved	in	transcriptional	regulation
Nucleus
M
ay	act	as	a	negative	regulatory	factor	in	CD4-dependent	T-cell	activation
Plays	a	role	in	the	norm
al	function	of	the	endoplasm
ic	reticulum
	(ER)	and	its	associated	m
icrotubules.	M
ay	play	a	role	in	the	NF-κB	pathw
ay
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Table 6.2 continued 
 Table 6.2. M
atchm
aker® Gold hum
an brain cDNA yeast tw
o-hybrid library screen results. Refined list of potential interaction partners identified 
from
 M
atchm
aker® Gold Y2H library screens. Previously identified binary interactions (know
n direct), are highlighted in orange. 
            CCT5
Cytoskeleton,	Cytosol,	Extracellular,	Nucleus
Gene
Protein	Nam
e	(UniProt)
Function
Localisation	(UniProt)
COM
M
D7
COM
M
	dom
ain-containing	7
M
ay	m
odulate	the	activity	of	cullin-RING	E3	ubiquitin	ligase	(CRL)	com
plexes.	Associates	w
ith	NF-κB	com
plex	to	suppress	its	
transcriptional	activity
Extracellular
CDK5RAP2
CDK5	regulatory	subunit-associated	Protein	2
Localizes	to	the	centrosom
e	and	Golgi	com
plex,	plays	a	role	in	centriole	engagem
ent	and	m
icrotubule	nucleation
Cytoskeleton,	Cytosol,	Extracellular,	Golgi	app.
RBM
X
RNA-binding	m
otif	protein,	X	chrom
osom
e	
RNA-binding	protein	that	has	several	roles	in	the	regulation	of	pre-	and	post-transcriptional	processes
Extracellular
CCT5
T-com
plex	protein	1	subunit	epsilon
M
olecular	chaperone,	involved	in	the	folding	of	proteins	follow
ing	ATP	hydrolysis	(inc	actin	and	tubulin)
Cytoskeleton,	Cytosol,	Extracellular,	Nucleus
PUM
1
Pum
ilio	hom
olog	1
RNA	binding	protein	involved	in	various	post-transcriptional	processes
Cytosol
M
olecular	chaperone	involved	in	the	folding	of	proteins	follow
ing	ATP	hydrolysis	(including	actin	and	tubulin)
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Figure 6.3 
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     Figure 6.3. Traditional yeast tw
o-hybrid library screen results sum
m
ary com
parison. (A) Table show
ing refined list of potential interaction 
partners identified from
 M
atchm
aker® Y2H library screens. pGBAE-B bait HSPs (horizontal) and pACTBE-B prey library hits (vertical) are ordered 
alphabetically. (B) Table show
ing refined list of potential interaction partners identified from
 M
atchm
aker® Gold Y2H library screens. pGBKT7 
bait HSPs (horizontal) and pGADT7 prey library hits (vertical) are ordered alphabetically. The overlap of the proteins identified as potential 
interaction partners for SPG21 and CCT5 in each corresponding library screen are show
n in (C), colours m
atch accordingly. Previously identified 
(know
n) interactions, are annotated as such in the tables above.
ABCG2
AKIRIN2
ANKRD36
ATL1
ATP5O
CCT5
CDK5RAP2
CEP126
COG1
COMMD7
COQ3
ERCC3	
FAM104B
FAM13A
FAM13B	
GLMN
GPM6B
HHLA3
HNRNPC	
KIAA1755
LDHB
MAGT1
NAP1L2
PARG
POLR2C
PSMD8
PUM1
PUM1
RBMX
RPL27A
RSL24D1
SNRPG
SNX6
TANK
TCF4
TFG
USO1
YBX1
ZNF251
SPG21
SPG57/	TFG
CCT5
pGBKT7	
(bait)
Library	hits	(prey)	
ADGRL1
APLP2
ARIH2
BCCIP
C12orf10
C1QBP
C7orf50
CCT5
CD63
CD81
CDV3
COPS5
COX6C
DCTN2
DDA1
DIAPH1
EEF1G
ELF1
FLOT2
FUS
HMGA1
HNRNPH3
LSR
MCM2
MRPS18A
NLRP2
NOTCH1
NQO2
NUBP2
PLIN3
POLR2G
PRAME
PRPF8
PSMD8
RBMX
RBMX2
RNF5
RPAIN
RPL7
RUFY2
SDHB
SLC26A8
SPECC1
SRPX2
TAF10
TCP1
TIMM13
TK1
TOR3A
TRIM56
TUBA1B
SPG2/	PLP1
SPG12/	RTN2
SPG21
SPG28/	DDHD1
SPG43/	C19orf12
SPG47/	AP4B1
SPG48/	AP5Z1
SPG55/	C12orf65
CCT5
pGBAE-B	(bait)
Library	hits	(prey)	
Know
n	Direct
Know
n	Indirect
Predicted	Indirect
SPG21
16
11
1
CCT5
4
4
1
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6.3.4 Functional relevance of Matchmaker® Gold Y2H library hits 
 
The interaction data generated from these Matchmaker® Gold human brain cDNA 
library screens was analysed to gain a better understanding of the novel interactions 
identified and their functional relevance.  
SPG21: 
The Y2H library screens identified 12 binary SPG21 interaction partners, 10 of which 
were found to be novel SPG21 interactors. An overview of 6, particularly interesting 
interactors, are given here.  
 
As already mentioned, AKIRIN2 and TCF4 are both known binary interactors of SPG21 
identified in previous screens as well as our own. AKIRIN2 is an evolutionary 
conserved nuclear protein, which stimulates pro-inflammatory gene transcription 
during innate immune responses to viral or bacterial infection in mouse 
macrophages (Tartey et al., 2014). TCF4, often referred to as immunoglobulin 
transcription factor 2 (ITF2) is known to have an important role in various 
developmental processes, including regulation of gene expression during 
neurodevelopment (Forrest et al., 2014). This is particularly interesting given the 
association of human TCF4 variants with a range of common diseases including, 
schizophrenia and intellectual disability (Stefansson et al., 2009; Hamdan et al., 
2014). 
 
GPM6B is a transmembrane glycoprotein that belongs to the proteolipid family, 
described as the structural proteins of the CNS myelin. Other members of this family 
include GPM6A and PLP1 (SPG2), both also major structural components of the 
myelin sheath (Mikoshiba et al., 1991). As GPM6B and PLP1 share a high degree of 
protein sequence similarity (Yan, Lagenaur and Narayanan, 1993), GPM6B may be a 
potential HSP candidate gene. 
 
COG1, a component of the multi-subunit membrane protein Conserved Oligomeric 
Golgi (COG) complex, which has an important role in Golgi-associated membrane 
trafficking and glycol-conjugate synthesis (Oka et al., 2005; Vasile et al., 2006). COG 
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appears to be involved in retrograde vesicular transport, and it has multiple features 
associated with maintaining Golgi structure and function (Ungar et al., 2006). 
 
MAGT1 is a magnesium-specific transporter located in the plasma membrane, which 
is ubiquitously expressed. MAGT1 loss or deficiency leads to the absence of a T cell 
antigen receptor (TCR)-stimulated Mg2+ flux and attenuation of T cell activation 
which was found to result in a novel primary immunodeficiency, XMEN disease (Li et 
al., 2014). 
 
TFG (SPG57): 
The Y2H library screens identified 22 binary TFG interaction partners, 20 of which 
were found to be novel TFG interactors. A brief overview of 6, particularly interesting 
interactors, are given here.  
 
As already mentioned, TFG and CEP126 are both known binary interactors of TFG, 
which were also identified in this study. TFG is thought to self-associate to form 
hexamers facilitating its role as a regulator of protein secretion from the ER (Witte et 
al., 2011), therefore identification of the known TFG-TFG interaction gives added 
confidence in the novel interactors identified. CEP126 is thought to be involved in 
regulating pericentriolar-satellite transport to the centrosome, where it appears to 
indirectly regulate the microtubule anchoring to the centrosome through its 
interaction with dynactin p150Glued, affecting other crucial cellular functions. It is 
therefore important in regulating centrosome-based functions, and is crucial for 
correct intracellular organisation (Bonavita et al., 2014). 
 
TANK (TRAF family member-associated NF-kB activator) negatively regulates NF-kB 
activation by DNA damage by inhibiting TRAF6 ubiquitination (Wang et al., 2015). 
 
SNX6 (sorting nexin 6), a member of the evolutionary conserved family of proteins 
involved in membrane trafficking and protein sorting. SNX6, now known to be a 
component of the retromer complex (Wassmer et al., 2006), interacts with dynactin 
 220 
p150Glued to mediate retrograde transport from endosome-to-trans Golgi network 
(Hong et al., 2009). 
 
USO1 (vesicle transport factor) is involved in vesicle trafficking and Golgi organisation 
(Puthenveedu and Linstedt, 2001). Uso1 is an essential ER-to-Golgi tethering factor 
in yeast vesicular transport (Noda, Yamagishi and Yoda, 2007), as it binds to the ER-
derived COPII vesicles budded from the ER (Cao, Ballew and Barlowe, 1998). The 
packaging of cargo and formation of vesicles at the ER membrane is mediated by the 
COPII complex (McCaughey et al., 2016), and COPII-dependent export of secretory 
cargo from the ER is essential for the normal function of all mammalian cells (Zanetti 
et al., 2011). TFG is also involved as it was previously identified as a Sec16-interacting 
protein regulating COPII-dependent budding form the ER (Witte et al., 2011), 
directing the organisation of the very earliest stages of COPII-dependent budding 
(McCaughey et al., 2016). HSP-associated mutations of TFG, appear to be related to 
changes in ER architecture (Beetz, Johnson, et al., 2013), which given these results, 
could arise from defects in vesicular transport and protein secretion (McCaughey et 
al., 2016). 
 
Interestingly, ATL1 (SPG3) was identified as a novel binary interactor of TFG. ATL1 is 
one of the most well-characterised HSP genes, regulating ER morphology and 
network organisation (Park et al., 2010). Interestingly, TFG is also involved in 
regulating ER morphology (Beetz, Johnson, et al., 2013). TFG may also regulate 
intracellular protein homeostasis in the ER as it was recently shown to function as an 
inhibitory regulator of the UPS (Yagi, Ito and Suzuki, 2014). This interaction may 
therefore provide pathological insight, as we concluded that the pathogenesis of HSP 
may be associated with the disruption of intracellular protein homeostasis and ER 
stress.  
 
CCT5: 
The Y2H library screens identified in total 5 binary CCT5 interaction partners, all of 
which were novel. COMMD7, a member of the COpper Metabolism MURR I Domain-
Containing (COMMD) family of structurally conserved proteins which appear to have 
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specific roles in the termination of canonical NF-kB signalling (Bartuzi, Hofker and 
van de Sluis, 2013). Lacking in catalytic activity, it is suggested that they function as 
scaffolding proteins, facilitating the assembly of molecular components involved in 
the control of various biological processes, including NF-kB signalling (Esposito et al., 
2016). 
 
6.4 Membrane Yeast two-Hybrid (MYTH) library screens 
 
6.4.1 Membrane yeast two-hybrid (MYTH) system 
 
The traditional yeast two-hybrid system is a powerful tool for in vivo analysis of 
protein-protein interactions (Bartel and Fields, 1995), however this system is more 
suited to the analysis of soluble proteins or soluble domains of membrane proteins, 
which means that interactions between integral membrane proteins can be 
problematic and as such are not well studied (Stagljar et al., 1998). As a result, the 
split-ubiquitin based membrane yeast two-hybrid (MYTH) system was developed (as 
described in Chapter 1), which allows the high-throughput identification of 
interactions between a membrane protein (full-length integral or membrane-
associated) and a membrane or soluble protein, in an in vivo environment (Stagljar 
et al., 1998; Fetchko and Stagljar, 2004). Briefly, if there is a direct interaction 
between a bait and prey proteins, the two fragments of ubiquitin are brought into 
close proximity, allowing for the spontaneous reconstitution of the ‘pseudo-
ubiquitin’ molecule which can be recognised by the cytosolic proteases, DUBs 
(Johnsson and Varshavsky, 1994; Stagljar et al., 1998; Snider et al., 2010). As a result, 
the artificial transcription factor (LexA-VP16) is released from the membrane-bound 
bait, which allows it to translocate to the nucleus, where it activates reporter gene 
transcription (e.g. HIS3, ADE2 and lacZ) under the control of promoters containing 
LexA binding sites (Snider et al., 2010). Reporter genes typically used in the MYTH 
screen are the same as those used in the ‘classical’ Y2H system, which include the 
more commonly used auxotrophic growth markers (e.g. HIS3, and ADE2) as well as 
the lacZ gene, allowing interactions to be specifically selected for using appropriate 
selective media (Iyer et al., 2005). 
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6.4.2 Generation of HSP membrane yeast two-hybrid (MYTH) bait constructs 
 
The MYTH system can be used to identify novel interactions between a membrane 
protein (full-length integral or membrane-associated) and a cytosolic/ membrane-
associated interaction partner. For the MYTH system to function properly, the 
protein of interest must have either its N and/or C terminus in the cytosol of the cell.  
 
To identify additional novel HSP interaction partners for membrane HSP proteins, a 
set of HSP membrane yeast two-hybrid (MYTH) bait constructs had to be generated 
and screened against the MYTH human brain cDNA prey library. Initially, the 
membrane topology of each HSP was analysed in order to select HSP candidates that 
would be appropriate for analysis using the MYTH system. Protter, a web-based tool 
that automatically integrates reference protein annotation sources (e.g. UniProt) for 
the visual analysis of predicted membrane protein topology (Omasits et al., 2014), 
was used to analyse the membrane topology for each HSP candidate protein known 
to contain one or more transmembrane domain and is presented in Table 6.3.  
 
Table 6.3 
SPG Symbol Gene ID No. of TM domains Membrane Topology 
SPG1 L1CAM 3897 1 C 
SPG2 PLP1 5354 4 N/C 
SPG3 ATL1 51062 2 N/C 
SPG4 SPAST 6683 1 N 
SPG6 NIPA1 123606 9 C 
SPG7 SPG7 6687 2 - 
SPG12 RTN2 6253 2 - 
SPG17 BSCL2 26580 2 N/C 
SPG18 ERLIN2 11160 1 N 
SPG22 SLC16A2 6567 12 N/C 
SPG26 B4GALNT1 2583 1 N 
SPG31 REEP1 65055 2 - 
SPG33 ZFYVE27 118813 3 N 
SPG35 FA2H 79152 4 N/C 
SPG39 PNPLA6 10908 1 C 
SPG42 SLC33A1 9197 11 N 
SPG43 C19orf12 83636 1 N 
SPG44 GJC2 57165 4 N/C 
SPG49 CYP2U1 113612 5 C 
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SPG61 ARL6IP1 23204 3 N/C 
SPG62 ERLIN1 10613 1 N 
SPG64 ENTPD1 953 2 N/C 
SPG67 PGAP1 80055 7 N 
SPG68 FLRT1 23769 1 C 
SPG72 REEP2 51308 2 - 
SPG73 CPT1C 126129 2 N/C 
SPG75 MAG 4099 1 C 
SPG78 ATP13A2 23400 12 N/C 
- AFG3L2 10939 2 N/C 
- ELOVL4 6785 7 C 
- FAM134B 54463 4 N/C 
- GJA1 2697 4 N/C 
- KCNA2 3737 6 N/C 
- KIDINS220 57498 4 N/C 
- MT-ATP6 4508 6 - 
- MT-ND4 4538 11 N 
- MT-CO3 4514 7 N 
 
Table 6.3. List of HSP proteins with one or more transmembrane domain. HSP genes 
are listed by spastic gait disease-loci (SPG), those not part of the SPG classification 
system are listed alphabetically. Entrez Gene IDs were obtained from the NCBI 
database. Information regarding transmembrane domains was obtained from 
UniProt, whilst membrane topology was analysed using Protter (Omasits et al., 
2014). HSPs selected for MYTH analysis are highlighted in green. 
 
The chosen HSP ORFs were cloned in-frame with the Cub-LexA-VP16 tag of an 
appropriate vector, using either C-terminal vectors (pAMBV4, pCMBV4 or pTMBV4) 
and/or N-terminal vectors (pBT3N or pTLB1), depending on membrane topology 
(Chapter 2, section 2.4.3). Bait constructs that showed signs of auto-activation or 
toxicity in yeast (SPG18 and ELOVL4) were removed, resulting in 10 HSP MYTH bait 
clones, representing 10 human HSPs.  
 
6.4.3 MYTH library screen reveals 124 potentially novel HSP interactors 
 
An outline of the optimised MYTH library screen used is described in Figure 6.4. In 
brief, NMY51 yeast cells transfected with a HSP bait construct was transformed with 
the human embryonic brain cDNA library. The transformation yeast mixture was 
plated onto SD-WLAH (±3-AT depending on control test) and left to grow for 3-5 days, 
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to select for positive protein-protein interactions. To increase confidence of the 
interactions identified from these library screens, all prey library hits identified were 
re-confirmed. The library prey inserts were amplified from diploid colonies and 
cloned back into the pPR3N prey vector for reconfirmation mating with the original 
or negative control (empty vector) bait. Only those that selectively activate all three 
reporters (ADE2, HIS3 and lacZ) with the original bait and not the negative control 
(empty) bait, were selected for DNA sequencing to identify the encoded prey 
proteins. 
 
In total, 10 HSP MYTH bait clones were individually screened against the human 
embryonic whole brain cDNA prey library, identifying a total of 235 interactions. 
After removing previously identified false positive interactors (Passantino et al., 
2013), a total of 195 potentially novel interactions remained, identifying 124 
potentially novel HSP interactors. The identification of previously identified 
interactions provides additional confidence in the overall MYTH system and the data 
generated. Successfully reconfirmed interaction partners identified in each individual 
library screen, including functional annotations, are presented in Table 6.4. 
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Figure 6.4 
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selection of positive protein-protein interactions. Only those that selectively activate all three reporters (ADE2, HIS3 and lacZ) w
ith the original 
bait and not the em
pty bait vector w
ere selected for DNA sequencing and prey identification via NCBI BLASTN. 
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Table 6.4  
 A 
 
SPG2/	PLP1
Plasm
a	m
em
brane
Gene
Protein	Nam
e	(UniProt)
Function
Localisation	(UniProt)
HSP
ATP13A2
Probable	cation-transporting	ATPase	13A2
M
em
ber	of	the	ATPase	P5	subfam
ily	and	m
ay	have	a	role	in	intracellular	cation	hom
eostasis	and	the	m
aintenance	of	neuronal	integrity
Endosom
e,	Lysosom
e,	Plasm
a	m
em
brane,	Vacuole
ATP5G2
ATP	synthase	F(0)	com
plex	subunit	C2,	m
itochondrial
Encodes	subunit	of	the	proton	channel	involved	in	m
itochondrial	ATP	synthase
M
itochondrion
ATP5G3
ATP	synthase	F(0)	com
plex	subunit	C3,	m
itochondrial
Encodes	subunit	of	the	proton	channel	involved	in	m
itochondrial	ATP	synthase
M
itochondrion
ATP6AP2
Renin	receptor
Renin	and	pro-renin	receptor
Extracellular,	Plasm
a	m
em
brane
ATP6V0B
V-type	proton	ATPase	21	kDa	proteolipid	subunit
Encodes	V0	dom
ain	of	vacuolar	ATPase	(v-ATPase),	im
portant	for	acidifying	various	intracellular	com
partm
ents
Vacuole
CD320
CD320	antigen
Encodes	a	receptor	required	for	cellular	uptake	of	vitam
in	B12,	B-cell	proliferation	and	im
m
unoglobulin	secretion
Extracellular,	Plasm
a	m
em
brane,	ER,	Endosom
e
CD63
CD63	antigen
Cell	surface	glycoprotein	know
n	to	com
plex	w
ith	integrins,	and	is	involved	in	various	cellular	signaling	cascades
Endosom
e,	Lysosom
e	m
em
brane
CD81
CD81	antigen
Cell	surface	glycoprotein	know
n	to	com
plex	w
ith	integrins,	m
ay	be	involved	in	signal	transduction
Extracellular,	Plasm
a	m
em
brane
DPM
2
Dolichol	phosphate-m
annose	biosynthesis	regulatory	protein
Regulates	dolichol	phosphate-m
annose	(DPM
)	biosynthesis	
ER
FAM
177A1
Protein	FAM
177A1
-
Nucleus
GLIPR1
Gliom
a	pathogenesis-related	protein	1
-
Plasm
a	m
em
brane
PCDHB	fam
ily
Protocadherin	beta	fam
ily
M
ay	be	involved	in	establishing	and	m
aintaining	specific	neuronal	connections	in	the	brain
-
RPL17
60S	ribosom
al	protein	L17
Com
ponent	of	the	60S	ribosom
al	subunit
-
SHISA4
Protein	shisa-4
-
-
SLC25A3
Phosphate	carrier	protein,	m
itochondrial
Catalyses	the	transport	of	phosphate	groups	from
	cytosol	into	m
itochondrial	m
atrix	
Extracellular,	Plasm
a	m
em
brane,	M
itochondrion,	
Nucleus
SPCS1
Signal	peptidase	com
plex	subunit	1
Rem
oves	signal	peptides	from
	nascent	proteins	translocating	into	the	ER	lum
en
ER
TM
EFF2
Tom
oregulin-2
Transm
em
brane	protein	w
hich	m
ay	be	a	survival	factor	for	hippocam
pal	and	m
esencephalic	neurons
Extracellular
GPM
6B
Neuronal	m
em
brane	glycoprotein	M
6-b
M
ay	be	involved	in	m
em
brane	trafficking	and	cell-cell	com
m
unication	as	w
ell	as	neural	developm
ent
Plasm
a	m
em
brane
RNF41
E3	ubiquitin-protein	ligase	NRDP1
Plays	a	role	in	type	1	cytokine	receptor	signaling
Cytosol
TM
EM
14A
Transm
em
brane	protein	14A
-
M
em
brane
YIPF6
Protein	YIPF6
-
M
em
brane
SPG3/	ATL1
ER,	Golgi	app.
Gene
Protein	Nam
e	(UniProt)
Function
Localisation	(UniProt)
ADCY8
Adenylate	cyclase	type	8
M
em
brane-bound	enzym
e	that	catalyses	the	form
ation	of	cyclic	AM
P	from
	ATP
Plasm
a	m
em
brane
ARL6IP5
ADP-ribosylation	factor-like	protein	6-interacting	protein	1
Involved	in	the	form
ation	and	stabilisation	of	ER	tubules
ER,	Plasm
a	m
em
brane
ATP10B
Probable	phospholipid-transporting	ATPase	VB
Catalyses	ATP	hydrolysis	coupled	w
ith	am
inophospholipid	translocation	through	various	m
em
branes
ER,	Extracellular,	Plasm
a	m
em
brane
BCAP31
B-cell	receptor-associated	protein	31
Chaperone	protein	-	m
ost	abundant	protein	in	ER	and	is	involved	recognition	and	targeting	or	proteins	to	the	ERAD
ER,	Plasm
a	m
em
brane,	Cytosol
C10orf35
Uncharacterised	protein	C10orf35
-
-
C18orf32
UPF0729	protein	C18orf32
M
ay	activate	NF-κB	signaling	pathw
ay
Extracellular
C4orf3
Uncharacterised	protein	C4orf3
-
Cytosol,	Plasm
a	m
em
brane
CCDC167
Coiled-coil	dom
ain-containing	protein	167
-
Cytosol
COPA
Coatom
er	subunit	alpha
Com
ponent	of	cytosolic	protein	com
plex	that	m
ediates	protein	transport	betw
een	ER	and	Golgi	com
partm
ents
Cytosol,	Extracellular,	Golgi	app.
CYB5B
Cytochrom
e	b5	type	B
M
em
brane-bound	hem
oprotein,	m
ay	act	as	an	electron	carrier	for	various	m
em
brane-bound	oxygenases
M
itochondrion
EIF3B
Eukaryotic	translation	initiation	factor	3	subunit	B
RNA-binding	com
ponent	of	the	eIF-3	com
plex,	required	for	the	initiation	of	protein	synthesis	
Cytosol,	Extracellular,	Nucleus
EM
C7
ER	m
em
brane	protein	com
plex	subunit	7
-
ER
FAM
177A1
Protein	FAM
177A1
-
Nucleus
FZD1
Frizzled-1
Receptor	for	W
nt	signaling	proteins
-
HDDC2
HD	dom
ain-containing	protein	2
-
Extracellular,	m
itochondrion
IARS2
Isoleucine-tRNA	ligase,	m
itochondrial
M
em
ber	of	the	Class	I	am
inoacyl-tRNA	synthetase	fam
ily
M
itochondrion
This	is	the	m
ajor	m
yelin	protein	from
	the	central	nervous	system
.	It	plays	an	im
portant	role	in	m
yelin	form
ation	and	m
aintenance.
GTPase	and	Golgi	body	transm
em
brane	protein.	Functions	in	ER	tubular	netw
ork	biogenesis,	m
ay	also	regulate	Golgi	biogenesis	and	axonal	developm
ent.	
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Table 6.4 continued 
 
IARS2
Isoleucine-tRNA	ligase,	m
itochondrial
M
em
ber	of	the	Class	I	am
inoacyl-tRNA	synthetase	fam
ily
M
itochondrion
M
KRN1
E3	ubiquitin-protein	ligase	m
akorin-1
E3	ubiquitin	ligase	and	transcriptional	co-regulator	thereby	controlling	cell	cycle	arrest	and	apoptosis	
Nucleus
NIN
Ninein
Im
portant	for	centrosom
al	function	-	involved	in	positioning	and	anchoring	m
icrotubule	m
inus-end	in	epithelial	cells
Cytoskeleton,	Nucleus
PCDHB10
Protocadherin	beta-10
M
ay	be	involved	in	establishing	and	m
aintaining	specific	neuronal	connections	in	the	brain
-
REEP5
Receptor	expression-enhancing	protein	5
M
ay	prom
ote	expression	of	functional	cell	surface	olfactory	receptors
Extracellular
RPS8
40S	ribosom
al	protein	S8
Com
ponent	of	the	40S	ribosom
al	subunit
Cytosol,	Extracellular,	Nucleus
RTN4
Reticulon-4
Developm
ental	neurite	outgrow
th	regulator
ER,	Extracellular,	Nucleus,	Plasm
a	m
em
brane
SLC35B1
Solute	carrier	fam
ily	35	m
em
ber	B1
Nucleotide	sugar	transporter
ER
TM
EM
147
Transm
em
brane	protein	147
-
ER
TM
EM
230
Transm
em
brane	protein	230
Involved	in	the	trafficking	and	recycling	of	synaptic	vesicles
Plasm
a	m
em
brane
YIF1A
Protein	YIF1A
M
ay	be	involved	in	transport	betw
een	ER	and	Golgi
Cytoskeleton,	ER,	Golgi	app.
C14orf1
Probable	ergosterol	biosynthetic	protein	28
ER
RNF41
E3	ubiquitin-protein	ligase	NRDP1
Plays	a	role	in	type	1	cytokine	receptor	signaling
Cytosol
SELENO
K
Selenoprotein	K
Involved	in	ERAD	and	in	the	protection	of	cells	from
	ER	stress-induced	apoptosis
ER,	Plasm
a	m
em
brane
TM
EM
14A
Transm
em
brane	protein	14A
-
M
em
brane
YIPF6
Protein	YIPF6
-
M
em
brane
SPG17/	BSCL2
ER
Gene
Protein	Nam
e	(UniProt)
Function
Localisation	(UniProt)
ANKRD39
Ankyrin	repeat	dom
ain-containing	protein	39
-
Cytosol
ATP10B
Probable	phospholipid-transporting	ATPase	VB
Catalyses	ATP	hydrolysis	coupled	w
ith	am
inophospholipid	translocation	through	various	m
em
branes
ER,	Plasm
a	m
em
brane
ATP6AP2
Renin	receptor
Renin	and	pro-renin	receptor
Extracellular,	Plasm
a	m
em
brane
CCDC167
Coiled-coil	dom
ain-containing	protein	167
-
Cytosol
CD63
CD63	antigen
Cell	surface	glycoprotein	know
n	to	com
plex	w
ith	integrins,	and	is	involved	in	various	cellular	signaling	cascades
-
CEND1
Cell	cycle	exit	and	neuronal	differentiation	protein	1
Neuron-specific	protein	involved	in	neuronal	differentiation
-
CFL1
Cofilin-1
Intracellular	actin-m
odulating	protein	-	various	roles	including	regulation	of	cell	m
orphology	and	cytoskeletal	organisation
Extracellular,	Nucleus
GABBR2
Gam
m
a-am
inobutyric	acid	receptor-associated	protein-like	2
Ubiquitin-like	m
odifier	involved	in	intra-Golgi	traffic
Cytosol,	Vacuole,	Golgi	app.
M
AP1LC3A
M
icrotubule-associated	proteins	1A/1B	light	chain	3A
Associates	w
ith	m
icrotubule-associated	proteins	w
hich	m
ediate	interactions	betw
een	m
icrotubules	and	cytoskeletal	com
ponents
Cytosol,	Vacuole
M
FSD5
M
olybdate-anion	transporter
M
ediates	intracellular	uptake	of	m
olybdenum
Plasm
a	m
em
brane
NDUFB11
NADH	dehydrogenase	[ubiquinone]	1	beta	subcom
plex	subunit	
11,	m
itochondrial
Subunit	of	the	NADH:ubiquinone	oxidoreductase	(com
plex	I),	w
here	it	transfers	electrons	from
	NADH	to	ubiquinone.
M
itochondrion
NFXL1
NF-X1-type	zinc	finger	protein	NFXL1
-
Nucleus
NSDHL
Sterol-4-alpha-carboxylate	3-dehydrogenase,	decarboxylating
Involved	in	cholesterol	biosynthesis
ER
REEP5
Receptor	expression-enhancing	protein	5
M
ay	prom
ote	expression	of	functional	cell	surface	olfactory	receptors
Extracellular
RPL13A
60S	ribosom
al	protein	L13a
Com
ponent	of	the	60S	ribosom
al	subunit,	but	also	has	a	role	in	the	repression	of	inflam
m
atory	genes
Cytosol,	Extracellular,	Nucleus
RPL34
60S	ribosom
al	protein	L34
Com
ponent	of	the	60S	ribosom
al	subunit
Cytosol,	Extracellular,	Nucleus
RPLP1
60S	acidic	ribosom
al	protein	P1
Com
ponent	of	the	60S	ribosom
al	subunit	and	is	im
portant	in	the	elongation	step	of	protein	synthesis
Cytosol,	Extracellular
SLC35B1
Solute	carrier	fam
ily	35	m
em
ber	B1
Nucleotide	sugar	transporter
ER
SUM
O1
Sm
all	ubiquitin-related	m
odifier	1
Ubiquitin-like	m
odifier	involved	in	a	variety	of	cellular	processes	such	as	nuclear	transport	and	signal	transduction
Cytosol,	Nucleus,	Plasm
a	m
em
brane
TM
EM
134
Transm
em
brane	protein	134
-
Plasm
a	m
em
brane
TM
EM
230
Transm
em
brane	protein	230
Involved	in	the	trafficking	and	recycling	of	synaptic	vesicles
Plasm
a	m
em
brane
TXNDC15
Thioredoxin	dom
ain-containing	protein	15
-
-
YIF1A
Protein	YIF1A
M
ay	be	involved	in	transport	betw
een	ER	and	Golgi
Cytoskeleton,	ER,	Golgi	app.
C14orf1
Probable	ergosterol	biosynthetic	protein	28
ER
GPM
6B
Neuronal	m
em
brane	glycoprotein	M
6-b
M
ay	be	involved	in	m
em
brane	trafficking	and	cell-cell	com
m
unication	as	w
ell	as	neural	developm
ent
Plasm
a	m
em
brane
RNF41
E3	ubiquitin-protein	ligase	NRDP1
Plays	a	role	in	type	1	cytokine	receptor	signaling
Cytosol
YIPF6
Protein	YIPF6
-
M
em
brane
Necessary	for	correct	lipid	storage	and	lipid	droplet	m
aintenance,	as	w
ell	as	regulating	lipid	catabolism
.
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SPG61/	ARL6IP1
ER
Gene
Protein	Nam
e	(UniProt)
Function
Localisation	(UniProt)
ACOT7
Cytosolic	acyl	coenzym
e	A	thioester	hydrolase
Hydrolyses	the	CoA	thioester	of	palm
itoyl-CoA	and	other	long-chain	fatty	acids.	M
ay	play	an	im
portant	physiological	function	in	the	brain
Cytosol,	Extracellular,	M
itochondrion,	Nucleus
ADCY8
Adenylate	cyclase	type	8
M
em
brane-bound	enzym
e	that	catalyses	the	form
ation	of	cyclic	AM
P	from
	ATP
Plasm
a	m
em
brane
ARL6IP1
ADP-ribosylation	factor-like	protein	6-interacting	protein	1
Im
portant	role	in	the	form
ation	and	stabilisation	of	ER	tubules.	Also,	negatively	regulates	apoptosis
ER
ARL6IP5
ADP-ribosylation	factor-like	protein	6-interacting	protein	1
Involved	in	the	form
ation	and	stabilisation	of	ER	tubules
ER,	Plasm
a	m
em
brane
ATP10B
Probable	phospholipid-transporting	ATPase	VB
Catalyses	ATP	hydrolysis	coupled	w
ith	am
inophospholipid	translocation	through	various	m
em
branes
ER,	Plasm
a	m
em
brane
C10orf35
Uncharacterised	protein	C10orf35
-
-
C4orf3
Uncharacterised	protein	C4orf3
-
Cytosol,	Plasm
a	m
em
brane
CCDC167
Coiled-coil	dom
ain-containing	protein	167
-
Cytosol
CYB5B
Cytochrom
e	b5	type	B
M
em
brane-bound	hem
oprotein,	m
ay	act	as	an	electron	carrier	for	various	m
em
brane-bound	oxygenases
M
itochondrion
EEF1A1
Elongation	factor	1-alpha	1
Responsible	for	the	GTP-dependent	delivery	of	am
inoacyl	tRNA	to	ribosom
es	during	protein	biosynthesis
Cytoskeleton,	Cytosol,	Extracellular,	Nucleus,	
Plasm
a	m
em
brane,	Vacuole
EM
C7
ER	m
em
brane	protein	com
plex	subunit	7
-
ER
GABABR2
Gam
m
a-am
inobutyric	acid	type	B	receptor	subunit	2
Belongs	to	GABA-B	receptor	subfam
ily,	inhibiting	neuronal	activity	through	the	regulation	of	neurotransm
itter	release,	ion	channels	and	
adenylyl	cyclase
Plasm
a	m
em
brane
HERPUD1
Hom
ocysteine-responsive	endoplasm
ic	reticulum
-resident	
ubiquitin-like	dom
ain	m
em
ber	1	protein
Involved	in	ER-associated	protein	degradation	(ERAD)
ER,	Cytosol
HM
OX2
Hem
e	oxygenase	2
Essential	enzym
e	in	hem
e	catabolism
ER,	Plasm
a	m
em
brane,	Cytosol
IARS2
Isoleucine-tRNA	ligase,	m
itochondrial
M
em
ber	of	the	Class	I	am
inoacyl-tRNA	synthetase	fam
ily
M
itochondrion
INPP5K
Inositol	polyphosphate	5-phosphatase	K
5-phosphatase	activity	tow
ards	polyphosphate	inositol,	m
ay	negatively	regulate	actin	cytoskeleton
Cytosol,	ER,	Golgi	app.,	Nucleus,	Plasm
a	m
em
brane
JAGN1
Protein	jagunal	hom
olog	1
Involved	in	vesicle-m
ediated	transport	in	the	early	secretory	pathw
ay,	w
here	it	is	required	for	neutrophil	differentiation	and	survival
ER
M
GAT4C
Alpha-1,3-m
annosyl-glycoprotein	4-beta-N-
acetylglucosam
inyltransferase	C
-
Golgi	app.
NFXL1
NF-X1-type	zinc	finger	protein	NFXL1
-
Nucleus
NUP107
Nuclear	pore	com
plex	protein	Nup107
Essential	com
ponent	of	nuclear	pore	com
plex	(NPC)	required	for	assem
bly	and	m
aintenance
Cytoskeleton,	Cytosol,	Nucleus
RABAC1
Prenylated	Rab	acceptor	protein	1
Rab	protein	regulator	required	for	vesicle	form
ation	from
	Golgi	com
plex
Golgi	app.,	Plasm
a	m
em
brane
REEP5
Receptor	expression-enhancing	protein	5
M
ay	prom
ote	expression	of	functional	cell	surface	olfactory	receptors
Extracellular
RPL3
60S	ribosom
al	protein	L3
Com
ponent	of	the	60S	ribosom
al	subunit
Cytosol,	Extracellular,	Nucleus
RTN4
Reticulon-4
Developm
ental	neurite	outgrow
th	regulator
ER,	Extracellular,	Nucleus,	Plasm
a	m
em
brane
SPCS1
Signal	peptidase	com
plex	subunit	1
Rem
oves	signal	peptides	from
	nascent	proteins	translocating	into	the	ER	lum
en
ER
SSR3
Translocon-associated	protein	subunit	gam
m
a
Glycosylated	ER	m
em
brane	receptor	required	for	the	regulation	of	protein	translocation	across	ER	m
em
brane	
ER
STM
N4	
Stathm
in-4
Associated	w
ith	m
icrotubule-destabilizing	activity
Golgi	app.
YIF1A
Protein	YIF1A
M
ay	be	involved	in	transport	betw
een	ER	and	Golgi
Cytoskeleton,	ER,	Golgi	app.
C14orf1
Probable	ergosterol	biosynthetic	protein	28
ER
RNF41
E3	ubiquitin-protein	ligase	NRDP1
Plays	a	role	in	type	1	cytokine	receptor	signaling
Cytosol
TM
EM
14A
Transm
em
brane	protein	14A
-
M
em
brane
GJA1
ER,	Extracellular,	M
itochondrion,	Golgi	app.
Gene
Protein	Nam
e	(UniProt)
Function
Localisation	(UniProt)
ADGRB3
Adhesion	G	protein-coupled	receptor	B3
Brain-specific	angiogenesis	inhibitor
-
ANKRD46
Ankyrin	repeat	dom
ain-containing	protein	46
-
-
AQ
P4
Aquaporin-4
W
ater-selective	channels,	has	a	specific	role	in	brain	w
ater	hom
eostasis
Plasm
a	m
em
brane
ARV1
Protein	ARV1
Acts	as	a	m
ediator	of	sterol	hom
eostasis	in	the	ER	as	w
ell	as	regulation	of	bile	acid	hom
eostasis
ER
Im
portant	role	in	the	form
ation	and	stabilisation	of	ER	tubules.	Also,	negatively	regulates	apoptosis
Com
ponent	of	gap	junctions,	w
hich	contain	arrays	intracellular	channels	allow
ing	the	diffusion	of	low
	m
olecular	w
eight	m
aterials	from
	cell	to	cell
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                       ARV1
Protein	ARV1
Acts	as	a	m
ediator	of	sterol	hom
eostasis	in	the	ER	as	w
ell	as	regulation	of	bile	acid	hom
eostasis
ER
ATP10B
Probable	phospholipid-transporting	ATPase	VB
Catalyses	ATP	hydrolysis	coupled	w
ith	am
inophospholipid	translocation	through	various	m
em
branes
ER,	Plasm
a	m
em
brane
ATP5G3
ATP	synthase	F(0)	com
plex	subunit	C3,	m
itochondrial
Encodes	subunit	of	the	proton	channel	involved	in	m
itochondrial	ATP	synthase
M
itochondrion
ATP6V0B
V-type	proton	ATPase	21	kDa	proteolipid	subunit
Encodes	V0	dom
ain	of	vacuolar	ATPase	(v-ATPase),	im
portant	for	acidifying	various	intracellular	com
partm
ents
Vacuole
BCAP31
B-cell	receptor-associated	protein	31
Chaperone	protein	-	m
ost	abundant	protein	in	ER	and	is	involved	recognition	and	targeting	or	proteins	to	the	ERAD
ER,	Plasm
a	m
em
brane,	Cytosol
BRICD5
BRICHOS	dom
ain-containing	protein	5
-
Plasm
a	m
em
brane
C10orf35
Uncharacterised	protein	C10orf35
-
-
C18orf32
UPF0729	protein	C18orf32
M
ay	activate	NF-κB	signaling	pathw
ay
Extracellular
C4orf3
Uncharacterised	protein	C4orf3
-
Cytosol,	Plasm
a	m
em
brane
CCDC167
Coiled-coil	dom
ain-containing	protein	167
-
Cytosol
CDC42BPA
Serine/threonine-protein	kinase	M
RCK	alpha
Involved	in	the	regulation	of	cytoskeleton	reorganisation	and	cell	m
igration.
Cytoskeleton,	Extracellular
CDKAL1
Threonylcarbam
oyladenosine	tRNA	m
ethylthiotransferase
-
-
CEND1
Cell	cycle	exit	and	neuronal	differentiation	protein	1
Neuron-specific	protein	involved	in	neuronal	differentiation
-
CYB5B
Cytochrom
e	b5	type	B
M
em
brane-bound	hem
oprotein,	m
ay	act	as	an	electron	carrier	for	various	m
em
brane-bound	oxygenases
M
itochondrion
EM
C7
ER	m
em
brane	protein	com
plex	subunit	7
-
ER
FAM
177A1
Protein	FAM
177A1
-
Nucleus
FZD1
Frizzled-1
Receptor	for	W
nt	signaling	proteins
-
GHITM
Grow
th	horm
one-inducible	transm
em
brane	protein
Im
portant	for	m
itochondrial	tubular	netw
ork	organisation.	
Extracellular,	M
itochondrion
HM
OX2
Hem
e	oxygenase	2
Essential	enzym
e	in	hem
e	catabolism
ER,	Plasm
a	m
em
brane,	Cytosol
LM
NA
Prelam
in-A/C
Im
portant	for	developm
ent	of	peripheral	nervous	system
	as	it	has	roles	in	nuclear	assem
bly,	nuclear	m
em
brane	and	telom
ere	dynam
ics.
Cytoskeleton,	Cytosol,	Nucleus
M
SM
O1
M
ethylsterol	m
onooxygenase	1
M
ay	have	a	role	in	cholesterol	biosynthesis
ER
NACA
Nascent	polypeptide-associated	com
plex	subunit	alpha
Prevents	translocation	of	non-secretory	polypeptides	to	the	ER	by	form
ing	the	nascent	polypeptide-associated	com
plex	(NAC)
Extracellular,	Nucleus
NDUFB11
NADH	dehydrogenase	[ubiquinone]	1	beta	subcom
plex	subunit	
11,	m
itochondrial
Subunit	of	the	NADH:ubiquinone	oxidoreductase	(com
plex	I),	w
here	it	transfers	electrons	from
	NADH	to	ubiquinone.
M
itochondrion
NSDHL
Sterol-4-alpha-carboxylate	3-dehydrogenase,	decarboxylating
Involved	in	cholesterol	biosynthesis
ER
OST4
Dolichyl-diphosphooligosaccharide--protein	glycosyltransferase	
subunit	4
M
ay	be	involved	in	N-glycosylation
ER
PSM
A7
Proteasom
e	subunit	alpha	type-7
Com
ponent	of	the	20S	core	proteasom
e	com
plex
Cytosol,	Extracellular,	Nucleus
REEP5
Receptor	expression-enhancing	protein	5
M
ay	prom
ote	expression	of	functional	cell	surface	olfactory	receptors
Extracellular
SPCS1
Signal	peptidase	com
plex	subunit	1
Rem
oves	signal	peptides	from
	nascent	proteins	translocating	into	the	ER	lum
en
ER
STX4	
Syntaxin-4
Plasm
a	m
em
brane	t-SNARE	involved	in	vesicle-m
ediated	transport
Cytosol,	Endosom
e,	Extracellular,	Plasm
a	
m
em
brane,	Vacuole
TM
CC2
TM
CC2	protein
-
Nucleus,	Plasm
a	m
em
brane
TM
EM
101
Transm
em
brane	protein	101
M
ay	activate	NF-κB	signaling	pathw
ay
Plasm
a	m
em
brane
TM
EM
134
Transm
em
brane	protein	134
-
Plasm
a	m
em
brane
TM
EM
184B
Transm
em
brane	protein	184B
M
ay	be	involved	in	the	activation	of	M
AP	kinase	signaling	pathw
ay
Plasm
a	m
em
brane
TM
EM
230
Transm
em
brane	protein	230
Involved	in	the	trafficking	and	recycling	of	synaptic	vesicles
Plasm
a	m
em
brane
TUBA1A
Tubulin	alpha-1A	chain
M
ajor	constituent	of	m
icrotubules
Cytosol,	Endosom
e,	Extracellular,	Cytoskeleton,	
Nucleus
VTI1B
Vesicle	transport	through	interaction	w
ith	t-SNAREs	hom
olog	1B
Interacts	w
ith	t-SNAREs	on	target	m
em
brane	to	m
ediate	vesicle	transport	pathw
ays
Endosom
e,	Golgi	app.,	Lysosom
e,	Vacuole
W
RB
Tail-anchored	protein	insertion	receptor	W
RB
Receptor	involved	in	the	insertion	of	tail-anchored	proteins	into	the	ER	m
em
brane
ER,	Nucleus
YIF1A
Protein	YIF1A
M
ay	be	involved	in	transport	betw
een	ER	and	Golgi
Cytoskeleton,	ER,	Golgi	app.
ZM
YM
2
Zinc	finger	M
YM
-type	protein	2
M
ay	acts	as	a	transcription	factor
Cytosol,	Nucleus
C14orf1
Probable	ergosterol	biosynthetic	protein	28
ER
RNF41
E3	ubiquitin-protein	ligase	NRDP1
Plays	a	role	in	type	1	cytokine	receptor	signaling
Cytosol
TM
EM
14A
Transm
em
brane	protein	14A
-
M
em
brane
TM
EM
128
Transm
em
brane	protein	128
-
M
em
brane
SELENO
K
Selenoprotein	K
Involved	in	ERAD	and	in	the	protection	of	cells	from
	ER	stress-induced	apoptosis
ER,	Plasm
a	m
em
brane
YIPF6
Protein	YIPF6
-
M
em
brane
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 B 
                      SPG2/	PLP1
Plasm
a	m
em
brane
Gene
Protein	Nam
e	(UniProt)
Function
Localisation	(UniProt)
ATP10B
Probable	phospholipid-transporting	ATPase	VB
Catalyses	ATP	hydrolysis	coupled	w
ith	am
inophospholipid	translocation	through	various	m
em
branes
ER,	Plasm
a	m
em
brane
ATP5G3
ATP	synthase	F(0)	com
plex	subunit	C3,	m
itochondrial
Encodes	subunit	of	the	proton	channel	involved	in	m
itochondrial	ATP	synthase
-
ATP6V0B
V-type	proton	ATPase	21	kDa	proteolipid	subunit
Encodes	V0	dom
ain	of	vacuolar	ATPase	(v-ATPase),	im
portant	for	acidifying	various	intracellular	com
partm
ents
Vacuole
CCDC167
Coiled-coil	dom
ain-containing	protein	167
-
Cytosol
CD63
CD63	antigen
Cell	surface	glycoprotein	know
n	to	com
plex	w
ith	integrins,	and	is	involved	in	various	cellular	signaling	cascades
-
CDKAL1
Threonylcarbam
oyladenosine	tRNA	m
ethylthiotransferase
-
-
DPM
2
Dolichol	phosphate-m
annose	biosynthesis	regulatory	protein
Regulates	dolichol	phosphate-m
annose	(DPM
)	biosynthesis	
ER
FUNDC2
FUN14	dom
ain-containing	protein	2
-
M
itochondrion,	Nucleus
NUP107
Nuclear	pore	com
plex	protein	Nup107
Essential	com
ponent	of	nuclear	pore	com
plex	(NPC)	required	for	assem
bly	and	m
aintenance
Cytoskeleton,	Cytosol,	Nucleus
SPCS1
Signal	peptidase	com
plex	subunit	1
Rem
oves	signal	peptides	from
	nascent	proteins	translocating	into	the	ER	lum
en
ER
TM
EM
242
Transm
em
brane	protein	242
-
Nucleus
TRO	
Trophinin
M
ediates	cell	adhesion	betw
een	trophoblastic	cells	and	epithelial	cells	of	the	endom
etrium
Plasm
a	m
em
brane
VKORC1L1
Vitam
in	K	epoxide	reductase	com
plex	subunit	1-like	protein	1
Im
portant	role	in	Vitam
in	K	m
etabolism
ER
YIF1A
Protein	YIF1A
M
ay	be	involved	in	transport	betw
een	ER	and	Golgi
Cytoskeleton,	ER,	Golgi
C14orf1
Probable	ergosterol	biosynthetic	protein	28
-
ER
GPM
6B
Neuronal	m
em
brane	glycoprotein	M
6-b
M
ay	be	involved	in	m
em
brane	trafficking	and	cell-cell	com
m
unication	as	w
ell	as	neural	developm
ent
Plasm
a	m
em
brane
RNF41
E3	ubiquitin-protein	ligase	NRDP1
Plays	a	role	in	type	1	cytokine	receptor	signaling
Cytosol
TM
EM
128
Transm
em
brane	protein	128
-
M
em
brane
TM
EM
14A
Transm
em
brane	protein	14A
-
M
em
brane
SPG4/	SPAST
Cytoskeleton,	ER,	endosom
e,	Extracellular
Gene
Protein	Nam
e	(UniProt)
Function
Localisation	(UniProt)
ARL6IP5
ADP-ribosylation	factor-like	protein	6-interacting	protein	1
Involved	in	the	form
ation	and	stabilisation	of	ER	tubules
ER,	Plasm
a	m
em
brane
SPG33/	ZFYVE27
ER,	endosom
e,	Plasm
a	m
em
brane
Gene
Protein	Nam
e	(UniProt)
Function
Localisation	(UniProt)
ARL6IP5
ADP-ribosylation	factor-like	protein	6-interacting	protein	1
Involved	in	the	form
ation	and	stabilisation	of	ER	tubules
ER,	Plasm
a	m
em
brane
ATP6AP2
Renin	receptor
Renin	and	pro-renin	receptor
Extracellular,	Plasm
a	m
em
brane
C4orf3
Uncharacterised	protein	C4orf3
-
Cytosol,	Plasm
a	m
em
brane
CCDC167
Coiled-coil	dom
ain-containing	protein	167
-
Cytosol
CDKAL1
Threonylcarbam
oyladenosine	tRNA	m
ethylthiotransferase
-
ER
EM
C7
ER	m
em
brane	protein	com
plex	subunit	7
-
ER
FUNDC2
FUN14	dom
ain-containing	protein	2
-
M
itochondrion,	Nucleus
H3F3B
Histone	H3.3
replication-independent	histone
Extracellular,	Nucleus
LRPAP1
Alpha-2-m
acroglobulin	receptor-associated	protein
M
olecular	chaperone	for	LDL	receptor-related	proteins,	facilitating	proper	folding	and	localisation
ER,	Extracellular,	Plasm
a	m
em
brane
REEP5
Receptor	expression-enhancing	protein	5
M
ay	prom
ote	expression	of	functional	cell	surface	olfactory	receptors
Extracellular
RPL17
60S	ribosom
al	protein	L17
Com
ponent	of	the	60S	ribosom
al	subunit
Cytosol,	Nucleus
RTN4
Reticulon-4
Developm
ental	neurite	outgrow
th	regulator
ER,	Extracellular,	Nucleus,	Plasm
a	m
em
brane
SEC11C
Signal	peptidase	com
plex	catalytic	subunit	SEC11C
Com
ponent	of	m
icrosom
al	signal	peptidase	com
plex,	associates	w
ith	nascent	proteins	as	they	translocate	into	lum
en	of	ER
ER
SSR3
Translocon-associated	protein	subunit	gam
m
a
Glycosylated	ER	m
em
brane	receptor	required	for	the	regulation	of	protein	translocation	across	ER	m
em
brane	
ER
TM
EM
134
Transm
em
brane	protein	134
-
Plasm
a	m
em
brane
This	is	the	m
ajor	m
yelin	protein	from
	the	central	nervous	system
.	It	plays	an	im
portant	role	in	m
yelin	form
ation	and	m
aintenance.
ATP-dependent	m
icrotubule	severing	protein.	Required	for	m
em
brane	traffic	from
	the	endoplasm
ic	reticulum
	(ER)	to	the	Golgi	and	endosom
e	recycling.	
Involved	in	vesicular	trafficking	during	neurite	extension.	Involved	in	form
ation	and	stabilisation	of	the	tubular	ER	netw
ork.
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                       TM
EM
134
Transm
em
brane	protein	134
-
Plasm
a	m
em
brane
TM
EM
230
Transm
em
brane	protein	230
Involved	in	the	trafficking	and	recycling	of	synaptic	vesicles
Plasm
a	m
em
brane
RNF41
E3	ubiquitin-protein	ligase	NRDP1
Plays	a	role	in	type	1	cytokine	receptor	signaling
Cytosol
SELENO
K
Selenoprotein	K
Involved	in	ERAD	and	in	the	protection	of	cells	from
	ER	stress-induced	apoptosis
ER,	Plasm
a	m
em
brane
TM
EM
128
Transm
em
brane	protein	128
-
M
em
brane
TM
EM
14A
Transm
em
brane	protein	14A
-
M
em
brane
SPG43/	C19orf12
ER,	M
itochondrion
Gene
Protein	Nam
e	(UniProt)
Function
Localisation	(UniProt)
C18orf32
UPF0729	protein	C18orf32
M
ay	activate	NF-κB	signaling	pathw
ay
Extracellular
COM
T
Catechol	O-m
ethyltransferase
Catalyses	the	O-m
ethylation	of	catecholam
ine	neurotransm
itters	and	catechol	horm
ones,	rendering	them
	inactive
Cytosol,	Extracellular,	Plasm
a	m
em
brane
DCTPP1
dCTP	pyrophosphatase	1
Hydrolyses	dCTP	to	dCM
P	after	DNA	synthesis	
Cytosol
EDF1
Endothelial	differentiation-related	factor	1
Regulates	endothelial	cell	differentiation,	lipid	m
etabolism
	and	horm
one-induced	cardiom
yocyte	hypertrophy
Extracellular,	Nucleus
FKBP1A
Peptidyl-prolyl	cis-trans	isom
erase	FKBP1A
Im
portant	in	im
m
unoregulation	and	various	cellular	processes	involving	protein	folding	and	trafficking
Cytosol,	Extracellular,	ER
HM
GN2
Non-histone	chrom
osom
al	protein	HM
G-17
Binds	nucleosom
al	DNA	and	associates	w
ith	transcriptionally	active	chrom
atin
Nucleus
M
LLT11
Protein	AF1q
-
Nucleus
M
RPS34
28S	ribosom
al	protein	S34,	m
itochondrial
Com
ponent	of	28S	m
itochondrial	ribosom
al	subunit
M
itochondrion
NFXL1
NF-X1-type	zinc	finger	protein	NFXL1
-
Nucleus
PSM
A1
Proteasom
e	subunit	alpha	type-1
Com
ponent	of	the	20S	core	proteasom
e	com
plex
Cytoskeleton,	Cytosol,	Extracellular,	Nucleus
SOD1
Superoxide	dism
utase	[Cu-Zn]
Acts	as	a	hom
odim
er	to	destroy	naturally	occurring	harm
ful	radicals	
Cytosol,	Extracellular,	M
itochondrion,	Nucleus,		
Peroxisom
e
TIRAP
Toll/interleukin-1	receptor	dom
ain-containing	adapter	protein
Adapter	protein	involved	in	signaling	pathw
ays	of	the	innate	im
m
une	response	resulting	in	cytokine	secretion	and	the	inflam
m
atory	
response
Cytosol,	Nucleus,	Plasm
a	m
em
brane
TM
EM
106C
Transm
em
brane	protein	106C
-
ER
TUBB2A
Tubulin	beta-2A	chain
M
ajor	constituent	of	m
icrotubules
Cytoskeleton,	Extracellular,	Nucleus
UQ
CRB
Cytochrom
e	b-c1	com
plex	subunit	7
Com
ponent	of	the	ubiquinol-cytochrom
e	c	reductase	com
plex	(com
plex	III)	of	the	m
itochondrial	respiratory	chain,	involved	in	redox-
linked	proton	pum
ping
M
itochondrion
VPS8
Vacuolar	protein	sorting-associated	protein	8	hom
olog
Involved	in	vesicle-m
ediated	protein	trafficking	of	the	endocytic	m
em
brane	transport	pathw
ay
endosom
e
C14orf1
Probable	ergosterol	biosynthetic	protein	28
-
ER
RNF41
E3	ubiquitin-protein	ligase	NRDP1
Plays	a	role	in	type	1	cytokine	receptor	signaling
Cytosol
YIPF6
Protein	YIPF6
-
M
em
brane
SPG62/	ERLIN1
ER
Gene
Protein	Nam
e	(UniProt)
Function
Localisation	(UniProt)
APLP1	
Am
yloid-like	protein	1
M
em
brane-associated	glycoprotein	that	is	cleaved,	releasing	a	cytoplasm
ic	fragm
ent	that	m
ay	act	as	a	transcriptional	activator.
Extracellular,	Plasm
a	m
em
brane
ATP6V0B
V-type	proton	ATPase	21	kDa	proteolipid	subunit
Encodes	V0	dom
ain	of	vacuolar	ATPase	(v-ATPase),	im
portant	for	acidifying	various	intracellular	com
partm
ents
Vacuole
DNAJC30
DnaJ	hom
olog	subfam
ily	C	m
em
ber	30
DNAJ	m
olecular	chaperone	hom
ology	dom
ain-containing	protein	fam
ily	m
em
ber
M
itochondrion
ETFB	
Electron	transfer	flavoprotein	subunit	beta
Transfers	electrons	to	the	m
ain	m
itochondrial	respiratory	chain	
Extracellular,	M
itochondrion
FLRT2
Leucine-rich	repeat	transm
em
brane	protein	FLRT2
Cell	adhesion	m
olecule	w
hich	regulates	early	em
bryonic	vascular	and	neural	developm
ent
Extracellular,	Plasm
a	m
em
brane
H3F3B
Histone	H3.3
replication-independent	histone
Extracellular,	Nucleus
IDS
Iduronate	2-sulfatase
Required	for	lysosom
al	degradation	of	heparan	sulfate	and	derm
atan	sulfate
lysosom
e,	Vacuole
M
GM
T
M
ethylated-DNA--protein-cysteine	m
ethyltransferase
DNA	repair	protein	involved	in	cellular	defense	
Nucleus
M
RPL50
39S	ribosom
al	protein	L50,	m
itochondrial
Com
ponent	of	39S	m
itochondrial	ribosom
al	subunit
M
itochondrion
RPL37A
60S	ribosom
al	protein	L37a
Com
ponent	of	the	60S	ribosom
al	subunit
Cytosol,	Extracellular,	Nucleus
RPL4
60S	ribosom
al	protein	L4
Com
ponent	of	the	60S	ribosom
al	subunit
Cytosol,	Extracellular,	Nucleus
RTN4
Reticulon-4
Developm
ental	neurite	outgrow
th	regulator
ER,	Extracellular,	Nucleus,	Plasm
a	m
em
brane
Com
ponent	of	the	ERLIN1/ERLIN2	com
plex	w
hich	m
ediates	the	endoplasm
ic	reticulum
-associated	degradation	(ERAD)	of	IP3Rs.	Involved	in	regulation	of	cellular	cholesterol	hom
eostasis	
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 Table 6.4. M
em
brane Yeast Tw
o-Hybrid (M
YTH) library screen results. (A) Refined list of potential interactors identified from
 C-term
inally 
tagged pAM
BV and (B) N-term
inally tagged pBT3N bait proteins. Potential false positive interaction partners are show
n in bold. False positives 
correspond to proteins that are repeatedly identified in our M
YTH library screens and/or com
m
only identified false positives in previous M
YTH 
library screens (Passantino et al., 2013). Previously identified interactions are highlighted in orange (know
n direct) or green (know
n indirect). 
RTN4
Reticulon-4
Developm
ental	neurite	outgrow
th	regulator
ER,	Extracellular,	Nucleus,	Plasm
a	m
em
brane
TM
SB10
Thym
osin	beta-10
Im
portant	role	in	cytoskeleton	organisation
Cytoskeleton
TM
X2
Thioredoxin-related	transm
em
brane	protein	2
M
em
ber	of	the	disulphide	isom
erase	(PDI)	fam
ily.	Involved	in	protein	folding	and	thiol-disulphide	interchange	reactions
ER
TSPAN7
Tetraspanin-7
Cell	surface	glycoprotein	w
hich	m
ay	be	involved	in	the	regulating	neurite	outgrow
th
Plasm
a	m
em
brane
TUBB2A
Tubulin	beta-2A	chain
M
ajor	constituent	of	m
icrotubules
Cytosol
BNIP3
BCL2/adenovirus	E1B	19	kDa	protein-interacting	protein	3
Pro-apoptotic	factor
M
itochondrion
RNF41
E3	ubiquitin-protein	ligase	NRDP1
Plays	a	role	in	type	1	cytokine	receptor	signalling
Cytosol
 234 
Significantly, the MYTH library screens identified several previously identified 
interactors, increasing our confidence in the MYTH system and the novel interactions 
identified. Using C-terminally tagged pAMBV bait constructs, multiple known 
interaction partners (INPP5K, ARL6IP1 and RTN4) were identified for ARL6IP1 
(SPG61) (Rual et al., 2005; Rolland et al., 2014). Whilst the interaction between ATL1 
(SPG3) and RTN4, which had previously been identified through mass spectrometry 
(Hu et al., 2009), was also identified and recorded as a novel binary interaction. 
Similarly, when screening N-terminally tagged pBT3N bait constructs, we identified 
the interaction between ZFYVE27 (SPG33) and REEP5, which had previously been 
reported as an indirect interaction via co-immunoprecipitation and co-expression 
techniques (Chang, Lee and Blackstone, 2013). Data from this study means that these 
previously identified indirect interactions, can now be re-annotated as novel binary 
interactions.  
 
A summary of interaction data generated from all MYTH library screens performed is 
presented in Figure 6.5. Interaction data for C-terminally tagged HSP baits (Figure 6.5 
A) was compared with that of the N-terminally tagged HSP baits (Figure 6.5 B), to 
reveal an 18 % (22/124) overlap between the two (see Figure 6.5 C). It is expected 
that different partner profiles may result from different bait clone topologies. 
 
6.4.4 Common HSP interaction partners identified in the MYTH library screens 
 
A graphical representation of the data compiled in Table 6.4 is presented in Figure 
6.6. HSP interaction partners were arranged by degree (number of interactions) using 
interaction data generated from the MYTH library screens (Figure 6.6 A). This data 
shows that 15 % (19/124) of the HSP interactors identified in these library screens 
interacted with three or more HSP proteins. These highly connected HSP interactors 
were used to generate the subnetwork as presented in Figure 6.6 B, which was 
functionally annotated and analysed for common binding partners.  
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Figure 6.5 
  A 
       B 
 
 
 
 
 
 
 
 
 
 
 
 
 
C 
      Figure 6.5. Sum
m
ary of data from
 all m
em
brane yeast tw
o-hybrid (M
YTH) library screens perform
ed in this study. Bait HSPs (horizontal) and 
prey M
YTH library hits (vertical) are ordered alphabetically. C-term
inally tagged pAM
BV baits are show
n in (A) w
hile N-term
inally tagged pBT3N 
baits are show
n in (B). The overlap of the proteins identified as potential interaction partners in both A and B M
YTH library screens are show
n in 
(C), colours m
atch accordingly. Potential false positives, highlighted in Table 6.4, have been rem
oved. Previously identified (know
n) interactions, 
are annotated as such in the tables above. 
  
Know
n	Direct
Know
n	Indirect
Predicted	Indirect
ACOT7
ADCY8
ADGRB3
ANKRD39
ANKRD46
AQP4
ARL6IP1
ARL6IP5
ARV1
ATP10B
ATP13A2
ATP5G2
ATP5G3
ATP6AP2
ATP6V0B
BCAP31
BRICD5
C10orf35
C18orf32
C4orf3
CCDC167
CD320
CD63
CD81
CDC42BPA
CDKAL1
CEND1
CFL1
COPA
CYB5B
DPM2
EEF1A1
EIF3B
EMC7
FAM177A1
FAM177A1
FZD1
GABBR2
GABARAPL2
GHITM
GLIPR1
HDDC2
HERPUD1
HMOX2
IARS2
INPP5K
JAGN1
LMNA
MAP1LC3A
MFSD5
MGAT4C
MKRN1
MSMO1
NACA
NDUFB11
NFXL1
NIN
NSDHL
NUP107
OST4
PCDHB	family
PCDHB10
PSMA7
RABAC1
REEP5
RPL13A
RPL17
RPL34
RPLP1
RPS8
RTN4
SHISA4
SLC25A3
SLC35B1
SPCS1
SSR3
STMN4	
STX4	
SUMO1
TMCC2
TMEFF2
TMEM101
TMEM134
TMEM147
TMEM184B
TMEM230
TUBA1A
TXNDC15
VTI1B
WRB
YIF1A
ZMYM2
SPG2/	PLP1
SPG3/	ATL1
SPG17/	BSCL2
SPG61/	ARL6IP1
GJA1
Library	hits	(prey)
AMBV	(bait)
APLP1 
ARL6IP5
ATP10B
ATP5G3
ATP6AP2
ATP6V0B
C18orf32
C4orf3
CCDC167
CD63
CDKAL1
COMT
DCTPP1
DNAJC30
DPM2
EDF1
EMC7
ETFB 
FKBP1A
FLRT2
FUNDC2
H3F3B
HMGN2
IDS
LRPAP1
MGMT
MLLT11
MRPL50
MRPS34
NFXL1
NUP107
PSMA1
REEP5
RPL17
RPL37A
RPL4
RTN4
SEC11C
SOD1
SPCS1
SSR3
TIRAP
TMEM106C
TMEM134
TMEM230
TMEM242
TMSB10
TMX2
TRO 
TSPAN7
TUBB2A
UQCRB
VKORC1L1
VPS8
YIF1A
SPG2/ PLP1
SPG4/ SPAST
SPG33/ FYVE27
SP43/ C19orf12
SPG62/ ERLIN1
Library hits (prey)
BT3N (bait)
Know
n Indirect
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ARL6IP5 
ATP6AP2 
EMC7 
RTN4 
REEP5 
C18orf32 
ATP6V0B 
TMEM230 
CYB5B 
C19orf12 
ATP13A2 
PLP1 
ATL1 
ZFYVE27 ARL6IP1 
FAM177A1 
TMEM134 
NFXL1 
CDKAL1 
SPAST 
GJA1 
BSCL2 
ERLIN1 
CCDC167 
C4orf3 
SPCS1 
C10orf35 
ATP10B 
YIF1A 
Activates NF-κB
signaling pathway
Removes signal 
peptides from proteins 
entering ER lumen
Phospholipid 
translocation through 
ER membrane
ER-to-Golgi 
transport
Synaptic vesicle 
trafficking & 
recycling
ER morphology & 
stabilisation
Regulates LDL 
metabolism
ER tubule 
formation & 
stabilisation
Linked to ERAD
Strong association 
with late-onset 
Alzheimer's Disease
ATP6AP2 ATP6V0B 
FAM177A1 
SPCS1 
C10orf35 
CYB5B C18orf32 
YIF1A 
ARL6IP5 
RTN4 
SPAST 
C4orf3 
TMEM230 
REEP5 
NFXL1 
TMEM134 
C19orf12 
EMC7 
CCDC167 
CDKAL1 
ATP10B 
ATL1 
BSCL2 
ZFYVE27 GJA1 
PLP1 
ARL6IP1 
ERLIN1 
HSP Nodes: 10
Total Nodes: 134
Total Edges:  194
1-2
3
4
5
6
MYTH library 
interactions:
Figure 6.6 
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Figure 6.6. Degree clustering of interaction partners identified in MYTH library 
screens. (A) Interaction partners identified in the MYTH library screens are coloured 
according to the number of interactions (degree) formed with HSPs screened, as 
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indicted in the key. HSPs are displayed in grey. Subnetwork (B) was derived from (A), 
using interactors identified in the MYTH library screens with a degree ³ 3, and 
functionally annotated using literature-derived sources.  
 
As already mentioned, ATL1 and ARL6IP1 are previously known RTN4 interaction 
partners, also identified in our studies, following successful MYTH library screening. 
RTN4 is a structural ER protein involved in the maintenance of tubular ER structure 
and function (Voeltz et al., 2006), whilst ARL6IP1 and ATL1 are both ER-shaping 
proteins required for ER network organisation (Park et al., 2010; Fowler and 
O’Sullivan, 2016). Interestingly, ZFYVE27, which is known to interact with tubular ER 
proteins and has a role in ER morphogenesis (Chang, Lee and Blackstone, 2013), and 
ERLIN1, a component of the ERLIN1/ERLIN2 ER membrane complex which is able to 
mediate inositol 1,4,5-triphosphate receptors (IP3Rs) ER-associated degradation 
(Pearce et al., 2009), were both identified as binary interactors of RTN4 in our study. 
These RTN4 interactions are of particular interest as another reticulon family 
member, RTN2 (reticulon 2) is associated with HSP. Mutations in the RTN2 gene 
causes the autosomal dominant spastic paraplegia type 12 (SPG12) (Montenegro et 
al., 2012), therefore RTN4 may be a potential HSP candidate gene. 
 
ARL6IP5 is a microtubule-binding protein which can exert neuroprotective roles 
against dopaminergic neuron degeneration, through the regulation of intracellular 
redox status and NF-kB signalling pathway (Miao et al., 2014). ARL6IP5 was shown 
to interact with ER-shaping proteins ATL1, ARL6IP1 and ZFYVE27, in our studies. 
Additionally, ARL6IP5 was also identified as a spastin interaction partner. Spastin is 
an ATP-dependent microtubule-severing protein (Hazan et al., 1999), whose full-
length isoform, M1, interacts with tubular ER membrane to co-ordinate ER-shaping 
(Park et al., 2010).  
 
REEP5, a DP1/REEP/Yop1p family member, is a conserved integral ER membrane 
protein, involved in shaping the curvature of the tubular ER (Voeltz et al., 2006). We 
identified binary interactions between REEP5 and the ER-shaping proteins ATL1, 
ARL6IP1 and ZFYVE27. Interestingly, the ‘predicted’ indirect interaction between 
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ATL1 and the REEP5 yeast ortholog, YOP1, was previously inferred by a synthetic 
rescue study (Anwar et al., 2012). BSCL2 was also identified as a binary interactor of 
REEP5, in our study. BSCL2 is an ER transmembrane glycoprotein involved in lipid 
droplet morphology and metabolism (Fei et al., 2008). HSP-associated BSCL2 
mutations (N88S and S90L), cause misfolded seipin to accumulate in the ER, leading 
to ER stress and enhance ubiquitination and degradation (Ito et al., 2008). These 
REEP5 interactions are of particular interest as REEP1 is another REEP family member 
associated with HSP, with mutations in the REEP1 gene causing the autosomal 
dominant spastic paraplegia type 31 (SPG31) (Züchner et al., 2006). Like spastin, 
REEP1 is also able to mediate microtubule interactions with the tubular ER network 
(Park et al., 2010).  
 
Although these disorders have 75 distinct genetic loci (SPG1-78), more than half of 
all those affected, harbour autosomal dominant mutations in proteins known to 
function in ER network formation, most notably spastin (SPG4), atlastin-1 (SPG3A), 
REEP1 (SPG31) and reticulon-2 (SPG12) (Goyal and Blackstone, 2013). These HSP 
proteins interact with one another and mediate interactions between the 
microtubule cytoskeleton and the tubular ER network to co-ordinate tubular ER 
shaping (Park et al., 2010; Blackstone, 2012).  
 
This study identified common interactors of known HSP proteins, which are involved 
in various aspects of ER network formation, highlighting the importance for proper 
ER morphology and distribution in neurons. Given the hydrophobic properties 
associated with membrane proteins, structural and functional studies remain 
challenging, and so new methodologies to investigate these candidate proteins are 
required. It is unlikely that many of the binary interactions identified in the MYTH 
library screens would have been identified without using this system, or a system like 
this. 
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6.5 Network Analysis  
 
6.5.1  Network construction: HSPome+ 
 
Each of the positive binary HSP interaction partners identified in this study, through 
targeted and library yeast two-hybrid screens, were mapped to an Entrez Gene ID. 
After removing 10 duplicate interactions due to bait/prey configurations, a total of 
385 unique interactions were identified (see Appendix 6.1 for all raw interaction 
data). These were combined with the initial HSPome (Chapter 3) to generate the 
updated HSPome+ network (Figure 6.7) which contains a total of 4,688 interactions 
between 3,074 different human proteins. 
 
Figure 6.7 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.7. Generation of the HSPome+ network. The HSPome was combined with 
all results from the Y2H targeted matrix matings and Y2H library studies to generate 
the HSPome+ network. 
 
6.5.2 Network properties  
 
To evaluate the inherent properties of the HSPome+ network, computational 
analysis of the protein interaction data was performed looking at network structure 
and function. This type of analysis can be useful as it can be hard to visualise and 
describe large networks within a functional context. 
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Figure 6.8 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.8. Properties of the human predicted HSPome+ Network. (A) Distribution 
of the shortest path length (l) between pairs of proteins in the predicted HSPome+ 
network. On average, the path length between any two proteins within the network 
is 3.74 links. (B) Degree distribution of network proteins. On average, proteins in the 
network have 3.03 interaction partners. (C) Degree distribution of the clustering 
coefficients of the network proteins. The average clustering coefficient of all proteins 
(nodes) with k links was plotted against the number of links, k. (D) Degree distribution 
of the topological coefficients of the network proteins. The topological coefficient 
was calculated for each network protein with >1 interaction partners and plotted 
against the number of links, k. 
 
Path length is a measure of the distance between nodes in the network, calculated 
as the mean of the shortest distance between all possible node pairs. For the 
HSPome+ network, a mean shortest path length between any two proteins within 
the network was calculated as 3.74 links (Figure 6.8 A), which suggests that most 
proteins are very closely linked ensuring that information spreads easily throughout 
the network, a property which is often seen in ‘small-world’ networks. ‘Small-world’ 
networks have short path lengths between nodes in the network, as they tend to be 
more highly clustered than ‘random’ networks (Watts and Strogatz, 1998). For 
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example, if node A is linked to node B and node B is linked to node C, then there is 
an increased probability that A will also be linked to C (Strogatz, 2001).  
 
In the study of networks, the degree of a protein(node) is the number of connections 
or edges the protein has to other proteins. The degree distribution P(k) is the number 
of proteins in the network with degree, k. As shown in Figure 6.8 B, the degree 
distribution of the HSPome+ network proteins is highly right-skewed, which means 
that the large majority of proteins have low degree but a small number, known as 
‘hubs’, have a high degree. This observation is common to most networks in the real 
world and is in agreement with most biological networks (Barabási and Oltvai, 2004). 
Proteins in the HSPome+ network have on average, 3.03 interaction partners. 
However, 2,163 proteins have only one partner (which includes 6 HSP protein nodes), 
whilst there are 42 HSP ‘hub’ proteins each with more than 30 interaction partners. 
Studies in yeast have previously demonstrated the importance of protein hubs, as 
they were shown to be three times more likely to be essential for cells than proteins 
with fewer interactions (Jeong et al., 2001). It is therefore important for the hubs 
identified in our HSPome+ network to be analysed further, with regards to cellular 
function.  
 
Looking at the topological properties of our HSPome+ interaction network, we 
calculated the average clustering coefficient C(k), which is a measure of the tendency 
of network proteins to form clusters or groups (Barabási and Oltvai, 2004). As shown 
in Figure 6.8 C, the overall clustering of the HSPome+ network decreased as the 
number of interactions (links) per protein increased, indicating a potential 
hierarchical organisation in the HSPome+ network (Ravasz et al., 2002; Ravasz and 
Barabási, 2003). Interestingly, this hierarchical-type manner of organisation is a key 
feature in the organisation of complex biological systems, and is particularly 
associated with the structure and function of neural networks (Kaiser, Hilgetag and 
Kötter, 2010).  
 
The topological coefficient, was also used to study the topological characteristics of 
the HSPome+ network. The topological coefficient TC(k), is a relative measure for the 
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tendency of proteins within the network to share common interaction partners 
(Ravasz et al., 2002; Goldberg and Roth, 2003). Proteins that have no, or one 
interaction partner are assigned a topological coefficient of 0. As shown in Figure 6.8 
D, the topological coefficient also decreased as the number of interactions (links) per 
protein increased, proving that in the HSPome+ network, ‘hub’ proteins do not have 
more common interactors than proteins with fewer links. Therefore, highly-
connected proteins do not artificially cluster together. Furthermore, this confirms 
the modular hierarchical network organisation implicated by the clustering 
coefficient. 
 
6.5.3 Functional annotation 
 
Some of the known HSP interaction partners, such as RTN4, which interacts with both 
ATL1 and ARL6IP1, are known to be functionally associated with HSP (Hu et al., 2009). 
However, the majority of the interactors identified in this study have no prior link 
with HSP. Therefore, a number of bioinformatics and computational analyses were 
carried out to investigate functional trends or common themes. 
 
6.5.3.1 Reactome pathway analysis  
 
The Reactome Knowledgebase (www.reactome.org) is a freely available, manually 
curated and peer-reviewed pathway database, which allows the analysis of complex 
experimental and computational data. This pathway-based tool identifies human 
proteins that are enriched in specific cellular pathways linking them to their 
molecular functions and biological pathways (Croft et al., 2014; Fabregat et al., 2016). 
Enrichment of a particular pathway or process requires a statistically significant p-
value of <0.05.  
 
The HSP seed 3 gene list containing 83 HSP proteins was uploaded onto Reactome 
and the Pathway Analysis tool was used to analyse the dataset (see Appendix 6.2 for 
full Reactome dataset). Results from this analysis show an enrichment of proteins 
involved in vesicle-mediated transport processes, including membrane trafficking, 
Golgi-to-ER retrograde transport and other transport-related processes (see Figure 
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6.9 A). The enrichment of proteins in this particular process is important as it is 
thought to be one of the main functional processes involved in the pathophysiology 
of HSPs. The pathway analysis tools, were unable to match 22 HSP proteins to any of 
the pre-defined Reactome pathways. 
 
Figure 6.9 
 
A 
 
 
 
 
 
 
 
 
 
 
 
 
B 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.9. Comparative pathway analysis of HSP seed 3 proteins and the predicted 
HSPome+ network proteins. Reactome pathway enrichment analysis was performed 
on (A) the HSP seed 3 list (83 proteins), and (B) the HSP interaction partners from the 
predicted HSPome+ network (3,074 proteins). In each case, enriched pathways are 
highlighted in yellow. 
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To understand more about the overall biological processes involved in HSP, the full 
set of HSP interaction partners identified in the HSPome+ network were 
subsequently analysed using Reactome and the results were compared with those 
obtained in the initial analysis (Figure 6.9). As a result, proteins involved in cell cycle, 
DNA replication, signal transduction and metabolism of proteins were found to be 
comparatively enriched in the HSPome+ network (Figure 6.9 B). Interestingly, there 
was also an enrichment of proteins involved in the immune system signalling, 
focusing on both adaptive and innate immune signalling, involving over 300 proteins, 
correlating well with results discussed in Chapter 5. Furthermore, upon closer 
inspection of the proteins implicated in the cell cycle and DNA replication, a number 
of proteins from each group were found to be involved in the immune system, more 
specifically NF-κB signalling.  
 
The Reactome pathway analysis tools, were however unable to match 610/ 3,074 
HSP interacting proteins to any of the pre-defined Reactome pathways. Moreover, 
232/ 610 were HSP interactors identified following the studies described in this 
thesis. Having identified a considerable number of potentially new HSP-related 
proteins it is therefore not surprising that a proportion of these are not already pre-
defined in Reactome pathways as they are novel and not previously annotated.  
 
6.5.3.2 PANTHER functional analysis 
 
The PANTHER (Protein ANalysis THrough Evolutionary Relationships) Classification 
System (www.pantherdb.org) is a freely available, manually curated bioinformatics 
resource, which was designed to classify proteins (and their genes) to facilitate large-
scale, high-throughput gene function analysis by combining gene function, ontology 
and pathway data (Mi et al., 2013). The entire HSPome+ protein interaction data was 
uploaded into PANTHER and analysed (see Appendix 6.3 for full PANTHER dataset). 
As shown in Figure 6.10, only gene ontology (GO) categories with a statistically 
significant p-value of <0.05 are displayed. 
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Figure 6.10 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.10. PANTHER functional GO term enrichment analysis. PANTHER gene 
function analysis was performed on HSP interaction partners identified in the 
HSPome+. The relative representation of cellular components (A), biological 
processes (B) or molecular functions (C) was compared. In each case, the numbers 
within each section of the pie chart represent the number of enriched proteins 
assigned to a given GO category.  
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The GO Cellular Component analysis (Figure 6.10 A) highlighted a significant 
proportion of proteins found to be enriched in the Cell Part (GO:0044464), which 
consisted mainly of cytoplasmic proteins and membrane-bound proteins, including 
ER-membrane network proteins. Organelle (GO:0043226) was the second largest 
category identified, and this was found to be predominantly composed of the nucleus 
and cytoskeleton.  
 
In addition to assessing the enrichment of ‘cellular component’ identifiers, proteins 
were also assessed for their involvement in GO Biological Processes (Figure 6.10 B). 
A large proportion of proteins were found to be associated with Cellular Processes 
(GO:0009987) such as ‘cell communication’, ‘cell growth’ and ‘cellular component 
movement’. A similar number of proteins were also associated with Metabolic 
Processes (GO:0008152). Interestingly, 250 proteins were enriched in Immune 
System Processes (GO:0002376), in particular ‘immune response’. 
 
Finally, proteins were annotated for GO Molecular Function (Figure 6.10 C). A large 
proportion of proteins were found to be involved in Binding (GO:0005488), and in 
particular ‘antigen binding’ and ‘nucleic acid binding’. Another, similarly enriched 
function was Catalytic Activity (GO:0003824), in particular ‘hydrolase activity’ and 
‘transferase activity’. Furthermore, there were over 250 proteins which were found 
to be enriched for Structural Molecule Activity (GO:0005198), and predominantly 
involved in the ‘structural constituent of the cytoskeleton’.  
 
The re-occurrence of pathways involving cytoskeletal dynamics and immune 
signalling in the results from different bioinformatics tools and databases provide an 
increase in confidence in the functional prediction/conclusions gathered following 
our targeted Y2H studies (as discussed in Chapters 4 and 5).  
 
6.5.4  Disease annotations 
 
Functional annotation using freely available bioinformatics resources, such as 
Reactome and PANTHER, can provide detailed information regarding the molecular 
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function of an individual protein and its interactors, as well as its role in an overall 
biological process. In addition, identification of diseases associated with HSP 
interaction partners may also provide further insight into the mechanism of 
development and progression of disease. 
 
6.5.4.1 MGI (Mouse Genome Informatics) 
 
MGI (Mouse Genome Informatics) is online laboratory mouse database which 
incorporates genomic, genetic and biological data to facilitate the study of human 
health and disease. MGI has a number of tools, including the Human – Mouse: 
Disease Connection (HMDC) tool, in which mouse mutation, phenotype and disease 
model data is integrated with human gene-to-disease relationships from the NCBI, 
Online Mendelian Inheritance in Man (OMIM), and the Human Phenotype Ontology 
(HPO), which allows the projection of human gene lists onto mouse phenotype and 
disease data. This tool generates a list of phenotypes and/or diseases associated with 
a particular gene, and the potential human relevance where applicable. 
 
The full list of interactors from the HSPome+ network (2,991) was uploaded onto MGI 
and analysed using the HMDC tool. The HSPome+ human gene IDs were converted 
into 4,106 mouse genes, of which 2,397 were associated with abnormal mouse 
phenotypes and more specifically 1,325/2,395 (55.28 %) were associated with 
defects in ‘behaviour/neurological’ or ‘nervous system’ (see Appendix 6.4 for full MGI 
analysis). There were also 627 human connected proteins associated with human 
diseases. Interestingly, the mouse-to human connections showed associations with 
several neurological disorders including, Alzheimer’s disease, amyotrophic lateral 
sclerosis (ALS) and Charcot-Marie-Tooth disease (CMT).  
 
To determine whether there was an inherent bias towards an abnormal neurological 
phenotype, we performed the same analysis on a ‘control’ set of 2,991 human gene 
IDs, which were randomly chosen from the Expanded Global network generated in 
Chapter 3 using the Excel RAND function. The randomly generated list of human gene 
IDs were converted into mouse genes and the percentage of the abnormal mouse 
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phenotypes, more specifically those associated with defects in 
‘behaviour/neurological’ or ‘nervous system’ was calculated as above (see Appendix 
6.4 for full MGI analysis). This was repeated in order for appropriate statistical 
analysis to be done, see Table 6.5 and 6.6.  
 
Table 6.5 
 n Mean Std. Deviation Std. Error Mean 
% 20 52.169 0.2675 0.0598 
 
Table 6.5. One-Sample Statistics. Basic statistical information about the selected 
variable, % of abnormal mouse phenotypes associated with defects in 
‘behaviour/neurological’ or ‘nervous system’, including sample size (n), mean, 
standard deviation and standard error. 
 
Table 6.6 
 Test Value = 55.28 % 
t df p-value Mean Difference 
% 52.0065 19 5.921E-22 -3.1 
 
Table 6.6. One-Sample Test. Displays the results most relevant to the One-Sample  
t Test, including the test statistic of the one-sample t test, denoted t, the degrees of 
freedom for the test (df = n-1), the two-tailed p-value corresponding to the test 
statistic and the mean difference. 
 
These results show that there is a high proportion of proteins associated with 
abnormal neurological phenotypes, which given the naturally large abundance of 
proteins expressed in the brain (Uhlen et al., 2015) would seem like a normal 
background reading. However, these results also show that there is a significant 
difference in the mean percentage of abnormal mouse phenotypes associated with 
defects in ‘behaviour/neurological’ or ‘nervous system’ between the randomly 
selected control samples and the HSPome+ (p < 0.001), which could suggest a 
potential role for the HSPome+ proteins in neurological disorders, and this may 
provide insight into the molecular mechanisms involved in HSP pathology. 
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The combined functional and disease annotation results provide potential insight 
into the physiological and pathophysiological processes potentially associated with 
HSP. Although these analysis tools generate predictions, they may provide new 
insight into the molecular mechanisms of HSP pathology, which could also be applied 
to future work and also to other axonopathy-related neurodegenerative diseases. 
 
6.6 Discussion 
 
The interaction partners identified in the various Y2H library screens are involved in 
a variety of cellular processes, including translational and transcriptional regulation. 
Some of these proteins are also involved in the pro-inflammatory NF-κB pathway, 
which could be significant given the strong evidence for functional crosstalk between 
innate inflammatory responses and neurodegeneration (Glass et al., 2010). In 
addition, many of the interacting proteins identified are involved in various aspects 
of ER dynamics, including the mechanisms underlying ER network formation. Several 
of these proteins were found to be participating in a network of interactions among 
HSP proteins involved in ER shaping (Figure 6.10 B), which further supports the 
hypothesis that abnormal ER morphology and distribution is a pathogenic 
mechanism in HSP and related neurologic disorders, such as amyotrophic lateral 
sclerosis (ALS) (Goyal and Blackstone, 2013).  
 
Neurodegeneration is a condition in which changes in neuronal structure and 
function lead to a decrease in neuronal survival and an increase in neuronal death in 
the CNS (Kempuraj et al., 2016). Despite the extensive heterogeneity associated with 
hereditary spastic paraplegia (HSP), there is a relatively small number of common 
pathogenic themes which link sets of HSP proteins to different function modules 
including endoplasmic reticulum (ER) shaping/distribution, mitochondrial function, 
myelination, lipid/cholesterol metabolism and endocytic sorting (Blackstone, O’Kane 
and Reid, 2011; Blackstone, 2012). 
 
The ER is a continuous membranous network comprising the nuclear envelope and a 
dynamic network of branched, highly curved tubules and peripheral sheet-like 
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cisternae, often studded with ribosomes, and distributed throughout the cytoplasm 
(Montenegro et al., 2012). Highly polarised cells such as neurons can be large and 
complex in nature, which can present issues for shaping and distribution of the ER 
network (Renvoisé and Blackstone, 2010). Disruption in the tubular ER network in 
cells has emerged as a key pathogenic theme in HSP (Blackstone, O’Kane and Reid, 
2011; Blackstone, 2012), indicating the importance of proper ER morphology and 
distribution, which likely plays an important role in neuronal maintenance (Renvoisé 
and Blackstone, 2010; Beetz, Johnson, et al., 2013). Protein synthesis, transport and 
quality control in the ER are well-studied, however, the mechanisms underlying the 
distinct ER architecture have only more recently emerged, with the identification of 
several protein families known to be involved (Park and Blackstone, 2010; Goyal and 
Blackstone, 2013). Significantly, many of the proteins involved are known to harbour 
autosomal dominant mutations associated with some of the most common forms of 
HSP: SPAST, ATL1 and REEP1 (spastin, atlastin-1, and REEP1 proteins, respectively) 
(Blackstone, O’Kane and Reid, 2011; Blackstone, 2012). 
 
The main ER-shaping protein families include the curvature-stabilizing reticulon and 
REEP/DP1/Yop1p families (Montenegro et al., 2012). Although these protein families, 
have little sequence homology, they do share common elongated hydrophobic 
segments, which are important for targeting to different ER domains and contribute 
to ER shaping (Voeltz et al., 2006; Ronchi et al., 2008). These segments are predicted 
to be partially membrane-spanning hairpin (or wedge) domains, which contribute to 
‘hydrophobic wedging’, thus inducing membrane curvature, as the majority of the 
hydrophobic segment is located in the outer leaflet of the membrane (Collins, 2006; 
Hu et al., 2008). These ER-shaping proteins are essential for generating and stabilising 
the high membrane curvature found in both ER tubules and sheets (Montenegro et 
al., 2012). In addition to producing highly-curved ER tubules, the ER-shaping reticulon 
and REEP/DP1/Ypo1p families also interact with the atlastin/RHD3/Sey1p family to 
mediate the formation of three-way junctions in the ER (Rismanchi et al., 2008; Hu 
et al., 2009), enabling the fusion of tubules required to generate the characteristic 
tubular ER network. The atlastin family of dynamin-related GTPases are large, 
multimeric, integral membrane proteins located mainly on highly-curved ER 
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membranes, which include ER tubules and sheets (Zhu et al., 2003; Rismanchi et al., 
2008; Hu et al., 2009).  
 
Furthermore, links between the microtubule cytoskeleton and ER proteins can 
provide additional information with regards to the overall distribution dynamics of 
the ER network (Goyal and Blackstone, 2013). Atlastins can also interact with the 
hydrophobic hairpin domain of the microtubule-severing AAA ATPase protein, 
spastin, located near the N-terminus of the larger isoform, M1 (Sanderson et al., 
2006; Park et al., 2010). Atlastins and M1 spastin, can also interact directly with 
REEPs/DP1 and reticulons in the tubular ER (Park et al., 2010). The human REEP 
family is composed of 6 members: REEP1-6, which can be divided into two 
structurally and phylogenetically distinct groups, comprising REEP1-4 and REEP5-6 
(Park et al., 2010). REEP1-4 are directly involved in ER shaping, like REEP5-6, however 
they are also involved in ER network remodelling as they can interact directly with 
microtubules through the C-terminal cytoplasmic domain (Park et al., 2010).  
 
Additionally, ZFYVE27 (protrudin), was more recently identified as a protein involved 
in the formation of the tubular ER, and like the reticulon and REEP/DP1/Yop1p 
families, it too has hydrophobic hairpins that generate high curvature in ER tubules. 
ZFYVE27 also interacts with other ER-shaping proteins such as REEP1, ATL1 (Chang et 
al., 2013) and SPAST (Mannan et al., 2006). In neurons, ER distribution is coupled to 
cytoskeletal dynamics, involving predominantly microtubules (Blackstone, O’Kane 
and Reid, 2011) and so it is therefore important that these co-ordinated interactions 
provide an insight into the potential mechanism for connecting ER membrane 
remodelling with cytoskeletal dynamics (Park et al., 2010). 
 
Understanding more about ER structural dynamics and its role in neurodegeneration 
will provide a greater insight into the mechanisms by which loss of ER-shaping 
proteins may give rise to neurodegeneration in HSPs and other neurodegenerative 
diseases. The HSPome+ network can be used as a resource to guide future 
hypothesis-driven research into the physiological mechanisms and functional 
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relevance of these interactions, providing a greater insight into the potential 
molecular mechanisms of HSP pathology.  
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Chapter 7: Discussion 
 
7.1 Introduction 
 
The study of protein-protein interactions is essential in understanding how biological 
processes work, since most proteins function as part of dynamic multi-protein 
complexes.  
 
Human disease is usually a result from the imposed perturbation of protein-protein 
interactions (PPIs), which confer a net functional change of various pathobiological 
processes within complex global interaction networks. Systematic network-based 
approaches to human disease, provides an unbiased mechanism to explore the 
detailed nature of physiological regulation, which may provide new insight into the 
identification of specific disease modules and pathways, identifying potential novel 
biomarkers and/or strategies for therapeutic intervention (Barabási, Gulbahce and 
Loscalzo, 2011). Traditionally, protein interactions were studied individually, through 
large numbers of relatively small-scale hypothesis-driven approaches (Ng et al., 
2003). However, technological advances in proteomics led to the rapid discovery of 
new proteins, which created a need for high-throughput “binary” and “non-binary” 
interaction detection methods for the identification of large numbers of protein-
protein interactions, such as yeast two-hybrid (Y2H) (Stelzl et al., 2005; Yu et al., 
2008) and affinity purification-mass spectrometry (AP/MS) approaches (Guruharsha 
et al., 2011). 
 
To date, several large-scale high-throughput studies have contributed to the increase 
in coverage of the human interactome. These include a high-throughput yeast two-
hybrid study conducted by Rolland et al. (2014), in which ~14,000 human binary 
protein-protein interactions were identified. More recently, an affinity purification-
mass spectrometry (AP/MS) approach identified interacting partners for 2,594 
human proteins, resulting in a network containing 23,744 interactions among 7,668 
human proteins, revealing complexes/clusters of functionally-related proteins 
(Huttlin et al., 2015). The majority of known binary protein-protein interactions are 
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identified using only a single detection method (Rolland et al., 2014), although using 
different detection methods generally produces complementary rather than 
redundant data (Zhao et al., 2005).  
 
Therefore, identifying proteins that either directly or indirectly interact with known 
HSP proteins, may identify new candidate genes for genetic screening, whilst also 
providing insights into the molecular mechanisms of HSP pathology. In this context, 
the main aim of this study was to systematically identify novel HSP interactions, 
which in conjunction with known interaction profiles could then be used to generate 
an extended high-confidence map of the human HSP interactome, thereby providing 
a resource to inform future hypothesis-driven research. 
 
7.2 Increased coverage of the human HSP network 
 
7.2.1 Binary protein-protein interactions (PPIs) 
 
To achieve this aim, a collection of human HSP open reading frames (ORFs) was 
generated. As described in Chapter 3, an initial search of public databases and 
literature was undertaken, identifying current HSP-encoding genes, resulting in an 
initial list of 58 putative HSP-related proteins, with unique gene identifiers, referred 
to as ‘HSP seed 1’ in this study. A final panel of 44 unique HSP ORFs were successfully 
cloned into the Gateway cloning system. These sequence-verified HSP ORFs were 
used to generate a collection of Y2H HSP bait (33) and HSP prey (24) clones, for use 
in high-throughput targeted yeast two-hybrid assays to investigate potential binary 
HSP:HSP protein interactions. Significantly, this targeted Y2H matrix mating approach 
identified 15 binary HSP:HSP interactions, 12 of which were novel (Chapter 4). 
 
In an attempt to identify new mechanisms of regulating the abundance or function 
of known HSP proteins, we also investigated the interaction of 33 Y2H HSP bait clones 
with an existing collection of 177 human RING E3 ligase (including 39 TM-RING-E3) 
prey clones. Results from targeted Y2H matrix mating assays identified 88 binary 
HSP:RING E3 ligase interactions, of which 86 were found to be novel. Additionally, 
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the interaction of 24 Y2H HSP prey clones with an existing collection of 59 
deubiquitinating enzymes (DUBs) bait clones, were also investigated. Results from 
these targeted Y2H matrix mating assays identified 15 binary HSP:DUB interactions, 
of which 13 of were novel (Chapter 5). 
 
Following targeted Y2H assays, a selection of 10 Y2H HSP bait constructs were 
successfully generated and individually screened against two, high complexity cDNA 
prey libraries. The combined results from these screens identified 89 potentially 
novel binary interactions, and 85 potentially novel HSP interaction partners. As a 
significant number of HSP proteins contain one or more transmembrane domain. The 
membrane yeast two-hybrid (MYTH) library system was employed to investigate the 
interaction profiles for 10 MYTH HSP bait constructs. Each of the MYTH bait 
constructs were individually screened against a human whole brain cDNA prey 
library, resulting in the identification of 195 potentially novel interactions and 124 
potentially novel HSP interactors (Chapter 6).  
  
7.2.2 Global HSP interactome  
 
In addition to generating a defined high-density binary HSP interaction network, it is 
also important to know which proteins may associate indirectly with known HSP 
proteins, as components of large multi-protein complexes. Therefore, all binary HSP 
interactions identified in this study were combined with the high-density, 
comprehensive interaction data of the initial HSPome, resulting in an ‘updated’ HSP 
network containing 4,688 interactions between 3,074 human proteins. This new 
high-density network, referred to as the HSPome+ network, represents an increase 
of >60 % in the number of direct (binary) HSP protein-protein interactions. This high-
density, comprehensive HSP interactome can be continually enriched with 
experimental interactions data and used to inform future hypothesis-driven 
research, as well as for the development of new strategies for therapeutic 
intervention.  
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7.3 Functional significance of novel HSP interactions 
 
As most proteins function as part of dynamic, multiprotein complexes, high-density 
protein-protein interaction maps can be used to facilitate the identification of 
common biological pathways, and potential pathophysiological mechanisms of 
disease (Vallabhajosyula et al., 2009).  
 
ER stress in neurodegenerative diseases 
The ongoing identification of HSP-associated loci/genes has been critical to our 
understanding of the clinical and pathological features of this group of disorders. 
HSP-related proteins are known to cluster into several functional subgroups or 
modules, with many HSP proteins functioning in more than one cellular process (as 
discussed in Chapter 1). Although the number of HSP-related pathogenic themes 
have evolved over time, it is thought that the largest group of HSP proteins involved 
in ER membrane trafficking and/or organelle morphogenesis and distribution 
(Blackstone, O’Kane and Reid, 2011). 
 
Most individuals with HSP are affected by autosomal dominant mutations (Salinas et 
al., 2008), which predominantly affect organelle dynamics, in particular the ER and 
ER morphology and distribution (Beetz et al., 2013). Interestingly, we identified links 
between several functionally-related cellular processes which also have the potential 
to affect the overall dynamics of the ER network. Therefore, if multiple HSP-related 
proteins are involved in ER network dynamics, it is pertinent to ask how 
abnormalities in this process might lead to a neurodegenerative HSP phenotype.  
 
The endoplasmic reticulum (ER) is a multifunctional organelle, which is also essential 
for the synthesis, modification, quality control and transport of integral membrane 
and secreted proteins (Oslowski and Urano, 2011). The ER is continuously monitoring 
protein folding and degradation, in order to avoid the accumulation of misfolded 
proteins (Vembar and Brodsky, 2008). The accumulation and aggregation of 
misfolded proteins is a common feature among neurodegenerative diseases such as 
Alzheimer’s disease (AD), Parkinson’s disease (PD), Huntington’s disease (HD) and 
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amyotrophic lateral sclerosis (ALS) (Kopito and Ron, 2000; Taylor, Hardy and 
Fischbeck, 2002; Selkoe, 2003; Soto and Estrada, 2008). The presence of misfolded 
proteins can trigger cellular stress responses, which activate the UPR, thereby 
protecting cells against the toxic build-up of misfolded proteins and maintaining 
normal biological processes within the brain during periods of cellular stress (Kopito, 
2000; Dobson, 2003; Rao and Bredesen, 2004). Accumulation of misfolded proteins 
in excessive amounts can overwhelm the ‘cellular quality control’ system and the 
prolonged stress observed in neurodegenerative diseases is thought to disrupt the 
protective mechanisms of the UPR. Failure of the UPR system to alleviate ER stress 
can result in chronic ER stress causing cell dysfunction and death through the 
activation of inflammation and apoptotic pathways, which promote neurotoxicity 
(Rao and Bredesen, 2004; Kim, Xu and Reed, 2008; Sprenkle et al., 2017). Therefore, 
understanding more about the role of ER stress in neurodegenerative diseases may 
provide a novel insight into disease mechanisms involved in the progressive axonal 
degeneration observed in HSPs and other neurodegenerative diseases, and 
identifying potentially novel therapeutic strategies for these disorders may be 
possible. 
 
In addition, it is significant to note that high-throughput interaction profiling 
performed in this study led to the identification of novel ‘edgetic’ effects within the 
HSP interactome. As a consequence, the re-structuring of the HSP protein interaction 
networks may confer changes in ER structure and/or function as well as associated 
cellular processes, which in turn may lead to increased levels of ER stress. 
Furthermore, this study identified interactions between several disease-associated 
mutant HSP proteins and HSPD1. HSPD1 is a highly conserved protein initially 
identified as a mitochondrial chaperone (Quintana and Cohen, 2011), which upon 
exposure to stress stimuli, functions as a signalling molecule in the immune system, 
activating both adaptive and innate immune responses (Landstein, Ulmansky and 
Naparstek, 2015), thereby highlighting a potential link between HSP, ER stress and 
the immune response. 
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ER stress-linked inflammation in neurodegenerative diseases 
Interestingly, we identified 37 RING E3 ligases and 9 DUBs, which interacted with 
various HSP-related proteins. Interrogation of the publicly available bioinformatics 
resource DAVID, provided functional data suggesting that immune response 
mechanisms, more specifically, ‘positive regulation of NF-kB signalling’, and UPR-
related processes, in particular ‘protein K48-linked ubiquitination’ were two 
significantly enriched functional clusters. At present, we can only speculate on the 
functional role that HSPs interacting with RING E3 ligases or DUBs may have. 
However, if HSP proteins are involved in ‘immune response mechanisms’ and ‘UPR-
related processes’, then this raises the question of how abnormalities in these 
processes lead to a neurodegenerative HSP phenotype. 
 
The unfolded protein response (UPR) has traditionally been viewed as a highly 
conserved, adaptive cellular response to ER stress, which is typically activated by an 
accumulation of unfolded or misfolded proteins. The UPR aims to reduce cellular 
stress and restore ER homeostasis by co-ordinating the expression of ER stress 
response signal transducers during ER stress (Oslowski and Urano, 2011; Walter and 
Ron, 2011). However, the UPR is also able to mediate inflammatory pathways 
essential for innate immune response. The UPR is able to activate several primary 
inflammatory signalling proteins, including the Mitogen Activated Protein Kinase 
(MAPK) family proteins: c-Jun N-terminal kinase (JNK) and p38, and the Nuclear 
Factor-kappa-light-chain-enhancer of activated B cells (NF-kB) (Sprenkle et al., 2017). 
NF-kB is a family of transcription factors which play a crucial role in the inflammatory 
response, regulating the expression of many inflammatory cytokines (Wang et al., 
2006; Ghosh and Hayden, 2008; Baltimore, 2009). Inflammation is an initial 
protective response of the innate immune system, carried out by different immune 
and inflammatory cells in order to repair, regenerate and remove damaged 
tissues/cells and harmful stimuli (Kulkarni et al., 2016). In the brain microglia are the 
main immune cells which constantly monitor the microenvironment and under 
physiological conditions, they remain in an ‘inactive’ state (Streit, 2002). However, in 
response to pathogens or tissue damage, they become ‘active’, promoting an 
inflammatory response (Glass et al., 2010).  
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In the absence of harmful stimuli, NF-kB resides in the cytoplasm where it is bound 
to a member of the family of inhibitors of NF-kB (IkB), which are constitutively 
expressed, thus NF-kB remains in an inactive state (Shih, Wang and Yang, 2015). 
Ubiquitin-mediated protein degradation has a regulatory role in both canonical and 
non-canonical NF-kB activation pathways. Abnormal activation occurs in many 
pathological conditions such as auto-inflammatory diseases (Iwai, 2012).  
 
Innate immune activation appears to be an important factor in the pathology of 
neurodegenerative diseases. The involvement of immunity was first described over 
20 years ago (McGeer et al., 1987; Griffin et al., 1989), however the potential 
consequences of inflammation in the pathogenesis of neurological disorders is a 
more recent development (Heneka, Kummer and Latz, 2014). In the CNS, 
neuroinflammation is the initial protective response mechanism carried out by 
microglia and astrocytes, to restore damaged glial cells and neuronal cells (Streit and 
Kincaid-Colton, 1995; Shabab et al., 2017). However, sustained or chronic microglial 
activation can promote a neurotoxic environment (Prinz and Priller, 2014; Sofroniew, 
2015). Abnormalities in UPR-mediated inflammatory pathways may lead to sustained 
neuroinflammation. Sustained or chronic neuroinflammation is considered to be a 
potential pathogenic factor contributing to neuronal dysfunction, injury and loss (and 
hence disease progression) in a number of neurodegenerative diseases, including 
Alzheimer’s disease (AD), Parkinson’s disease (PD), Multiple Sclerosis (MS) and 
amyotrophic lateral sclerosis (ALS) (Glass et al., 2010; Chen, Zhang and Huang, 2016; 
Kempuraj et al., 2016). 
 
ER stress and neuroinflammation are both pathological features observed in several 
neurodegenerative diseases, and whilst a connection between the two has been 
observed in a number of other diseases, including autoimmune disease (Li et al., 
2005; Gargalovic et al., 2006) and metabolic disorders (Ozcan et al., 2004, 2006), 
understanding of the mechanisms by which ER stress mediated neuroinflammation 
during neurodegeneration remains unclear. However, exploring the cross-talk 
between ER stress and inflammation may provide us with new insight into whether 
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targeting cellular stress pathways, such as ER stress in neurodegeneration, may 
contribute to the control of aberrant neuroinflammation, thereby contributing to 
neurological disorders (Sprenkle et al., 2017). 
 
7.4 Future directions 
 
The data presented in this study extends our understanding of the potential 
complexity of the human HSP interactome. However, there are still areas of data 
paucity. For example, 25 of the 83 known HSP-related proteins have not yet been 
systematically investigated. As these proteins were only discovered and/or assigned 
as HSP-related after the start of this study, they were not included in our initial high-
throughput Y2H screens, therefore these present as obvious candidates for future 
investigation. In addition, the 14 HSP proteins from the original ‘HSP seed 1’ list that 
were excluded due to size could be truncated and/or fragmented. Truncation and/or 
fragmentation studies would also be useful for further investigation, identifying 
specific domains and/or binding sites. 
 
Yeast two-hybrid is a powerful technique to assess binary protein-protein 
interactions. It is mainly used to obtain qualitative results, which in conjunction with 
other interaction data can be used to generate protein-protein interaction networks, 
a useful tool to inform future hypothesis-driven research. However, qualitative 
genetic and biochemical techniques like yeast two-hybrid or affinity purification-
based approaches do not reflect the cellular situation of the dynamic nature of many 
PPIs. To gain a better understanding of the complex cellular processes, not only do 
we need to know which proteins interact, but we also need to develop a more 
comprehensive understanding of the functional characteristics of a particular 
interaction. This can be done using quantitative PPI detection methods such as, 
Förster resonance energy transfer (FRET), fluorescence cross-correlation 
spectroscopy (FCCS) and dual luminescence-based co-immunoprecipitation (DULIP), 
which can provide quantitative information regarding the interaction strength 
(Buntru et al., 2016). It would therefore be advisable to expand the current analysis 
by performing a targeted secondary analysis of these putative interactions, to 
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confirm the physiological relevance of each interaction in mammalian cells using one 
of the techniques mentioned. 
 
ER stress and the UPR, are rapidly developing into an important area of research. 
There is growing evidence for the accumulation of misfolded and unfolded proteins, 
and the involvement of the UPR in several neurodegenerative diseases. Data 
presented in this study, also suggest the involvement of these processes in 
Hereditary Spastic Paraplegia. Although there is strong evidence for the occurrence 
of ER stress responses in neurodegenerative diseases, the exact role of ER stress and 
the importance of ER stress and UPR, in terms of the evolution of neurodegeneration, 
is not clear. To understand more about the role that ER stress may play in 
neurodegenerative disorders, including HSP, it will be important to target the UPR 
and the individual UPR master regulators: PERK, IRE1 and ATF6 using both 
pharmacological and genetic manipulation (Hetz and Mollereau, 2014). A logical 
initial step would be to characterise how the UPR is affected using an in vitro model 
of a particular HSP, possibly utilising a patient-derived stem cell model as described 
by Abrahamsen et al. (2013), which could be used to assess how the knockdown of 
each individual UPR master regulator affects cell fate. In addition, there are a number 
of different animal models available, including a number of mouse models 
representing different types of HSP (Ferreirinha et al., 2004; Tarrade et al., 2006; 
Beetz, Johnson, et al., 2013; Khundadze et al., 2013), which would facilitate our 
understanding of the phenotypic consequence of un-regulated UPR activity. If ER 
stress is the cause of neurodegeneration in HSP, this raises the possibility of 
developing new neuroprotective treatment strategies. 
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